<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg width="2400" height="2400" xmlns="http://www.w3.org/2000/svg" style="background-color:black">
<circle cx="1200" cy="1200" r="1052" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1028" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1026" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="175" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="173" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="161" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<text font-size="4.0em" x="50" y="60" fill="white">SARS-CoV-2 mutations 2020 timemap</text>
<text font-size="2.8em" x="50" y="105" fill="white">Genbank MN908947 vs 60,302 GISAID genomes</text>
<line x1="1200" y1="83.1314031180401" x2="1200" y2="133.13140311804" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1176" y="73.1314031180401" fill="white">Winter</text>
<line x1="2267" y1="1200" x2="2317" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="2267" y="1245" fill="white">Spring</text>
<line x1="1200" y1="2267" x2="1200" y2="2317" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1045" y="2352" fill="white">Summer</text>
<line x1="133" y1="1200" x2="73" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="59" y="1185" fill="white">Fall</text>
<g>	<title>orf1ab gene (21500-21555)</title>
	<line x1="1208" y1="1039" x2="1208" y2="1027" style="stroke:grey;stroke-width:8" />
</g><g>	<title>S gene (21563-25384)</title>
	<line x1="1208" y1="1025" x2="1208" y2="174" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF3a gene (25393-25500)</title>
	<line x1="1208" y1="172" x2="1208" y2="148" style="stroke:grey;stroke-width:8" />
</g><line x1="1200" y1="148.13140311804" x2="1200" y2="1039" style="stroke:white;stroke-width:3" />
<line x1="1204" y1="148.13140311804" x2="1210" y2="148.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="148.13140311804" x2="1215" y2="123.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1204" y1="1039" x2="1210" y2="1039" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="1039" x2="1215" y2="1064" style="stroke:white;stroke-width:2" />
<text font-size="2.0em" x="1215" y="123.13140311804" fill="white">25.5 kb</text>
<text font-size="2.0em" x="1215" y="1084" fill="white">21.5 kb</text>
<text font-size="2.5em" x="110" y="175" fill="white">Top countries</text>
<circle cx="60" cy="205" r="8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="215" fill="white">USA</text>
<circle cx="60" cy="235" r="8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="245" fill="white">Canada</text>
<circle cx="60" cy="265" r="8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="275" fill="white">Mexico</text>
<circle cx="60" cy="295" r="8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="305" fill="white">Costa Rica</text>
<circle cx="60" cy="325" r="8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="335" fill="white">Bermuda</text>
<circle cx="60" cy="355" r="8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="365" fill="white">Guatemala</text>
<circle cx="60" cy="385" r="8" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="395" fill="white">Guadeloupe</text>
<circle cx="60" cy="415" r="8" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="425" fill="white">Aruba</text>
<circle cx="60" cy="445" r="8" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="455" fill="white">Puerto Rico</text>
<circle cx="60" cy="475" r="8" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="485" fill="white">Jamaica</text>
<circle cx="280" cy="205" r="8" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="215" fill="white">Belize</text>
<circle cx="280" cy="235" r="8" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="245" fill="white">El Salvador</text>
<circle cx="280" cy="265" r="8" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="275" fill="white">Dominican Rep.</text>
<circle cx="280" cy="295" r="8" style="fill:#b2df8a;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="305" fill="white">Cuba</text>
<circle cx="280" cy="325" r="8" style="fill:#CC00FF;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="335" fill="white">Panama</text>
<circle cx="60" cy="530" r="1.20411998265592" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="101" cy="530" r="4" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="142" cy="530" r="8" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="183" cy="530" r="12" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="224" cy="530" r="16" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<text font-size="2.0em" x="50" y="575" fill="white">2      10        100        1k        10k</text>
<text font-size="2.0em" x="50" y="605" fill="white">genome samples</text>
<g>
	<title>2020-01-19 USA: 2 samples</title>
	<line x1="1206.5" y1="1181.1" x2="1207.2" y2="1179.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-01-22 USA: 2 samples</title>
	<line x1="1207.5" y1="1181.5" x2="1208.3" y2="1179.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-01-23 Canada: 2 samples</title>
	<line x1="1207.8" y1="1181.6" x2="1208.7" y2="1179.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-01-25 USA: 2 samples</title>
	<line x1="1208.5" y1="1181.9" x2="1209.4" y2="1179.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-01-29 USA: 4 samples</title>
	<line x1="1209.7" y1="1182.5" x2="1211.2" y2="1179.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-17 USA: 8 samples</title>
	<line x1="1214.9" y1="1186.6" x2="1218.1" y2="1183.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-18 USA: 6 samples</title>
	<line x1="1215.1" y1="1186.9" x2="1218.0" y2="1184.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-20 USA: 2 samples</title>
	<line x1="1215.5" y1="1187.4" x2="1217.2" y2="1186.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-21 USA: 7 samples</title>
	<line x1="1215.8" y1="1187.7" x2="1219.0" y2="1185.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-22 USA: 2 samples</title>
	<line x1="1216.0" y1="1188.0" x2="1217.7" y2="1186.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-24 USA: 6 samples</title>
	<line x1="1216.4" y1="1188.5" x2="1219.5" y2="1186.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-25 USA: 2 samples</title>
	<line x1="1216.6" y1="1188.8" x2="1218.4" y2="1187.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-26 USA: 5 samples</title>
	<line x1="1216.8" y1="1189.1" x2="1219.7" y2="1187.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-27 USA: 9 samples</title>
	<line x1="1217.0" y1="1189.4" x2="1220.8" y2="1187.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-28 USA: 21 samples</title>
	<line x1="1217.1" y1="1189.7" x2="1222.3" y2="1186.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-28  A23403G  USA=2 [9.5%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="898.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-02-29 USA: 34 samples</title>
	<line x1="1217.3" y1="1190.0" x2="1223.3" y2="1186.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-29  C21774T  USA=2 [5.9%]  surface glycoprotein, S71F</title>
	<circle cx="1392.7" cy="1088.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-02-29  T23010C  USA=2 [5.9%]  surface glycoprotein, V483A</title>
	<circle cx="1631.1" cy="951.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-02-29  A23403G  USA=4 [11.8%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="907.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-01 USA: 20 samples</title>
	<line x1="1217.5" y1="1190.3" x2="1222.7" y2="1187.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-01 Canada: 5 samples</title>
	<line x1="1222.7" y1="1187.4" x2="1225.8" y2="1185.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-01  A23403G  USA=3 [15.0%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="916.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-01  A23403G  USA=3 [15.0%] Canada=2 [40.0%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="916.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-02 USA: 34 samples</title>
	<line x1="1217.7" y1="1190.6" x2="1223.8" y2="1187.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-02  G22988A  USA=2 [5.9%]  surface glycoprotein, G476S</title>
	<circle cx="1635.2" cy="968.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-02  T23010C  USA=4 [11.8%]  surface glycoprotein, V483A</title>
	<circle cx="1639.5" cy="966.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-02  A23403G  USA=7 [20.6%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="925.2" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-03 USA: 33 samples</title>
	<line x1="1217.8" y1="1190.9" x2="1224.0" y2="1187.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-03 Canada: 2 samples</title>
	<line x1="1224.0" y1="1187.8" x2="1225.9" y2="1186.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-03  A23403G  USA=8 [24.2%]  surface glycoprotein, D614G</title>
	<circle cx="1721.5" cy="934.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-04 USA: 48 samples</title>
	<line x1="1218.0" y1="1191.2" x2="1224.8" y2="1187.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-04 Canada: 2 samples</title>
	<line x1="1224.8" y1="1187.9" x2="1226.7" y2="1187.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-04  A23403G  USA=25 [52.1%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="943.4" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-05 USA: 79 samples</title>
	<line x1="1218.1" y1="1191.5" x2="1225.9" y2="1187.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-05 Canada: 5 samples</title>
	<line x1="1225.9" y1="1187.9" x2="1229.1" y2="1186.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-05  T23010C  USA=5 [6.3%]  surface glycoprotein, V483A</title>
	<circle cx="1651.1" cy="989.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-05  A23403G  USA=23 [29.1%]  surface glycoprotein, D614G</title>
	<circle cx="1730.5" cy="952.6" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-06 USA: 62 samples</title>
	<line x1="1218.3" y1="1191.9" x2="1225.7" y2="1188.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-06 Costa Rica: 2 samples</title>
	<line x1="1225.7" y1="1188.6" x2="1227.6" y2="1187.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-06  A23403G  USA=36 [58.1%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="961.9" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-06  A23403G  USA=36 [58.1%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="961.9" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-07 USA: 72 samples</title>
	<line x1="1218.4" y1="1192.2" x2="1226.1" y2="1188.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-07  G22335T  USA=2 [2.8%]  surface glycoprotein, W258L</title>
	<circle cx="1519.8" cy="1064.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-07  A23403G  USA=46 [63.9%]  surface glycoprotein, D614G</title>
	<circle cx="1738.8" cy="971.3" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-08 USA: 76 samples</title>
	<line x1="1218.5" y1="1192.5" x2="1226.4" y2="1189.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-08  A23403G  USA=45 [59.2%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="980.7" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-09 USA: 113 samples</title>
	<line x1="1218.7" y1="1192.8" x2="1227.3" y2="1189.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-09 Canada: 5 samples</title>
	<line x1="1227.3" y1="1189.5" x2="1230.6" y2="1188.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-09  A23403G  USA=73 [64.6%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="990.2" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-09  G23755T  USA=2 [1.8%]  surface glycoprotein, M731I</title>
	<circle cx="1819.6" cy="962.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-09  C23997T  USA=3 [2.7%]  surface glycoprotein, P812L</title>
	<circle cx="1869.9" cy="942.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-10 USA: 123 samples</title>
	<line x1="1218.8" y1="1193.2" x2="1227.6" y2="1189.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-10 Canada: 15 samples</title>
	<line x1="1227.6" y1="1189.9" x2="1232.7" y2="1188.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-10 Mexico: 2 samples</title>
	<line x1="1232.7" y1="1188.1" x2="1234.8" y2="1187.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-10  A23403G  USA=71 [57.7%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="999.8" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-10  A23403G  Canada=7 [46.7%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="999.8" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-10  C25469T  USA=3 [2.4%]  ORF3a protein, S26L</title>
	<circle cx="2182.4" cy="842.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11 USA: 145 samples</title>
	<line x1="1218.9" y1="1193.5" x2="1228.1" y2="1190.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11 Canada: 19 samples</title>
	<line x1="1228.1" y1="1190.3" x2="1233.7" y2="1188.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11 Mexico: 2 samples</title>
	<line x1="1233.7" y1="1188.4" x2="1235.7" y2="1187.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11 Costa Rica: 2 samples</title>
	<line x1="1235.7" y1="1187.7" x2="1237.7" y2="1187.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11 Jamaica: 2 samples</title>
	<line x1="1237.7" y1="1187.0" x2="1239.7" y2="1186.3" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11  C21575T  USA=3 [2.1%]  surface glycoprotein, L5F</title>
	<circle cx="1368.5" cy="1142.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11  C21638T  Costa Rica=2 [100.0%]  surface glycoprotein, P26S</title>
	<circle cx="1381.7" cy="1137.4" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11  A23403G  USA=85 [58.6%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1009.4" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11  A23403G  Canada=9 [47.4%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1009.4" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11  A23403G  Canada=9 [47.4%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1009.4" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11  C23987T  USA=2 [1.4%]  surface glycoprotein, P809S</title>
	<circle cx="1876.4" cy="967.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11  G24077T  USA=3 [2.1%]  surface glycoprotein, D839Y</title>
	<circle cx="1895.3" cy="960.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11  G25429T  USA=2 [1.4%]  ORF3a protein, V13L</title>
	<circle cx="2180.1" cy="862.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12 USA: 259 samples</title>
	<line x1="1219.0" y1="1193.8" x2="1229.4" y2="1190.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-12 Canada: 30 samples</title>
	<line x1="1229.4" y1="1190.5" x2="1235.7" y2="1188.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-12 Mexico: 8 samples</title>
	<line x1="1235.7" y1="1188.4" x2="1239.8" y2="1187.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-12  C21575T  USA=2 [0.8%]  surface glycoprotein, L5F</title>
	<circle cx="1369.5" cy="1144.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  C21707T  Mexico=3 [37.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1397.4" cy="1135.9" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  T23010C  USA=7 [2.7%]  surface glycoprotein, V483A</title>
	<circle cx="1673.4" cy="1046.2" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  A23403G  USA=157 [60.6%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1019.1" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  A23403G  USA=157 [60.6%] Canada=25 [83.3%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1019.1" r="5.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  A23403G  Mexico=2 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1019.1" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  G25337T  Mexico=2 [25.0%]  surface glycoprotein, D1259Y</title>
	<circle cx="2166.3" cy="886.0" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  G25429T  USA=2 [0.8%]  ORF3a protein, V13L</title>
	<circle cx="2185.8" cy="879.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12  C25433T  Canada=3 [10.0%]  ORF3a protein, T14I</title>
	<circle cx="2186.6" cy="879.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13 USA: 438 samples</title>
	<line x1="1219.1" y1="1194.2" x2="1230.5" y2="1190.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-13 Canada: 35 samples</title>
	<line x1="1230.5" y1="1190.7" x2="1237.2" y2="1188.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-13  C21575T  USA=4 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1370.4" cy="1147.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13  C21614T  USA=2 [0.5%]  surface glycoprotein, L18F</title>
	<circle cx="1378.7" cy="1145.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13  T21995C  USA=2 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1459.8" cy="1120.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13  G23120T  USA=2 [0.5%]  surface glycoprotein, A520S</title>
	<circle cx="1699.5" cy="1047.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13  A23403G  USA=253 [57.8%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1028.9" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13  A23403G  USA=253 [57.8%] Canada=25 [71.4%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1028.9" r="5.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13  G24794T  USA=3 [0.7%]  surface glycoprotein, A1078S</title>
	<circle cx="2056.0" cy="938.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14 USA: 438 samples</title>
	<line x1="1219.2" y1="1194.5" x2="1230.7" y2="1191.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-14 Canada: 35 samples</title>
	<line x1="1230.7" y1="1191.2" x2="1237.4" y2="1189.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-14 Mexico: 2 samples</title>
	<line x1="1237.4" y1="1189.3" x2="1239.5" y2="1188.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-14 Costa Rica: 4 samples</title>
	<line x1="1239.5" y1="1188.7" x2="1242.5" y2="1187.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-14 Guadeloupe: 2 samples</title>
	<line x1="1242.5" y1="1187.8" x2="1244.5" y2="1187.2" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-14  C21575T  USA=3 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1371.3" cy="1150.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14  G22988A  USA=2 [0.5%]  surface glycoprotein, G476S</title>
	<circle cx="1673.8" cy="1064.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14  A23403G  USA=315 [71.9%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1038.7" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14  A23403G  USA=315 [71.9%] Canada=31 [88.6%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1038.7" r="6.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14  A23403G  USA=315 [71.9%] Canada=31 [88.6%] Costa Rica=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1038.7" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14  A23403G  USA=315 [71.9%] Canada=31 [88.6%] Costa Rica=4 [100.0%] Guadeloupe=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1038.7" r="1.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14  A23403G  USA=315 [71.9%] Canada=31 [88.6%] Costa Rica=4 [100.0%] Guadeloupe=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1038.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14  G24794T  USA=3 [0.7%]  surface glycoprotein, A1078S</title>
	<circle cx="2060.4" cy="953.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15 USA: 530 samples</title>
	<line x1="1219.3" y1="1194.8" x2="1231.2" y2="1191.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15 Canada: 23 samples</title>
	<line x1="1231.2" y1="1191.6" x2="1237.2" y2="1190.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15 Mexico: 2 samples</title>
	<line x1="1237.2" y1="1190.0" x2="1239.2" y2="1189.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15 Costa Rica: 3 samples</title>
	<line x1="1239.2" y1="1189.5" x2="1241.9" y2="1188.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15 Guatemala: 4 samples</title>
	<line x1="1241.9" y1="1188.8" x2="1244.9" y2="1188.0" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15 Guadeloupe: 3 samples</title>
	<line x1="1244.9" y1="1188.0" x2="1247.5" y2="1187.3" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15  G23311T  USA=2 [0.4%]  surface glycoprotein, E583D</title>
	<circle cx="1745.6" cy="1053.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15  A23403G  USA=392 [74.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="10.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15  A23403G  USA=392 [74.0%] Canada=19 [82.6%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="5.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15  A23403G  USA=392 [74.0%] Canada=19 [82.6%] Guatemala=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="2.4" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15  A23403G  USA=392 [74.0%] Canada=19 [82.6%] Guatemala=4 [100.0%] Guadeloupe=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="1.9" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15  A23403G  USA=392 [74.0%] Canada=19 [82.6%] Guatemala=4 [100.0%] Guadeloupe=3 [100.0%] Costa Rica=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15  A23403G  USA=392 [74.0%] Canada=19 [82.6%] Guatemala=4 [100.0%] Guadeloupe=3 [100.0%] Costa Rica=3 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16 USA: 793 samples</title>
	<line x1="1219.4" y1="1195.2" x2="1232.1" y2="1192.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16 Canada: 27 samples</title>
	<line x1="1232.1" y1="1192.0" x2="1238.4" y2="1190.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16 Mexico: 3 samples</title>
	<line x1="1238.4" y1="1190.4" x2="1241.0" y2="1189.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16 Costa Rica: 3 samples</title>
	<line x1="1241.0" y1="1189.8" x2="1243.6" y2="1189.1" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16 Guadeloupe: 2 samples</title>
	<line x1="1243.6" y1="1189.1" x2="1245.7" y2="1188.6" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16 Jamaica: 3 samples</title>
	<line x1="1245.7" y1="1188.6" x2="1248.4" y2="1187.9" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16  C21575T  USA=8 [1.0%]  surface glycoprotein, L5F</title>
	<circle cx="1372.9" cy="1156.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  C21614T  USA=2 [0.3%]  surface glycoprotein, L18F</title>
	<circle cx="1381.3" cy="1154.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  G21641T  Canada=2 [7.4%]  surface glycoprotein, A27S</title>
	<circle cx="1387.1" cy="1153.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  C21648T  USA=2 [0.3%]  surface glycoprotein, T29I</title>
	<circle cx="1388.7" cy="1153.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  T21995C  USA=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1463.6" cy="1134.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A22005G  USA=2 [0.3%]  surface glycoprotein, N148S</title>
	<circle cx="1465.8" cy="1133.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  T23010C  USA=6 [0.8%]  surface glycoprotein, V483A</title>
	<circle cx="1683.0" cy="1079.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A23403G  USA=572 [72.1%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="11.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A23403G  USA=572 [72.1%] Canada=21 [77.8%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A23403G  USA=572 [72.1%] Canada=21 [77.8%] Costa Rica=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A23403G  USA=572 [72.1%] Canada=21 [77.8%] Costa Rica=3 [100.0%] Guadeloupe=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="1.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A23403G  Jamaica=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="1.2" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  G23587C  USA=2 [0.3%]  surface glycoprotein, Q675H</title>
	<circle cx="1807.7" cy="1048.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  C24237T  USA=2 [0.3%]  surface glycoprotein, A892V</title>
	<circle cx="1948.1" cy="1013.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17 USA: 656 samples</title>
	<line x1="1219.5" y1="1195.5" x2="1231.8" y2="1192.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17 Canada: 25 samples</title>
	<line x1="1231.8" y1="1192.6" x2="1238.0" y2="1191.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17 Guadeloupe: 3 samples</title>
	<line x1="1238.0" y1="1191.2" x2="1240.7" y2="1190.6" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17  C21575T  USA=3 [0.5%]  surface glycoprotein, L5F</title>
	<circle cx="1373.6" cy="1159.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  C22224T  USA=3 [0.5%]  surface glycoprotein, S221L</title>
	<circle cx="1514.4" cy="1127.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  C22986T  USA=2 [0.3%]  surface glycoprotein, A475V</title>
	<circle cx="1679.8" cy="1089.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  T23010C  USA=2 [0.3%]  surface glycoprotein, V483A</title>
	<circle cx="1685.0" cy="1088.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  A23403G  USA=496 [75.6%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1068.3" r="10.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  A23403G  USA=496 [75.6%] Canada=20 [80.0%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1068.3" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  A23403G  USA=496 [75.6%] Canada=20 [80.0%] Guadeloupe=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1068.3" r="1.9" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  C23625T  USA=2 [0.3%]  surface glycoprotein, A688V</title>
	<circle cx="1818.5" cy="1057.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  C24795T  USA=2 [0.3%]  surface glycoprotein, A1078V</title>
	<circle cx="2072.4" cy="998.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  G25429T  USA=3 [0.5%]  ORF3a protein, V13L</title>
	<circle cx="2210.0" cy="966.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  G25471T  USA=2 [0.3%]  ORF3a protein, D27Y</title>
	<circle cx="2219.1" cy="964.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18 USA: 666 samples</title>
	<line x1="1219.6" y1="1195.8" x2="1232.0" y2="1193.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18 Canada: 25 samples</title>
	<line x1="1232.0" y1="1193.2" x2="1238.2" y2="1191.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18 Costa Rica: 3 samples</title>
	<line x1="1238.2" y1="1191.9" x2="1240.9" y2="1191.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18  C21575T  USA=3 [0.5%]  surface glycoprotein, L5F</title>
	<circle cx="1374.3" cy="1163.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  C21614T  USA=3 [0.5%]  surface glycoprotein, L18F</title>
	<circle cx="1382.8" cy="1161.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  C21648T  USA=2 [0.3%]  surface glycoprotein, T29I</title>
	<circle cx="1390.2" cy="1159.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  C21774T  USA=2 [0.3%]  surface glycoprotein, S71F</title>
	<circle cx="1417.6" cy="1153.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  T21995C  USA=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1465.8" cy="1143.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  A23403G  USA=514 [77.2%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1078.3" r="10.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  A23403G  USA=514 [77.2%] Canada=20 [80.0%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1078.3" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  A23403G  USA=514 [77.2%] Canada=20 [80.0%] Costa Rica=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1078.3" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  C23453T  USA=2 [0.3%]  surface glycoprotein, P631S</title>
	<circle cx="1783.4" cy="1076.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  C25463T  USA=2 [0.3%]  ORF3a protein, T24I</title>
	<circle cx="2221.3" cy="982.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19 USA: 516 samples</title>
	<line x1="1219.6" y1="1196.2" x2="1231.6" y2="1193.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-19 Canada: 25 samples</title>
	<line x1="1231.6" y1="1193.9" x2="1237.9" y2="1192.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-19 Costa Rica: 2 samples</title>
	<line x1="1237.9" y1="1192.6" x2="1240.0" y2="1192.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-19  T21698G  USA=2 [0.4%]  surface glycoprotein, S46A</title>
	<circle cx="1401.8" cy="1160.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  T21995C  USA=2 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1466.7" cy="1148.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  G22335T  USA=2 [0.4%]  surface glycoprotein, W258L</title>
	<circle cx="1541.1" cy="1133.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  G23120T  USA=3 [0.6%]  surface glycoprotein, A520S</title>
	<circle cx="1712.7" cy="1100.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  A23403G  USA=380 [73.6%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1088.3" r="10.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  A23403G  USA=380 [73.6%] Canada=18 [72.0%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1088.3" r="5.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  A23403G  USA=380 [73.6%] Canada=18 [72.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1088.3" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  G24926T  Canada=2 [8.0%]  surface glycoprotein, V1122L</title>
	<circle cx="2107.5" cy="1023.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  G25217A  USA=2 [0.4%]  surface glycoprotein, G1219S</title>
	<circle cx="2171.1" cy="1011.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  C25418T  USA=2 [0.4%]  ORF3a protein, T9I</title>
	<circle cx="2215.1" cy="1002.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  G25429T  USA=2 [0.4%]  ORF3a protein, V13L</title>
	<circle cx="2217.5" cy="1002.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20 USA: 428 samples</title>
	<line x1="1219.7" y1="1196.5" x2="1231.4" y2="1194.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20 Canada: 43 samples</title>
	<line x1="1231.4" y1="1194.5" x2="1238.6" y2="1193.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20 Mexico: 3 samples</title>
	<line x1="1238.6" y1="1193.2" x2="1241.3" y2="1192.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20 Costa Rica: 4 samples</title>
	<line x1="1241.3" y1="1192.7" x2="1244.4" y2="1192.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20 Aruba: 2 samples</title>
	<line x1="1244.4" y1="1192.2" x2="1246.5" y2="1191.8" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20  C21575T  USA=5 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1375.5" cy="1169.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  G21746C  Canada=2 [4.7%]  surface glycoprotein, V62L</title>
	<circle cx="1413.0" cy="1162.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  A23403G  USA=322 [75.2%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  A23403G  USA=322 [75.2%] Canada=35 [81.4%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="6.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  A23403G  Costa Rica=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  A23403G  Costa Rica=3 [75.0%] Aruba=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  A23403G  Mexico=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  G25429T  Canada=2 [4.7%]  ORF3a protein, V13L</title>
	<circle cx="2220.8" cy="1020.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21 USA: 317 samples</title>
	<line x1="1219.8" y1="1196.9" x2="1230.9" y2="1195.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-21 Canada: 64 samples</title>
	<line x1="1230.9" y1="1195.1" x2="1238.9" y2="1193.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-21 Costa Rica: 2 samples</title>
	<line x1="1238.9" y1="1193.8" x2="1241.1" y2="1193.5" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-21  C21575T  Canada=2 [3.1%]  surface glycoprotein, L5F</title>
	<circle cx="1376.0" cy="1172.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  C21648T  USA=2 [0.6%]  surface glycoprotein, T29I</title>
	<circle cx="1392.0" cy="1169.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  A23403G  USA=243 [76.7%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1108.4" r="9.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  A23403G  USA=243 [76.7%] Canada=56 [87.5%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1108.4" r="7.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  A23403G  USA=243 [76.7%] Canada=56 [87.5%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1108.4" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22 USA: 262 samples</title>
	<line x1="1219.8" y1="1197.2" x2="1230.6" y2="1195.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22 Canada: 89 samples</title>
	<line x1="1230.6" y1="1195.7" x2="1239.3" y2="1194.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22 Mexico: 4 samples</title>
	<line x1="1239.3" y1="1194.5" x2="1242.4" y2="1194.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22 Guadeloupe: 4 samples</title>
	<line x1="1242.4" y1="1194.0" x2="1245.5" y2="1193.6" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22  C21575T  USA=4 [1.5%]  surface glycoprotein, L5F</title>
	<circle cx="1376.4" cy="1175.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  A23403G  USA=214 [81.7%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1118.5" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  A23403G  USA=214 [81.7%] Canada=77 [86.5%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1118.5" r="7.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  A23403G  USA=214 [81.7%] Canada=77 [86.5%] Guadeloupe=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1118.5" r="2.4" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  A23403G  USA=214 [81.7%] Canada=77 [86.5%] Guadeloupe=4 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1118.5" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  G25217T  Canada=2 [2.2%]  surface glycoprotein, G1219C</title>
	<circle cx="2179.7" cy="1062.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  C25433T  Canada=3 [3.4%]  ORF3a protein, T14I</title>
	<circle cx="2227.3" cy="1055.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23 USA: 396 samples</title>
	<line x1="1219.9" y1="1197.6" x2="1231.5" y2="1196.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-23 Canada: 96 samples</title>
	<line x1="1231.5" y1="1196.1" x2="1240.3" y2="1195.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-23 Guadeloupe: 2 samples</title>
	<line x1="1240.3" y1="1195.0" x2="1242.5" y2="1194.8" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-23 Puerto Rico: 5 samples</title>
	<line x1="1242.5" y1="1194.8" x2="1245.9" y2="1194.4" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-23  C21575T  USA=3 [0.8%]  surface glycoprotein, L5F</title>
	<circle cx="1376.8" cy="1178.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  C21767T  USA=2 [0.5%]  surface glycoprotein, H69Y</title>
	<circle cx="1419.3" cy="1173.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  G21986A  USA=2 [0.5%]  surface glycoprotein, G142S</title>
	<circle cx="1467.7" cy="1167.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  A23403G  USA=311 [78.5%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1128.7" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  A23403G  USA=311 [78.5%] Canada=81 [84.4%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1128.7" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  A23403G  Puerto Rico=3 [60.0%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1128.7" r="1.9" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  A23403G  Puerto Rico=3 [60.0%] Guadeloupe=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1128.7" r="1.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  G25217T  Canada=5 [5.2%]  surface glycoprotein, G1219C</title>
	<circle cx="2181.9" cy="1079.4" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  C25418A  USA=2 [0.5%]  ORF3a protein, T9K</title>
	<circle cx="2226.4" cy="1074.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  C25433T  Canada=7 [7.3%]  ORF3a protein, T14I</title>
	<circle cx="2229.7" cy="1073.6" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24 USA: 405 samples</title>
	<line x1="1219.9" y1="1197.9" x2="1231.6" y2="1196.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24 Canada: 69 samples</title>
	<line x1="1231.6" y1="1196.7" x2="1239.8" y2="1195.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24 Mexico: 3 samples</title>
	<line x1="1239.8" y1="1195.8" x2="1242.5" y2="1195.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24 Puerto Rico: 3 samples</title>
	<line x1="1242.5" y1="1195.5" x2="1245.2" y2="1195.2" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24  C21575T  USA=3 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1377.2" cy="1181.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  C21648T  USA=2 [0.5%]  surface glycoprotein, T29I</title>
	<circle cx="1393.4" cy="1179.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  T23010C  USA=2 [0.5%]  surface glycoprotein, V483A</title>
	<circle cx="1695.0" cy="1148.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  A23403G  USA=315 [77.8%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  A23403G  USA=315 [77.8%] Canada=60 [87.0%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  A23403G  Puerto Rico=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  A23403G  Puerto Rico=2 [66.7%] Mexico=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  G25217T  Canada=3 [4.3%]  surface glycoprotein, G1219C</title>
	<circle cx="2183.9" cy="1096.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  C25433T  Canada=5 [7.2%]  ORF3a protein, T14I</title>
	<circle cx="2231.7" cy="1091.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25 USA: 432 samples</title>
	<line x1="1219.9" y1="1198.3" x2="1231.7" y2="1197.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25 Canada: 80 samples</title>
	<line x1="1231.7" y1="1197.2" x2="1240.3" y2="1196.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25 Costa Rica: 2 samples</title>
	<line x1="1240.3" y1="1196.5" x2="1242.4" y2="1196.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25  C21575T  USA=5 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1377.5" cy="1184.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  C21767T  USA=2 [0.5%]  surface glycoprotein, H69Y</title>
	<circle cx="1420.1" cy="1180.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  T21995C  Canada=3 [3.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1470.7" cy="1176.3" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  A23403G  USA=330 [76.4%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1149.0" r="10.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  A23403G  USA=330 [76.4%] Canada=69 [86.2%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1149.0" r="7.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  A23403G  USA=330 [76.4%] Canada=69 [86.2%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1149.0" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  C23453T  USA=2 [0.5%]  surface glycoprotein, P631S</title>
	<circle cx="1794.2" cy="1148.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  C24795T  USA=5 [1.2%]  surface glycoprotein, A1078V</title>
	<circle cx="2091.9" cy="1122.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  G25217T  Canada=2 [2.5%]  surface glycoprotein, G1219C</title>
	<circle cx="2185.5" cy="1113.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  T25272C  Canada=2 [2.5%]  surface glycoprotein, M1237T</title>
	<circle cx="2197.7" cy="1112.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  C25433T  Canada=5 [6.2%]  ORF3a protein, T14I</title>
	<circle cx="2233.5" cy="1109.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26 USA: 408 samples</title>
	<line x1="1220.0" y1="1198.6" x2="1231.7" y2="1197.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26 Canada: 65 samples</title>
	<line x1="1231.7" y1="1197.8" x2="1239.8" y2="1197.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26 Guadeloupe: 2 samples</title>
	<line x1="1239.8" y1="1197.2" x2="1242.0" y2="1197.1" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26  C21575T  USA=5 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1377.7" cy="1187.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  G21604T  USA=2 [0.5%]  surface glycoprotein, Q14H</title>
	<circle cx="1384.2" cy="1187.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  G22988A  USA=2 [0.5%]  surface glycoprotein, G476S</title>
	<circle cx="1691.7" cy="1165.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  A23403G  USA=321 [78.7%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1159.2" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  A23403G  USA=321 [78.7%] Canada=58 [89.2%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1159.2" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  A23403G  USA=321 [78.7%] Canada=58 [89.2%] Guadeloupe=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1159.2" r="1.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C23525T  USA=2 [0.5%]  surface glycoprotein, H655Y</title>
	<circle cx="1811.0" cy="1157.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C24138T  USA=2 [0.5%]  surface glycoprotein, T859I</title>
	<circle cx="1947.2" cy="1147.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C24378T  USA=3 [0.7%]  surface glycoprotein, S939F</title>
	<circle cx="2000.5" cy="1144.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  G25217T  Canada=6 [9.2%]  surface glycoprotein, G1219C</title>
	<circle cx="2186.9" cy="1131.0" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C25433T  Canada=7 [10.8%]  ORF3a protein, T14I</title>
	<circle cx="2234.9" cy="1127.6" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C25433T  USA=2 [0.5%]  ORF3a protein, T14I</title>
	<circle cx="2234.9" cy="1127.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C25466T  USA=2 [0.5%]  ORF3a protein, P25L</title>
	<circle cx="2242.2" cy="1127.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27 USA: 425 samples</title>
	<line x1="1220.0" y1="1199.0" x2="1231.8" y2="1198.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27 Canada: 94 samples</title>
	<line x1="1231.8" y1="1198.3" x2="1240.7" y2="1197.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27  C21575T  USA=5 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1377.9" cy="1190.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  C21648T  USA=2 [0.5%]  surface glycoprotein, T29I</title>
	<circle cx="1394.2" cy="1189.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  G21724T  USA=2 [0.5%]  surface glycoprotein, L54F</title>
	<circle cx="1411.1" cy="1188.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  A23403G  USA=349 [82.1%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1169.4" r="10.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  A23403G  USA=349 [82.1%] Canada=83 [88.3%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1169.4" r="7.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  G23587C  USA=3 [0.7%]  surface glycoprotein, Q675H</title>
	<circle cx="1825.4" cy="1167.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  G23909T  USA=2 [0.5%]  surface glycoprotein, A783S</title>
	<circle cx="1897.0" cy="1163.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  C24378T  USA=3 [0.7%]  surface glycoprotein, S939F</title>
	<circle cx="2001.4" cy="1158.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  G25217T  Canada=6 [6.4%]  surface glycoprotein, G1219C</title>
	<circle cx="2188.0" cy="1148.2" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  G25429T  Canada=3 [3.2%]  ORF3a protein, V13L</title>
	<circle cx="2235.1" cy="1145.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  C25433T  Canada=10 [10.6%]  ORF3a protein, T14I</title>
	<circle cx="2236.0" cy="1145.7" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28 USA: 305 samples</title>
	<line x1="1220.0" y1="1199.3" x2="1231.2" y2="1198.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-28 Canada: 62 samples</title>
	<line x1="1231.2" y1="1198.9" x2="1239.3" y2="1198.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-28  C21575T  USA=2 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1378.1" cy="1193.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28  A23403G  USA=221 [72.5%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1179.6" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28  A23403G  USA=221 [72.5%] Canada=54 [87.1%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1179.6" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28  G23621A  Canada=2 [3.2%]  surface glycoprotein, V687I</title>
	<circle cx="1833.5" cy="1177.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28  C25433T  Canada=3 [4.8%]  ORF3a protein, T14I</title>
	<circle cx="2236.8" cy="1163.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29 USA: 212 samples</title>
	<line x1="1220.0" y1="1199.7" x2="1230.5" y2="1199.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-29 Canada: 46 samples</title>
	<line x1="1230.5" y1="1199.5" x2="1238.0" y2="1199.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-29  C21575T  USA=3 [1.4%]  surface glycoprotein, L5F</title>
	<circle cx="1378.1" cy="1196.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  G21578T  USA=2 [0.9%]  surface glycoprotein, V6F</title>
	<circle cx="1378.8" cy="1196.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  C21621T  Canada=2 [4.3%]  surface glycoprotein, T20I</title>
	<circle cx="1388.4" cy="1196.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  G22632A  Canada=2 [4.3%]  surface glycoprotein, R357K</title>
	<circle cx="1613.5" cy="1192.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  A23403G  USA=170 [80.2%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1189.8" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  A23403G  USA=170 [80.2%] Canada=39 [84.8%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1189.8" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  C23604A  USA=4 [1.9%]  surface glycoprotein, P681H</title>
	<circle cx="1830.0" cy="1189.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  C24378T  USA=2 [0.9%]  surface glycoprotein, S939F</title>
	<circle cx="2002.3" cy="1186.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  G25437T  USA=2 [0.9%]  ORF3a protein, L15F</title>
	<circle cx="2238.1" cy="1181.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30 USA: 457 samples</title>
	<line x1="1220.0" y1="1200.0" x2="1232.0" y2="1200.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-30 Canada: 63 samples</title>
	<line x1="1232.0" y1="1200.0" x2="1240.1" y2="1200.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-30  C21575T  USA=4 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1378.2" cy="1200.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  C23277T  USA=3 [0.7%]  surface glycoprotein, T572I</title>
	<circle cx="1757.2" cy="1200.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  A23403G  USA=390 [85.3%]  surface glycoprotein, D614G</title>
	<circle cx="1785.3" cy="1200.0" r="10.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  A23403G  USA=390 [85.3%] Canada=58 [92.1%]  surface glycoprotein, D614G</title>
	<circle cx="1785.3" cy="1200.0" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  C23453T  USA=2 [0.4%]  surface glycoprotein, P631S</title>
	<circle cx="1796.4" cy="1200.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  C24138T  USA=3 [0.7%]  surface glycoprotein, T859I</title>
	<circle cx="1949.0" cy="1200.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  G25217T  Canada=3 [4.8%]  surface glycoprotein, G1219C</title>
	<circle cx="2189.3" cy="1200.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  C25350T  USA=5 [1.1%]  surface glycoprotein, P1263L</title>
	<circle cx="2218.9" cy="1200.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  G25429T  USA=3 [0.7%]  ORF3a protein, V13L</title>
	<circle cx="2236.5" cy="1200.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  C25463T  USA=6 [1.3%]  ORF3a protein, T24I</title>
	<circle cx="2244.1" cy="1200.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31 USA: 359 samples</title>
	<line x1="1220.0" y1="1200.3" x2="1231.5" y2="1200.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-31 Canada: 39 samples</title>
	<line x1="1231.5" y1="1200.5" x2="1238.7" y2="1200.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-31  C21627T  USA=2 [0.6%]  surface glycoprotein, T22I</title>
	<circle cx="1389.7" cy="1203.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  C21707T  USA=2 [0.6%]  surface glycoprotein, H49Y</title>
	<circle cx="1407.5" cy="1203.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  C23277T  USA=2 [0.6%]  surface glycoprotein, T572I</title>
	<circle cx="1757.2" cy="1209.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  A23403G  USA=268 [74.7%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1210.2" r="9.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  A23403G  USA=268 [74.7%] Canada=34 [87.2%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1210.2" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  C23423T  USA=2 [0.6%]  surface glycoprotein, P621S</title>
	<circle cx="1789.7" cy="1210.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  C25418A  USA=2 [0.6%]  ORF3a protein, T9K</title>
	<circle cx="2233.9" cy="1218.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  C25433T  Canada=7 [17.9%]  ORF3a protein, T14I</title>
	<circle cx="2237.3" cy="1218.1" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01 USA: 507 samples</title>
	<line x1="1220.0" y1="1200.7" x2="1232.2" y2="1201.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01 Canada: 21 samples</title>
	<line x1="1232.2" y1="1201.1" x2="1238.2" y2="1201.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01 Mexico: 3 samples</title>
	<line x1="1238.2" y1="1201.3" x2="1240.9" y2="1201.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01  C21575T  USA=7 [1.4%]  surface glycoprotein, L5F</title>
	<circle cx="1378.1" cy="1206.2" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  T21995C  USA=2 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1471.5" cy="1209.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C22295T  USA=2 [0.4%]  surface glycoprotein, H245Y</title>
	<circle cx="1538.3" cy="1211.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C23277T  USA=2 [0.4%]  surface glycoprotein, T572I</title>
	<circle cx="1756.9" cy="1219.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  USA=420 [82.8%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="10.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  USA=420 [82.8%] Canada=21 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  Mexico=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  G23426T  USA=2 [0.4%]  surface glycoprotein, V622F</title>
	<circle cx="1790.1" cy="1220.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  G23593T  Canada=2 [9.5%]  surface glycoprotein, Q677H</title>
	<circle cx="1827.2" cy="1221.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C24138T  USA=3 [0.6%]  surface glycoprotein, T859I</title>
	<circle cx="1948.5" cy="1226.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  G24985T  USA=4 [0.8%]  surface glycoprotein, L1141F</title>
	<circle cx="2137.1" cy="1232.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C25169T  USA=2 [0.4%]  surface glycoprotein, L1203F</title>
	<circle cx="2178.0" cy="1234.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C25350T  USA=2 [0.4%]  surface glycoprotein, P1263L</title>
	<circle cx="2218.3" cy="1235.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C25433T  Canada=2 [9.5%]  ORF3a protein, T14I</title>
	<circle cx="2236.8" cy="1236.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C25433T  USA=2 [0.4%]  ORF3a protein, T14I</title>
	<circle cx="2236.8" cy="1236.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  C25487T  USA=2 [0.4%]  ORF3a protein, T32I</title>
	<circle cx="2248.8" cy="1236.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02 USA: 426 samples</title>
	<line x1="1220.0" y1="1201.0" x2="1231.8" y2="1201.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-02 Canada: 32 samples</title>
	<line x1="1231.8" y1="1201.7" x2="1238.6" y2="1202.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-02 Mexico: 2 samples</title>
	<line x1="1238.6" y1="1202.0" x2="1240.8" y2="1202.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-02  C21575T  USA=3 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1377.9" cy="1209.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C21627T  USA=2 [0.5%]  surface glycoprotein, T22I</title>
	<circle cx="1389.5" cy="1209.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C21998T  USA=4 [0.9%]  surface glycoprotein, H146Y</title>
	<circle cx="1472.0" cy="1214.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  A22320G  Canada=2 [6.2%]  surface glycoprotein, D253G</title>
	<circle cx="1543.6" cy="1218.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  A23403G  USA=368 [86.4%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1230.6" r="10.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  A23403G  USA=368 [86.4%] Canada=29 [90.6%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1230.6" r="5.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  A23403G  USA=368 [86.4%] Canada=29 [90.6%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1230.6" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C23673T  USA=2 [0.5%]  surface glycoprotein, S704L</title>
	<circle cx="1844.5" cy="1233.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C24138T  USA=8 [1.9%]  surface glycoprotein, T859I</title>
	<circle cx="1948.0" cy="1239.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C24378T  USA=2 [0.5%]  surface glycoprotein, S939F</title>
	<circle cx="2001.4" cy="1242.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  G24977C  USA=3 [0.7%]  surface glycoprotein, D1139H</title>
	<circle cx="2134.6" cy="1249.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  G25217A  USA=2 [0.5%]  surface glycoprotein, G1219S</title>
	<circle cx="2188.0" cy="1251.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C25350T  USA=17 [4.0%]  surface glycoprotein, P1263L</title>
	<circle cx="2217.5" cy="1253.3" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C25418T  USA=2 [0.5%]  ORF3a protein, T9I</title>
	<circle cx="2232.7" cy="1254.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C25433T  Canada=2 [6.2%]  ORF3a protein, T14I</title>
	<circle cx="2236.0" cy="1254.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  C25463T  USA=2 [0.5%]  ORF3a protein, T24I</title>
	<circle cx="2242.7" cy="1254.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  T25468G  USA=18 [4.2%]  ORF3a protein, S26A</title>
	<circle cx="2243.8" cy="1254.7" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03 USA: 356 samples</title>
	<line x1="1220.0" y1="1201.4" x2="1231.4" y2="1202.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-03 Canada: 32 samples</title>
	<line x1="1231.4" y1="1202.2" x2="1238.2" y2="1202.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-03 Mexico: 2 samples</title>
	<line x1="1238.2" y1="1202.7" x2="1240.4" y2="1202.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-03  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1377.7" cy="1212.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  G21830T  USA=2 [0.6%]  surface glycoprotein, V90F</title>
	<circle cx="1434.4" cy="1216.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  C21998T  USA=8 [2.2%]  surface glycoprotein, H146Y</title>
	<circle cx="1471.7" cy="1219.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  G22205C  USA=2 [0.6%]  surface glycoprotein, D215H</title>
	<circle cx="1517.7" cy="1222.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  C23124G  USA=2 [0.6%]  surface glycoprotein, P521R</title>
	<circle cx="1721.9" cy="1236.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  A23403G  USA=312 [87.6%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1240.8" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  A23403G  Canada=26 [81.2%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1240.8" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  A23403G  Canada=26 [81.2%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1240.8" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  C24138T  USA=3 [0.8%]  surface glycoprotein, T859I</title>
	<circle cx="1947.2" cy="1252.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  G24751T  USA=2 [0.6%]  surface glycoprotein, L1063F</title>
	<circle cx="2083.4" cy="1261.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  C25350T  USA=5 [1.4%]  surface glycoprotein, P1263L</title>
	<circle cx="2216.4" cy="1271.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  C25433T  Canada=4 [12.5%]  ORF3a protein, T14I</title>
	<circle cx="2234.9" cy="1272.4" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  G25459T  USA=3 [0.8%]  ORF3a protein, A23S</title>
	<circle cx="2240.7" cy="1272.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04 USA: 243 samples</title>
	<line x1="1219.9" y1="1201.7" x2="1230.6" y2="1202.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-04 Canada: 19 samples</title>
	<line x1="1230.6" y1="1202.7" x2="1236.5" y2="1203.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-04 Mexico: 2 samples</title>
	<line x1="1236.5" y1="1203.2" x2="1238.6" y2="1203.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-04  C21575T  USA=7 [2.9%]  surface glycoprotein, L5F</title>
	<circle cx="1377.5" cy="1215.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  G21578T  USA=3 [1.2%]  surface glycoprotein, V6F</title>
	<circle cx="1378.2" cy="1215.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  G22346T  USA=2 [0.8%]  surface glycoprotein, A262S</title>
	<circle cx="1548.6" cy="1230.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  A23403G  USA=202 [83.1%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1251.0" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  A23403G  USA=202 [83.1%] Canada=18 [94.7%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1251.0" r="5.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  A23403G  USA=202 [83.1%] Canada=18 [94.7%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1251.0" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  C24138T  USA=4 [1.6%]  surface glycoprotein, T859I</title>
	<circle cx="1946.1" cy="1265.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  A24369G  Canada=2 [10.5%]  surface glycoprotein, D936G</title>
	<circle cx="1997.4" cy="1269.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  C24378T  USA=2 [0.8%]  surface glycoprotein, S939F</title>
	<circle cx="1999.4" cy="1269.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  C25350T  USA=5 [2.1%]  surface glycoprotein, P1263L</title>
	<circle cx="2215.1" cy="1288.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  C25433T  Canada=3 [15.8%]  ORF3a protein, T14I</title>
	<circle cx="2233.5" cy="1290.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05 USA: 182 samples</title>
	<line x1="1219.9" y1="1202.1" x2="1230.0" y2="1203.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-05 Canada: 22 samples</title>
	<line x1="1230.0" y1="1203.2" x2="1236.1" y2="1203.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-05  G21604T  USA=2 [1.1%]  surface glycoprotein, Q14H</title>
	<circle cx="1383.6" cy="1219.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  C21707T  USA=2 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1406.4" cy="1221.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  A23403G  USA=153 [84.1%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1261.2" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  A23403G  USA=153 [84.1%] Canada=21 [95.5%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1261.2" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  C24138T  USA=2 [1.1%]  surface glycoprotein, T859I</title>
	<circle cx="1944.9" cy="1278.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  C24378T  USA=2 [1.1%]  surface glycoprotein, S939F</title>
	<circle cx="1998.1" cy="1283.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  A24782G  Canada=2 [9.1%]  surface glycoprotein, N1074D</title>
	<circle cx="2087.5" cy="1293.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  C25350T  USA=5 [2.7%]  surface glycoprotein, P1263L</title>
	<circle cx="2213.3" cy="1306.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  C25433T  Canada=8 [36.4%]  ORF3a protein, T14I</title>
	<circle cx="2231.7" cy="1308.4" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  G25459T  USA=3 [1.6%]  ORF3a protein, A23S</title>
	<circle cx="2237.5" cy="1309.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06 USA: 354 samples</title>
	<line x1="1219.9" y1="1202.4" x2="1231.2" y2="1203.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06 Canada: 24 samples</title>
	<line x1="1231.2" y1="1203.8" x2="1237.5" y2="1204.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06 Mexico: 5 samples</title>
	<line x1="1237.5" y1="1204.6" x2="1241.0" y2="1205.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1376.8" cy="1221.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  C22295T  USA=2 [0.6%]  surface glycoprotein, H245Y</title>
	<circle cx="1536.0" cy="1241.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  A23403G  USA=297 [83.9%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1271.3" r="9.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  A23403G  USA=297 [83.9%] Canada=24 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1271.3" r="5.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  A23403G  USA=297 [83.9%] Canada=24 [100.0%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1271.3" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  C24378T  USA=3 [0.8%]  surface glycoprotein, S939F</title>
	<circle cx="1996.5" cy="1297.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  A24782G  Canada=2 [8.3%]  surface glycoprotein, N1074D</title>
	<circle cx="2085.8" cy="1308.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  G24821T  Canada=2 [8.3%]  surface glycoprotein, A1087S</title>
	<circle cx="2094.4" cy="1309.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  C25350T  Canada=2 [8.3%]  surface glycoprotein, P1263L</title>
	<circle cx="2211.3" cy="1324.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  G25429T  USA=2 [0.6%]  ORF3a protein, V13L</title>
	<circle cx="2228.8" cy="1326.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  C25433T  Canada=5 [20.8%]  ORF3a protein, T14I</title>
	<circle cx="2229.7" cy="1326.4" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07 USA: 279 samples</title>
	<line x1="1219.8" y1="1202.8" x2="1230.7" y2="1204.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-07 Canada: 33 samples</title>
	<line x1="1230.7" y1="1204.3" x2="1237.5" y2="1205.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-07  C21575T  USA=2 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1376.4" cy="1224.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07  A23403G  USA=231 [82.8%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1281.5" r="9.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07  A23403G  USA=231 [82.8%] Canada=32 [97.0%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1281.5" r="6.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07  G23593T  Canada=2 [6.1%]  surface glycoprotein, Q677H</title>
	<circle cx="1821.5" cy="1287.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07  C24378T  USA=2 [0.7%]  surface glycoprotein, S939F</title>
	<circle cx="1994.6" cy="1311.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07  C25433T  Canada=8 [24.2%]  ORF3a protein, T14I</title>
	<circle cx="2227.3" cy="1344.4" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08 USA: 333 samples</title>
	<line x1="1219.8" y1="1203.1" x2="1231.0" y2="1204.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-08 Canada: 18 samples</title>
	<line x1="1231.0" y1="1204.9" x2="1236.7" y2="1205.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-08 Mexico: 6 samples</title>
	<line x1="1236.7" y1="1205.8" x2="1240.4" y2="1206.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-08  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1376.0" cy="1227.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  G21724T  USA=2 [0.6%]  surface glycoprotein, L54F</title>
	<circle cx="1408.8" cy="1233.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  A23403G  USA=269 [80.8%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1291.6" r="9.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  A23403G  USA=269 [80.8%] Canada=17 [94.4%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1291.6" r="4.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  A23403G  USA=269 [80.8%] Canada=17 [94.4%] Mexico=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1291.6" r="3.1" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  C23604T  USA=4 [1.2%]  surface glycoprotein, P681L</title>
	<circle cx="1822.3" cy="1298.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  G24348T  USA=3 [0.9%]  surface glycoprotein, S929I</title>
	<circle cx="1986.0" cy="1324.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  C25350T  USA=4 [1.2%]  surface glycoprotein, P1263L</title>
	<circle cx="2206.4" cy="1359.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  C25433T  Canada=4 [22.2%]  ORF3a protein, T14I</title>
	<circle cx="2224.6" cy="1362.3" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  T25468G  USA=18 [5.4%]  ORF3a protein, S26A</title>
	<circle cx="2232.3" cy="1363.5" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09 USA: 218 samples</title>
	<line x1="1219.7" y1="1203.5" x2="1230.1" y2="1205.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09 Canada: 47 samples</title>
	<line x1="1230.1" y1="1205.3" x2="1237.5" y2="1206.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09  T21771C  Canada=4 [8.5%]  surface glycoprotein, V70A</title>
	<circle cx="1418.5" cy="1238.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  C22295T  USA=2 [0.9%]  surface glycoprotein, H245Y</title>
	<circle cx="1533.4" cy="1258.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  A23403G  USA=177 [81.2%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1301.6" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  A23403G  USA=177 [81.2%] Canada=44 [93.6%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1301.6" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  C24138T  USA=2 [0.9%]  surface glycoprotein, T859I</title>
	<circle cx="1937.6" cy="1330.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  A24369G  Canada=2 [4.3%]  surface glycoprotein, D936G</title>
	<circle cx="1988.3" cy="1339.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  C24378T  USA=2 [0.9%]  surface glycoprotein, S939F</title>
	<circle cx="1990.3" cy="1339.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  C25350T  USA=2 [0.9%]  surface glycoprotein, P1263L</title>
	<circle cx="2203.5" cy="1376.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  C25433T  Canada=9 [19.1%]  ORF3a protein, T14I</title>
	<circle cx="2221.7" cy="1380.1" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  G25459T  USA=2 [0.9%]  ORF3a protein, A23S</title>
	<circle cx="2227.4" cy="1381.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  C25466T  USA=2 [0.9%]  ORF3a protein, P25L</title>
	<circle cx="2228.9" cy="1381.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10 USA: 272 samples</title>
	<line x1="1219.6" y1="1203.8" x2="1230.4" y2="1205.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-10 Canada: 46 samples</title>
	<line x1="1230.4" y1="1205.9" x2="1237.8" y2="1207.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-10 Mexico: 7 samples</title>
	<line x1="1237.8" y1="1207.3" x2="1241.8" y2="1208.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-10  C21575T  USA=3 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1374.9" cy="1234.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  C22227T  Canada=3 [6.5%]  surface glycoprotein, A222V</title>
	<circle cx="1517.4" cy="1261.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  C22295T  USA=2 [0.7%]  surface glycoprotein, H245Y</title>
	<circle cx="1532.3" cy="1264.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  G22335T  USA=2 [0.7%]  surface glycoprotein, W258L</title>
	<circle cx="1541.1" cy="1266.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  G22894T  Canada=2 [4.3%]  surface glycoprotein, K444N</title>
	<circle cx="1663.3" cy="1290.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  A23403G  USA=230 [84.6%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1311.7" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  A23403G  USA=230 [84.6%] Canada=44 [95.7%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1311.7" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  A23403G  USA=230 [84.6%] Canada=44 [95.7%] Mexico=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1311.7" r="3.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  C24642T  USA=2 [0.7%]  surface glycoprotein, T1027I</title>
	<circle cx="2045.4" cy="1364.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  G25217T  Canada=3 [6.5%]  surface glycoprotein, G1219C</title>
	<circle cx="2171.1" cy="1388.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  C25433T  USA=2 [0.7%]  ORF3a protein, T14I</title>
	<circle cx="2218.4" cy="1397.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11 USA: 190 samples</title>
	<line x1="1219.6" y1="1204.2" x2="1229.6" y2="1206.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-11 Canada: 53 samples</title>
	<line x1="1229.6" y1="1206.3" x2="1237.2" y2="1207.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-11  C21575T  USA=3 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1374.3" cy="1237.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  C21998T  USA=2 [1.1%]  surface glycoprotein, H146Y</title>
	<circle cx="1466.4" cy="1256.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  A23403G  USA=168 [88.4%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1321.7" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  A23403G  USA=168 [88.4%] Canada=50 [94.3%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1321.7" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  G25217T  Canada=2 [3.8%]  surface glycoprotein, G1219C</title>
	<circle cx="2167.7" cy="1405.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  C25433T  Canada=7 [13.2%]  ORF3a protein, T14I</title>
	<circle cx="2214.7" cy="1415.7" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12 USA: 96 samples</title>
	<line x1="1219.5" y1="1204.5" x2="1228.2" y2="1206.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-12 Canada: 49 samples</title>
	<line x1="1228.2" y1="1206.5" x2="1235.6" y2="1208.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-12  C22227T  Canada=3 [6.1%]  surface glycoprotein, A222V</title>
	<circle cx="1515.1" cy="1272.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  C23127T  USA=2 [2.1%]  surface glycoprotein, A522V</title>
	<circle cx="1710.4" cy="1317.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  A23403G  USA=68 [70.8%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1331.7" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  A23403G  USA=68 [70.8%] Canada=47 [95.9%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1331.7" r="6.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  G25234T  Canada=2 [4.1%]  surface glycoprotein, L1224F</title>
	<circle cx="2167.6" cy="1423.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  G25437T  USA=2 [2.1%]  ORF3a protein, L15F</title>
	<circle cx="2211.7" cy="1433.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13 USA: 341 samples</title>
	<line x1="1219.4" y1="1204.8" x2="1230.5" y2="1207.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-13 Canada: 90 samples</title>
	<line x1="1230.5" y1="1207.6" x2="1239.0" y2="1209.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-13 Mexico: 3 samples</title>
	<line x1="1239.0" y1="1209.7" x2="1241.7" y2="1210.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-13  C21575T  Canada=6 [6.7%]  surface glycoprotein, L5F</title>
	<circle cx="1372.9" cy="1243.1" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1372.9" cy="1243.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  A22320G  USA=2 [0.6%]  surface glycoprotein, D253G</title>
	<circle cx="1533.9" cy="1283.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  C22949T  USA=2 [0.6%]  surface glycoprotein, P463S</title>
	<circle cx="1669.8" cy="1317.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  A23403G  USA=278 [81.5%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1341.6" r="9.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  A23403G  USA=278 [81.5%] Canada=87 [96.7%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1341.6" r="7.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  A23403G  USA=278 [81.5%] Canada=87 [96.7%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1341.6" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  G25217A  USA=2 [0.6%]  surface glycoprotein, G1219S</title>
	<circle cx="2159.9" cy="1439.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  G25217T  USA=2 [0.6%]  surface glycoprotein, G1219C</title>
	<circle cx="2159.9" cy="1439.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  G25234T  Canada=8 [8.9%]  surface glycoprotein, L1224F</title>
	<circle cx="2163.6" cy="1440.3" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  C25418T  USA=2 [0.6%]  ORF3a protein, T9I</title>
	<circle cx="2203.4" cy="1450.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  C25433T  Canada=7 [7.8%]  ORF3a protein, T14I</title>
	<circle cx="2206.6" cy="1451.0" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13  G25471C  USA=2 [0.6%]  ORF3a protein, D27H</title>
	<circle cx="2214.8" cy="1453.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14 USA: 235 samples</title>
	<line x1="1219.3" y1="1205.2" x2="1229.6" y2="1207.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-14 Canada: 83 samples</title>
	<line x1="1229.6" y1="1207.9" x2="1238.0" y2="1210.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-14 Mexico: 3 samples</title>
	<line x1="1238.0" y1="1210.2" x2="1240.6" y2="1210.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-14  C21575T  Canada=3 [3.6%]  surface glycoprotein, L5F</title>
	<circle cx="1372.1" cy="1246.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  A22320G  USA=2 [0.9%]  surface glycoprotein, D253G</title>
	<circle cx="1532.4" cy="1289.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  G22894T  Canada=2 [2.4%]  surface glycoprotein, K444N</title>
	<circle cx="1655.9" cy="1322.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  A23403G  USA=192 [81.7%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1351.5" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  A23403G  USA=192 [81.7%] Canada=80 [96.4%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1351.5" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  A23403G  USA=192 [81.7%] Canada=80 [96.4%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1351.5" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  G23426T  USA=2 [0.9%]  surface glycoprotein, V622F</title>
	<circle cx="1770.3" cy="1352.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  C23538T  Canada=2 [2.4%]  surface glycoprotein, S659L</title>
	<circle cx="1794.4" cy="1359.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  G24368T  Canada=2 [2.4%]  surface glycoprotein, D936Y</title>
	<circle cx="1973.0" cy="1407.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  G25217T  USA=2 [0.9%]  surface glycoprotein, G1219C</title>
	<circle cx="2155.6" cy="1456.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  G25234T  Canada=5 [6.0%]  surface glycoprotein, L1224F</title>
	<circle cx="2159.3" cy="1457.0" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  C25433T  Canada=3 [3.6%]  ORF3a protein, T14I</title>
	<circle cx="2202.1" cy="1468.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15 USA: 257 samples</title>
	<line x1="1219.2" y1="1205.5" x2="1229.7" y2="1208.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15 Canada: 68 samples</title>
	<line x1="1229.7" y1="1208.5" x2="1237.6" y2="1210.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15 Mexico: 2 samples</title>
	<line x1="1237.6" y1="1210.8" x2="1239.7" y2="1211.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15  C21575T  USA=3 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1371.3" cy="1249.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  A23403G  USA=218 [84.8%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  A23403G  USA=218 [84.8%] Canada=65 [95.6%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  A23403G  USA=218 [84.8%] Canada=65 [95.6%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  G23915A  USA=5 [1.9%]  surface glycoprotein, V785I</title>
	<circle cx="1872.2" cy="1392.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  A24369G  Canada=3 [4.4%]  surface glycoprotein, D936G</title>
	<circle cx="1969.4" cy="1420.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  G24821T  Canada=3 [4.4%]  surface glycoprotein, A1087S</title>
	<circle cx="2066.2" cy="1448.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  G25234T  Canada=10 [14.7%]  surface glycoprotein, L1224F</title>
	<circle cx="2154.6" cy="1473.7" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  T25468G  USA=15 [5.8%]  ORF3a protein, S26A</title>
	<circle cx="2204.7" cy="1488.1" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16 USA: 203 samples</title>
	<line x1="1219.1" y1="1205.8" x2="1229.1" y2="1208.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-16 Canada: 99 samples</title>
	<line x1="1229.1" y1="1208.9" x2="1237.7" y2="1211.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-16 Mexico: 5 samples</title>
	<line x1="1237.7" y1="1211.5" x2="1241.0" y2="1212.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-16  C21575T  Canada=2 [2.0%]  surface glycoprotein, L5F</title>
	<circle cx="1370.4" cy="1252.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  C21575T  Canada=2 [2.0%] USA=2 [1.0%]  surface glycoprotein, L5F</title>
	<circle cx="1370.4" cy="1252.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  C22295T  USA=5 [2.5%]  surface glycoprotein, H245Y</title>
	<circle cx="1523.7" cy="1299.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  A23403G  USA=179 [88.2%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1371.1" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  A23403G  USA=179 [88.2%] Canada=98 [99.0%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1371.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  A23403G  USA=179 [88.2%] Canada=98 [99.0%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1371.1" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  C23604T  USA=6 [3.0%]  surface glycoprotein, P681L</title>
	<circle cx="1802.5" cy="1384.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  C24642T  USA=2 [1.0%]  surface glycoprotein, T1027I</title>
	<circle cx="2023.6" cy="1451.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  G24933T  USA=2 [1.0%]  surface glycoprotein, G1124V</title>
	<circle cx="2085.6" cy="1470.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  G25234T  Canada=10 [10.1%]  surface glycoprotein, L1224F</title>
	<circle cx="2149.7" cy="1490.4" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17 USA: 167 samples</title>
	<line x1="1219.0" y1="1206.2" x2="1228.5" y2="1209.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-17 Canada: 102 samples</title>
	<line x1="1228.5" y1="1209.3" x2="1237.2" y2="1212.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-17 Mexico: 4 samples</title>
	<line x1="1237.2" y1="1212.1" x2="1240.2" y2="1213.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-17  C21575T  Canada=3 [2.9%]  surface glycoprotein, L5F</title>
	<circle cx="1369.5" cy="1255.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  C22224T  USA=2 [1.2%]  surface glycoprotein, S221L</title>
	<circle cx="1506.9" cy="1299.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  C22550T  USA=2 [1.2%]  surface glycoprotein, P330S</title>
	<circle cx="1576.0" cy="1322.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  A23403G  USA=149 [89.2%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1380.9" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  A23403G  USA=149 [89.2%] Canada=99 [97.1%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1380.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  A23403G  USA=149 [89.2%] Canada=99 [97.1%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1380.9" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  G24368T  Mexico=2 [50.0%]  surface glycoprotein, D936Y</title>
	<circle cx="1961.1" cy="1447.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  G25234T  Canada=26 [25.5%]  surface glycoprotein, L1224F</title>
	<circle cx="2144.5" cy="1506.9" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  C25433T  Canada=4 [3.9%]  ORF3a protein, T14I</title>
	<circle cx="2186.6" cy="1520.6" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18 USA: 156 samples</title>
	<line x1="1218.9" y1="1206.5" x2="1228.3" y2="1209.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-18 Canada: 57 samples</title>
	<line x1="1228.3" y1="1209.7" x2="1235.8" y2="1212.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-18 Mexico: 4 samples</title>
	<line x1="1235.8" y1="1212.3" x2="1238.7" y2="1213.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-18  C21575T  USA=6 [3.8%]  surface glycoprotein, L5F</title>
	<circle cx="1368.5" cy="1258.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  T21644C  Canada=2 [3.5%]  surface glycoprotein, Y28H</title>
	<circle cx="1383.0" cy="1263.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  C22224T  USA=7 [4.5%]  surface glycoprotein, S221L</title>
	<circle cx="1505.1" cy="1305.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  C22295T  USA=2 [1.3%]  surface glycoprotein, H245Y</title>
	<circle cx="1520.1" cy="1310.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  A23403G  USA=144 [92.3%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1390.6" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  A23403G  USA=144 [92.3%] Canada=55 [96.5%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1390.6" r="7.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  A23403G  USA=144 [92.3%] Canada=55 [96.5%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1390.6" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  C23655T  USA=3 [1.9%]  surface glycoprotein, S698L</title>
	<circle cx="1806.5" cy="1408.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  G25234T  Canada=14 [24.6%]  surface glycoprotein, L1224F</title>
	<circle cx="2139.0" cy="1523.3" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  C25433T  Canada=3 [5.3%]  ORF3a protein, T14I</title>
	<circle cx="2180.9" cy="1537.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-19 USA: 81 samples</title>
	<line x1="1218.8" y1="1206.8" x2="1226.9" y2="1209.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-19 Canada: 40 samples</title>
	<line x1="1226.9" y1="1209.8" x2="1233.7" y2="1212.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-19 Mexico: 2 samples</title>
	<line x1="1233.7" y1="1212.3" x2="1235.7" y2="1213.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-19  C21575T  USA=2 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1367.4" cy="1260.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-19  A23403G  USA=75 [92.6%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="1400.2" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-19  A23403G  USA=75 [92.6%] Canada=40 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="1400.2" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-19  A23403G  USA=75 [92.6%] Canada=40 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="1400.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-19  G25234T  Canada=13 [32.5%]  surface glycoprotein, L1224F</title>
	<circle cx="2133.2" cy="1539.7" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20 USA: 247 samples</title>
	<line x1="1218.7" y1="1207.2" x2="1228.7" y2="1211.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-20 Canada: 76 samples</title>
	<line x1="1228.7" y1="1211.0" x2="1236.7" y2="1214.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-20 Mexico: 3 samples</title>
	<line x1="1236.7" y1="1214.1" x2="1239.2" y2="1215.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-20  C21575T  USA=4 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1366.3" cy="1263.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  C21575T  USA=4 [1.6%] Canada=2 [2.6%]  surface glycoprotein, L5F</title>
	<circle cx="1366.3" cy="1263.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  G21578T  USA=2 [0.8%]  surface glycoprotein, V6F</title>
	<circle cx="1367.0" cy="1264.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  C22224T  USA=2 [0.8%]  surface glycoprotein, S221L</title>
	<circle cx="1501.3" cy="1315.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  C22295T  USA=2 [0.8%]  surface glycoprotein, H245Y</title>
	<circle cx="1516.0" cy="1321.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  A23403G  USA=221 [89.5%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="1409.8" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  A23403G  USA=221 [89.5%] Canada=76 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="1409.8" r="7.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  A23403G  USA=221 [89.5%] Canada=76 [100.0%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="1409.8" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  C24378T  USA=3 [1.2%]  surface glycoprotein, S939F</title>
	<circle cx="1949.2" cy="1487.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  G25234T  Canada=20 [26.3%]  surface glycoprotein, L1224F</title>
	<circle cx="2127.1" cy="1555.9" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21 USA: 251 samples</title>
	<line x1="1218.5" y1="1207.5" x2="1228.6" y2="1211.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21 Canada: 76 samples</title>
	<line x1="1228.6" y1="1211.5" x2="1236.4" y2="1214.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21 Mexico: 3 samples</title>
	<line x1="1236.4" y1="1214.7" x2="1238.9" y2="1215.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21  C21575T  USA=2 [0.8%]  surface glycoprotein, L5F</title>
	<circle cx="1365.2" cy="1266.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  G21578T  USA=6 [2.4%]  surface glycoprotein, V6F</title>
	<circle cx="1365.8" cy="1267.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  C22224T  USA=3 [1.2%]  surface glycoprotein, S221L</title>
	<circle cx="1499.2" cy="1320.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  A22320G  USA=3 [1.2%]  surface glycoprotein, D253G</title>
	<circle cx="1519.0" cy="1328.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  A23403G  USA=223 [88.8%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  A23403G  USA=223 [88.8%] Canada=75 [98.7%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="7.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  A23403G  USA=223 [88.8%] Canada=75 [98.7%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  G23755T  USA=2 [0.8%]  surface glycoprotein, M731I</title>
	<circle cx="1815.4" cy="1448.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  G23915A  USA=2 [0.8%]  surface glycoprotein, V785I</title>
	<circle cx="1848.4" cy="1462.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  G25217A  USA=2 [0.8%]  surface glycoprotein, G1219S</title>
	<circle cx="2117.3" cy="1570.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  G25234T  Canada=17 [22.4%]  surface glycoprotein, L1224F</title>
	<circle cx="2120.8" cy="1572.0" r="4.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  C25433T  USA=2 [0.8%]  ORF3a protein, T14I</title>
	<circle cx="2161.9" cy="1588.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22 USA: 227 samples</title>
	<line x1="1218.4" y1="1207.8" x2="1228.2" y2="1212.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-22 Canada: 93 samples</title>
	<line x1="1228.2" y1="1212.0" x2="1236.4" y2="1215.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-22  C21575T  Canada=3 [3.2%]  surface glycoprotein, L5F</title>
	<circle cx="1364.0" cy="1269.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  C21575T  Canada=3 [3.2%] USA=3 [1.3%]  surface glycoprotein, L5F</title>
	<circle cx="1364.0" cy="1269.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  G21800A  Canada=2 [2.2%]  surface glycoprotein, D80N</title>
	<circle cx="1410.1" cy="1289.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  C22224T  USA=4 [1.8%]  surface glycoprotein, S221L</title>
	<circle cx="1497.1" cy="1326.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  A23403G  USA=203 [89.4%]  surface glycoprotein, D614G</title>
	<circle cx="1738.8" cy="1428.7" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  A23403G  USA=203 [89.4%] Canada=93 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1738.8" cy="1428.7" r="7.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  A24129G  USA=5 [2.2%]  surface glycoprotein, N856S</title>
	<circle cx="1887.6" cy="1491.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  G25234T  Canada=18 [19.4%]  surface glycoprotein, L1224F</title>
	<circle cx="2114.1" cy="1588.0" r="5.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  G25429T  USA=2 [0.9%]  ORF3a protein, V13L</title>
	<circle cx="2154.1" cy="1605.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  C25433T  Canada=2 [2.2%]  ORF3a protein, T14I</title>
	<circle cx="2154.9" cy="1605.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22  T25468G  USA=6 [2.6%]  ORF3a protein, S26A</title>
	<circle cx="2162.1" cy="1608.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23 USA: 242 samples</title>
	<line x1="1218.3" y1="1208.1" x2="1228.1" y2="1212.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23 Canada: 68 samples</title>
	<line x1="1228.1" y1="1212.5" x2="1235.6" y2="1215.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23 Mexico: 2 samples</title>
	<line x1="1235.6" y1="1215.9" x2="1237.6" y2="1216.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23  C21575T  Canada=3 [4.4%]  surface glycoprotein, L5F</title>
	<circle cx="1362.8" cy="1272.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  C21627A  USA=5 [2.1%]  surface glycoprotein, T22N</title>
	<circle cx="1373.3" cy="1277.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  A22320G  USA=4 [1.7%]  surface glycoprotein, D253G</title>
	<circle cx="1514.3" cy="1340.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G22484T  USA=2 [0.8%]  surface glycoprotein, V308L</title>
	<circle cx="1547.7" cy="1354.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  A23403G  USA=222 [91.7%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  A23403G  USA=222 [91.7%] Canada=68 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  A23403G  USA=222 [91.7%] Canada=68 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  C23655T  USA=5 [2.1%]  surface glycoprotein, S698L</title>
	<circle cx="1786.0" cy="1460.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G23915A  USA=2 [0.8%]  surface glycoprotein, V785I</title>
	<circle cx="1838.9" cy="1484.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G24328C  USA=2 [0.8%]  surface glycoprotein, L922F</title>
	<circle cx="1922.9" cy="1521.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G24764T  USA=2 [0.8%]  surface glycoprotein, V1068F</title>
	<circle cx="2011.6" cy="1561.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G24776C  USA=2 [0.8%]  surface glycoprotein, E1072Q</title>
	<circle cx="2014.1" cy="1562.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G24821T  Canada=2 [2.9%]  surface glycoprotein, A1087S</title>
	<circle cx="2023.2" cy="1566.5" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G25234T  Canada=20 [29.4%]  surface glycoprotein, L1224F</title>
	<circle cx="2107.2" cy="1603.9" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  C25427T  USA=2 [0.8%]  ORF3a protein, T12I</title>
	<circle cx="2146.5" cy="1621.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  C25433T  Canada=3 [4.4%]  ORF3a protein, T14I</title>
	<circle cx="2147.7" cy="1622.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  G25437T  USA=3 [1.2%]  ORF3a protein, L15F</title>
	<circle cx="2148.5" cy="1622.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24 USA: 211 samples</title>
	<line x1="1218.1" y1="1208.5" x2="1227.6" y2="1212.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-24 Canada: 42 samples</title>
	<line x1="1227.6" y1="1212.9" x2="1234.3" y2="1216.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-24  C21575T  USA=2 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1361.5" cy="1275.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  A22320G  USA=6 [2.8%]  surface glycoprotein, D253G</title>
	<circle cx="1511.9" cy="1345.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  C22550T  USA=4 [1.9%]  surface glycoprotein, P330S</title>
	<circle cx="1558.3" cy="1367.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  C23202T  USA=3 [1.4%]  surface glycoprotein, T547I</title>
	<circle cx="1689.9" cy="1428.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  A23403G  USA=198 [93.8%]  surface glycoprotein, D614G</title>
	<circle cx="1730.5" cy="1447.4" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  A23403G  USA=198 [93.8%] Canada=42 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1730.5" cy="1447.4" r="6.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  C23997T  USA=2 [0.9%]  surface glycoprotein, P812L</title>
	<circle cx="1850.4" cy="1503.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  G24368T  USA=2 [0.9%]  surface glycoprotein, D936Y</title>
	<circle cx="1925.2" cy="1538.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  G25217T  USA=2 [0.9%]  surface glycoprotein, G1219C</title>
	<circle cx="2096.6" cy="1618.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  G25234T  Canada=15 [35.7%]  surface glycoprotein, L1224F</title>
	<circle cx="2100.1" cy="1619.7" r="4.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25 USA: 111 samples</title>
	<line x1="1218.0" y1="1208.8" x2="1226.3" y2="1212.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-25 Canada: 50 samples</title>
	<line x1="1226.3" y1="1212.8" x2="1233.2" y2="1216.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-25 Mexico: 2 samples</title>
	<line x1="1233.2" y1="1216.2" x2="1235.1" y2="1217.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-25  A23403G  USA=101 [91.0%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="1456.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25  A23403G  USA=101 [91.0%] Canada=50 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="1456.6" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25  A23403G  USA=101 [91.0%] Canada=50 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="1456.6" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25  G25234T  Canada=17 [34.0%]  surface glycoprotein, L1224F</title>
	<circle cx="2092.6" cy="1635.3" r="4.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25  C25433T  Canada=2 [4.0%]  ORF3a protein, T14I</title>
	<circle cx="2132.4" cy="1654.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25  G25437T  USA=3 [2.7%]  ORF3a protein, L15F</title>
	<circle cx="2133.2" cy="1655.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26 USA: 92 samples</title>
	<line x1="1217.8" y1="1209.1" x2="1225.7" y2="1213.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-26 Canada: 58 samples</title>
	<line x1="1225.7" y1="1213.1" x2="1232.8" y2="1216.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-26  A22320G  USA=3 [3.3%]  surface glycoprotein, D253G</title>
	<circle cx="1506.6" cy="1356.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26  A23403G  USA=79 [85.9%]  surface glycoprotein, D614G</title>
	<circle cx="1721.5" cy="1465.7" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26  A23403G  USA=79 [85.9%] Canada=56 [96.6%]  surface glycoprotein, D614G</title>
	<circle cx="1721.5" cy="1465.7" r="7.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26  G25234T  Canada=16 [27.6%]  surface glycoprotein, L1224F</title>
	<circle cx="2084.9" cy="1650.9" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26  C25433T  Canada=3 [5.2%]  ORF3a protein, T14I</title>
	<circle cx="2124.3" cy="1671.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26  G25437T  USA=3 [3.3%]  ORF3a protein, L15F</title>
	<circle cx="2125.1" cy="1671.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26  C25465T  USA=2 [2.2%]  ORF3a protein, P25S</title>
	<circle cx="2130.7" cy="1674.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27 USA: 217 samples</title>
	<line x1="1217.7" y1="1209.4" x2="1227.0" y2="1214.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-27 Canada: 39 samples</title>
	<line x1="1227.0" y1="1214.3" x2="1233.3" y2="1217.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-27  C21621T  USA=2 [0.9%]  surface glycoprotein, T20I</title>
	<circle cx="1366.4" cy="1288.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  G22021A  USA=2 [0.9%]  surface glycoprotein, M153I</title>
	<circle cx="1445.0" cy="1330.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  A23403G  USA=199 [91.7%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="1474.8" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  A23403G  USA=199 [91.7%] Canada=38 [97.4%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="1474.8" r="6.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  A25121T  USA=2 [0.9%]  surface glycoprotein, N1187Y</title>
	<circle cx="2054.6" cy="1654.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  G25234T  Canada=16 [41.0%]  surface glycoprotein, L1224F</title>
	<circle cx="2076.9" cy="1666.2" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  A25335T  USA=2 [0.9%]  surface glycoprotein, E1258V</title>
	<circle cx="2096.7" cy="1676.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28 USA: 194 samples</title>
	<line x1="1217.5" y1="1209.7" x2="1226.5" y2="1214.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-28 Canada: 42 samples</title>
	<line x1="1226.5" y1="1214.7" x2="1232.9" y2="1218.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-28 Mexico: 2 samples</title>
	<line x1="1232.9" y1="1218.3" x2="1234.8" y2="1219.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-28  C21575T  Canada=2 [4.8%]  surface glycoprotein, L5F</title>
	<circle cx="1355.8" cy="1286.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  C21648T  USA=2 [1.0%]  surface glycoprotein, T29I</title>
	<circle cx="1370.1" cy="1294.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  C22224T  USA=2 [1.0%]  surface glycoprotein, S221L</title>
	<circle cx="1482.3" cy="1356.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  G23236T  USA=2 [1.0%]  surface glycoprotein, K558N</title>
	<circle cx="1679.4" cy="1465.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  A23403G  USA=181 [93.3%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="1483.8" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  A23403G  USA=181 [93.3%] Canada=40 [95.2%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="1483.8" r="6.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  A23403G  USA=181 [93.3%] Canada=40 [95.2%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="1483.8" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  G25234T  Canada=12 [28.6%]  surface glycoprotein, L1224F</title>
	<circle cx="2068.6" cy="1681.5" r="4.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  G25429T  USA=2 [1.0%]  ORF3a protein, V13L</title>
	<circle cx="2106.6" cy="1702.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  G25437T  USA=5 [2.6%]  ORF3a protein, L15F</title>
	<circle cx="2108.1" cy="1703.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29 USA: 257 samples</title>
	<line x1="1217.3" y1="1210.0" x2="1226.7" y2="1215.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29 Canada: 56 samples</title>
	<line x1="1226.7" y1="1215.4" x2="1233.6" y2="1219.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29 Mexico: 4 samples</title>
	<line x1="1233.6" y1="1219.4" x2="1236.3" y2="1220.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29  C21575T  USA=9 [3.5%]  surface glycoprotein, L5F</title>
	<circle cx="1354.3" cy="1289.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  C21575T  USA=9 [3.5%] Canada=2 [3.6%]  surface glycoprotein, L5F</title>
	<circle cx="1354.3" cy="1289.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G21578T  USA=4 [1.6%]  surface glycoprotein, V6F</title>
	<circle cx="1354.9" cy="1289.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  T21644C  Canada=4 [7.1%]  surface glycoprotein, Y28H</title>
	<circle cx="1367.6" cy="1296.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  C21648T  USA=3 [1.2%]  surface glycoprotein, T29I</title>
	<circle cx="1368.4" cy="1297.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G21800A  Canada=2 [3.6%]  surface glycoprotein, D80N</title>
	<circle cx="1397.7" cy="1314.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A22320G  USA=2 [0.8%]  surface glycoprotein, D253G</title>
	<circle cx="1498.0" cy="1372.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A23403G  USA=243 [94.6%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="9.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A23403G  USA=243 [94.6%] Canada=55 [98.2%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="7.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A23403G  USA=243 [94.6%] Canada=55 [98.2%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G24075A  USA=3 [1.2%]  surface glycoprotein, G838D</title>
	<circle cx="1836.5" cy="1567.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G24368T  USA=2 [0.8%]  surface glycoprotein, D936Y</title>
	<circle cx="1893.0" cy="1600.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A25121T  USA=2 [0.8%]  surface glycoprotein, N1187Y</title>
	<circle cx="2038.3" cy="1684.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G25217T  Canada=2 [3.6%]  surface glycoprotein, G1219C</title>
	<circle cx="2056.8" cy="1694.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G25234T  Canada=20 [35.7%]  surface glycoprotein, L1224F</title>
	<circle cx="2060.0" cy="1696.5" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G25429T  USA=4 [1.6%]  ORF3a protein, V13L</title>
	<circle cx="2097.7" cy="1718.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  C25433T  Canada=3 [5.4%]  ORF3a protein, T14I</title>
	<circle cx="2098.4" cy="1718.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  C25463T  Canada=2 [3.6%]  ORF3a protein, T24I</title>
	<circle cx="2104.2" cy="1722.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  T25468G  USA=2 [0.8%]  ORF3a protein, S26A</title>
	<circle cx="2105.2" cy="1722.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30 USA: 316 samples</title>
	<line x1="1217.1" y1="1210.3" x2="1226.8" y2="1216.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30 Canada: 33 samples</title>
	<line x1="1226.8" y1="1216.1" x2="1232.7" y2="1219.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30  C21575T  USA=3 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1352.7" cy="1291.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G21578T  USA=2 [0.6%]  surface glycoprotein, V6F</title>
	<circle cx="1353.3" cy="1292.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  T21644C  Canada=3 [9.1%]  surface glycoprotein, Y28H</title>
	<circle cx="1365.9" cy="1299.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  C22208T  USA=8 [2.5%]  surface glycoprotein, L216F</title>
	<circle cx="1473.6" cy="1364.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  C22224T  USA=2 [0.6%]  surface glycoprotein, S221L</title>
	<circle cx="1476.6" cy="1366.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A22320G  USA=7 [2.2%]  surface glycoprotein, D253G</title>
	<circle cx="1494.9" cy="1377.2" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G22335T  USA=2 [0.6%]  surface glycoprotein, W258L</title>
	<circle cx="1497.8" cy="1378.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  C22879A  USA=2 [0.6%]  surface glycoprotein, N439K</title>
	<circle cx="1601.7" cy="1441.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  C23220T  USA=2 [0.6%]  surface glycoprotein, T553I</title>
	<circle cx="1666.8" cy="1480.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A23403G  USA=292 [92.4%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="9.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A23403G  USA=292 [92.4%] Canada=33 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G23522A  USA=2 [0.6%]  surface glycoprotein, E654K</title>
	<circle cx="1724.4" cy="1515.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G24075A  USA=2 [0.6%]  surface glycoprotein, G838D</title>
	<circle cx="1830.0" cy="1578.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G24236T  Canada=3 [9.1%]  surface glycoprotein, A892S</title>
	<circle cx="1860.7" cy="1597.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G24368T  USA=2 [0.6%]  surface glycoprotein, D936Y</title>
	<circle cx="1885.9" cy="1612.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  C24863T  USA=3 [0.9%]  surface glycoprotein, H1101Y</title>
	<circle cx="1980.4" cy="1668.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G25177T  USA=2 [0.6%]  surface glycoprotein, K1205N</title>
	<circle cx="2040.4" cy="1704.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G25217T  Canada=3 [9.1%]  surface glycoprotein, G1219C</title>
	<circle cx="2048.0" cy="1709.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A25335T  USA=2 [0.6%]  surface glycoprotein, E1258V</title>
	<circle cx="2070.5" cy="1723.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G25396T  USA=2 [0.6%]  ORF3a protein, D2Y</title>
	<circle cx="2082.2" cy="1730.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  C25433T  Canada=2 [6.1%]  ORF3a protein, T14I</title>
	<circle cx="2089.2" cy="1734.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G25437T  USA=6 [1.9%]  ORF3a protein, L15F</title>
	<circle cx="2090.0" cy="1734.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G25455T  USA=2 [0.6%]  ORF3a protein, K21N</title>
	<circle cx="2093.4" cy="1736.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01 USA: 238 samples</title>
	<line x1="1217.0" y1="1210.6" x2="1226.0" y2="1216.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-01 Canada: 34 samples</title>
	<line x1="1226.0" y1="1216.3" x2="1231.9" y2="1220.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-01  C21575T  Canada=4 [11.8%]  surface glycoprotein, L5F</title>
	<circle cx="1351.1" cy="1294.4" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C21575T  USA=3 [1.3%]  surface glycoprotein, L5F</title>
	<circle cx="1351.1" cy="1294.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  G21578T  USA=2 [0.8%]  surface glycoprotein, V6F</title>
	<circle cx="1351.7" cy="1294.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C21627A  USA=13 [5.5%]  surface glycoprotein, T22N</title>
	<circle cx="1360.9" cy="1300.6" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  T21644C  Canada=3 [8.8%]  surface glycoprotein, Y28H</title>
	<circle cx="1364.1" cy="1302.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C21648T  USA=2 [0.8%]  surface glycoprotein, T29I</title>
	<circle cx="1364.9" cy="1303.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C21714T  USA=2 [0.8%]  surface glycoprotein, T51I</title>
	<circle cx="1377.4" cy="1310.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  T22220C  USA=3 [1.3%]  surface glycoprotein, F220L</title>
	<circle cx="1472.9" cy="1370.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C22295T  USA=2 [0.8%]  surface glycoprotein, H245Y</title>
	<circle cx="1487.1" cy="1379.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  A22320G  USA=3 [1.3%]  surface glycoprotein, D253G</title>
	<circle cx="1491.8" cy="1382.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C22550T  USA=3 [1.3%]  surface glycoprotein, P330S</title>
	<circle cx="1535.3" cy="1409.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  A23403G  USA=208 [87.4%]  surface glycoprotein, D614G</title>
	<circle cx="1696.4" cy="1510.2" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  A23403G  USA=208 [87.4%] Canada=34 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1696.4" cy="1510.2" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  A23586G  USA=2 [0.8%]  surface glycoprotein, Q675R</title>
	<circle cx="1730.9" cy="1531.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C23655T  USA=13 [5.5%]  surface glycoprotein, S698L</title>
	<circle cx="1744.0" cy="1539.9" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  A24014G  USA=2 [0.8%]  surface glycoprotein, I818V</title>
	<circle cx="1811.8" cy="1582.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C24381T  USA=2 [0.8%]  surface glycoprotein, S940F</title>
	<circle cx="1881.1" cy="1625.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  G25234T  Canada=5 [14.7%]  surface glycoprotein, L1224F</title>
	<circle cx="2042.2" cy="1726.3" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  G25396T  USA=2 [0.8%]  ORF3a protein, D2Y</title>
	<circle cx="2072.8" cy="1745.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C25433T  Canada=10 [29.4%]  ORF3a protein, T14I</title>
	<circle cx="2079.8" cy="1749.7" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  C25463T  Canada=2 [5.9%]  ORF3a protein, T24I</title>
	<circle cx="2085.4" cy="1753.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02 USA: 107 samples</title>
	<line x1="1216.8" y1="1210.9" x2="1224.4" y2="1215.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-02 Canada: 18 samples</title>
	<line x1="1224.4" y1="1215.9" x2="1229.3" y2="1219.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-02  G22770A  USA=3 [2.8%]  surface glycoprotein, R403K</title>
	<circle cx="1572.6" cy="1442.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02  A23403G  USA=104 [97.2%]  surface glycoprotein, D614G</title>
	<circle cx="1690.9" cy="1518.8" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02  A23403G  USA=104 [97.2%] Canada=18 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1690.9" cy="1518.8" r="5.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02  G25234T  Canada=3 [16.7%]  surface glycoprotein, L1224F</title>
	<circle cx="2032.9" cy="1740.9" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02  C25433T  Canada=2 [11.1%]  ORF3a protein, T14I</title>
	<circle cx="2070.1" cy="1765.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02  G25459T  USA=3 [2.8%]  ORF3a protein, A23S</title>
	<circle cx="2074.9" cy="1768.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03 USA: 84 samples</title>
	<line x1="1216.6" y1="1211.2" x2="1223.8" y2="1216.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-03 Canada: 36 samples</title>
	<line x1="1223.8" y1="1216.0" x2="1229.6" y2="1220.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-03  C21575T  Canada=2 [5.6%]  surface glycoprotein, L5F</title>
	<circle cx="1347.7" cy="1299.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  T21644C  Canada=4 [11.1%]  surface glycoprotein, Y28H</title>
	<circle cx="1360.5" cy="1308.2" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  G22793T  USA=2 [2.4%]  surface glycoprotein, A411S</title>
	<circle cx="1572.6" cy="1451.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  A23403G  USA=83 [98.8%]  surface glycoprotein, D614G</title>
	<circle cx="1685.2" cy="1527.3" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  A23403G  USA=83 [98.8%] Canada=36 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1685.2" cy="1527.3" r="6.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  A23586G  USA=2 [2.4%]  surface glycoprotein, Q675R</title>
	<circle cx="1719.0" cy="1550.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  G25234T  Canada=2 [5.6%]  surface glycoprotein, L1224F</title>
	<circle cx="2023.3" cy="1755.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  G25429T  USA=2 [2.4%]  ORF3a protein, V13L</title>
	<circle cx="2059.3" cy="1779.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  C25433T  Canada=5 [13.9%]  ORF3a protein, T14I</title>
	<circle cx="2060.1" cy="1780.1" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03  C25463T  Canada=3 [8.3%]  ORF3a protein, T24I</title>
	<circle cx="2065.6" cy="1783.9" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04 USA: 273 samples</title>
	<line x1="1216.4" y1="1211.5" x2="1225.4" y2="1217.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-04 Canada: 31 samples</title>
	<line x1="1225.4" y1="1217.8" x2="1230.9" y2="1221.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-04  T21644C  Canada=2 [6.5%]  surface glycoprotein, Y28H</title>
	<circle cx="1358.5" cy="1311.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  T21656C  USA=2 [0.7%]  surface glycoprotein, F32L</title>
	<circle cx="1360.7" cy="1312.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  A22320G  USA=3 [1.1%]  surface glycoprotein, D253G</title>
	<circle cx="1481.9" cy="1397.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  A23403G  USA=258 [94.5%]  surface glycoprotein, D614G</title>
	<circle cx="1679.5" cy="1535.7" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  A23403G  USA=258 [94.5%] Canada=31 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1679.5" cy="1535.7" r="6.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  C23457T  USA=2 [0.7%]  surface glycoprotein, T632I</title>
	<circle cx="1689.3" cy="1542.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  A24129G  USA=9 [3.3%]  surface glycoprotein, N856S</title>
	<circle cx="1811.9" cy="1628.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  G24666T  Canada=2 [6.5%]  surface glycoprotein, G1035V</title>
	<circle cx="1909.9" cy="1697.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  G24914T  USA=2 [0.7%]  surface glycoprotein, D1118Y</title>
	<circle cx="1955.1" cy="1728.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  G25244C  USA=2 [0.7%]  surface glycoprotein, V1228L</title>
	<circle cx="2015.3" cy="1770.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  C25463T  Canada=4 [12.9%]  ORF3a protein, T24I</title>
	<circle cx="2055.3" cy="1798.9" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05 USA: 159 samples</title>
	<line x1="1216.2" y1="1211.8" x2="1224.2" y2="1217.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-05 Canada: 31 samples</title>
	<line x1="1224.2" y1="1217.6" x2="1229.7" y2="1221.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-05  C21575T  Canada=4 [12.9%]  surface glycoprotein, L5F</title>
	<circle cx="1344.1" cy="1304.7" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  G22205T  USA=2 [1.3%]  surface glycoprotein, D215Y</title>
	<circle cx="1457.7" cy="1387.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  G22770A  USA=5 [3.1%]  surface glycoprotein, R403K</title>
	<circle cx="1559.5" cy="1461.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  A23403G  USA=143 [89.9%]  surface glycoprotein, D614G</title>
	<circle cx="1673.5" cy="1544.0" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  A23403G  USA=143 [89.9%] Canada=31 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1673.5" cy="1544.0" r="6.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  A24129G  USA=3 [1.9%]  surface glycoprotein, N856S</title>
	<circle cx="1804.3" cy="1639.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  C25433T  Canada=10 [32.3%]  ORF3a protein, T14I</title>
	<circle cx="2039.3" cy="1809.8" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  G25455T  USA=3 [1.9%]  ORF3a protein, K21N</title>
	<circle cx="2043.3" cy="1812.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  G25459T  USA=5 [3.1%]  ORF3a protein, A23S</title>
	<circle cx="2044.0" cy="1813.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  C25463T  Canada=2 [6.5%]  ORF3a protein, T24I</title>
	<circle cx="2044.7" cy="1813.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06 USA: 168 samples</title>
	<line x1="1216.0" y1="1212.0" x2="1224.0" y2="1218.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-06 Canada: 34 samples</title>
	<line x1="1224.0" y1="1218.1" x2="1229.5" y2="1222.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-06 Dominican Republic: 2 samples</title>
	<line x1="1229.5" y1="1222.3" x2="1231.2" y2="1223.5" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-06  C21575T  Canada=3 [8.8%]  surface glycoprotein, L5F</title>
	<circle cx="1342.3" cy="1307.2" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  T21644C  Canada=2 [5.9%]  surface glycoprotein, Y28H</title>
	<circle cx="1354.6" cy="1316.5" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  C22224T  USA=2 [1.2%]  surface glycoprotein, S221L</title>
	<circle cx="1457.7" cy="1394.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  G22793T  USA=2 [1.2%]  surface glycoprotein, A411S</title>
	<circle cx="1558.9" cy="1470.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  C23277T  USA=10 [6.0%]  surface glycoprotein, T572I</title>
	<circle cx="1645.0" cy="1535.4" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  A23403G  USA=154 [91.7%]  surface glycoprotein, D614G</title>
	<circle cx="1667.4" cy="1552.2" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  A23403G  USA=154 [91.7%] Canada=33 [97.1%]  surface glycoprotein, D614G</title>
	<circle cx="1667.4" cy="1552.2" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  A23403G  USA=154 [91.7%] Canada=33 [97.1%] Dominican Republic=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1667.4" cy="1552.2" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  G24236T  Canada=2 [5.9%]  surface glycoprotein, A892S</title>
	<circle cx="1815.6" cy="1663.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  G25217T  Canada=2 [5.9%]  surface glycoprotein, G1219C</title>
	<circle cx="1990.1" cy="1795.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  G25234T  Canada=2 [5.9%]  surface glycoprotein, L1224F</title>
	<circle cx="1993.1" cy="1797.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  C25350T  Canada=2 [5.9%]  surface glycoprotein, P1263L</title>
	<circle cx="2013.8" cy="1813.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  C25433T  Canada=12 [35.3%]  ORF3a protein, T14I</title>
	<circle cx="2028.5" cy="1824.3" r="4.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07 USA: 159 samples</title>
	<line x1="1215.8" y1="1212.3" x2="1223.6" y2="1218.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-07 Canada: 43 samples</title>
	<line x1="1223.6" y1="1218.4" x2="1229.4" y2="1223.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-07 Mexico: 2 samples</title>
	<line x1="1229.4" y1="1223.0" x2="1231.1" y2="1224.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-07  C21575T  Canada=3 [7.0%]  surface glycoprotein, L5F</title>
	<circle cx="1340.4" cy="1309.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  T21644C  Canada=7 [16.3%]  surface glycoprotein, Y28H</title>
	<circle cx="1352.5" cy="1319.2" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  A22320G  USA=2 [1.3%]  surface glycoprotein, D253G</title>
	<circle cx="1471.2" cy="1411.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G22484T  USA=2 [1.3%]  surface glycoprotein, V308L</title>
	<circle cx="1499.9" cy="1434.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G22894T  Canada=2 [4.7%]  surface glycoprotein, K444N</title>
	<circle cx="1571.9" cy="1490.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G23224T  USA=2 [1.3%]  surface glycoprotein, E554D</title>
	<circle cx="1629.8" cy="1535.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  A23403G  USA=157 [98.7%]  surface glycoprotein, D614G</title>
	<circle cx="1661.2" cy="1560.3" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  A23403G  USA=157 [98.7%] Canada=42 [97.7%]  surface glycoprotein, D614G</title>
	<circle cx="1661.2" cy="1560.3" r="6.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  A23403G  USA=157 [98.7%] Canada=42 [97.7%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1661.2" cy="1560.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  C23934A  USA=2 [1.3%]  surface glycoprotein, T791K</title>
	<circle cx="1754.4" cy="1633.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G24236T  Canada=2 [4.7%]  surface glycoprotein, A892S</title>
	<circle cx="1807.4" cy="1674.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G25062T  Canada=2 [4.7%]  surface glycoprotein, G1167V</title>
	<circle cx="1952.4" cy="1787.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G25217T  Canada=2 [4.7%]  surface glycoprotein, G1219C</title>
	<circle cx="1979.6" cy="1809.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G25234T  Canada=2 [4.7%]  surface glycoprotein, L1224F</title>
	<circle cx="1982.6" cy="1811.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G25429T  USA=3 [1.9%]  ORF3a protein, V13L</title>
	<circle cx="2016.8" cy="1838.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  C25433T  Canada=8 [18.6%]  ORF3a protein, T14I</title>
	<circle cx="2017.5" cy="1838.7" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08 USA: 149 samples</title>
	<line x1="1215.5" y1="1212.6" x2="1223.2" y2="1218.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-08 Canada: 43 samples</title>
	<line x1="1223.2" y1="1218.7" x2="1228.9" y2="1223.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-08 Mexico: 2 samples</title>
	<line x1="1228.9" y1="1223.4" x2="1230.6" y2="1224.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-08  C21575T  Canada=2 [4.7%]  surface glycoprotein, L5F</title>
	<circle cx="1338.5" cy="1312.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  A22320G  USA=9 [6.0%]  surface glycoprotein, D253G</title>
	<circle cx="1467.4" cy="1416.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  C22550T  USA=2 [1.3%]  surface glycoprotein, P330S</title>
	<circle cx="1507.2" cy="1448.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  C23124G  USA=2 [1.3%]  surface glycoprotein, P521R</title>
	<circle cx="1606.6" cy="1529.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  A23403G  USA=146 [98.0%]  surface glycoprotein, D614G</title>
	<circle cx="1654.9" cy="1568.3" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  A23403G  USA=146 [98.0%] Canada=42 [97.7%]  surface glycoprotein, D614G</title>
	<circle cx="1654.9" cy="1568.3" r="6.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  A23403G  USA=146 [98.0%] Canada=42 [97.7%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1654.9" cy="1568.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  G24236T  Canada=2 [4.7%]  surface glycoprotein, A892S</title>
	<circle cx="1799.0" cy="1685.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  C24378T  USA=2 [1.3%]  surface glycoprotein, S939F</title>
	<circle cx="1823.6" cy="1705.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  G25217T  Canada=2 [4.7%]  surface glycoprotein, G1219C</title>
	<circle cx="1968.8" cy="1822.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  G25234T  Canada=2 [4.7%]  surface glycoprotein, L1224F</title>
	<circle cx="1971.8" cy="1825.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  C25433T  Canada=10 [23.3%]  ORF3a protein, T14I</title>
	<circle cx="2006.2" cy="1852.9" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  G25444T  USA=2 [1.3%]  ORF3a protein, G18C</title>
	<circle cx="2008.1" cy="1854.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  C25466T  USA=15 [10.1%]  ORF3a protein, P25L</title>
	<circle cx="2011.9" cy="1857.5" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09 USA: 70 samples</title>
	<line x1="1215.3" y1="1212.9" x2="1221.7" y2="1218.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-09 Canada: 31 samples</title>
	<line x1="1221.7" y1="1218.2" x2="1226.9" y2="1222.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-09  C21575T  Canada=3 [9.7%]  surface glycoprotein, L5F</title>
	<circle cx="1336.5" cy="1314.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  A22320G  USA=2 [2.9%]  surface glycoprotein, D253G</title>
	<circle cx="1463.6" cy="1421.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  A23403G  USA=69 [98.6%]  surface glycoprotein, D614G</title>
	<circle cx="1648.4" cy="1576.2" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  A23403G  USA=69 [98.6%] Canada=31 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1648.4" cy="1576.2" r="6.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  C24378T  USA=3 [4.3%]  surface glycoprotein, S939F</title>
	<circle cx="1814.7" cy="1715.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  G24821T  Canada=3 [9.7%]  surface glycoprotein, A1087S</title>
	<circle cx="1890.3" cy="1779.2" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  C25433T  Canada=11 [35.5%]  ORF3a protein, T14I</title>
	<circle cx="1994.7" cy="1866.8" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-10 USA: 35 samples</title>
	<line x1="1215.1" y1="1213.1" x2="1220.4" y2="1217.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-10 Canada: 20 samples</title>
	<line x1="1220.4" y1="1217.7" x2="1224.9" y2="1221.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-10  T21644C  Canada=3 [15.0%]  surface glycoprotein, Y28H</title>
	<circle cx="1346.1" cy="1327.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-10  A23403G  USA=34 [97.1%]  surface glycoprotein, D614G</title>
	<circle cx="1641.7" cy="1584.0" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-10  A23403G  USA=34 [97.1%] Canada=19 [95.0%]  surface glycoprotein, D614G</title>
	<circle cx="1641.7" cy="1584.0" r="5.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-10  C25433T  Canada=3 [15.0%]  ORF3a protein, T14I</title>
	<circle cx="1982.9" cy="1880.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11 USA: 170 samples</title>
	<line x1="1214.9" y1="1213.4" x2="1222.3" y2="1220.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-11 Canada: 28 samples</title>
	<line x1="1222.3" y1="1220.1" x2="1227.2" y2="1224.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-11 Mexico: 2 samples</title>
	<line x1="1227.2" y1="1224.5" x2="1228.8" y2="1225.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-11  C21575T  Canada=2 [7.1%]  surface glycoprotein, L5F</title>
	<circle cx="1332.4" cy="1319.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  C21575T  USA=2 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1332.4" cy="1319.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A22320G  USA=16 [9.4%]  surface glycoprotein, D253G</title>
	<circle cx="1455.7" cy="1430.2" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  C23202T  USA=2 [1.2%]  surface glycoprotein, T547I</title>
	<circle cx="1601.7" cy="1561.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A23403G  USA=164 [96.5%]  surface glycoprotein, D614G</title>
	<circle cx="1635.0" cy="1591.6" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A23403G  USA=164 [96.5%] Canada=28 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1635.0" cy="1591.6" r="5.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A23403G  USA=164 [96.5%] Canada=28 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1635.0" cy="1591.6" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A23923C  Canada=2 [7.1%]  surface glycoprotein, Q787H</title>
	<circle cx="1721.0" cy="1669.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  C23934A  USA=2 [1.2%]  surface glycoprotein, T791K</title>
	<circle cx="1722.8" cy="1670.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  G24095T  USA=2 [1.2%]  surface glycoprotein, A845S</title>
	<circle cx="1749.5" cy="1694.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  C25433T  Canada=8 [28.6%]  ORF3a protein, T14I</title>
	<circle cx="1971.0" cy="1894.2" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  G25444T  USA=2 [1.2%]  ORF3a protein, G18C</title>
	<circle cx="1972.8" cy="1895.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  C25487T  USA=2 [1.2%]  ORF3a protein, T32I</title>
	<circle cx="1979.9" cy="1902.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12 USA: 194 samples</title>
	<line x1="1214.6" y1="1213.6" x2="1222.2" y2="1220.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-12 Canada: 32 samples</title>
	<line x1="1222.2" y1="1220.7" x2="1227.2" y2="1225.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-12  G21641T  Canada=5 [15.6%]  surface glycoprotein, A27S</title>
	<circle cx="1341.1" cy="1331.5" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  A22320G  USA=17 [8.8%]  surface glycoprotein, D253G</title>
	<circle cx="1451.7" cy="1434.7" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  G22331A  USA=2 [1.0%]  surface glycoprotein, G257S</title>
	<circle cx="1453.4" cy="1436.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  G22349A  USA=2 [1.0%]  surface glycoprotein, A263T</title>
	<circle cx="1456.4" cy="1439.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  C22502A  USA=2 [1.0%]  surface glycoprotein, Q314K</title>
	<circle cx="1481.3" cy="1462.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  C23277T  USA=5 [2.6%]  surface glycoprotein, T572I</title>
	<circle cx="1607.5" cy="1580.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  A23403G  USA=171 [88.1%]  surface glycoprotein, D614G</title>
	<circle cx="1628.1" cy="1599.2" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  A23403G  USA=171 [88.1%] Canada=30 [93.8%]  surface glycoprotein, D614G</title>
	<circle cx="1628.1" cy="1599.2" r="5.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  C24378T  USA=2 [1.0%]  surface glycoprotein, S939F</title>
	<circle cx="1786.9" cy="1747.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  C24909A  USA=2 [1.0%]  surface glycoprotein, T1116N</title>
	<circle cx="1873.4" cy="1827.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  G25234T  Canada=4 [12.5%]  surface glycoprotein, L1224F</title>
	<circle cx="1926.3" cy="1877.3" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  G25244T  USA=2 [1.0%]  surface glycoprotein, V1228L</title>
	<circle cx="1927.9" cy="1878.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  C25433T  Canada=8 [25.0%]  ORF3a protein, T14I</title>
	<circle cx="1958.7" cy="1907.5" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  G25444T  USA=3 [1.5%]  ORF3a protein, G18C</title>
	<circle cx="1960.5" cy="1909.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13 USA: 242 samples</title>
	<line x1="1214.4" y1="1213.9" x2="1222.1" y2="1221.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-13 Canada: 33 samples</title>
	<line x1="1222.1" y1="1221.4" x2="1227.1" y2="1226.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-13  C21575T  USA=3 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1328.2" cy="1323.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  C22208T  USA=2 [0.8%]  surface glycoprotein, L216F</title>
	<circle cx="1429.6" cy="1421.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  A22320G  USA=19 [7.9%]  surface glycoprotein, D253G</title>
	<circle cx="1447.5" cy="1439.0" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  G22349A  USA=2 [0.8%]  surface glycoprotein, A263T</title>
	<circle cx="1452.2" cy="1443.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  A23403G  USA=233 [96.3%]  surface glycoprotein, D614G</title>
	<circle cx="1621.0" cy="1606.6" r="9.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  A23403G  USA=233 [96.3%] Canada=33 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1621.0" cy="1606.6" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  G24328C  USA=5 [2.1%]  surface glycoprotein, L922F</title>
	<circle cx="1769.2" cy="1749.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  C24909A  USA=2 [0.8%]  surface glycoprotein, T1116N</title>
	<circle cx="1862.3" cy="1839.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  G25217T  Canada=7 [21.2%]  surface glycoprotein, G1219C</title>
	<circle cx="1911.6" cy="1887.2" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  G25234T  Canada=3 [9.1%]  surface glycoprotein, L1224F</title>
	<circle cx="1914.4" cy="1889.9" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  G25244T  USA=3 [1.2%]  surface glycoprotein, V1228L</title>
	<circle cx="1916.0" cy="1891.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  C25433T  Canada=7 [21.2%]  ORF3a protein, T14I</title>
	<circle cx="1946.3" cy="1920.7" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  G25444T  USA=3 [1.2%]  ORF3a protein, G18C</title>
	<circle cx="1948.0" cy="1922.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14 USA: 261 samples</title>
	<line x1="1214.1" y1="1214.1" x2="1221.8" y2="1221.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-14 Canada: 45 samples</title>
	<line x1="1221.8" y1="1221.8" x2="1227.1" y2="1227.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-14 Mexico: 5 samples</title>
	<line x1="1227.1" y1="1227.1" x2="1229.6" y2="1229.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-14  C21575T  Canada=2 [4.4%]  surface glycoprotein, L5F</title>
	<circle cx="1326.0" cy="1326.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  T21644C  Canada=6 [13.3%]  surface glycoprotein, Y28H</title>
	<circle cx="1336.9" cy="1336.9" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  T22220C  USA=5 [1.9%]  surface glycoprotein, F220L</title>
	<circle cx="1427.6" cy="1427.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  A22320G  USA=18 [6.9%]  surface glycoprotein, D253G</title>
	<circle cx="1443.3" cy="1443.3" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G22349A  USA=2 [0.8%]  surface glycoprotein, A263T</title>
	<circle cx="1447.9" cy="1447.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  A23403G  USA=257 [98.5%]  surface glycoprotein, D614G</title>
	<circle cx="1613.9" cy="1613.9" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  A23403G  USA=257 [98.5%] Canada=45 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1613.9" cy="1613.9" r="6.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  A23403G  USA=257 [98.5%] Canada=45 [100.0%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1613.9" cy="1613.9" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  C23934A  USA=2 [0.8%]  surface glycoprotein, T791K</title>
	<circle cx="1697.5" cy="1697.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G24236T  Canada=4 [8.9%]  surface glycoprotein, A892S</title>
	<circle cx="1745.1" cy="1745.1" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G24328C  USA=2 [0.8%]  surface glycoprotein, L922F</title>
	<circle cx="1759.5" cy="1759.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G24368C  USA=2 [0.8%]  surface glycoprotein, D936H</title>
	<circle cx="1765.8" cy="1765.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G25217T  Canada=4 [8.9%]  surface glycoprotein, G1219C</title>
	<circle cx="1899.5" cy="1899.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G25234T  Canada=2 [4.4%]  surface glycoprotein, L1224F</title>
	<circle cx="1902.2" cy="1902.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G25244T  USA=2 [0.8%]  surface glycoprotein, V1228L</title>
	<circle cx="1903.8" cy="1903.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G25429T  USA=2 [0.8%]  ORF3a protein, V13L</title>
	<circle cx="1932.9" cy="1932.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  C25433T  Canada=5 [11.1%]  ORF3a protein, T14I</title>
	<circle cx="1933.6" cy="1933.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  G25444A  Canada=3 [6.7%]  ORF3a protein, G18S</title>
	<circle cx="1935.3" cy="1935.3" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  C25463T  Canada=5 [11.1%]  ORF3a protein, T24I</title>
	<circle cx="1938.3" cy="1938.3" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15 USA: 189 samples</title>
	<line x1="1213.9" y1="1214.4" x2="1221.0" y2="1221.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-15 Canada: 32 samples</title>
	<line x1="1221.0" y1="1221.8" x2="1225.8" y2="1226.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-15 Mexico: 4 samples</title>
	<line x1="1225.8" y1="1226.7" x2="1227.9" y2="1228.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-15  C21575T  USA=2 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1323.8" cy="1328.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  T21644C  Canada=3 [9.4%]  surface glycoprotein, Y28H</title>
	<circle cx="1334.4" cy="1339.2" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  T22220C  USA=2 [1.1%]  surface glycoprotein, F220L</title>
	<circle cx="1423.6" cy="1431.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  C22295T  USA=2 [1.1%]  surface glycoprotein, H245Y</title>
	<circle cx="1435.2" cy="1443.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  A22320G  USA=23 [12.2%]  surface glycoprotein, D253G</title>
	<circle cx="1439.0" cy="1447.5" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  C22502A  USA=2 [1.1%]  surface glycoprotein, Q314K</title>
	<circle cx="1467.2" cy="1476.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  C23277T  USA=6 [3.2%]  surface glycoprotein, T572I</title>
	<circle cx="1587.1" cy="1600.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  G23311T  USA=4 [2.1%]  surface glycoprotein, E583D</title>
	<circle cx="1592.4" cy="1606.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  A23403G  USA=186 [98.4%]  surface glycoprotein, D614G</title>
	<circle cx="1606.6" cy="1621.0" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  A23403G  USA=186 [98.4%] Canada=32 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1606.6" cy="1621.0" r="6.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  A23403G  USA=186 [98.4%] Canada=32 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1606.6" cy="1621.0" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  C23601T  USA=2 [1.1%]  surface glycoprotein, S680F</title>
	<circle cx="1637.2" cy="1652.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  G23628T  USA=2 [1.1%]  surface glycoprotein, S689I</title>
	<circle cx="1641.4" cy="1657.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  G24236T  Canada=4 [12.5%]  surface glycoprotein, A892S</title>
	<circle cx="1735.5" cy="1754.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  G25217T  Canada=5 [15.6%]  surface glycoprotein, G1219C</title>
	<circle cx="1887.2" cy="1911.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  G25396T  USA=2 [1.1%]  ORF3a protein, D2Y</title>
	<circle cx="1914.9" cy="1940.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  C25433T  Canada=6 [18.8%]  ORF3a protein, T14I</title>
	<circle cx="1920.7" cy="1946.3" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  G25444A  Canada=3 [9.4%]  ORF3a protein, G18S</title>
	<circle cx="1922.4" cy="1948.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-15  C25463T  Canada=5 [15.6%]  ORF3a protein, T24I</title>
	<circle cx="1925.3" cy="1951.1" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16 USA: 80 samples</title>
	<line x1="1213.6" y1="1214.6" x2="1219.5" y2="1220.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-16 Canada: 31 samples</title>
	<line x1="1219.5" y1="1220.9" x2="1224.1" y2="1225.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-16  C22295T  USA=5 [6.2%]  surface glycoprotein, H245Y</title>
	<circle cx="1430.9" cy="1447.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16  A22320G  USA=6 [7.5%]  surface glycoprotein, D253G</title>
	<circle cx="1434.7" cy="1451.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16  A23403G  USA=79 [98.8%]  surface glycoprotein, D614G</title>
	<circle cx="1599.2" cy="1628.1" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16  A23403G  USA=79 [98.8%] Canada=31 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1599.2" cy="1628.1" r="6.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16  G25217T  Canada=11 [35.5%]  surface glycoprotein, G1219C</title>
	<circle cx="1874.7" cy="1923.5" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16  G25249T  USA=3 [3.8%]  surface glycoprotein, M1229I</title>
	<circle cx="1879.6" cy="1928.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16  C25433T  Canada=3 [9.7%]  ORF3a protein, T14I</title>
	<circle cx="1907.5" cy="1958.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17 USA: 59 samples</title>
	<line x1="1213.4" y1="1214.9" x2="1218.7" y2="1220.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-17 Canada: 20 samples</title>
	<line x1="1218.7" y1="1220.8" x2="1222.7" y2="1225.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-17  C21575T  Canada=4 [20.0%]  surface glycoprotein, L5F</title>
	<circle cx="1319.2" cy="1332.4" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17  A22320G  USA=4 [6.8%]  surface glycoprotein, D253G</title>
	<circle cx="1430.2" cy="1455.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17  A23403G  USA=57 [96.6%]  surface glycoprotein, D614G</title>
	<circle cx="1591.6" cy="1635.0" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17  A23403G  USA=57 [96.6%] Canada=20 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1591.6" cy="1635.0" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17  G24328C  USA=3 [5.1%]  surface glycoprotein, L922F</title>
	<circle cx="1729.5" cy="1788.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17  G25234T  Canada=5 [25.0%]  surface glycoprotein, L1224F</title>
	<circle cx="1864.5" cy="1938.0" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17  C25433T  Canada=3 [15.0%]  ORF3a protein, T14I</title>
	<circle cx="1894.2" cy="1971.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-17  C25463T  Canada=2 [10.0%]  ORF3a protein, T24I</title>
	<circle cx="1898.6" cy="1975.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18 USA: 207 samples</title>
	<line x1="1213.1" y1="1215.1" x2="1220.0" y2="1223.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-18 Canada: 16 samples</title>
	<line x1="1220.0" y1="1223.0" x2="1223.6" y2="1227.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-18 Mexico: 3 samples</title>
	<line x1="1223.6" y1="1227.1" x2="1225.4" y2="1229.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-18  C21575T  USA=2 [1.0%]  surface glycoprotein, L5F</title>
	<circle cx="1316.9" cy="1334.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  T21644C  Canada=2 [12.5%]  surface glycoprotein, Y28H</title>
	<circle cx="1327.0" cy="1346.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  C21707T  USA=2 [1.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1336.2" cy="1356.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  G22319T  USA=3 [1.4%]  surface glycoprotein, D253Y</title>
	<circle cx="1425.6" cy="1459.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  A22320G  USA=21 [10.1%]  surface glycoprotein, D253G</title>
	<circle cx="1425.7" cy="1459.7" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  C22502A  USA=2 [1.0%]  surface glycoprotein, Q314K</title>
	<circle cx="1452.3" cy="1490.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  A23403G  USA=198 [95.7%]  surface glycoprotein, D614G</title>
	<circle cx="1584.0" cy="1641.7" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  A23403G  USA=198 [95.7%] Canada=15 [93.8%]  surface glycoprotein, D614G</title>
	<circle cx="1584.0" cy="1641.7" r="4.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  A23403G  USA=198 [95.7%] Canada=15 [93.8%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1584.0" cy="1641.7" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  C23604T  USA=4 [1.9%]  surface glycoprotein, P681L</title>
	<circle cx="1613.4" cy="1675.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  A23756G  Mexico=2 [66.7%]  surface glycoprotein, T732A</title>
	<circle cx="1635.6" cy="1701.1" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  G25217T  Canada=3 [18.8%]  surface glycoprotein, G1219C</title>
	<circle cx="1849.0" cy="1946.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  G25249T  USA=2 [1.0%]  surface glycoprotein, M1229I</title>
	<circle cx="1853.7" cy="1952.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  G25429T  USA=2 [1.0%]  ORF3a protein, V13L</title>
	<circle cx="1880.0" cy="1982.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  C25433T  Canada=5 [31.2%]  ORF3a protein, T14I</title>
	<circle cx="1880.6" cy="1982.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  C25463T  Canada=2 [12.5%]  ORF3a protein, T24I</title>
	<circle cx="1885.0" cy="1988.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18  C25466T  USA=2 [1.0%]  ORF3a protein, P25L</title>
	<circle cx="1885.4" cy="1988.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19 USA: 189 samples</title>
	<line x1="1212.9" y1="1215.3" x2="1219.4" y2="1223.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19 Canada: 14 samples</title>
	<line x1="1219.4" y1="1223.2" x2="1222.8" y2="1227.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19 Mexico: 6 samples</title>
	<line x1="1222.8" y1="1227.2" x2="1225.3" y2="1230.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19 Guatemala: 2 samples</title>
	<line x1="1225.3" y1="1230.1" x2="1226.7" y2="1231.8" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19  C21575T  Canada=3 [21.4%]  surface glycoprotein, L5F</title>
	<circle cx="1314.5" cy="1336.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  G22017T  USA=2 [1.1%]  surface glycoprotein, W152L</title>
	<circle cx="1377.8" cy="1411.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  A22320G  USA=5 [2.6%]  surface glycoprotein, D253G</title>
	<circle cx="1421.2" cy="1463.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  T23010C  USA=2 [1.1%]  surface glycoprotein, V483A</title>
	<circle cx="1520.0" cy="1581.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  A23403G  USA=176 [93.1%]  surface glycoprotein, D614G</title>
	<circle cx="1576.2" cy="1648.4" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  A23403G  USA=176 [93.1%] Canada=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1576.2" cy="1648.4" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  A23403G  USA=176 [93.1%] Canada=14 [100.0%] Mexico=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1576.2" cy="1648.4" r="3.1" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  A23403G  USA=176 [93.1%] Canada=14 [100.0%] Mexico=6 [100.0%] Guatemala=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1576.2" cy="1648.4" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  T23427C  USA=2 [1.1%]  surface glycoprotein, V622A</title>
	<circle cx="1579.7" cy="1652.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  C23802T  USA=2 [1.1%]  surface glycoprotein, T747I</title>
	<circle cx="1633.3" cy="1716.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  C24378T  USA=4 [2.1%]  surface glycoprotein, S939F</title>
	<circle cx="1715.8" cy="1814.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  C24863T  USA=2 [1.1%]  surface glycoprotein, H1101Y</title>
	<circle cx="1785.2" cy="1897.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  G25234T  Canada=2 [14.3%]  surface glycoprotein, L1224F</title>
	<circle cx="1838.3" cy="1960.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  C25433T  Canada=3 [21.4%]  ORF3a protein, T14I</title>
	<circle cx="1866.8" cy="1994.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  G25444T  USA=2 [1.1%]  ORF3a protein, G18C</title>
	<circle cx="1868.4" cy="1996.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20 USA: 165 samples</title>
	<line x1="1212.6" y1="1215.5" x2="1218.9" y2="1223.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20 Canada: 15 samples</title>
	<line x1="1218.9" y1="1223.3" x2="1222.3" y2="1227.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20 Mexico: 3 samples</title>
	<line x1="1222.3" y1="1227.5" x2="1224.0" y2="1229.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20  C21575T  USA=4 [2.4%]  surface glycoprotein, L5F</title>
	<circle cx="1312.1" cy="1338.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  C22224T  USA=2 [1.2%]  surface glycoprotein, S221L</title>
	<circle cx="1403.1" cy="1450.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  C22295T  USA=2 [1.2%]  surface glycoprotein, H245Y</title>
	<circle cx="1413.0" cy="1463.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  A22320G  USA=13 [7.9%]  surface glycoprotein, D253G</title>
	<circle cx="1416.5" cy="1467.4" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  C23271T  USA=2 [1.2%]  surface glycoprotein, A570V</title>
	<circle cx="1549.8" cy="1632.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  C23277T  USA=2 [1.2%]  surface glycoprotein, T572I</title>
	<circle cx="1550.7" cy="1633.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  A23403G  USA=165 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1568.3" cy="1654.9" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  A23403G  Canada=14 [93.3%]  surface glycoprotein, D614G</title>
	<circle cx="1568.3" cy="1654.9" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  A23403G  Canada=14 [93.3%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1568.3" cy="1654.9" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  C23481T  USA=2 [1.2%]  surface glycoprotein, S640F</title>
	<circle cx="1579.3" cy="1668.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  G24236T  Canada=2 [13.3%]  surface glycoprotein, A892S</title>
	<circle cx="1685.1" cy="1799.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  G25217T  Canada=3 [20.0%]  surface glycoprotein, G1219C</title>
	<circle cx="1822.6" cy="1968.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  C25317T  USA=4 [2.4%]  surface glycoprotein, S1252F</title>
	<circle cx="1836.6" cy="1986.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  C25433T  Canada=4 [26.7%]  ORF3a protein, T14I</title>
	<circle cx="1852.9" cy="2006.2" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  G25444A  Canada=2 [13.3%]  ORF3a protein, G18S</title>
	<circle cx="1854.4" cy="2008.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21 USA: 188 samples</title>
	<line x1="1212.3" y1="1215.8" x2="1218.6" y2="1223.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-21 Canada: 10 samples</title>
	<line x1="1218.6" y1="1223.8" x2="1221.5" y2="1227.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-21 Mexico: 2 samples</title>
	<line x1="1221.5" y1="1227.5" x2="1222.8" y2="1229.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-21  C22295T  USA=2 [1.1%]  surface glycoprotein, H245Y</title>
	<circle cx="1408.4" cy="1466.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  A22320G  USA=10 [5.3%]  surface glycoprotein, D253G</title>
	<circle cx="1411.8" cy="1471.2" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  G22349A  USA=2 [1.1%]  surface glycoprotein, A263T</title>
	<circle cx="1415.8" cy="1476.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  C23277T  USA=4 [2.1%]  surface glycoprotein, T572I</title>
	<circle cx="1543.1" cy="1639.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  A23403G  USA=182 [96.8%]  surface glycoprotein, D614G</title>
	<circle cx="1560.3" cy="1661.2" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  A23403G  Canada=9 [90.0%]  surface glycoprotein, D614G</title>
	<circle cx="1560.3" cy="1661.2" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  A23403G  Canada=9 [90.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1560.3" cy="1661.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  G25244T  USA=2 [1.1%]  surface glycoprotein, V1228L</title>
	<circle cx="1812.8" cy="1984.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  G25429T  USA=2 [1.1%]  ORF3a protein, V13L</title>
	<circle cx="1838.1" cy="2016.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  C25433T  Canada=4 [40.0%]  ORF3a protein, T14I</title>
	<circle cx="1838.7" cy="2017.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  G25437T  USA=3 [1.6%]  ORF3a protein, L15F</title>
	<circle cx="1839.2" cy="2018.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  C25463T  Canada=2 [20.0%]  ORF3a protein, T24I</title>
	<circle cx="1842.8" cy="2022.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22 USA: 178 samples</title>
	<line x1="1212.0" y1="1216.0" x2="1218.1" y2="1224.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-22 Canada: 9 samples</title>
	<line x1="1218.1" y1="1224.1" x2="1220.8" y2="1227.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-22  G21974T  USA=2 [1.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1360.7" cy="1413.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  C22224T  USA=4 [2.2%]  surface glycoprotein, S221L</title>
	<circle cx="1394.2" cy="1457.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  C22227T  USA=2 [1.1%]  surface glycoprotein, A222V</title>
	<circle cx="1394.6" cy="1458.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  C22295T  USA=4 [2.2%]  surface glycoprotein, H245Y</title>
	<circle cx="1403.7" cy="1470.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  A22320G  USA=10 [5.6%]  surface glycoprotein, D253G</title>
	<circle cx="1407.1" cy="1474.8" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  A23403G  USA=171 [96.1%]  surface glycoprotein, D614G</title>
	<circle cx="1552.2" cy="1667.4" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  A23403G  USA=171 [96.1%] Canada=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1552.2" cy="1667.4" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  C23481T  USA=3 [1.7%]  surface glycoprotein, S640F</title>
	<circle cx="1562.7" cy="1681.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  C23987T  USA=2 [1.1%]  surface glycoprotein, P809S</title>
	<circle cx="1630.5" cy="1771.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  C24378T  USA=3 [1.7%]  surface glycoprotein, S939F</title>
	<circle cx="1682.9" cy="1840.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  G25217T  Canada=3 [33.3%]  surface glycoprotein, G1219C</title>
	<circle cx="1795.4" cy="1990.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  A25253G  USA=2 [1.1%]  surface glycoprotein, T1231A</title>
	<circle cx="1800.2" cy="1996.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  G25429T  USA=2 [1.1%]  ORF3a protein, V13L</title>
	<circle cx="1823.8" cy="2027.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  C25433T  Canada=4 [44.4%]  ORF3a protein, T14I</title>
	<circle cx="1824.3" cy="2028.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  G25444T  USA=2 [1.1%]  ORF3a protein, G18C</title>
	<circle cx="1825.8" cy="2030.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23 USA: 78 samples</title>
	<line x1="1211.8" y1="1216.2" x2="1216.8" y2="1223.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-23 Canada: 10 samples</title>
	<line x1="1216.8" y1="1223.1" x2="1219.5" y2="1226.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-23 Mexico: 5 samples</title>
	<line x1="1219.5" y1="1226.9" x2="1221.6" y2="1229.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-23  A22320G  USA=10 [12.8%]  surface glycoprotein, D253G</title>
	<circle cx="1402.3" cy="1478.4" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23  A23403G  USA=78 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1544.0" cy="1673.5" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23  A23403G  USA=78 [100.0%] Canada=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1544.0" cy="1673.5" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23  A23403G  USA=78 [100.0%] Canada=10 [100.0%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1544.0" cy="1673.5" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23  C23934A  USA=4 [5.1%]  surface glycoprotein, T791K</title>
	<circle cx="1613.5" cy="1769.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23  G24992C  USA=3 [3.8%]  surface glycoprotein, E1144Q</title>
	<circle cx="1752.0" cy="1959.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23  C25433T  Canada=3 [30.0%]  ORF3a protein, T14I</title>
	<circle cx="1809.8" cy="2039.3" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24 USA: 55 samples</title>
	<line x1="1211.5" y1="1216.4" x2="1216.0" y2="1222.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-24 Canada: 7 samples</title>
	<line x1="1216.0" y1="1222.8" x2="1218.3" y2="1226.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-24  A22320G  USA=3 [5.5%]  surface glycoprotein, D253G</title>
	<circle cx="1397.4" cy="1481.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24  A23403G  USA=55 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1535.7" cy="1679.5" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24  A23403G  USA=55 [100.0%] Canada=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1535.7" cy="1679.5" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24  G25287T  USA=3 [5.5%]  surface glycoprotein, S1242I</title>
	<circle cx="1776.4" cy="2023.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24  C25433T  Canada=4 [57.1%]  ORF3a protein, T14I</title>
	<circle cx="1795.0" cy="2049.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-25 USA: 75 samples</title>
	<line x1="1211.2" y1="1216.6" x2="1215.9" y2="1223.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25 Canada: 8 samples</title>
	<line x1="1215.9" y1="1223.6" x2="1218.3" y2="1227.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25 Mexico: 2 samples</title>
	<line x1="1218.3" y1="1227.2" x2="1219.5" y2="1228.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25  A23403G  USA=69 [92.0%]  surface glycoprotein, D614G</title>
	<circle cx="1527.3" cy="1685.2" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-25  A23403G  USA=69 [92.0%] Canada=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1527.3" cy="1685.2" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-25  A23403G  USA=69 [92.0%] Canada=8 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1527.3" cy="1685.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-25  C25433T  Canada=4 [50.0%]  ORF3a protein, T14I</title>
	<circle cx="1780.1" cy="2060.1" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26 USA: 238 samples</title>
	<line x1="1210.9" y1="1216.8" x2="1216.7" y2="1225.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-26 Canada: 9 samples</title>
	<line x1="1216.7" y1="1225.7" x2="1219.2" y2="1229.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-26 Mexico: 8 samples</title>
	<line x1="1219.2" y1="1229.5" x2="1221.5" y2="1233.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-26  C21575T  USA=3 [1.3%]  surface glycoprotein, L5F</title>
	<circle cx="1297.0" cy="1349.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  A21717T  USA=2 [0.8%]  surface glycoprotein, Q52L</title>
	<circle cx="1314.3" cy="1376.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  G22021T  USA=2 [0.8%]  surface glycoprotein, M153I</title>
	<circle cx="1351.1" cy="1432.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  G22319T  USA=2 [0.8%]  surface glycoprotein, D253Y</title>
	<circle cx="1387.3" cy="1488.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  A22320G  USA=41 [17.2%]  surface glycoprotein, D253G</title>
	<circle cx="1387.4" cy="1488.6" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  C22482T  USA=2 [0.8%]  surface glycoprotein, T307I</title>
	<circle cx="1407.1" cy="1518.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  C22949T  USA=2 [0.8%]  surface glycoprotein, P463S</title>
	<circle cx="1463.7" cy="1606.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  A23403G  USA=227 [95.4%]  surface glycoprotein, D614G</title>
	<circle cx="1518.8" cy="1690.9" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  A23403G  USA=227 [95.4%] Canada=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1518.8" cy="1690.9" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  A23403G  USA=227 [95.4%] Canada=9 [100.0%] Mexico=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1518.8" cy="1690.9" r="3.6" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  C23604T  USA=2 [0.8%]  surface glycoprotein, P681L</title>
	<circle cx="1543.2" cy="1728.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  A23922G  USA=2 [0.8%]  surface glycoprotein, Q787R</title>
	<circle cx="1581.7" cy="1787.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  C23987T  USA=2 [0.8%]  surface glycoprotein, P809S</title>
	<circle cx="1589.6" cy="1800.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  G24751T  USA=2 [0.8%]  surface glycoprotein, L1063F</title>
	<circle cx="1682.3" cy="1942.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  G24781T  USA=7 [2.9%]  surface glycoprotein, K1073N</title>
	<circle cx="1685.9" cy="1948.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  G24812T  USA=2 [0.8%]  surface glycoprotein, D1084Y</title>
	<circle cx="1689.7" cy="1954.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  G24933T  USA=2 [0.8%]  surface glycoprotein, G1124V</title>
	<circle cx="1704.4" cy="1976.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  C25433T  Canada=3 [33.3%]  ORF3a protein, T14I</title>
	<circle cx="1765.0" cy="2070.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  T25451C  USA=6 [2.5%]  ORF3a protein, I20T</title>
	<circle cx="1767.2" cy="2073.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27 USA: 224 samples</title>
	<line x1="1210.6" y1="1217.0" x2="1216.2" y2="1225.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-27 Canada: 3 samples</title>
	<line x1="1216.2" y1="1225.9" x2="1217.6" y2="1228.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-27 Mexico: 5 samples</title>
	<line x1="1217.6" y1="1228.2" x2="1219.5" y2="1231.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-27  C21575T  USA=4 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1294.4" cy="1351.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  C21789T  USA=4 [1.8%]  surface glycoprotein, T76I</title>
	<circle cx="1319.7" cy="1391.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  C22224T  USA=2 [0.9%]  surface glycoprotein, S221L</title>
	<circle cx="1371.0" cy="1473.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  C22295T  USA=2 [0.9%]  surface glycoprotein, H245Y</title>
	<circle cx="1379.4" cy="1487.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  A22320G  USA=8 [3.6%]  surface glycoprotein, D253G</title>
	<circle cx="1382.3" cy="1491.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  C22482T  USA=6 [2.7%]  surface glycoprotein, T307I</title>
	<circle cx="1401.5" cy="1522.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  A23403G  USA=212 [94.6%]  surface glycoprotein, D614G</title>
	<circle cx="1510.2" cy="1696.4" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  A23403G  Mexico=4 [80.0%]  surface glycoprotein, D614G</title>
	<circle cx="1510.2" cy="1696.4" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  A23403G  Mexico=4 [80.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1510.2" cy="1696.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  C23604T  USA=2 [0.9%]  surface glycoprotein, P681L</title>
	<circle cx="1533.9" cy="1734.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  G25429T  USA=2 [0.9%]  ORF3a protein, V13L</title>
	<circle cx="1749.3" cy="2079.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28 USA: 116 samples</title>
	<line x1="1210.3" y1="1217.1" x2="1215.1" y2="1225.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-28 Canada: 5 samples</title>
	<line x1="1215.1" y1="1225.1" x2="1216.9" y2="1228.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-28 Mexico: 3 samples</title>
	<line x1="1216.9" y1="1228.1" x2="1218.3" y2="1230.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-28  C21575T  USA=2 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1291.8" cy="1352.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  A22320G  USA=5 [4.3%]  surface glycoprotein, D253G</title>
	<circle cx="1377.2" cy="1494.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  C23277T  USA=3 [2.6%]  surface glycoprotein, T572I</title>
	<circle cx="1487.0" cy="1677.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  A23403G  USA=115 [99.1%]  surface glycoprotein, D614G</title>
	<circle cx="1501.5" cy="1701.7" r="8.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  A23403G  USA=115 [99.1%] Canada=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1501.5" cy="1701.7" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  A23403G  USA=115 [99.1%] Canada=5 [100.0%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1501.5" cy="1701.7" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  G24236T  USA=2 [1.7%]  surface glycoprotein, A892S</title>
	<circle cx="1597.0" cy="1860.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  T25451C  USA=4 [3.4%]  ORF3a protein, I20T</title>
	<circle cx="1736.4" cy="2092.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29 USA: 202 samples</title>
	<line x1="1210.0" y1="1217.3" x2="1215.2" y2="1226.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-29 Canada: 11 samples</title>
	<line x1="1215.2" y1="1226.3" x2="1217.6" y2="1230.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-29 Mexico: 11 samples</title>
	<line x1="1217.6" y1="1230.5" x2="1220.0" y2="1234.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-29  C21575T  USA=3 [1.5%]  surface glycoprotein, L5F</title>
	<circle cx="1289.1" cy="1354.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  C21575T  USA=3 [1.5%] Canada=2 [18.2%]  surface glycoprotein, L5F</title>
	<circle cx="1289.1" cy="1354.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  C21627A  USA=2 [1.0%]  surface glycoprotein, T22N</title>
	<circle cx="1294.9" cy="1364.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  C21707T  USA=2 [1.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1303.8" cy="1379.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  G21786T  USA=2 [1.0%]  surface glycoprotein, G75V</title>
	<circle cx="1312.6" cy="1395.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  C21789T  USA=2 [1.0%]  surface glycoprotein, T76I</title>
	<circle cx="1312.9" cy="1395.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  T22220C  USA=2 [1.0%]  surface glycoprotein, F220L</title>
	<circle cx="1360.9" cy="1478.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  A22320G  USA=9 [4.5%]  surface glycoprotein, D253G</title>
	<circle cx="1372.0" cy="1498.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  G22349A  USA=4 [2.0%]  surface glycoprotein, A263T</title>
	<circle cx="1375.3" cy="1503.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  A23403G  USA=199 [98.5%]  surface glycoprotein, D614G</title>
	<circle cx="1492.7" cy="1706.9" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  A23403G  USA=199 [98.5%] Canada=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1492.7" cy="1706.9" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  A23403G  USA=199 [98.5%] Canada=11 [100.0%] Mexico=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1492.7" cy="1706.9" r="4.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  C23655T  USA=2 [1.0%]  surface glycoprotein, S698L</title>
	<circle cx="1520.7" cy="1755.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  A23756G  Mexico=2 [18.2%]  surface glycoprotein, T732A</title>
	<circle cx="1532.0" cy="1775.0" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  G24794T  USA=2 [1.0%]  surface glycoprotein, A1078S</title>
	<circle cx="1647.6" cy="1975.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  G25244T  USA=4 [2.0%]  surface glycoprotein, V1228L</title>
	<circle cx="1697.7" cy="2062.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  G25249T  USA=3 [1.5%]  surface glycoprotein, M1229I</title>
	<circle cx="1698.2" cy="2062.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  G25429T  USA=2 [1.0%]  ORF3a protein, V13L</title>
	<circle cx="1718.3" cy="2097.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29  C25433T  Canada=3 [27.3%]  ORF3a protein, T14I</title>
	<circle cx="1718.7" cy="2098.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30 USA: 73 samples</title>
	<line x1="1209.7" y1="1217.5" x2="1213.8" y2="1224.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-30 Canada: 4 samples</title>
	<line x1="1213.8" y1="1224.8" x2="1215.3" y2="1227.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-30 Mexico: 3 samples</title>
	<line x1="1215.3" y1="1227.6" x2="1216.6" y2="1230.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-30  A22320G  USA=14 [19.2%]  surface glycoprotein, D253G</title>
	<circle cx="1366.8" cy="1501.0" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  A23403G  USA=73 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1483.8" cy="1711.9" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  A23403G  USA=73 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1483.8" cy="1711.9" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  A23403G  USA=73 [100.0%] Canada=4 [100.0%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1483.8" cy="1711.9" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  G24197T  USA=4 [5.5%]  surface glycoprotein, A879S</title>
	<circle cx="1569.5" cy="1866.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  G24794T  USA=3 [4.1%]  surface glycoprotein, A1078S</title>
	<circle cx="1634.0" cy="1982.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  G24812T  USA=2 [2.7%]  surface glycoprotein, D1084Y</title>
	<circle cx="1635.9" cy="1986.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  A25165T  USA=2 [2.7%]  surface glycoprotein, Q1201H</title>
	<circle cx="1674.0" cy="2055.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31 USA: 69 samples</title>
	<line x1="1209.4" y1="1217.7" x2="1213.3" y2="1225.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-31 Canada: 6 samples</title>
	<line x1="1213.3" y1="1225.0" x2="1215.1" y2="1228.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-31 Mexico: 2 samples</title>
	<line x1="1215.1" y1="1228.3" x2="1216.1" y2="1230.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-31  A22320G  USA=7 [10.1%]  surface glycoprotein, D253G</title>
	<circle cx="1361.5" cy="1503.8" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31  G22592T  USA=2 [2.9%]  surface glycoprotein, A344S</title>
	<circle cx="1390.0" cy="1557.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31  A23403G  USA=68 [98.6%]  surface glycoprotein, D614G</title>
	<circle cx="1474.8" cy="1716.8" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31  A23403G  USA=68 [98.6%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1474.8" cy="1716.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31  A23403G  USA=68 [98.6%] Canada=6 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1474.8" cy="1716.8" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31  C23604T  USA=2 [2.9%]  surface glycoprotein, P681L</title>
	<circle cx="1495.8" cy="1756.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31  G23873T  USA=2 [2.9%]  surface glycoprotein, A771S</title>
	<circle cx="1523.9" cy="1809.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31  G24197T  USA=2 [2.9%]  surface glycoprotein, A879S</title>
	<circle cx="1557.8" cy="1872.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01 USA: 200 samples</title>
	<line x1="1209.1" y1="1217.8" x2="1213.8" y2="1227.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-01 Canada: 7 samples</title>
	<line x1="1213.8" y1="1227.1" x2="1215.6" y2="1230.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-01 Mexico: 2 samples</title>
	<line x1="1215.6" y1="1230.7" x2="1216.6" y2="1232.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-01  C21575T  Canada=2 [28.6%]  surface glycoprotein, L5F</title>
	<circle cx="1280.9" cy="1358.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  A21717T  USA=3 [1.5%]  surface glycoprotein, Q52L</title>
	<circle cx="1295.2" cy="1386.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  G21800T  USA=2 [1.0%]  surface glycoprotein, D80Y</title>
	<circle cx="1303.6" cy="1403.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  A22320G  USA=18 [9.0%]  surface glycoprotein, D253G</title>
	<circle cx="1356.2" cy="1506.6" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  G22343C  USA=2 [1.0%]  surface glycoprotein, G261R</title>
	<circle cx="1358.5" cy="1511.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  G22349A  USA=2 [1.0%]  surface glycoprotein, A263T</title>
	<circle cx="1359.1" cy="1512.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  C23277T  USA=2 [1.0%]  surface glycoprotein, T572I</title>
	<circle cx="1453.0" cy="1696.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  A23403G  USA=197 [98.5%]  surface glycoprotein, D614G</title>
	<circle cx="1465.7" cy="1721.5" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  A23403G  USA=197 [98.5%] Canada=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1465.7" cy="1721.5" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  A23403G  USA=197 [98.5%] Canada=7 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1465.7" cy="1721.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  C23604T  USA=3 [1.5%]  surface glycoprotein, P681L</title>
	<circle cx="1486.0" cy="1761.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  G24368C  USA=2 [1.0%]  surface glycoprotein, D936H</title>
	<circle cx="1563.3" cy="1913.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  C24718A  USA=2 [1.0%]  surface glycoprotein, F1052L</title>
	<circle cx="1598.7" cy="1982.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  G25088T  USA=4 [2.0%]  surface glycoprotein, V1176F</title>
	<circle cx="1636.1" cy="2055.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  G25244T  USA=2 [1.0%]  surface glycoprotein, V1228L</title>
	<circle cx="1651.9" cy="2086.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  C25433T  Canada=2 [28.6%]  ORF3a protein, T14I</title>
	<circle cx="1671.0" cy="2124.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  T25451C  USA=7 [3.5%]  ORF3a protein, I20T</title>
	<circle cx="1672.8" cy="2127.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02 USA: 174 samples</title>
	<line x1="1208.8" y1="1218.0" x2="1213.2" y2="1227.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-02 Canada: 3 samples</title>
	<line x1="1213.2" y1="1227.0" x2="1214.4" y2="1229.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-02  G21578T  USA=3 [1.7%]  surface glycoprotein, V6F</title>
	<circle cx="1278.4" cy="1360.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  G21800T  USA=2 [1.1%]  surface glycoprotein, D80Y</title>
	<circle cx="1300.1" cy="1405.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  A22320G  USA=9 [5.2%]  surface glycoprotein, D253G</title>
	<circle cx="1350.8" cy="1509.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  A23403G  USA=164 [94.3%]  surface glycoprotein, D614G</title>
	<circle cx="1456.6" cy="1726.1" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  A23403G  USA=164 [94.3%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1456.6" cy="1726.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  C23604T  USA=4 [2.3%]  surface glycoprotein, P681L</title>
	<circle cx="1476.2" cy="1766.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  G24992C  USA=6 [3.4%]  surface glycoprotein, E1144Q</title>
	<circle cx="1611.7" cy="2044.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  G25088T  USA=3 [1.7%]  surface glycoprotein, V1176F</title>
	<circle cx="1621.1" cy="2063.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  T25451C  USA=5 [2.9%]  ORF3a protein, I20T</title>
	<circle cx="1656.5" cy="2136.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  G25489T  USA=5 [2.9%]  ORF3a protein, A33S</title>
	<circle cx="1660.2" cy="2143.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03 USA: 223 samples</title>
	<line x1="1208.5" y1="1218.1" x2="1212.9" y2="1227.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-03 Canada: 2 samples</title>
	<line x1="1212.9" y1="1227.7" x2="1213.8" y2="1229.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-03 Mexico: 3 samples</title>
	<line x1="1213.8" y1="1229.7" x2="1215.0" y2="1232.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-03  C21575T  USA=2 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1275.3" cy="1361.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  A22320G  USA=5 [2.2%]  surface glycoprotein, D253G</title>
	<circle cx="1345.4" cy="1511.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  G22592T  USA=2 [0.9%]  surface glycoprotein, A344S</title>
	<circle cx="1371.0" cy="1566.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  G22616T  USA=2 [0.9%]  surface glycoprotein, A352S</title>
	<circle cx="1373.3" cy="1571.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  A23403G  USA=219 [98.2%]  surface glycoprotein, D614G</title>
	<circle cx="1447.4" cy="1730.5" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  A23403G  USA=219 [98.2%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1447.4" cy="1730.5" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  A23403G  USA=219 [98.2%] Mexico=3 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1447.4" cy="1730.5" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  A23586G  USA=2 [0.9%]  surface glycoprotein, Q675R</title>
	<circle cx="1464.6" cy="1767.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  G25088T  USA=2 [0.9%]  surface glycoprotein, V1176F</title>
	<circle cx="1606.0" cy="2070.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03  C25427A  USA=5 [2.2%]  ORF3a protein, T12N</title>
	<circle cx="1637.9" cy="2139.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04 USA: 176 samples</title>
	<line x1="1208.1" y1="1218.3" x2="1212.2" y2="1227.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-04 Canada: 2 samples</title>
	<line x1="1212.2" y1="1227.5" x2="1213.1" y2="1229.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-04 Mexico: 2 samples</title>
	<line x1="1213.1" y1="1229.5" x2="1214.0" y2="1231.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-04  G21718T  USA=2 [1.1%]  surface glycoprotein, Q52H</title>
	<circle cx="1285.4" cy="1391.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  G21724T  USA=2 [1.1%]  surface glycoprotein, L54F</title>
	<circle cx="1286.0" cy="1393.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  T22220C  USA=2 [1.1%]  surface glycoprotein, F220L</title>
	<circle cx="1330.9" cy="1494.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  A23403G  USA=172 [97.7%]  surface glycoprotein, D614G</title>
	<circle cx="1438.1" cy="1734.7" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  A23403G  USA=172 [97.7%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1438.1" cy="1734.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  A23403G  USA=172 [97.7%] Canada=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1438.1" cy="1734.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  A23922G  USA=3 [1.7%]  surface glycoprotein, Q787R</title>
	<circle cx="1485.1" cy="1840.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  C24718A  USA=2 [1.1%]  surface glycoprotein, F1052L</title>
	<circle cx="1557.2" cy="2002.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  G24794T  USA=2 [1.1%]  surface glycoprotein, A1078S</title>
	<circle cx="1564.1" cy="2017.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  G25445A  USA=2 [1.1%]  ORF3a protein, G18D</title>
	<circle cx="1623.0" cy="2150.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  T25451C  USA=2 [1.1%]  ORF3a protein, I20T</title>
	<circle cx="1623.6" cy="2151.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05 USA: 198 samples</title>
	<line x1="1207.8" y1="1218.4" x2="1211.9" y2="1227.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-05 Canada: 4 samples</title>
	<line x1="1211.9" y1="1227.9" x2="1213.1" y2="1230.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-05  G21578T  USA=4 [2.0%]  surface glycoprotein, V6F</title>
	<circle cx="1269.9" cy="1364.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  G21724T  USA=5 [2.5%]  surface glycoprotein, L54F</title>
	<circle cx="1282.6" cy="1394.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  ACC23076GGA  USA=3 [1.5%]  surface glycoprotein, Y505W</title>
	<circle cx="1400.2" cy="1671.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  A23403G  USA=186 [93.9%]  surface glycoprotein, D614G</title>
	<circle cx="1428.7" cy="1738.8" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  A23403G  USA=186 [93.9%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1428.7" cy="1738.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  A23922G  USA=2 [1.0%]  surface glycoprotein, Q787R</title>
	<circle cx="1473.9" cy="1845.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  C24718A  USA=2 [1.0%]  surface glycoprotein, F1052L</title>
	<circle cx="1543.1" cy="2008.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  G24751T  USA=4 [2.0%]  surface glycoprotein, L1063F</title>
	<circle cx="1546.0" cy="2015.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  T25451C  USA=5 [2.5%]  ORF3a protein, I20T</title>
	<circle cx="1606.9" cy="2158.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05  G25489T  USA=5 [2.5%]  ORF3a protein, A33S</title>
	<circle cx="1610.2" cy="2166.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06 USA: 58 samples</title>
	<line x1="1207.5" y1="1218.5" x2="1210.5" y2="1225.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-06 Mexico: 3 samples</title>
	<line x1="1210.5" y1="1225.9" x2="1211.5" y2="1228.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-06  C21575T  USA=2 [3.4%]  surface glycoprotein, L5F</title>
	<circle cx="1266.7" cy="1365.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06  C22224T  USA=3 [5.2%]  surface glycoprotein, S221L</title>
	<circle cx="1320.9" cy="1499.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06  A23403G  USA=53 [91.4%]  surface glycoprotein, D614G</title>
	<circle cx="1419.3" cy="1742.7" r="6.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06  A23403G  USA=53 [91.4%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1419.3" cy="1742.7" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06  A23756G  Mexico=2 [66.7%]  surface glycoprotein, T732A</title>
	<circle cx="1448.7" cy="1815.6" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-07 USA: 66 samples</title>
	<line x1="1207.2" y1="1218.7" x2="1210.1" y2="1226.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-07 Canada: 2 samples</title>
	<line x1="1210.1" y1="1226.3" x2="1210.9" y2="1228.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-07  A23403G  USA=64 [97.0%]  surface glycoprotein, D614G</title>
	<circle cx="1409.8" cy="1746.4" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-07  A23403G  USA=64 [97.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1409.8" cy="1746.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-07  G25088T  USA=2 [3.0%]  surface glycoprotein, V1176F</title>
	<circle cx="1544.2" cy="2096.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08 USA: 237 samples</title>
	<line x1="1206.8" y1="1218.8" x2="1210.5" y2="1228.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-08 Canada: 4 samples</title>
	<line x1="1210.5" y1="1228.8" x2="1211.6" y2="1231.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-08 Mexico: 4 samples</title>
	<line x1="1211.6" y1="1231.8" x2="1212.6" y2="1234.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-08  C21575T  USA=3 [1.3%]  surface glycoprotein, L5F</title>
	<circle cx="1260.9" cy="1367.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G21718T  USA=4 [1.7%]  surface glycoprotein, Q52H</title>
	<circle cx="1271.8" cy="1397.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G21800T  USA=2 [0.8%]  surface glycoprotein, D80Y</title>
	<circle cx="1278.1" cy="1414.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  A22320G  USA=2 [0.8%]  surface glycoprotein, D253G</title>
	<circle cx="1317.7" cy="1523.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G22335T  USA=2 [0.8%]  surface glycoprotein, W258L</title>
	<circle cx="1318.8" cy="1526.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G23311T  USA=3 [1.3%]  surface glycoprotein, E583D</title>
	<circle cx="1393.2" cy="1730.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  A23403G  USA=227 [95.8%]  surface glycoprotein, D614G</title>
	<circle cx="1400.2" cy="1750.0" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  A23403G  USA=227 [95.8%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1400.2" cy="1750.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  A23403G  USA=227 [95.8%] Canada=4 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1400.2" cy="1750.0" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  A23586G  USA=4 [1.7%]  surface glycoprotein, Q675R</title>
	<circle cx="1414.1" cy="1788.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  C23604T  USA=2 [0.8%]  surface glycoprotein, P681L</title>
	<circle cx="1415.5" cy="1792.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  A23949G  USA=7 [3.0%]  surface glycoprotein, D796G</title>
	<circle cx="1441.8" cy="1864.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G24038A  USA=3 [1.3%]  surface glycoprotein, V826M</title>
	<circle cx="1448.6" cy="1882.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  C24718A  USA=5 [2.1%]  surface glycoprotein, F1052L</title>
	<circle cx="1500.4" cy="2025.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G24998T  USA=3 [1.3%]  surface glycoprotein, D1146Y</title>
	<circle cx="1521.7" cy="2083.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G25244T  USA=2 [0.8%]  surface glycoprotein, V1228L</title>
	<circle cx="1540.4" cy="2135.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  A25335T  USA=2 [0.8%]  surface glycoprotein, E1258V</title>
	<circle cx="1547.4" cy="2154.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G25445A  USA=2 [0.8%]  ORF3a protein, G18D</title>
	<circle cx="1555.7" cy="2177.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  T25451C  USA=5 [2.1%]  ORF3a protein, I20T</title>
	<circle cx="1556.2" cy="2178.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08  G25489T  USA=2 [0.8%]  ORF3a protein, A33S</title>
	<circle cx="1559.1" cy="2186.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09 USA: 159 samples</title>
	<line x1="1206.5" y1="1218.9" x2="1209.7" y2="1228.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-09 Canada: 6 samples</title>
	<line x1="1209.7" y1="1228.3" x2="1211.0" y2="1231.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-09 Mexico: 2 samples</title>
	<line x1="1211.0" y1="1231.9" x2="1211.7" y2="1233.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-09  C21575T  USA=2 [1.3%]  surface glycoprotein, L5F</title>
	<circle cx="1258.0" cy="1368.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  C21627T  USA=2 [1.3%]  surface glycoprotein, T22I</title>
	<circle cx="1261.8" cy="1379.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  ATTA21993A  USA=2 [1.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1288.3" cy="1456.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  G22592T  USA=5 [3.1%]  surface glycoprotein, A344S</title>
	<circle cx="1331.7" cy="1582.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  A23403G  USA=158 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1390.6" cy="1753.4" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  A23403G  USA=158 [99.4%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1390.6" cy="1753.4" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  A23403G  USA=158 [99.4%] Canada=6 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1390.6" cy="1753.4" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  C23525T  USA=2 [1.3%]  surface glycoprotein, H655Y</title>
	<circle cx="1399.4" cy="1779.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  C23604T  USA=2 [1.3%]  surface glycoprotein, P681L</title>
	<circle cx="1405.1" cy="1795.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  C24718A  USA=2 [1.3%]  surface glycoprotein, F1052L</title>
	<circle cx="1485.9" cy="2030.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  G25177T  USA=5 [3.1%]  surface glycoprotein, K1205N</title>
	<circle cx="1519.2" cy="2127.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  C25317T  USA=2 [1.3%]  surface glycoprotein, S1252F</title>
	<circle cx="1529.3" cy="2156.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  G25429T  USA=2 [1.3%]  ORF3a protein, V13L</title>
	<circle cx="1537.5" cy="2180.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  G25445A  USA=2 [1.3%]  ORF3a protein, G18D</title>
	<circle cx="1538.6" cy="2183.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  T25451C  USA=2 [1.3%]  ORF3a protein, I20T</title>
	<circle cx="1539.1" cy="2184.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  G25489T  USA=2 [1.3%]  ORF3a protein, A33S</title>
	<circle cx="1541.8" cy="2192.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10 USA: 167 samples</title>
	<line x1="1206.2" y1="1219.0" x2="1209.3" y2="1228.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-10 Canada: 6 samples</title>
	<line x1="1209.3" y1="1228.5" x2="1210.4" y2="1232.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-10 Mexico: 2 samples</title>
	<line x1="1210.4" y1="1232.2" x2="1211.1" y2="1234.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-10  C21575T  USA=7 [4.2%]  surface glycoprotein, L5F</title>
	<circle cx="1255.1" cy="1369.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  G21624T  USA=2 [1.2%]  surface glycoprotein, R21I</title>
	<circle cx="1258.4" cy="1379.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  C21707T  USA=2 [1.2%]  surface glycoprotein, H49Y</title>
	<circle cx="1264.1" cy="1397.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  C22088T  USA=2 [1.2%]  surface glycoprotein, L176F</title>
	<circle cx="1290.4" cy="1478.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  C22208T  USA=2 [1.2%]  surface glycoprotein, L216F</title>
	<circle cx="1298.6" cy="1503.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  T22220C  USA=2 [1.2%]  surface glycoprotein, F220L</title>
	<circle cx="1299.4" cy="1506.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  G22484T  USA=2 [1.2%]  surface glycoprotein, V308L</title>
	<circle cx="1317.6" cy="1562.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  A23403G  USA=167 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1380.9" cy="1756.7" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  A23403G  USA=167 [100.0%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1380.9" cy="1756.7" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  A23403G  USA=167 [100.0%] Canada=6 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1380.9" cy="1756.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  A23586G  USA=2 [1.2%]  surface glycoprotein, Q675R</title>
	<circle cx="1393.5" cy="1795.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  C23604T  USA=4 [2.4%]  surface glycoprotein, P681L</title>
	<circle cx="1394.7" cy="1799.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  C24718A  USA=2 [1.2%]  surface glycoprotein, F1052L</title>
	<circle cx="1471.4" cy="2035.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  C25433T  Canada=2 [33.3%]  ORF3a protein, T14I</title>
	<circle cx="1520.6" cy="2186.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11 USA: 188 samples</title>
	<line x1="1205.8" y1="1219.1" x2="1208.8" y2="1228.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11 Canada: 2 samples</title>
	<line x1="1208.8" y1="1228.9" x2="1209.5" y2="1231.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11 Costa Rica: 2 samples</title>
	<line x1="1209.5" y1="1231.0" x2="1210.1" y2="1233.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11  C21575T  USA=2 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1252.1" cy="1370.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  G23311T  USA=2 [1.1%]  surface glycoprotein, E583D</title>
	<circle cx="1365.1" cy="1740.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23403G  USA=187 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23403G  USA=187 [99.5%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23403G  USA=187 [99.5%] Canada=2 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23586G  USA=2 [1.1%]  surface glycoprotein, Q675R</title>
	<circle cx="1383.0" cy="1798.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  C23604A  USA=7 [3.7%]  surface glycoprotein, P681H</title>
	<circle cx="1384.2" cy="1802.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  C24026T  USA=3 [1.6%]  surface glycoprotein, L822F</title>
	<circle cx="1411.7" cy="1892.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  C24718A  USA=3 [1.6%]  surface glycoprotein, F1052L</title>
	<circle cx="1456.8" cy="2039.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  C25427T  USA=3 [1.6%]  ORF3a protein, T12I</title>
	<circle cx="1502.9" cy="2190.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12 USA: 142 samples</title>
	<line x1="1205.5" y1="1219.2" x2="1208.2" y2="1228.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-12 Canada: 2 samples</title>
	<line x1="1208.2" y1="1228.5" x2="1208.8" y2="1230.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-12 Mexico: 4 samples</title>
	<line x1="1208.8" y1="1230.6" x2="1209.6" y2="1233.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-12  A23403G  USA=140 [98.6%]  surface glycoprotein, D614G</title>
	<circle cx="1361.3" cy="1762.6" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23403G  USA=140 [98.6%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1361.3" cy="1762.6" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23403G  USA=140 [98.6%] Mexico=4 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1361.3" cy="1762.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  C24026T  USA=2 [1.4%]  surface glycoprotein, L822F</title>
	<circle cx="1399.6" cy="1896.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  C25317T  USA=2 [1.4%]  surface glycoprotein, S1252F</title>
	<circle cx="1478.8" cy="2172.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13 USA: 119 samples</title>
	<line x1="1205.2" y1="1219.3" x2="1207.6" y2="1228.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-13  C21575T  USA=2 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1246.1" cy="1372.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  G23311T  USA=2 [1.7%]  surface glycoprotein, E583D</title>
	<circle cx="1346.2" cy="1745.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  A23403G  USA=113 [95.0%]  surface glycoprotein, D614G</title>
	<circle cx="1351.5" cy="1765.4" r="8.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  A23586G  USA=2 [1.7%]  surface glycoprotein, Q675R</title>
	<circle cx="1362.0" cy="1804.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  C24026T  USA=3 [2.5%]  surface glycoprotein, L822F</title>
	<circle cx="1387.4" cy="1899.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  C24718A  USA=3 [2.5%]  surface glycoprotein, F1052L</title>
	<circle cx="1427.3" cy="2048.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  C25466T  USA=3 [2.5%]  ORF3a protein, P25L</title>
	<circle cx="1470.4" cy="2209.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14 USA: 77 samples</title>
	<line x1="1204.8" y1="1219.4" x2="1206.9" y2="1227.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-14 Canada: 5 samples</title>
	<line x1="1206.9" y1="1227.7" x2="1207.7" y2="1231.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-14  C21575T  USA=5 [6.5%]  surface glycoprotein, L5F</title>
	<circle cx="1243.1" cy="1372.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14  G23311T  USA=2 [2.6%]  surface glycoprotein, E583D</title>
	<circle cx="1336.6" cy="1748.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14  A23403G  USA=75 [97.4%]  surface glycoprotein, D614G</title>
	<circle cx="1341.6" cy="1767.9" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14  A23403G  USA=75 [97.4%] Canada=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1341.6" cy="1767.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14  A23586G  USA=2 [2.6%]  surface glycoprotein, Q675R</title>
	<circle cx="1351.5" cy="1807.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14  G25266T  USA=2 [2.6%]  surface glycoprotein, C1235F</title>
	<circle cx="1442.0" cy="2170.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14  T25451C  USA=2 [2.6%]  ORF3a protein, I20T</title>
	<circle cx="1451.9" cy="2210.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15 USA: 283 samples</title>
	<line x1="1204.5" y1="1219.5" x2="1207.0" y2="1230.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-15 Canada: 3 samples</title>
	<line x1="1207.0" y1="1230.2" x2="1207.6" y2="1232.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-15 Mexico: 9 samples</title>
	<line x1="1207.6" y1="1232.9" x2="1208.6" y2="1237.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-15  C21575T  USA=3 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1240.1" cy="1373.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  C21707T  USA=7 [2.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1246.7" cy="1402.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A22101T  USA=3 [1.1%]  surface glycoprotein, E180V</title>
	<circle cx="1266.4" cy="1487.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A22320G  USA=2 [0.7%]  surface glycoprotein, D253G</title>
	<circle cx="1277.4" cy="1535.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  G23224T  USA=4 [1.4%]  surface glycoprotein, E554D</title>
	<circle cx="1322.7" cy="1731.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A23403G  USA=269 [95.1%]  surface glycoprotein, D614G</title>
	<circle cx="1331.7" cy="1770.3" r="9.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A23403G  USA=269 [95.1%] Mexico=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1331.7" cy="1770.3" r="3.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A23403G  USA=269 [95.1%] Mexico=9 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1331.7" cy="1770.3" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A23586G  USA=5 [1.8%]  surface glycoprotein, Q675R</title>
	<circle cx="1340.8" cy="1810.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  G23593T  USA=3 [1.1%]  surface glycoprotein, Q677H</title>
	<circle cx="1341.2" cy="1811.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  C23664T  USA=3 [1.1%]  surface glycoprotein, A701V</title>
	<circle cx="1344.7" cy="1826.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A23922G  USA=21 [7.4%]  surface glycoprotein, Q787R</title>
	<circle cx="1357.7" cy="1882.9" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  G24197T  USA=3 [1.1%]  surface glycoprotein, A879S</title>
	<circle cx="1371.4" cy="1942.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  C24718A  USA=4 [1.4%]  surface glycoprotein, F1052L</title>
	<circle cx="1397.5" cy="2055.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  G25249T  USA=4 [1.4%]  surface glycoprotein, M1229I</title>
	<circle cx="1424.1" cy="2170.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  C25317T  USA=3 [1.1%]  surface glycoprotein, S1252F</title>
	<circle cx="1427.6" cy="2185.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16 USA: 252 samples</title>
	<line x1="1204.2" y1="1219.6" x2="1206.4" y2="1230.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-16 Canada: 4 samples</title>
	<line x1="1206.4" y1="1230.1" x2="1207.1" y2="1233.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-16 Mexico: 6 samples</title>
	<line x1="1207.1" y1="1233.2" x2="1207.9" y2="1236.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-16  C21575T  USA=3 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1237.0" cy="1374.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  G21578T  USA=2 [0.8%]  surface glycoprotein, V6F</title>
	<circle cx="1237.2" cy="1374.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  C21707T  USA=2 [0.8%]  surface glycoprotein, H49Y</title>
	<circle cx="1243.2" cy="1403.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  C21846T  USA=2 [0.8%]  surface glycoprotein, T95I</title>
	<circle cx="1249.6" cy="1433.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  C22313T  USA=2 [0.8%]  surface glycoprotein, P251S</title>
	<circle cx="1271.2" cy="1535.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A22320G  USA=2 [0.8%]  surface glycoprotein, D253G</title>
	<circle cx="1271.5" cy="1536.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  G22592T  USA=3 [1.2%]  surface glycoprotein, A344S</title>
	<circle cx="1284.1" cy="1595.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  C23280T  USA=3 [1.2%]  surface glycoprotein, T573I</title>
	<circle cx="1316.0" cy="1745.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  G23311T  USA=3 [1.2%]  surface glycoprotein, E583D</title>
	<circle cx="1317.4" cy="1752.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A23403G  USA=239 [94.8%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="1772.5" r="9.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A23403G  USA=239 [94.8%] Mexico=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="1772.5" r="3.1" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A23403G  USA=239 [94.8%] Mexico=6 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="1772.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A23586G  USA=3 [1.2%]  surface glycoprotein, Q675R</title>
	<circle cx="1330.2" cy="1812.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A23586G  USA=3 [1.2%] Canada=2 [50.0%]  surface glycoprotein, Q675R</title>
	<circle cx="1330.2" cy="1812.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  C24026T  USA=4 [1.6%]  surface glycoprotein, L822F</title>
	<circle cx="1350.5" cy="1908.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  C24718A  USA=7 [2.8%]  surface glycoprotein, F1052L</title>
	<circle cx="1382.6" cy="2059.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  G24933T  USA=2 [0.8%]  surface glycoprotein, G1124V</title>
	<circle cx="1392.5" cy="2105.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  G25249T  USA=2 [0.8%]  surface glycoprotein, M1229I</title>
	<circle cx="1407.2" cy="2174.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  T25451C  USA=2 [0.8%]  ORF3a protein, I20T</title>
	<circle cx="1416.5" cy="2218.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  C25466T  USA=3 [1.2%]  ORF3a protein, P25L</title>
	<circle cx="1417.2" cy="2221.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17 USA: 234 samples</title>
	<line x1="1203.8" y1="1219.6" x2="1205.9" y2="1230.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17 Canada: 7 samples</title>
	<line x1="1205.9" y1="1230.1" x2="1206.6" y2="1234.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17 Mexico: 4 samples</title>
	<line x1="1206.6" y1="1234.1" x2="1207.2" y2="1237.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17  C21575T  USA=3 [1.3%]  surface glycoprotein, L5F</title>
	<circle cx="1234.0" cy="1374.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G21641T  Canada=2 [28.6%]  surface glycoprotein, A27S</title>
	<circle cx="1236.8" cy="1389.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  C21707T  USA=6 [2.6%]  surface glycoprotein, H49Y</title>
	<circle cx="1239.6" cy="1403.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G21724T  USA=2 [0.9%]  surface glycoprotein, L54F</title>
	<circle cx="1240.3" cy="1407.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G21986A  USA=2 [0.9%]  surface glycoprotein, G142S</title>
	<circle cx="1251.5" cy="1464.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A22320G  USA=3 [1.3%]  surface glycoprotein, D253G</title>
	<circle cx="1265.7" cy="1537.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G22592T  USA=2 [0.9%]  surface glycoprotein, A344S</title>
	<circle cx="1277.2" cy="1597.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  C23124G  USA=2 [0.9%]  surface glycoprotein, P521R</title>
	<circle cx="1299.8" cy="1713.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G23311T  USA=4 [1.7%]  surface glycoprotein, E583D</title>
	<circle cx="1307.8" cy="1754.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23403G  USA=228 [97.4%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23403G  USA=228 [97.4%] Canada=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23403G  USA=228 [97.4%] Canada=7 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  C23481T  USA=2 [0.9%]  surface glycoprotein, S640F</title>
	<circle cx="1315.0" cy="1791.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23586G  USA=6 [2.6%]  surface glycoprotein, Q675R</title>
	<circle cx="1319.5" cy="1814.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G23593T  USA=3 [1.3%]  surface glycoprotein, Q677H</title>
	<circle cx="1319.8" cy="1816.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23949G  USA=4 [1.7%]  surface glycoprotein, D796G</title>
	<circle cx="1334.9" cy="1893.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  C24026T  USA=4 [1.7%]  surface glycoprotein, L822F</title>
	<circle cx="1338.2" cy="1910.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A24129G  USA=2 [0.9%]  surface glycoprotein, N856S</title>
	<circle cx="1342.5" cy="1933.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G25217T  USA=2 [0.9%]  surface glycoprotein, G1219C</title>
	<circle cx="1388.8" cy="2171.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  C25427A  USA=2 [0.9%]  ORF3a protein, T12N</title>
	<circle cx="1397.7" cy="2217.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  C25433T  USA=7 [3.0%]  ORF3a protein, T14I</title>
	<circle cx="1397.9" cy="2218.4" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  G25445A  USA=2 [0.9%]  ORF3a protein, G18D</title>
	<circle cx="1398.5" cy="2221.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18 USA: 309 samples</title>
	<line x1="1203.5" y1="1219.7" x2="1205.4" y2="1230.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-18 Canada: 6 samples</title>
	<line x1="1205.4" y1="1230.7" x2="1206.1" y2="1234.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-18 Mexico: 3 samples</title>
	<line x1="1206.1" y1="1234.5" x2="1206.6" y2="1237.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-18 Costa Rica: 2 samples</title>
	<line x1="1206.6" y1="1237.2" x2="1206.9" y2="1239.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-18  C21707T  USA=3 [1.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1236.0" cy="1404.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A21717T  USA=2 [0.6%]  surface glycoprotein, Q52L</title>
	<circle cx="1236.4" cy="1406.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  G21724T  USA=3 [1.0%]  surface glycoprotein, L54F</title>
	<circle cx="1236.7" cy="1408.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A22101T  USA=12 [3.9%]  surface glycoprotein, E180V</title>
	<circle cx="1251.3" cy="1490.8" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A22320G  USA=10 [3.2%]  surface glycoprotein, D253G</title>
	<circle cx="1259.8" cy="1538.9" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C22482T  USA=2 [0.6%]  surface glycoprotein, T307I</title>
	<circle cx="1266.0" cy="1574.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  G22592T  USA=3 [1.0%]  surface glycoprotein, A344S</title>
	<circle cx="1270.3" cy="1598.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  G23224T  USA=4 [1.3%]  surface glycoprotein, E554D</title>
	<circle cx="1294.7" cy="1737.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  G23311T  USA=2 [0.6%]  surface glycoprotein, E583D</title>
	<circle cx="1298.1" cy="1756.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C23315T  USA=2 [0.6%]  surface glycoprotein, L585F</title>
	<circle cx="1298.2" cy="1757.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23403G  USA=308 [99.7%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="1776.4" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23403G  USA=308 [99.7%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="1776.4" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23403G  USA=308 [99.7%] Canada=6 [100.0%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="1776.4" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23403G  USA=308 [99.7%] Canada=6 [100.0%] Mexico=3 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="1776.4" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C23481T  USA=7 [2.3%]  surface glycoprotein, S640F</title>
	<circle cx="1304.7" cy="1793.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23586G  USA=2 [0.6%]  surface glycoprotein, Q675R</title>
	<circle cx="1308.7" cy="1816.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C23604T  USA=2 [0.6%]  surface glycoprotein, P681L</title>
	<circle cx="1309.4" cy="1820.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C23664T  USA=2 [0.6%]  surface glycoprotein, A701V</title>
	<circle cx="1311.7" cy="1833.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C24026T  USA=3 [1.0%]  surface glycoprotein, L822F</title>
	<circle cx="1325.7" cy="1913.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A24170G  USA=2 [0.6%]  surface glycoprotein, I870V</title>
	<circle cx="1331.3" cy="1944.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C24718A  USA=8 [2.6%]  surface glycoprotein, F1052L</title>
	<circle cx="1352.5" cy="2064.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  G24872T  USA=2 [0.6%]  surface glycoprotein, V1104L</title>
	<circle cx="1358.4" cy="2098.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A25165T  USA=2 [0.6%]  surface glycoprotein, Q1201H</title>
	<circle cx="1369.8" cy="2162.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  G25429T  USA=4 [1.3%]  ORF3a protein, V13L</title>
	<circle cx="1380.0" cy="2220.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  C25433T  Canada=4 [66.7%]  ORF3a protein, T14I</title>
	<circle cx="1380.1" cy="2221.7" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19 USA: 323 samples</title>
	<line x1="1203.1" y1="1219.8" x2="1204.9" y2="1230.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19 Canada: 5 samples</title>
	<line x1="1204.9" y1="1230.9" x2="1205.4" y2="1234.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19 Mexico: 4 samples</title>
	<line x1="1205.4" y1="1234.4" x2="1205.9" y2="1237.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19 Costa Rica: 4 samples</title>
	<line x1="1205.9" y1="1237.5" x2="1206.4" y2="1240.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1227.9" cy="1376.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  C21707T  USA=8 [2.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1232.5" cy="1405.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G21724T  USA=2 [0.6%]  surface glycoprotein, L54F</title>
	<circle cx="1233.1" cy="1408.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A22320G  USA=9 [2.8%]  surface glycoprotein, D253G</title>
	<circle cx="1253.8" cy="1539.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G22616T  USA=2 [0.6%]  surface glycoprotein, A352S</title>
	<circle cx="1264.1" cy="1605.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G23012C  USA=2 [0.6%]  surface glycoprotein, E484Q</title>
	<circle cx="1277.9" cy="1692.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23040T  USA=2 [0.6%]  surface glycoprotein, Q493L</title>
	<circle cx="1278.9" cy="1698.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G23120T  USA=2 [0.6%]  surface glycoprotein, A520S</title>
	<circle cx="1281.7" cy="1715.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G23224T  USA=3 [0.9%]  surface glycoprotein, E554D</title>
	<circle cx="1285.3" cy="1738.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23403G  USA=315 [97.5%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23403G  USA=315 [97.5%] Canada=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23403G  USA=315 [97.5%] Canada=5 [100.0%] Costa Rica=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23403G  USA=315 [97.5%] Canada=5 [100.0%] Costa Rica=4 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23586G  USA=3 [0.9%]  surface glycoprotein, Q675R</title>
	<circle cx="1297.9" cy="1818.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G23628T  USA=11 [3.4%]  surface glycoprotein, S689I</title>
	<circle cx="1299.4" cy="1827.6" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G24697T  USA=2 [0.6%]  surface glycoprotein, K1045N</title>
	<circle cx="1336.6" cy="2062.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  C24718A  USA=8 [2.5%]  surface glycoprotein, F1052L</title>
	<circle cx="1337.4" cy="2067.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G24812T  USA=2 [0.6%]  surface glycoprotein, D1084Y</title>
	<circle cx="1340.7" cy="2088.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A25050T  USA=2 [0.6%]  surface glycoprotein, D1163V</title>
	<circle cx="1348.9" cy="2140.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  T25451C  USA=2 [0.6%]  ORF3a protein, I20T</title>
	<circle cx="1362.9" cy="2228.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20 USA: 175 samples</title>
	<line x1="1202.8" y1="1219.8" x2="1204.2" y2="1229.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-20 Costa Rica: 2 samples</title>
	<line x1="1204.2" y1="1229.8" x2="1204.5" y2="1231.9" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-20  C21707T  USA=3 [1.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1228.9" cy="1405.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  A22320G  USA=3 [1.7%]  surface glycoprotein, D253G</title>
	<circle cx="1247.9" cy="1540.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  G22346T  USA=3 [1.7%]  surface glycoprotein, A262S</title>
	<circle cx="1248.7" cy="1546.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  G23224T  USA=2 [1.1%]  surface glycoprotein, E554D</title>
	<circle cx="1275.9" cy="1740.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  A23403G  USA=174 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="1779.6" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  A23403G  USA=174 [99.4%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="1779.6" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  C23481T  USA=2 [1.1%]  surface glycoprotein, S640F</title>
	<circle cx="1283.9" cy="1796.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  C24026T  USA=4 [2.3%]  surface glycoprotein, L822F</title>
	<circle cx="1300.8" cy="1917.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  C24718A  USA=5 [2.9%]  surface glycoprotein, F1052L</title>
	<circle cx="1322.2" cy="2069.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  C25433T  USA=2 [1.1%]  ORF3a protein, T14I</title>
	<circle cx="1344.4" cy="2227.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21 USA: 171 samples</title>
	<line x1="1202.4" y1="1219.9" x2="1203.7" y2="1229.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-21  C21575T  USA=2 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1221.7" cy="1376.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  C21707T  USA=5 [2.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1225.3" cy="1406.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  G21724T  USA=3 [1.8%]  surface glycoprotein, L54F</title>
	<circle cx="1225.8" cy="1409.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  G22592T  USA=5 [2.9%]  surface glycoprotein, A344S</title>
	<circle cx="1249.3" cy="1601.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  G23120T  USA=3 [1.8%]  surface glycoprotein, A520S</title>
	<circle cx="1263.6" cy="1718.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  A23403G  USA=170 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1271.3" cy="1780.9" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  G23426T  USA=2 [1.2%]  surface glycoprotein, V622F</title>
	<circle cx="1272.0" cy="1786.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  A23949G  USA=2 [1.2%]  surface glycoprotein, D796G</title>
	<circle cx="1286.1" cy="1901.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  C24026T  USA=3 [1.8%]  surface glycoprotein, L822F</title>
	<circle cx="1288.2" cy="1918.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  G24620T  USA=2 [1.2%]  surface glycoprotein, A1020S</title>
	<circle cx="1304.4" cy="2050.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  C24718A  USA=6 [3.5%]  surface glycoprotein, F1052L</title>
	<circle cx="1307.0" cy="2071.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  A25050T  USA=2 [1.2%]  surface glycoprotein, D1163V</title>
	<circle cx="1316.0" cy="2145.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22 USA: 371 samples</title>
	<line x1="1202.1" y1="1219.9" x2="1203.3" y2="1231.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-22 Mexico: 5 samples</title>
	<line x1="1203.3" y1="1231.4" x2="1203.7" y2="1234.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-22  C21575T  USA=4 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1218.6" cy="1377.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  C21614T  USA=4 [1.1%]  surface glycoprotein, L18F</title>
	<circle cx="1219.5" cy="1385.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  C21627T  USA=2 [0.5%]  surface glycoprotein, T22I</title>
	<circle cx="1219.8" cy="1388.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  C21707T  USA=4 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1221.7" cy="1406.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G21724T  USA=10 [2.7%]  surface glycoprotein, L54F</title>
	<circle cx="1222.1" cy="1410.2" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G21761T  USA=3 [0.8%]  surface glycoprotein, A67S</title>
	<circle cx="1223.0" cy="1418.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  A22320G  USA=16 [4.3%]  surface glycoprotein, D253G</title>
	<circle cx="1236.0" cy="1542.2" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G22484T  USA=2 [0.5%]  surface glycoprotein, V308L</title>
	<circle cx="1239.8" cy="1578.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G23120T  USA=6 [1.6%]  surface glycoprotein, A520S</title>
	<circle cx="1254.6" cy="1719.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G23224T  USA=3 [0.8%]  surface glycoprotein, E554D</title>
	<circle cx="1257.0" cy="1742.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G23311T  USA=5 [1.3%]  surface glycoprotein, E583D</title>
	<circle cx="1259.0" cy="1761.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  A23403G  USA=371 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1261.2" cy="1782.1" r="10.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  A23403G  USA=371 [100.0%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1261.2" cy="1782.1" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  A23586G  USA=4 [1.1%]  surface glycoprotein, Q675R</title>
	<circle cx="1265.4" cy="1822.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  A23756G  Mexico=2 [40.0%]  surface glycoprotein, T732A</title>
	<circle cx="1269.4" cy="1860.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  A23949G  USA=2 [0.5%]  surface glycoprotein, D796G</title>
	<circle cx="1273.9" cy="1903.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  C24026T  USA=7 [1.9%]  surface glycoprotein, L822F</title>
	<circle cx="1275.7" cy="1920.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G24348T  USA=3 [0.8%]  surface glycoprotein, S929I</title>
	<circle cx="1283.2" cy="1991.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  C24718A  USA=5 [1.3%]  surface glycoprotein, F1052L</title>
	<circle cx="1291.8" cy="2073.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G25019T  USA=3 [0.8%]  surface glycoprotein, D1153Y</title>
	<circle cx="1298.8" cy="2140.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G25429T  USA=3 [0.8%]  ORF3a protein, V13L</title>
	<circle cx="1308.3" cy="2230.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G25440T  USA=2 [0.5%]  ORF3a protein, K16N</title>
	<circle cx="1308.6" cy="2233.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  T25451C  USA=2 [0.5%]  ORF3a protein, I20T</title>
	<circle cx="1308.9" cy="2235.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  G25477T  USA=2 [0.5%]  ORF3a protein, V29F</title>
	<circle cx="1309.5" cy="2241.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23 USA: 283 samples</title>
	<line x1="1201.7" y1="1219.9" x2="1202.7" y2="1230.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-23 Mexico: 5 samples</title>
	<line x1="1202.7" y1="1230.9" x2="1203.0" y2="1234.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-23  C21575T  USA=2 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1215.5" cy="1377.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  C21707T  USA=7 [2.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1218.1" cy="1406.8" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  G21724T  USA=3 [1.1%]  surface glycoprotein, L54F</title>
	<circle cx="1218.4" cy="1410.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  A22320G  USA=11 [3.9%]  surface glycoprotein, D253G</title>
	<circle cx="1230.0" cy="1542.8" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  G23120T  USA=3 [1.1%]  surface glycoprotein, A520S</title>
	<circle cx="1245.5" cy="1720.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  G23311T  USA=4 [1.4%]  surface glycoprotein, E583D</title>
	<circle cx="1249.2" cy="1762.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  A23403G  USA=282 [99.6%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="1783.1" r="9.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  A23403G  USA=282 [99.6%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="1783.1" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  A23586G  USA=4 [1.4%]  surface glycoprotein, Q675R</title>
	<circle cx="1254.6" cy="1823.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  C23664T  USA=2 [0.7%]  surface glycoprotein, A701V</title>
	<circle cx="1256.1" cy="1841.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  C24026T  USA=4 [1.4%]  surface glycoprotein, L822F</title>
	<circle cx="1263.1" cy="1921.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  C24718A  USA=5 [1.8%]  surface glycoprotein, F1052L</title>
	<circle cx="1276.5" cy="2074.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  G24812T  USA=3 [1.1%]  surface glycoprotein, D1084Y</title>
	<circle cx="1278.4" cy="2095.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  G25019T  USA=2 [0.7%]  surface glycoprotein, D1153Y</title>
	<circle cx="1282.4" cy="2141.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  G25437T  USA=2 [0.7%]  ORF3a protein, L15F</title>
	<circle cx="1290.5" cy="2234.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24 USA: 315 samples</title>
	<line x1="1201.4" y1="1220.0" x2="1202.2" y2="1231.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-24 Mexico: 6 samples</title>
	<line x1="1202.2" y1="1231.2" x2="1202.4" y2="1235.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-24  C21575T  USA=3 [1.0%]  surface glycoprotein, L5F</title>
	<circle cx="1212.4" cy="1377.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  C21707T  USA=11 [3.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1214.5" cy="1407.1" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  G21724T  USA=4 [1.3%]  surface glycoprotein, L54F</title>
	<circle cx="1214.7" cy="1410.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  G23120T  USA=4 [1.3%]  surface glycoprotein, A520S</title>
	<circle cx="1236.4" cy="1721.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  G23311T  USA=2 [0.6%]  surface glycoprotein, E583D</title>
	<circle cx="1239.4" cy="1763.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  A23403G  USA=315 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="1783.9" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  A23403G  USA=315 [100.0%] Mexico=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="1783.9" r="3.1" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  C23481T  USA=2 [0.6%]  surface glycoprotein, S640F</title>
	<circle cx="1242.0" cy="1801.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  C23625T  USA=2 [0.6%]  surface glycoprotein, A688V</title>
	<circle cx="1244.3" cy="1833.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  A23756G  Mexico=2 [33.3%]  surface glycoprotein, T732A</title>
	<circle cx="1246.3" cy="1862.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  G23900C  USA=3 [1.0%]  surface glycoprotein, E780Q</title>
	<circle cx="1248.5" cy="1894.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  C24026T  USA=9 [2.9%]  surface glycoprotein, L822F</title>
	<circle cx="1250.5" cy="1922.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  G24236T  USA=3 [1.0%]  surface glycoprotein, A892S</title>
	<circle cx="1253.8" cy="1968.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  C24718A  USA=10 [3.2%]  surface glycoprotein, F1052L</title>
	<circle cx="1261.3" cy="2076.0" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  G25444A  USA=4 [1.3%]  ORF3a protein, G18S</title>
	<circle cx="1272.5" cy="2237.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  G25459A  USA=2 [0.6%]  ORF3a protein, A23T</title>
	<circle cx="1272.8" cy="2240.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25 USA: 320 samples</title>
	<line x1="1201.0" y1="1220.0" x2="1201.6" y2="1231.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-25 Canada: 2 samples</title>
	<line x1="1201.6" y1="1231.2" x2="1201.7" y2="1233.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-25 Mexico: 4 samples</title>
	<line x1="1201.7" y1="1233.4" x2="1201.9" y2="1236.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-25  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1209.3" cy="1377.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  G21624C  USA=2 [0.6%]  surface glycoprotein, R21T</title>
	<circle cx="1209.9" cy="1388.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  C21707T  USA=15 [4.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1210.9" cy="1407.3" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  A23403G  USA=318 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="1784.5" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  A23403G  USA=318 [99.4%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="1784.5" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  A23403G  USA=318 [99.4%] Mexico=4 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="1784.5" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  G23900C  USA=2 [0.6%]  surface glycoprotein, E780Q</title>
	<circle cx="1236.4" cy="1895.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  C24026T  USA=11 [3.4%]  surface glycoprotein, L822F</title>
	<circle cx="1237.9" cy="1923.1" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  C24138T  USA=2 [0.6%]  surface glycoprotein, T859I</title>
	<circle cx="1239.2" cy="1948.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  G24197T  USA=2 [0.6%]  surface glycoprotein, A879S</title>
	<circle cx="1239.9" cy="1961.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  C24718A  USA=6 [1.9%]  surface glycoprotein, F1052L</title>
	<circle cx="1246.0" cy="2077.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  G25445T  USA=2 [0.6%]  ORF3a protein, G18V</title>
	<circle cx="1254.4" cy="2238.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26 USA: 341 samples</title>
	<line x1="1200.7" y1="1220.0" x2="1201.1" y2="1231.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-26 Canada: 2 samples</title>
	<line x1="1201.1" y1="1231.4" x2="1201.2" y2="1233.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-26 Mexico: 2 samples</title>
	<line x1="1201.2" y1="1233.5" x2="1201.2" y2="1235.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-26  C21707T  USA=8 [2.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1207.2" cy="1407.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  C21846T  USA=4 [1.2%]  surface glycoprotein, T95I</title>
	<circle cx="1208.3" cy="1438.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  A22320G  USA=2 [0.6%]  surface glycoprotein, D253G</title>
	<circle cx="1212.0" cy="1543.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  G23224T  USA=2 [0.6%]  surface glycoprotein, E554D</title>
	<circle cx="1219.0" cy="1745.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  C23277T  USA=4 [1.2%]  surface glycoprotein, T572I</title>
	<circle cx="1219.4" cy="1756.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  G23311T  USA=3 [0.9%]  surface glycoprotein, E583D</title>
	<circle cx="1219.7" cy="1764.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  A23403G  USA=340 [99.7%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="1784.9" r="10.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  A23403G  USA=340 [99.7%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="1784.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  A23403G  USA=340 [99.7%] Canada=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="1784.9" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  C23481T  USA=2 [0.6%]  surface glycoprotein, S640F</title>
	<circle cx="1221.0" cy="1802.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  A23586G  USA=6 [1.8%]  surface glycoprotein, Q675R</title>
	<circle cx="1221.8" cy="1825.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  G23900C  USA=2 [0.6%]  surface glycoprotein, E780Q</title>
	<circle cx="1224.3" cy="1895.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  C24026T  USA=3 [0.9%]  surface glycoprotein, L822F</title>
	<circle cx="1225.3" cy="1923.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  C24198T  USA=2 [0.6%]  surface glycoprotein, A879V</title>
	<circle cx="1226.6" cy="1961.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  C24718A  USA=4 [1.2%]  surface glycoprotein, F1052L</title>
	<circle cx="1230.6" cy="2077.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  G25019T  USA=2 [0.6%]  surface glycoprotein, D1153Y</title>
	<circle cx="1233.0" cy="2144.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  G25444A  USA=3 [0.9%]  ORF3a protein, G18S</title>
	<circle cx="1236.3" cy="2239.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  G25459T  USA=2 [0.6%]  ORF3a protein, A23S</title>
	<circle cx="1236.4" cy="2242.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27 USA: 189 samples</title>
	<line x1="1200.3" y1="1220.0" x2="1200.5" y2="1230.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-27 Canada: 2 samples</title>
	<line x1="1200.5" y1="1230.2" x2="1200.6" y2="1232.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-27 Mexico: 4 samples</title>
	<line x1="1200.6" y1="1232.4" x2="1200.6" y2="1235.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-27  G21624T  USA=2 [1.1%]  surface glycoprotein, R21I</title>
	<circle cx="1203.3" cy="1389.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  C21707T  USA=7 [3.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1203.6" cy="1407.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  A23403G  USA=188 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="1785.2" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  A23403G  USA=188 [99.5%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="1785.2" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  A23403G  USA=188 [99.5%] Mexico=4 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="1785.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  C23481T  USA=2 [1.1%]  surface glycoprotein, S640F</title>
	<circle cx="1210.5" cy="1802.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  C24026T  USA=2 [1.1%]  surface glycoprotein, L822F</title>
	<circle cx="1212.6" cy="1923.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  G24368T  USA=2 [1.1%]  surface glycoprotein, D936Y</title>
	<circle cx="1214.0" cy="2000.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  G24812T  USA=2 [1.1%]  surface glycoprotein, D1084Y</title>
	<circle cx="1215.7" cy="2099.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  G25445T  USA=3 [1.6%]  ORF3a protein, G18V</title>
	<circle cx="1218.2" cy="2239.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28 USA: 164 samples</title>
	<line x1="1200.0" y1="1220.0" x2="1200.0" y2="1230.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-28  C21707T  USA=4 [2.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1200.0" cy="1407.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  G23311T  USA=4 [2.4%]  surface glycoprotein, E583D</title>
	<circle cx="1200.0" cy="1764.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  A23403G  USA=163 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1200.0" cy="1785.3" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  C23481T  USA=2 [1.2%]  surface glycoprotein, S640F</title>
	<circle cx="1200.0" cy="1802.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  A23586G  USA=3 [1.8%]  surface glycoprotein, Q675R</title>
	<circle cx="1200.0" cy="1826.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  C24026T  USA=4 [2.4%]  surface glycoprotein, L822F</title>
	<circle cx="1200.0" cy="1924.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  C24718A  USA=10 [6.1%]  surface glycoprotein, F1052L</title>
	<circle cx="1200.0" cy="2078.2" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  G25437T  USA=6 [3.7%]  ORF3a protein, L15F</title>
	<circle cx="1200.0" cy="2238.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29 USA: 460 samples</title>
	<line x1="1199.7" y1="1220.0" x2="1199.4" y2="1232.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-29 Mexico: 2 samples</title>
	<line x1="1199.4" y1="1232.0" x2="1199.4" y2="1234.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-29 Costa Rica: 3 samples</title>
	<line x1="1199.4" y1="1234.1" x2="1199.4" y2="1236.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-29  C21614T  USA=3 [0.7%]  surface glycoprotein, L18F</title>
	<circle cx="1196.7" cy="1386.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C21638T  USA=3 [0.7%]  surface glycoprotein, P26S</title>
	<circle cx="1196.6" cy="1392.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C21707T  USA=7 [1.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1196.4" cy="1407.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A22320G  USA=2 [0.4%]  surface glycoprotein, D253G</title>
	<circle cx="1194.0" cy="1544.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G22583A  USA=3 [0.7%]  surface glycoprotein, V341I</title>
	<circle cx="1193.0" cy="1602.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C23220T  USA=2 [0.4%]  surface glycoprotein, T553I</title>
	<circle cx="1190.5" cy="1744.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G23224T  USA=2 [0.4%]  surface glycoprotein, E554D</title>
	<circle cx="1190.5" cy="1745.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G23311T  USA=2 [0.4%]  surface glycoprotein, E583D</title>
	<circle cx="1190.1" cy="1764.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C23315T  USA=2 [0.4%]  surface glycoprotein, L585F</title>
	<circle cx="1190.1" cy="1765.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C23373T  USA=2 [0.4%]  surface glycoprotein, T604I</title>
	<circle cx="1189.9" cy="1778.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A23403G  USA=460 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1785.2" r="10.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A23403G  USA=460 [100.0%] Costa Rica=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1785.2" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A23403G  USA=460 [100.0%] Costa Rica=3 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1785.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C23481T  USA=2 [0.4%]  surface glycoprotein, S640F</title>
	<circle cx="1189.5" cy="1802.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A23586G  USA=2 [0.4%]  surface glycoprotein, Q675R</title>
	<circle cx="1189.1" cy="1826.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C23625T  USA=2 [0.4%]  surface glycoprotein, A688V</title>
	<circle cx="1188.9" cy="1834.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G23948C  USA=2 [0.4%]  surface glycoprotein, D796H</title>
	<circle cx="1187.7" cy="1906.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C24026T  USA=8 [1.7%]  surface glycoprotein, L822F</title>
	<circle cx="1187.4" cy="1923.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G24197T  USA=3 [0.7%]  surface glycoprotein, A879S</title>
	<circle cx="1186.7" cy="1962.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  T24212G  USA=3 [0.7%]  surface glycoprotein, S884A</title>
	<circle cx="1186.6" cy="1965.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C24718A  USA=10 [2.2%]  surface glycoprotein, F1052L</title>
	<circle cx="1184.7" cy="2078.0" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C24912T  Costa Rica=3 [100.0%]  surface glycoprotein, T1117I</title>
	<circle cx="1183.9" cy="2121.2" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G24998T  USA=2 [0.4%]  surface glycoprotein, D1146Y</title>
	<circle cx="1183.6" cy="2140.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A25076G  USA=3 [0.7%]  surface glycoprotein, I1172V</title>
	<circle cx="1183.3" cy="2157.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  C25350T  USA=3 [0.7%]  surface glycoprotein, P1263L</title>
	<circle cx="1182.2" cy="2218.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G25445T  USA=8 [1.7%]  ORF3a protein, G18V</title>
	<circle cx="1181.8" cy="2239.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30 USA: 415 samples</title>
	<line x1="1199.3" y1="1220.0" x2="1198.9" y2="1231.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30 Canada: 2 samples</title>
	<line x1="1198.9" y1="1231.8" x2="1198.8" y2="1233.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30 Mexico: 2 samples</title>
	<line x1="1198.8" y1="1233.9" x2="1198.7" y2="1236.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30 Costa Rica: 2 samples</title>
	<line x1="1198.7" y1="1236.1" x2="1198.7" y2="1238.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30  G21578T  USA=2 [0.5%]  surface glycoprotein, V6F</title>
	<circle cx="1193.8" cy="1378.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  C21707T  USA=18 [4.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1192.8" cy="1407.4" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  T22220C  USA=4 [1.0%]  surface glycoprotein, F220L</title>
	<circle cx="1188.8" cy="1521.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A22320G  USA=3 [0.7%]  surface glycoprotein, D253G</title>
	<circle cx="1188.0" cy="1543.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  G23311T  USA=3 [0.7%]  surface glycoprotein, E583D</title>
	<circle cx="1180.3" cy="1764.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23403G  USA=415 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="10.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23403G  USA=415 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23403G  USA=415 [100.0%] Canada=2 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23403G  USA=415 [100.0%] Canada=2 [100.0%] Costa Rica=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  C23481T  USA=3 [0.7%]  surface glycoprotein, S640F</title>
	<circle cx="1179.0" cy="1802.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23586G  USA=4 [1.0%]  surface glycoprotein, Q675R</title>
	<circle cx="1178.2" cy="1825.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  C23625T  USA=3 [0.7%]  surface glycoprotein, A688V</title>
	<circle cx="1177.8" cy="1834.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  C24026T  USA=2 [0.5%]  surface glycoprotein, L822F</title>
	<circle cx="1174.7" cy="1923.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  C24718A  USA=10 [2.4%]  surface glycoprotein, F1052L</title>
	<circle cx="1169.4" cy="2077.6" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  G24812T  USA=2 [0.5%]  surface glycoprotein, D1084Y</title>
	<circle cx="1168.6" cy="2098.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  C25350T  USA=2 [0.5%]  surface glycoprotein, P1263L</title>
	<circle cx="1164.4" cy="2218.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  G25445T  USA=5 [1.2%]  ORF3a protein, G18V</title>
	<circle cx="1163.7" cy="2239.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01 USA: 427 samples</title>
	<line x1="1199.0" y1="1220.0" x2="1198.3" y2="1231.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-01 Canada: 3 samples</title>
	<line x1="1198.3" y1="1231.8" x2="1198.2" y2="1234.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-01 Mexico: 4 samples</title>
	<line x1="1198.2" y1="1234.5" x2="1198.0" y2="1237.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-01  G21578T  USA=3 [0.7%]  surface glycoprotein, V6F</title>
	<circle cx="1190.6" cy="1378.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  C21707T  USA=16 [3.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1189.1" cy="1407.3" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  T21942C  USA=2 [0.5%]  surface glycoprotein, V127A</title>
	<circle cx="1186.4" cy="1459.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  G22014T  USA=3 [0.7%]  surface glycoprotein, S151I</title>
	<circle cx="1185.6" cy="1475.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  T22287C  USA=2 [0.5%]  surface glycoprotein, L242P</title>
	<circle cx="1182.4" cy="1536.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  C22323T  USA=2 [0.5%]  surface glycoprotein, S254F</title>
	<circle cx="1182.0" cy="1544.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  G22484T  USA=2 [0.5%]  surface glycoprotein, V308L</title>
	<circle cx="1180.1" cy="1580.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  G23311T  USA=3 [0.7%]  surface glycoprotein, E583D</title>
	<circle cx="1170.4" cy="1764.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A23403G  USA=425 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="1784.5" r="10.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A23403G  USA=425 [99.5%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="1784.5" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A23403G  USA=425 [99.5%] Mexico=4 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="1784.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  C23481T  USA=3 [0.7%]  surface glycoprotein, S640F</title>
	<circle cx="1168.5" cy="1801.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A23586G  USA=3 [0.7%]  surface glycoprotein, Q675R</title>
	<circle cx="1167.2" cy="1825.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  C24026T  USA=6 [1.4%]  surface glycoprotein, L822F</title>
	<circle cx="1162.1" cy="1923.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  C24718A  USA=2 [0.5%]  surface glycoprotein, F1052L</title>
	<circle cx="1154.0" cy="2077.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  G24812T  USA=3 [0.7%]  surface glycoprotein, D1084Y</title>
	<circle cx="1152.9" cy="2097.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A25336T  USA=2 [0.5%]  surface glycoprotein, E1258D</title>
	<circle cx="1146.8" cy="2214.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  G25445T  USA=3 [0.7%]  ORF3a protein, G18V</title>
	<circle cx="1145.6" cy="2238.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  T25451C  USA=2 [0.5%]  ORF3a protein, I20T</title>
	<circle cx="1145.5" cy="2240.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  G25459A  USA=2 [0.5%]  ORF3a protein, A23T</title>
	<circle cx="1145.4" cy="2241.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  C25484T  USA=4 [0.9%]  ORF3a protein, A31V</title>
	<circle cx="1145.1" cy="2247.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02 USA: 434 samples</title>
	<line x1="1198.6" y1="1220.0" x2="1197.8" y2="1231.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02 Canada: 4 samples</title>
	<line x1="1197.8" y1="1231.8" x2="1197.6" y2="1234.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02 Mexico: 4 samples</title>
	<line x1="1197.6" y1="1234.9" x2="1197.3" y2="1238.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02 Costa Rica: 6 samples</title>
	<line x1="1197.3" y1="1238.1" x2="1197.1" y2="1241.9" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02  C21575T  USA=3 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1187.6" cy="1377.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G21578T  USA=2 [0.5%]  surface glycoprotein, V6F</title>
	<circle cx="1187.5" cy="1378.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C21614T  USA=4 [0.9%]  surface glycoprotein, L18F</title>
	<circle cx="1187.0" cy="1386.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C21707T  USA=12 [2.8%]  surface glycoprotein, H49Y</title>
	<circle cx="1185.5" cy="1407.1" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G21724T  USA=3 [0.7%]  surface glycoprotein, L54F</title>
	<circle cx="1185.3" cy="1410.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C21767T  USA=2 [0.5%]  surface glycoprotein, H69Y</title>
	<circle cx="1184.6" cy="1420.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G21786T  USA=2 [0.5%]  surface glycoprotein, G75V</title>
	<circle cx="1184.3" cy="1424.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C21855T  USA=2 [0.5%]  surface glycoprotein, S98F</title>
	<circle cx="1183.2" cy="1439.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A22320G  USA=2 [0.5%]  surface glycoprotein, D253G</title>
	<circle cx="1176.0" cy="1543.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G23120T  USA=2 [0.5%]  surface glycoprotein, A520S</title>
	<circle cx="1163.6" cy="1721.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23125ATCC  USA=5 [1.2%]  surface glycoprotein, A522S</title>
	<circle cx="1163.5" cy="1722.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G23224T  USA=5 [1.2%]  surface glycoprotein, E554D</title>
	<circle cx="1162.0" cy="1744.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G23311T  USA=2 [0.5%]  surface glycoprotein, E583D</title>
	<circle cx="1160.6" cy="1763.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  USA=433 [99.8%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="10.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  USA=433 [99.8%] Costa Rica=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="3.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  USA=433 [99.8%] Costa Rica=6 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  USA=433 [99.8%] Costa Rica=6 [100.0%] Canada=4 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C23481T  USA=3 [0.7%]  surface glycoprotein, S640F</title>
	<circle cx="1158.0" cy="1801.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C23525T  USA=2 [0.5%]  surface glycoprotein, H655Y</title>
	<circle cx="1157.3" cy="1811.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23586G  USA=2 [0.5%]  surface glycoprotein, Q675R</title>
	<circle cx="1156.3" cy="1824.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C24026T  USA=15 [3.5%]  surface glycoprotein, L822F</title>
	<circle cx="1149.5" cy="1922.3" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  T24212G  USA=5 [1.2%]  surface glycoprotein, S884A</title>
	<circle cx="1146.6" cy="1963.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C24718A  USA=2 [0.5%]  surface glycoprotein, F1052L</title>
	<circle cx="1138.7" cy="2076.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G24812T  USA=2 [0.5%]  surface glycoprotein, D1084Y</title>
	<circle cx="1137.3" cy="2096.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A25121T  USA=4 [0.9%]  surface glycoprotein, N1187Y</title>
	<circle cx="1132.5" cy="2165.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G25305T  USA=2 [0.5%]  surface glycoprotein, C1248F</title>
	<circle cx="1129.6" cy="2206.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G25437T  USA=4 [0.9%]  ORF3a protein, L15F</title>
	<circle cx="1127.6" cy="2235.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G25444A  USA=2 [0.5%]  ORF3a protein, G18S</title>
	<circle cx="1127.5" cy="2237.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G25445T  USA=3 [0.7%]  ORF3a protein, G18V</title>
	<circle cx="1127.4" cy="2237.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03 USA: 296 samples</title>
	<line x1="1198.3" y1="1219.9" x2="1197.3" y2="1231.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-03 Mexico: 5 samples</title>
	<line x1="1197.3" y1="1231.0" x2="1197.0" y2="1234.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-03 Costa Rica: 5 samples</title>
	<line x1="1197.0" y1="1234.5" x2="1196.7" y2="1238.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-03  C21614T  USA=4 [1.4%]  surface glycoprotein, L18F</title>
	<circle cx="1183.7" cy="1386.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C21707T  USA=9 [3.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1181.9" cy="1406.8" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  G21724T  USA=2 [0.7%]  surface glycoprotein, L54F</title>
	<circle cx="1181.6" cy="1410.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  G23120T  USA=3 [1.0%]  surface glycoprotein, A520S</title>
	<circle cx="1154.5" cy="1720.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  A23125ATCC  USA=2 [0.7%]  surface glycoprotein, A522S</title>
	<circle cx="1154.4" cy="1721.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  G23311T  USA=4 [1.4%]  surface glycoprotein, E583D</title>
	<circle cx="1150.8" cy="1762.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  A23403G  USA=296 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="1783.1" r="9.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  A23403G  USA=296 [100.0%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="1783.1" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  A23403G  Costa Rica=4 [80.0%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="1783.1" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C23481T  USA=2 [0.7%]  surface glycoprotein, S640F</title>
	<circle cx="1147.5" cy="1800.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  A23586G  USA=6 [2.0%]  surface glycoprotein, Q675R</title>
	<circle cx="1145.4" cy="1823.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C23625T  USA=3 [1.0%]  surface glycoprotein, A688V</title>
	<circle cx="1144.7" cy="1832.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C23718T  USA=2 [0.7%]  surface glycoprotein, T719I</title>
	<circle cx="1142.9" cy="1853.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  A23756G  Mexico=2 [40.0%]  surface glycoprotein, T732A</title>
	<circle cx="1142.1" cy="1861.4" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C24026T  USA=6 [2.0%]  surface glycoprotein, L822F</title>
	<circle cx="1136.9" cy="1921.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C24138T  USA=2 [0.7%]  surface glycoprotein, T859I</title>
	<circle cx="1134.7" cy="1946.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  T24212G  USA=4 [1.4%]  surface glycoprotein, S884A</title>
	<circle cx="1133.3" cy="1962.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  G24368T  Costa Rica=2 [40.0%]  surface glycoprotein, D936Y</title>
	<circle cx="1130.3" cy="1997.2" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  G24812T  USA=3 [1.0%]  surface glycoprotein, D1084Y</title>
	<circle cx="1121.6" cy="2095.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  G25445T  USA=2 [0.7%]  ORF3a protein, G18V</title>
	<circle cx="1109.4" cy="2236.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C25466T  USA=2 [0.7%]  ORF3a protein, P25L</title>
	<circle cx="1108.9" cy="2240.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04 USA: 176 samples</title>
	<line x1="1197.9" y1="1219.9" x2="1196.9" y2="1230.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-04 Canada: 3 samples</title>
	<line x1="1196.9" y1="1230.0" x2="1196.6" y2="1232.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-04 Mexico: 5 samples</title>
	<line x1="1196.6" y1="1232.6" x2="1196.2" y2="1236.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-04  C21707T  USA=7 [4.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1178.3" cy="1406.4" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G21724T  USA=2 [1.1%]  surface glycoprotein, L54F</title>
	<circle cx="1177.9" cy="1410.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G23311T  USA=3 [1.7%]  surface glycoprotein, E583D</title>
	<circle cx="1141.0" cy="1761.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  A23403G  USA=176 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="1782.1" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  A23403G  USA=176 [100.0%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="1782.1" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  A23403G  USA=176 [100.0%] Mexico=5 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="1782.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  A23586G  USA=3 [1.7%]  surface glycoprotein, Q675R</title>
	<circle cx="1134.6" cy="1822.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G23593T  USA=2 [1.1%]  surface glycoprotein, Q677H</title>
	<circle cx="1134.4" cy="1824.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  C23604T  USA=2 [1.1%]  surface glycoprotein, P681L</title>
	<circle cx="1134.1" cy="1826.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  C23625T  USA=3 [1.7%]  surface glycoprotein, A688V</title>
	<circle cx="1133.7" cy="1831.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  C24026T  USA=2 [1.1%]  surface glycoprotein, L822F</title>
	<circle cx="1124.3" cy="1920.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  C24718A  USA=3 [1.7%]  surface glycoprotein, F1052L</title>
	<circle cx="1108.2" cy="2073.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G25445T  USA=2 [1.1%]  ORF3a protein, G18V</title>
	<circle cx="1091.3" cy="2234.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05 USA: 156 samples</title>
	<line x1="1197.6" y1="1219.9" x2="1196.4" y2="1229.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-05 Canada: 2 samples</title>
	<line x1="1196.4" y1="1229.7" x2="1196.1" y2="1231.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-05 Mexico: 4 samples</title>
	<line x1="1196.1" y1="1231.8" x2="1195.7" y2="1234.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-05  C21575T  USA=3 [1.9%]  surface glycoprotein, L5F</title>
	<circle cx="1178.3" cy="1376.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  C21707T  USA=10 [6.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1174.7" cy="1406.0" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  G23224T  USA=2 [1.3%]  surface glycoprotein, E554D</title>
	<circle cx="1133.5" cy="1741.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  A23403G  USA=155 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="1780.9" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  A23403G  USA=155 [99.4%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="1780.9" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  A23403G  USA=155 [99.4%] Mexico=4 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="1780.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  C24026T  USA=2 [1.3%]  surface glycoprotein, L822F</title>
	<circle cx="1111.8" cy="1918.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  C24138T  USA=2 [1.3%]  surface glycoprotein, T859I</title>
	<circle cx="1108.7" cy="1943.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  C24378T  USA=2 [1.3%]  surface glycoprotein, S939F</title>
	<circle cx="1102.2" cy="1996.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  G25269T  USA=2 [1.3%]  surface glycoprotein, C1236F</title>
	<circle cx="1078.0" cy="2193.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  G25437T  USA=2 [1.3%]  ORF3a protein, L15F</title>
	<circle cx="1073.5" cy="2230.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06 USA: 361 samples</title>
	<line x1="1197.2" y1="1219.8" x2="1195.6" y2="1231.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-06 Canada: 3 samples</title>
	<line x1="1195.6" y1="1231.2" x2="1195.2" y2="1233.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-06 Mexico: 7 samples</title>
	<line x1="1195.2" y1="1233.9" x2="1194.7" y2="1237.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-06  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1175.2" cy="1376.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  C21707T  USA=22 [6.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1171.1" cy="1405.6" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  G21724T  USA=2 [0.6%]  surface glycoprotein, L54F</title>
	<circle cx="1170.6" cy="1409.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  A23125ATCC  USA=2 [0.6%]  surface glycoprotein, A522S</title>
	<circle cx="1127.2" cy="1718.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  C23202T  USA=2 [0.6%]  surface glycoprotein, T547I</title>
	<circle cx="1124.8" cy="1735.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  G23224T  USA=2 [0.6%]  surface glycoprotein, E554D</title>
	<circle cx="1124.1" cy="1740.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  G23311T  USA=2 [0.6%]  surface glycoprotein, E583D</title>
	<circle cx="1121.4" cy="1759.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  A23403G  USA=357 [98.9%]  surface glycoprotein, D614G</title>
	<circle cx="1118.5" cy="1779.6" r="10.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  A23403G  USA=357 [98.9%] Mexico=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1118.5" cy="1779.6" r="3.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  A23403G  USA=357 [98.9%] Mexico=7 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1118.5" cy="1779.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  A23586G  USA=3 [0.8%]  surface glycoprotein, Q675R</title>
	<circle cx="1112.9" cy="1820.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  C24026T  USA=2 [0.6%]  surface glycoprotein, L822F</title>
	<circle cx="1099.2" cy="1917.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  T24212G  USA=4 [1.1%]  surface glycoprotein, S884A</title>
	<circle cx="1093.5" cy="1958.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  A25121T  USA=2 [0.6%]  surface glycoprotein, N1187Y</title>
	<circle cx="1065.3" cy="2158.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  G25489T  USA=2 [0.6%]  ORF3a protein, A33S</title>
	<circle cx="1053.9" cy="2239.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07 USA: 333 samples</title>
	<line x1="1196.9" y1="1219.8" x2="1195.1" y2="1231.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-07 Mexico: 5 samples</title>
	<line x1="1195.1" y1="1231.0" x2="1194.5" y2="1234.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-07  C21575T  USA=2 [0.6%]  surface glycoprotein, L5F</title>
	<circle cx="1172.1" cy="1376.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C21707T  USA=8 [2.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1167.5" cy="1405.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G21724T  USA=3 [0.9%]  surface glycoprotein, L54F</title>
	<circle cx="1166.9" cy="1408.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G21785A  USA=2 [0.6%]  surface glycoprotein, G75S</title>
	<circle cx="1164.8" cy="1422.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G22021A  USA=3 [0.9%]  surface glycoprotein, M153I</title>
	<circle cx="1156.6" cy="1474.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  A22320G  USA=2 [0.6%]  surface glycoprotein, D253G</title>
	<circle cx="1146.2" cy="1539.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G23224T  USA=3 [0.9%]  surface glycoprotein, E554D</title>
	<circle cx="1114.7" cy="1738.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G23270T  USA=2 [0.6%]  surface glycoprotein, A570S</title>
	<circle cx="1113.1" cy="1748.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C23277T  USA=2 [0.6%]  surface glycoprotein, T572I</title>
	<circle cx="1112.8" cy="1750.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G23311T  USA=4 [1.2%]  surface glycoprotein, E583D</title>
	<circle cx="1111.6" cy="1757.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  A23403G  USA=332 [99.7%]  surface glycoprotein, D614G</title>
	<circle cx="1108.4" cy="1778.1" r="10.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  A23403G  USA=332 [99.7%] Mexico=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1108.4" cy="1778.1" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  A23474G  USA=2 [0.6%]  surface glycoprotein, T638A</title>
	<circle cx="1106.0" cy="1793.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C23481T  USA=2 [0.6%]  surface glycoprotein, S640F</title>
	<circle cx="1105.7" cy="1795.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  A23586G  USA=2 [0.6%]  surface glycoprotein, Q675R</title>
	<circle cx="1102.1" cy="1818.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C23613T  USA=2 [0.6%]  surface glycoprotein, A684V</title>
	<circle cx="1101.1" cy="1824.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C24026T  USA=5 [1.5%]  surface glycoprotein, L822F</title>
	<circle cx="1086.7" cy="1915.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  T24212G  USA=3 [0.9%]  surface glycoprotein, S884A</title>
	<circle cx="1080.3" cy="1956.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C24378T  USA=4 [1.2%]  surface glycoprotein, S939F</title>
	<circle cx="1074.5" cy="1992.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C24718A  USA=3 [0.9%]  surface glycoprotein, F1052L</title>
	<circle cx="1062.6" cy="2067.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G24812T  USA=2 [0.6%]  surface glycoprotein, D1084Y</title>
	<circle cx="1059.3" cy="2088.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G25437T  USA=15 [4.5%]  ORF3a protein, L15F</title>
	<circle cx="1037.6" cy="2225.5" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08 USA: 377 samples</title>
	<line x1="1196.5" y1="1219.7" x2="1194.5" y2="1231.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-08 Mexico: 8 samples</title>
	<line x1="1194.5" y1="1231.1" x2="1193.8" y2="1235.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-08  C21575T  USA=3 [0.8%]  surface glycoprotein, L5F</title>
	<circle cx="1169.1" cy="1375.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C21627T  USA=2 [0.5%]  surface glycoprotein, T22I</title>
	<circle cx="1167.0" cy="1386.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C21648T  USA=2 [0.5%]  surface glycoprotein, T29I</title>
	<circle cx="1166.2" cy="1391.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C21707T  USA=18 [4.8%]  surface glycoprotein, H49Y</title>
	<circle cx="1164.0" cy="1404.4" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  G21724T  USA=3 [0.8%]  surface glycoprotein, L54F</title>
	<circle cx="1163.3" cy="1408.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  G21974T  Mexico=4 [50.0%]  surface glycoprotein, D138Y</title>
	<circle cx="1153.6" cy="1463.0" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  T22287C  USA=3 [0.8%]  surface glycoprotein, L242P</title>
	<circle cx="1141.5" cy="1531.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  G23009T  USA=2 [0.5%]  surface glycoprotein, V483F</title>
	<circle cx="1113.6" cy="1690.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  G23120T  USA=2 [0.5%]  surface glycoprotein, A520S</title>
	<circle cx="1109.3" cy="1714.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C23277T  USA=2 [0.5%]  surface glycoprotein, T572I</title>
	<circle cx="1103.2" cy="1748.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  A23403G  USA=377 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="1776.4" r="10.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  A23403G  USA=377 [100.0%] Mexico=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="1776.4" r="3.6" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C23453T  USA=2 [0.5%]  surface glycoprotein, P631S</title>
	<circle cx="1096.4" cy="1787.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  A23586G  USA=2 [0.5%]  surface glycoprotein, Q675R</title>
	<circle cx="1091.3" cy="1816.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C23625T  USA=2 [0.5%]  surface glycoprotein, A688V</title>
	<circle cx="1089.8" cy="1825.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  G23873T  USA=2 [0.5%]  surface glycoprotein, A771S</title>
	<circle cx="1080.2" cy="1879.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C23987T  USA=2 [0.5%]  surface glycoprotein, P809S</title>
	<circle cx="1075.8" cy="1904.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C24026T  USA=9 [2.4%]  surface glycoprotein, L822F</title>
	<circle cx="1074.3" cy="1913.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  G24812T  USA=2 [0.5%]  surface glycoprotein, D1084Y</title>
	<circle cx="1043.9" cy="2085.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C25046T  USA=2 [0.5%]  surface glycoprotein, P1162S</title>
	<circle cx="1034.8" cy="2136.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  A25336T  USA=3 [0.8%]  surface glycoprotein, E1258D</title>
	<circle cx="1023.6" cy="2200.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09 USA: 366 samples</title>
	<line x1="1196.2" y1="1219.6" x2="1194.0" y2="1231.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-09 Canada: 6 samples</title>
	<line x1="1194.0" y1="1231.0" x2="1193.3" y2="1234.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-09 Costa Rica: 2 samples</title>
	<line x1="1193.3" y1="1234.7" x2="1192.8" y2="1236.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-09  C21575T  USA=3 [0.8%]  surface glycoprotein, L5F</title>
	<circle cx="1166.0" cy="1374.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C21627T  USA=2 [0.5%]  surface glycoprotein, T22I</title>
	<circle cx="1163.8" cy="1386.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C21638T  USA=3 [0.8%]  surface glycoprotein, P26S</title>
	<circle cx="1163.3" cy="1388.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C21707T  USA=11 [3.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1160.4" cy="1403.8" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  G21724T  USA=4 [1.1%]  surface glycoprotein, L54F</title>
	<circle cx="1159.7" cy="1407.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  ATTA21993A  USA=2 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1148.2" cy="1466.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C22227T  USA=7 [1.9%]  surface glycoprotein, A222V</title>
	<circle cx="1138.3" cy="1517.4" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  G22249T  USA=7 [1.9%]  surface glycoprotein, L229F</title>
	<circle cx="1137.4" cy="1522.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C22323T  USA=2 [0.5%]  surface glycoprotein, S254F</title>
	<circle cx="1134.2" cy="1538.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  A23040T  USA=2 [0.5%]  surface glycoprotein, Q493L</title>
	<circle cx="1103.7" cy="1695.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  A23125ATCC  USA=2 [0.5%]  surface glycoprotein, A522S</title>
	<circle cx="1100.1" cy="1713.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  A23403G  USA=364 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="1774.5" r="10.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  A23403G  USA=364 [99.5%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="1774.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  A23403G  USA=364 [99.5%] Canada=6 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="1774.5" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C23481T  USA=3 [0.8%]  surface glycoprotein, S640F</title>
	<circle cx="1085.0" cy="1791.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C23525T  USA=2 [0.5%]  surface glycoprotein, H655Y</title>
	<circle cx="1083.1" cy="1801.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  A23586G  USA=2 [0.5%]  surface glycoprotein, Q675R</title>
	<circle cx="1080.5" cy="1814.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C23604A  USA=2 [0.5%]  surface glycoprotein, P681H</title>
	<circle cx="1079.8" cy="1818.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C25046T  USA=3 [0.8%]  surface glycoprotein, P1162S</title>
	<circle cx="1018.5" cy="2133.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  G25437T  USA=3 [0.8%]  ORF3a protein, L15F</title>
	<circle cx="1001.9" cy="2219.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C25463T  USA=4 [1.1%]  ORF3a protein, T24I</title>
	<circle cx="1000.8" cy="2224.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10 USA: 390 samples</title>
	<line x1="1195.8" y1="1219.6" x2="1193.4" y2="1231.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-10 Canada: 11 samples</title>
	<line x1="1193.4" y1="1231.0" x2="1192.4" y2="1235.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-10 Mexico: 2 samples</title>
	<line x1="1192.4" y1="1235.7" x2="1192.0" y2="1237.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-10 Costa Rica: 2 samples</title>
	<line x1="1192.0" y1="1237.8" x2="1191.5" y2="1239.9" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-10  C21575T  USA=3 [0.8%]  surface glycoprotein, L5F</title>
	<circle cx="1163.0" cy="1374.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  C21638T  USA=4 [1.0%]  surface glycoprotein, P26S</title>
	<circle cx="1160.0" cy="1388.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  C21707T  USA=5 [1.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1156.8" cy="1403.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G21785C  USA=4 [1.0%]  surface glycoprotein, G75R</title>
	<circle cx="1153.2" cy="1420.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  C22227T  USA=2 [0.5%]  surface glycoprotein, A222V</title>
	<circle cx="1132.8" cy="1516.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G22249T  USA=2 [0.5%]  surface glycoprotein, L229F</title>
	<circle cx="1131.7" cy="1521.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A22320G  USA=6 [1.5%]  surface glycoprotein, D253G</title>
	<circle cx="1128.5" cy="1536.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G23224T  USA=4 [1.0%]  surface glycoprotein, E554D</title>
	<circle cx="1086.6" cy="1733.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A23403G  USA=386 [99.0%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="1772.5" r="10.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A23403G  USA=386 [99.0%] Canada=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="1772.5" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A23403G  USA=386 [99.0%] Canada=11 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="1772.5" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A23403G  USA=386 [99.0%] Canada=11 [100.0%] Costa Rica=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="1772.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G23868T  USA=4 [1.0%]  surface glycoprotein, G769V</title>
	<circle cx="1056.8" cy="1873.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  C24026T  USA=2 [0.5%]  surface glycoprotein, L822F</title>
	<circle cx="1049.5" cy="1908.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  T24212G  USA=2 [0.5%]  surface glycoprotein, S884A</title>
	<circle cx="1040.8" cy="1948.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G24872C  USA=5 [1.3%]  surface glycoprotein, V1104L</title>
	<circle cx="1010.3" cy="2092.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A25076G  USA=2 [0.5%]  surface glycoprotein, I1172V</title>
	<circle cx="1000.8" cy="2137.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G25183T  USA=2 [0.5%]  surface glycoprotein, E1207D</title>
	<circle cx="995.9" cy="2160.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  C25350T  USA=2 [0.5%]  surface glycoprotein, P1263L</title>
	<circle cx="988.2" cy="2196.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G25437T  USA=2 [0.5%]  ORF3a protein, L15F</title>
	<circle cx="984.1" cy="2215.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11 USA: 71 samples</title>
	<line x1="1195.5" y1="1219.5" x2="1193.6" y2="1227.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-11 Canada: 6 samples</title>
	<line x1="1193.6" y1="1227.6" x2="1192.8" y2="1231.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-11 Mexico: 2 samples</title>
	<line x1="1192.8" y1="1231.3" x2="1192.3" y2="1233.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-11  C21575T  USA=2 [2.8%]  surface glycoprotein, L5F</title>
	<circle cx="1159.9" cy="1373.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  C21627T  USA=3 [4.2%]  surface glycoprotein, T22I</title>
	<circle cx="1157.3" cy="1384.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  G22232C  USA=2 [2.8%]  surface glycoprotein, E224Q</title>
	<circle cx="1127.0" cy="1516.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  C22286T  USA=2 [2.8%]  surface glycoprotein, L242F</title>
	<circle cx="1124.3" cy="1527.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  A23403G  USA=71 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1068.3" cy="1770.3" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  A23403G  USA=71 [100.0%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1068.3" cy="1770.3" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  A23403G  USA=71 [100.0%] Canada=6 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1068.3" cy="1770.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-12 USA: 69 samples</title>
	<line x1="1195.2" y1="1219.4" x2="1193.2" y2="1227.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-12  A23403G  USA=69 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1058.4" cy="1767.9" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-12  G25244T  USA=3 [4.3%]  surface glycoprotein, V1228L</title>
	<circle cx="959.2" cy="2165.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13 USA: 120 samples</title>
	<line x1="1194.8" y1="1219.3" x2="1192.4" y2="1228.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-13 Canada: 3 samples</title>
	<line x1="1192.4" y1="1228.4" x2="1191.7" y2="1231.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-13 Mexico: 2 samples</title>
	<line x1="1191.7" y1="1231.0" x2="1191.1" y2="1233.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-13  G21718T  USA=2 [1.7%]  surface glycoprotein, Q52H</title>
	<circle cx="1145.6" cy="1402.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  C21789T  USA=3 [2.5%]  surface glycoprotein, T76I</title>
	<circle cx="1141.5" cy="1418.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  ATTA21993A  USA=2 [1.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1129.8" cy="1462.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  G22205T  USA=2 [1.7%]  surface glycoprotein, D215Y</title>
	<circle cx="1117.6" cy="1507.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A22320G  USA=5 [4.2%]  surface glycoprotein, D253G</title>
	<circle cx="1110.9" cy="1532.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  C22329T  USA=2 [1.7%]  surface glycoprotein, S256L</title>
	<circle cx="1110.4" cy="1534.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A23403G  USA=120 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1048.5" cy="1765.4" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A23403G  USA=120 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1048.5" cy="1765.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A23403G  USA=120 [100.0%] Canada=3 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1048.5" cy="1765.4" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A23756G  Mexico=2 [100.0%]  surface glycoprotein, T732A</title>
	<circle cx="1028.2" cy="1841.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A25121T  USA=2 [1.7%]  surface glycoprotein, N1187Y</title>
	<circle cx="949.5" cy="2134.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  G25352T  USA=2 [1.7%]  surface glycoprotein, V1264L</title>
	<circle cx="936.2" cy="2184.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  G25440T  USA=2 [1.7%]  ORF3a protein, K16N</title>
	<circle cx="931.1" cy="2203.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14 USA: 163 samples</title>
	<line x1="1194.5" y1="1219.2" x2="1191.7" y2="1228.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-14 Canada: 3 samples</title>
	<line x1="1191.7" y1="1228.8" x2="1191.0" y2="1231.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-14 Mexico: 2 samples</title>
	<line x1="1191.0" y1="1231.4" x2="1190.4" y2="1233.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-14 Guatemala: 2 samples</title>
	<line x1="1190.4" y1="1233.5" x2="1189.8" y2="1235.5" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-14  C21575T  USA=5 [3.1%]  surface glycoprotein, L5F</title>
	<circle cx="1150.9" cy="1371.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23403G  USA=163 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="1762.6" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23403G  USA=163 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="1762.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23403G  USA=163 [100.0%] Canada=3 [100.0%] Guatemala=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="1762.6" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23403G  USA=163 [100.0%] Canada=3 [100.0%] Guatemala=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="1762.6" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23586G  USA=2 [1.2%]  surface glycoprotein, Q675R</title>
	<circle cx="1027.4" cy="1801.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23756G  Mexico=2 [100.0%]  surface glycoprotein, T732A</title>
	<circle cx="1017.0" cy="1838.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  G24399T  USA=2 [1.2%]  surface glycoprotein, G946V</title>
	<circle cx="977.5" cy="1975.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  C24621T  USA=2 [1.2%]  surface glycoprotein, A1020V</title>
	<circle cx="963.9" cy="2023.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  G24872C  USA=4 [2.5%]  surface glycoprotein, V1104L</title>
	<circle cx="948.5" cy="2077.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A25121T  USA=3 [1.8%]  surface glycoprotein, N1187Y</title>
	<circle cx="933.2" cy="2130.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  G25229A  USA=2 [1.2%]  surface glycoprotein, G1223S</title>
	<circle cx="926.6" cy="2153.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  G25437T  USA=2 [1.2%]  ORF3a protein, L15F</title>
	<circle cx="913.8" cy="2198.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  G25445T  USA=2 [1.2%]  ORF3a protein, G18V</title>
	<circle cx="913.3" cy="2199.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15 USA: 131 samples</title>
	<line x1="1194.2" y1="1219.1" x2="1191.4" y2="1228.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-15 Canada: 7 samples</title>
	<line x1="1191.4" y1="1228.3" x2="1190.2" y2="1232.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-15 Mexico: 2 samples</title>
	<line x1="1190.2" y1="1232.1" x2="1189.5" y2="1234.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-15 Costa Rica: 2 samples</title>
	<line x1="1189.5" y1="1234.2" x2="1188.9" y2="1236.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-15  C21575T  USA=3 [2.3%]  surface glycoprotein, L5F</title>
	<circle cx="1147.9" cy="1370.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  C21642T  USA=2 [1.5%]  surface glycoprotein, A27V</title>
	<circle cx="1143.5" cy="1384.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  G22232C  USA=3 [2.3%]  surface glycoprotein, E224Q</title>
	<circle cx="1105.1" cy="1510.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  C22286T  USA=3 [2.3%]  surface glycoprotein, L242F</title>
	<circle cx="1101.6" cy="1521.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A22320G  USA=2 [1.5%]  surface glycoprotein, D253G</title>
	<circle cx="1099.4" cy="1529.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  G23311T  USA=2 [1.5%]  surface glycoprotein, E583D</title>
	<circle cx="1034.9" cy="1740.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23403G  USA=131 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="1759.7" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23403G  USA=131 [100.0%] Canada=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="1759.7" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23403G  USA=131 [100.0%] Canada=7 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="1759.7" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23403G  USA=131 [100.0%] Canada=7 [100.0%] Costa Rica=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="1759.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23586G  USA=2 [1.5%]  surface glycoprotein, Q675R</title>
	<circle cx="1017.0" cy="1798.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  G23873T  USA=2 [1.5%]  surface glycoprotein, A771S</title>
	<circle cx="998.3" cy="1859.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  C23987T  USA=2 [1.5%]  surface glycoprotein, P809S</title>
	<circle cx="990.8" cy="1884.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  C24096T  USA=2 [1.5%]  surface glycoprotein, A845V</title>
	<circle cx="983.7" cy="1907.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  C24863T  USA=2 [1.5%]  surface glycoprotein, H1101Y</title>
	<circle cx="933.8" cy="2070.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16 USA: 124 samples</title>
	<line x1="1193.8" y1="1219.0" x2="1190.9" y2="1228.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-16 Canada: 10 samples</title>
	<line x1="1190.9" y1="1228.0" x2="1189.5" y2="1232.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-16 Mexico: 4 samples</title>
	<line x1="1189.5" y1="1232.5" x2="1188.5" y2="1235.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-16 Costa Rica: 2 samples</title>
	<line x1="1188.5" y1="1235.4" x2="1187.8" y2="1237.5" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-16  C21575T  USA=2 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1144.9" cy="1369.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G21724T  USA=2 [1.6%]  surface glycoprotein, L54F</title>
	<circle cx="1134.7" cy="1401.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  ATTA21993A  USA=2 [1.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1116.2" cy="1458.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G22017T  USA=2 [1.6%]  surface glycoprotein, W152L</title>
	<circle cx="1114.5" cy="1463.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  C22329T  USA=2 [1.6%]  surface glycoprotein, S256L</title>
	<circle cx="1093.0" cy="1529.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G22487C  USA=4 [3.2%]  surface glycoprotein, E309Q</title>
	<circle cx="1082.2" cy="1562.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G23311T  USA=2 [1.6%]  surface glycoprotein, E583D</title>
	<circle cx="1025.5" cy="1737.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  A23403G  USA=124 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="1756.7" r="8.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  A23403G  USA=124 [100.0%] Canada=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="1756.7" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  A23403G  USA=124 [100.0%] Canada=10 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="1756.7" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  A23403G  USA=124 [100.0%] Canada=10 [100.0%] Mexico=4 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="1756.7" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  A23586G  USA=2 [1.6%]  surface glycoprotein, Q675R</title>
	<circle cx="1006.5" cy="1795.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G24328T  USA=2 [1.6%]  surface glycoprotein, L922F</title>
	<circle cx="955.5" cy="1952.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  C24912T  Costa Rica=2 [100.0%]  surface glycoprotein, T1117I</title>
	<circle cx="915.3" cy="2076.3" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  A25076G  USA=3 [2.4%]  surface glycoprotein, I1172V</title>
	<circle cx="904.0" cy="2111.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G25311T  USA=4 [3.2%]  surface glycoprotein, C1250F</title>
	<circle cx="887.8" cy="2160.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G25440T  USA=3 [2.4%]  ORF3a protein, K16N</title>
	<circle cx="878.9" cy="2188.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17 USA: 144 samples</title>
	<line x1="1193.5" y1="1218.9" x2="1190.3" y2="1228.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-17 Canada: 19 samples</title>
	<line x1="1190.3" y1="1228.1" x2="1188.4" y2="1233.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-17 Mexico: 3 samples</title>
	<line x1="1188.4" y1="1233.6" x2="1187.5" y2="1236.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-17  A23403G  USA=144 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="1753.4" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  A23403G  USA=144 [100.0%] Canada=19 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="1753.4" r="5.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  A23403G  USA=144 [100.0%] Canada=19 [100.0%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="1753.4" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  C23895T  USA=2 [1.4%]  surface glycoprotein, T778I</title>
	<circle cx="973.8" cy="1857.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  G24794T  USA=2 [1.4%]  surface glycoprotein, A1078S</title>
	<circle cx="908.6" cy="2046.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  G24872T  USA=2 [1.4%]  surface glycoprotein, V1104L</title>
	<circle cx="902.9" cy="2062.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  A25121T  USA=3 [2.1%]  surface glycoprotein, N1187Y</title>
	<circle cx="884.9" cy="2115.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  G25127A  USA=2 [1.4%]  surface glycoprotein, V1189I</title>
	<circle cx="884.4" cy="2116.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  G25135T  USA=2 [1.4%]  surface glycoprotein, K1191N</title>
	<circle cx="883.9" cy="2118.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  G25311T  USA=4 [2.8%]  surface glycoprotein, C1250F</title>
	<circle cx="871.1" cy="2155.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18 USA: 103 samples</title>
	<line x1="1193.2" y1="1218.8" x2="1190.1" y2="1227.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-18 Canada: 4 samples</title>
	<line x1="1190.1" y1="1227.3" x2="1189.0" y2="1230.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-18 Mexico: 2 samples</title>
	<line x1="1189.0" y1="1230.3" x2="1188.2" y2="1232.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-18  C21575T  USA=3 [2.9%]  surface glycoprotein, L5F</title>
	<circle cx="1139.1" cy="1367.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  A21717T  USA=2 [1.9%]  surface glycoprotein, Q52L</title>
	<circle cx="1128.2" cy="1397.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  G21839T  USA=3 [2.9%]  surface glycoprotein, A93S</title>
	<circle cx="1119.0" cy="1422.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  G21893A  USA=6 [5.8%]  surface glycoprotein, D111N</title>
	<circle cx="1114.8" cy="1434.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  A22320G  USA=7 [6.8%]  surface glycoprotein, D253G</title>
	<circle cx="1082.3" cy="1523.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  A23403G  USA=101 [98.1%]  surface glycoprotein, D614G</title>
	<circle cx="999.8" cy="1750.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  A23403G  USA=101 [98.1%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="999.8" cy="1750.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  A23403G  USA=101 [98.1%] Canada=4 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="999.8" cy="1750.0" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  C23664T  USA=6 [5.8%]  surface glycoprotein, A701V</title>
	<circle cx="979.9" cy="1804.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  G24095T  USA=3 [2.9%]  surface glycoprotein, A845S</title>
	<circle cx="947.1" cy="1894.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  G25244T  USA=2 [1.9%]  surface glycoprotein, V1228L</title>
	<circle cx="859.6" cy="2135.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19 USA: 63 samples</title>
	<line x1="1192.8" y1="1218.7" x2="1189.9" y2="1226.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-19 Canada: 6 samples</title>
	<line x1="1189.9" y1="1226.3" x2="1188.6" y2="1229.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-19 Costa Rica: 2 samples</title>
	<line x1="1188.6" y1="1229.8" x2="1187.8" y2="1231.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-19  G21718T  USA=2 [3.2%]  surface glycoprotein, Q52H</title>
	<circle cx="1124.7" cy="1396.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  G21724T  USA=3 [4.8%]  surface glycoprotein, L54F</title>
	<circle cx="1124.3" cy="1397.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  G23120T  USA=3 [4.8%]  surface glycoprotein, A520S</title>
	<circle cx="1012.8" cy="1687.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  A23403G  USA=63 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="990.2" cy="1746.4" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  A23403G  USA=63 [100.0%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="990.2" cy="1746.4" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  A23403G  USA=63 [100.0%] Canada=6 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="990.2" cy="1746.4" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  A23586G  USA=3 [4.8%]  surface glycoprotein, Q675R</title>
	<circle cx="975.6" cy="1784.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  G23900C  USA=2 [3.2%]  surface glycoprotein, E780Q</title>
	<circle cx="950.6" cy="1849.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20 USA: 93 samples</title>
	<line x1="1192.5" y1="1218.5" x2="1189.2" y2="1226.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-20 Canada: 11 samples</title>
	<line x1="1189.2" y1="1226.8" x2="1187.4" y2="1231.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-20 Mexico: 3 samples</title>
	<line x1="1187.4" y1="1231.3" x2="1186.3" y2="1233.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-20  C21575T  USA=6 [6.5%]  surface glycoprotein, L5F</title>
	<circle cx="1133.3" cy="1365.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G22021A  Canada=2 [18.2%]  surface glycoprotein, M153I</title>
	<circle cx="1096.0" cy="1457.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A22101T  USA=7 [7.5%]  surface glycoprotein, E180V</title>
	<circle cx="1089.4" cy="1473.8" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G23270T  USA=2 [2.2%]  surface glycoprotein, A570S</title>
	<circle cx="991.8" cy="1715.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A23403G  USA=93 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="1742.7" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A23403G  USA=93 [100.0%] Canada=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="1742.7" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A23403G  USA=93 [100.0%] Canada=11 [100.0%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="1742.7" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G23587C  Canada=2 [18.2%]  surface glycoprotein, Q675H</title>
	<circle cx="965.4" cy="1780.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  C23625T  USA=2 [2.2%]  surface glycoprotein, A688V</title>
	<circle cx="962.2" cy="1788.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A23756G  Mexico=2 [66.7%]  surface glycoprotein, T732A</title>
	<circle cx="951.3" cy="1815.6" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A25121T  USA=2 [2.2%]  surface glycoprotein, N1187Y</title>
	<circle cx="837.4" cy="2097.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G25135T  USA=2 [2.2%]  surface glycoprotein, K1191N</title>
	<circle cx="836.2" cy="2100.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G25352T  USA=2 [2.2%]  surface glycoprotein, V1264L</title>
	<circle cx="818.1" cy="2145.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G25437T  Canada=2 [18.2%]  ORF3a protein, L15F</title>
	<circle cx="811.0" cy="2162.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21 USA: 117 samples</title>
	<line x1="1192.2" y1="1218.4" x2="1188.5" y2="1227.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21 Canada: 10 samples</title>
	<line x1="1188.5" y1="1227.0" x2="1186.7" y2="1231.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21 Mexico: 2 samples</title>
	<line x1="1186.7" y1="1231.3" x2="1185.9" y2="1233.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21 Costa Rica: 4 samples</title>
	<line x1="1185.9" y1="1233.3" x2="1184.6" y2="1236.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21  G21578T  USA=2 [1.7%]  surface glycoprotein, V6F</title>
	<circle cx="1130.1" cy="1364.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  ATTA21993A  USA=2 [1.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1094.0" cy="1449.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  USA=117 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  USA=117 [100.0%] Canada=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  USA=117 [100.0%] Canada=10 [100.0%] Costa Rica=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  USA=117 [100.0%] Canada=10 [100.0%] Costa Rica=4 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  C24378T  USA=2 [1.7%]  surface glycoprotein, S939F</title>
	<circle cx="886.5" cy="1938.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A25121T  USA=2 [1.7%]  surface glycoprotein, N1187Y</title>
	<circle cx="821.8" cy="2091.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  G25311T  USA=4 [3.4%]  surface glycoprotein, C1250F</title>
	<circle cx="805.3" cy="2129.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22 USA: 110 samples</title>
	<line x1="1191.9" y1="1218.3" x2="1188.1" y2="1226.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-22 Canada: 5 samples</title>
	<line x1="1188.1" y1="1226.7" x2="1186.7" y2="1229.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-22  C21575T  USA=2 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1127.5" cy="1362.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  G21786T  USA=2 [1.8%]  surface glycoprotein, G75V</title>
	<circle cx="1108.4" cy="1405.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  ATTA21993A  USA=2 [1.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1089.7" cy="1447.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A23403G  USA=110 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="961.9" cy="1734.7" r="8.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A23403G  USA=110 [100.0%] Canada=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="961.9" cy="1734.7" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A23586G  USA=2 [1.8%]  surface glycoprotein, Q675R</title>
	<circle cx="945.4" cy="1771.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  C23604A  USA=5 [4.5%]  surface glycoprotein, P681H</title>
	<circle cx="943.7" cy="1775.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  G24328T  USA=2 [1.8%]  surface glycoprotein, L922F</title>
	<circle cx="878.1" cy="1922.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A25121T  USA=2 [1.8%]  surface glycoprotein, N1187Y</title>
	<circle cx="806.3" cy="2084.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23 USA: 116 samples</title>
	<line x1="1191.5" y1="1218.1" x2="1187.6" y2="1226.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-23 Canada: 6 samples</title>
	<line x1="1187.6" y1="1226.6" x2="1186.0" y2="1230.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-23  C21575T  USA=8 [6.9%]  surface glycoprotein, L5F</title>
	<circle cx="1124.7" cy="1361.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  C21707T  USA=2 [1.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1112.3" cy="1388.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  A23403G  USA=115 [99.1%]  surface glycoprotein, D614G</title>
	<circle cx="952.6" cy="1730.5" r="8.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  A23403G  USA=115 [99.1%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="952.6" cy="1730.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  A23474G  USA=5 [4.3%]  surface glycoprotein, T638A</title>
	<circle cx="946.0" cy="1744.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  C24378T  USA=4 [3.4%]  surface glycoprotein, S939F</title>
	<circle cx="860.9" cy="1927.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  G25437T  USA=3 [2.6%]  ORF3a protein, L15F</title>
	<circle cx="761.2" cy="2141.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  G25471T  USA=2 [1.7%]  ORF3a protein, D27Y</title>
	<circle cx="758.0" cy="2147.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24 USA: 119 samples</title>
	<line x1="1191.2" y1="1218.0" x2="1187.1" y2="1226.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24 Canada: 9 samples</title>
	<line x1="1187.1" y1="1226.4" x2="1185.2" y2="1230.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24 Mexico: 3 samples</title>
	<line x1="1185.2" y1="1230.4" x2="1184.0" y2="1232.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24 Costa Rica: 2 samples</title>
	<line x1="1184.0" y1="1232.9" x2="1183.0" y2="1234.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24  C21575T  USA=4 [3.4%]  surface glycoprotein, L5F</title>
	<circle cx="1121.9" cy="1360.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  G22112A  USA=2 [1.7%]  surface glycoprotein, G184S</title>
	<circle cx="1069.5" cy="1467.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  G22205T  USA=2 [1.7%]  surface glycoprotein, D215Y</title>
	<circle cx="1060.4" cy="1486.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A23403G  USA=119 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="1726.1" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A23403G  USA=119 [100.0%] Canada=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="1726.1" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A23403G  USA=119 [100.0%] Canada=9 [100.0%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="1726.1" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A23403G  USA=119 [100.0%] Canada=9 [100.0%] Mexico=3 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="1726.1" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  G23522A  USA=2 [1.7%]  surface glycoprotein, E654K</title>
	<circle cx="931.8" cy="1749.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  C23604A  USA=4 [3.4%]  surface glycoprotein, P681H</title>
	<circle cx="923.8" cy="1766.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A23756G  Mexico=2 [66.7%]  surface glycoprotein, T732A</title>
	<circle cx="909.0" cy="1796.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  G24764T  USA=4 [3.4%]  surface glycoprotein, V1068F</title>
	<circle cx="810.5" cy="1998.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A24894C  USA=2 [1.7%]  surface glycoprotein, E1111A</title>
	<circle cx="797.9" cy="2024.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  G25471T  USA=4 [3.4%]  ORF3a protein, D27Y</title>
	<circle cx="741.5" cy="2140.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25 USA: 54 samples</title>
	<line x1="1190.9" y1="1217.8" x2="1187.4" y2="1224.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-25 Canada: 7 samples</title>
	<line x1="1187.4" y1="1224.8" x2="1185.5" y2="1228.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-25  A22320G  USA=3 [5.6%]  surface glycoprotein, D253G</title>
	<circle cx="1043.8" cy="1506.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25  A23403G  USA=54 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="934.3" cy="1721.5" r="6.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25  A23403G  USA=54 [100.0%] Canada=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="934.3" cy="1721.5" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25  G25437T  USA=2 [3.7%]  ORF3a protein, L15F</title>
	<circle cx="728.6" cy="2125.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-26 USA: 57 samples</title>
	<line x1="1190.6" y1="1217.7" x2="1186.9" y2="1224.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-26 Canada: 5 samples</title>
	<line x1="1186.9" y1="1224.7" x2="1185.2" y2="1227.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-26  A22320G  USA=4 [7.0%]  surface glycoprotein, D253G</title>
	<circle cx="1038.5" cy="1503.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-26  A23403G  USA=57 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="925.2" cy="1716.8" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-26  A23403G  USA=57 [100.0%] Canada=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="925.2" cy="1716.8" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27 USA: 172 samples</title>
	<line x1="1190.3" y1="1217.5" x2="1185.4" y2="1226.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-27 Canada: 4 samples</title>
	<line x1="1185.4" y1="1226.3" x2="1183.9" y2="1229.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-27 Mexico: 2 samples</title>
	<line x1="1183.9" y1="1229.1" x2="1182.9" y2="1230.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-27 Guatemala: 2 samples</title>
	<line x1="1182.9" y1="1230.9" x2="1181.8" y2="1232.8" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-27  T21568A  USA=3 [1.7%]  surface glycoprotein, F2L</title>
	<circle cx="1114.4" cy="1354.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C21575T  USA=2 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1113.6" cy="1355.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C21789T  USA=2 [1.2%]  surface glycoprotein, T76I</title>
	<circle cx="1090.5" cy="1397.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  T21992C  USA=2 [1.2%]  surface glycoprotein, Y144H</title>
	<circle cx="1068.6" cy="1437.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A22320G  USA=10 [5.8%]  surface glycoprotein, D253G</title>
	<circle cx="1033.2" cy="1501.0" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G22349A  USA=3 [1.7%]  surface glycoprotein, A263T</title>
	<circle cx="1030.0" cy="1506.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C23277T  USA=2 [1.2%]  surface glycoprotein, T572I</title>
	<circle cx="929.8" cy="1687.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A23403G  USA=172 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="1711.9" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A23403G  USA=172 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="1711.9" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A23403G  USA=172 [100.0%] Canada=4 [100.0%] Guatemala=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="1711.9" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A23403G  USA=172 [100.0%] Canada=4 [100.0%] Guatemala=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="1711.9" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G24305A  USA=2 [1.2%]  surface glycoprotein, V915I</title>
	<circle cx="818.8" cy="1887.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C24378T  USA=2 [1.2%]  surface glycoprotein, S939F</title>
	<circle cx="811.0" cy="1901.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G24410A  USA=2 [1.2%]  surface glycoprotein, D950N</title>
	<circle cx="807.5" cy="1908.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G25244T  USA=2 [1.2%]  surface glycoprotein, V1228L</title>
	<circle cx="717.5" cy="2070.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G25311T  USA=2 [1.2%]  surface glycoprotein, C1250F</title>
	<circle cx="710.2" cy="2083.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G25483A  USA=3 [1.7%]  ORF3a protein, A31T</title>
	<circle cx="691.7" cy="2117.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28 USA: 146 samples</title>
	<line x1="1190.0" y1="1217.3" x2="1185.1" y2="1225.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-28 Canada: 10 samples</title>
	<line x1="1185.1" y1="1225.8" x2="1182.8" y2="1229.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-28  C21575T  USA=8 [5.5%]  surface glycoprotein, L5F</title>
	<circle cx="1110.9" cy="1354.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  C21707T  USA=4 [2.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1096.2" cy="1379.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G21724T  USA=6 [4.1%]  surface glycoprotein, L54F</title>
	<circle cx="1094.3" cy="1383.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G22021A  Canada=2 [20.0%]  surface glycoprotein, M153I</title>
	<circle cx="1061.2" cy="1440.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G23120T  USA=6 [4.1%]  surface glycoprotein, A520S</title>
	<circle cx="938.9" cy="1652.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G23311T  USA=3 [2.1%]  surface glycoprotein, E583D</title>
	<circle cx="917.6" cy="1689.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  A23403G  USA=146 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="1706.9" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  A23403G  USA=146 [100.0%] Canada=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="1706.9" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  A23586G  USA=2 [1.4%]  surface glycoprotein, Q675R</title>
	<circle cx="887.0" cy="1742.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G23587C  Canada=2 [20.0%]  surface glycoprotein, Q675H</title>
	<circle cx="886.9" cy="1742.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  C23604A  USA=5 [3.4%]  surface glycoprotein, P681H</title>
	<circle cx="885.0" cy="1745.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  A23756G  USA=2 [1.4%]  surface glycoprotein, T732A</title>
	<circle cx="868.0" cy="1775.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G24933T  USA=3 [2.1%]  surface glycoprotein, G1124V</title>
	<circle cx="737.0" cy="2002.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G25437T  Canada=2 [20.0%]  ORF3a protein, L15F</title>
	<circle cx="680.8" cy="2099.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  C25487T  USA=2 [1.4%]  ORF3a protein, T32I</title>
	<circle cx="675.3" cy="2108.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29 USA: 107 samples</title>
	<line x1="1189.7" y1="1217.1" x2="1185.0" y2="1225.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-29 Canada: 12 samples</title>
	<line x1="1185.0" y1="1225.0" x2="1182.4" y2="1229.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-29 Mexico: 2 samples</title>
	<line x1="1182.4" y1="1229.3" x2="1181.3" y2="1231.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-29 Guatemala: 2 samples</title>
	<line x1="1181.3" y1="1231.1" x2="1180.2" y2="1233.0" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-29  C21575T  USA=7 [6.5%]  surface glycoprotein, L5F</title>
	<circle cx="1108.2" cy="1352.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  G22021T  Canada=4 [33.3%]  surface glycoprotein, M153I</title>
	<circle cx="1057.1" cy="1437.9" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  A23403G  USA=107 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="1701.7" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  A23403G  USA=107 [100.0%] Canada=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="1701.7" r="4.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  A23403G  USA=107 [100.0%] Canada=12 [100.0%] Guatemala=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="1701.7" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  A23403G  USA=107 [100.0%] Canada=12 [100.0%] Guatemala=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="1701.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  A23586G  USA=2 [1.9%]  surface glycoprotein, Q675R</title>
	<circle cx="877.6" cy="1736.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  C23604A  USA=7 [6.5%]  surface glycoprotein, P681H</title>
	<circle cx="875.5" cy="1740.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  C23625T  Canada=3 [25.0%]  surface glycoprotein, A688V</title>
	<circle cx="873.1" cy="1744.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  G24620T  Canada=4 [33.3%]  surface glycoprotein, A1020S</title>
	<circle cx="758.9" cy="1934.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  G25437T  USA=3 [2.8%]  ORF3a protein, L15F</title>
	<circle cx="665.2" cy="2090.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30 USA: 116 samples</title>
	<line x1="1189.4" y1="1217.0" x2="1184.5" y2="1224.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-30 Canada: 9 samples</title>
	<line x1="1184.5" y1="1224.9" x2="1182.1" y2="1228.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-30  C21575T  USA=2 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1105.6" cy="1351.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C21855T  USA=2 [1.7%]  surface glycoprotein, S98F</title>
	<circle cx="1072.5" cy="1404.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  G22021T  Canada=5 [55.6%]  surface glycoprotein, M153I</title>
	<circle cx="1052.9" cy="1435.3" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  T23042C  USA=2 [1.7%]  surface glycoprotein, S494P</title>
	<circle cx="932.4" cy="1628.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  G23270T  USA=2 [1.7%]  surface glycoprotein, A570S</title>
	<circle cx="905.5" cy="1671.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  G23311T  USA=2 [1.7%]  surface glycoprotein, E583D</title>
	<circle cx="900.7" cy="1679.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  A23403G  USA=116 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="889.8" cy="1696.4" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  A23403G  USA=116 [100.0%] Canada=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="889.8" cy="1696.4" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C23538T  USA=2 [1.7%]  surface glycoprotein, S659L</title>
	<circle cx="873.9" cy="1721.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  A23586G  USA=2 [1.7%]  surface glycoprotein, Q675R</title>
	<circle cx="868.2" cy="1730.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C23604A  USA=4 [3.4%]  surface glycoprotein, P681H</title>
	<circle cx="866.1" cy="1734.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C23625T  Canada=2 [22.2%]  surface glycoprotein, A688V</title>
	<circle cx="863.6" cy="1738.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  G24620T  Canada=5 [55.6%]  surface glycoprotein, A1020S</title>
	<circle cx="746.2" cy="1926.2" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31 USA: 94 samples</title>
	<line x1="1189.1" y1="1216.8" x2="1184.3" y2="1224.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-31 Canada: 2 samples</title>
	<line x1="1184.3" y1="1224.2" x2="1183.1" y2="1226.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-31 Mexico: 4 samples</title>
	<line x1="1183.1" y1="1226.0" x2="1181.4" y2="1228.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-31 Costa Rica: 2 samples</title>
	<line x1="1181.4" y1="1228.7" x2="1180.2" y2="1230.5" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-31  C21575T  USA=6 [6.4%]  surface glycoprotein, L5F</title>
	<circle cx="1103.0" cy="1349.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G22021T  Canada=2 [100.0%]  surface glycoprotein, M153I</title>
	<circle cx="1048.9" cy="1432.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G22661A  USA=2 [2.1%]  surface glycoprotein, V367I</title>
	<circle cx="971.2" cy="1552.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  A23403G  USA=94 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="881.2" cy="1690.9" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  A23403G  USA=94 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="881.2" cy="1690.9" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  A23403G  USA=94 [100.0%] Mexico=4 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="881.2" cy="1690.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  A23403G  USA=94 [100.0%] Mexico=4 [100.0%] Canada=2 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="881.2" cy="1690.9" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  A23586G  USA=2 [2.1%]  surface glycoprotein, Q675R</title>
	<circle cx="859.0" cy="1725.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  C23604A  USA=2 [2.1%]  surface glycoprotein, P681H</title>
	<circle cx="856.8" cy="1728.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G24620T  Canada=2 [100.0%]  surface glycoprotein, A1020S</title>
	<circle cx="733.6" cy="1918.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G24751T  USA=4 [4.3%]  surface glycoprotein, L1063F</title>
	<circle cx="717.7" cy="1942.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  C25469T  USA=2 [2.1%]  ORF3a protein, S26L</title>
	<circle cx="630.6" cy="2076.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G25471T  USA=6 [6.4%]  ORF3a protein, D27Y</title>
	<circle cx="630.4" cy="2077.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01 USA: 88 samples</title>
	<line x1="1188.8" y1="1216.6" x2="1183.9" y2="1223.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-01 Mexico: 4 samples</title>
	<line x1="1183.9" y1="1223.9" x2="1182.2" y2="1226.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-01  T21942C  USA=2 [2.3%]  surface glycoprotein, V127A</title>
	<circle cx="1054.7" cy="1415.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  G22203T  USA=3 [3.4%]  surface glycoprotein, R214L</title>
	<circle cx="1022.2" cy="1463.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  A23403G  USA=88 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="872.7" cy="1685.2" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  A23403G  USA=88 [100.0%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="872.7" cy="1685.2" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  A23586G  USA=2 [2.3%]  surface glycoprotein, Q675R</title>
	<circle cx="849.9" cy="1719.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  G24328T  USA=2 [2.3%]  surface glycoprotein, L922F</title>
	<circle cx="757.5" cy="1856.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02 USA: 42 samples</title>
	<line x1="1188.5" y1="1216.4" x2="1184.3" y2="1222.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-02 Mexico: 7 samples</title>
	<line x1="1184.3" y1="1222.4" x2="1182.0" y2="1225.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-02  C22482T  USA=4 [9.5%]  surface glycoprotein, T307I</title>
	<circle cx="981.9" cy="1511.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  A23403G  USA=42 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="864.3" cy="1679.5" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  A23403G  USA=42 [100.0%] Mexico=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="864.3" cy="1679.5" r="3.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  C23604A  USA=4 [9.5%]  surface glycoprotein, P681H</title>
	<circle cx="838.6" cy="1716.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  G25266T  Mexico=2 [28.6%]  surface glycoprotein, C1235F</title>
	<circle cx="626.3" cy="2019.3" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  G25459T  Mexico=2 [28.6%]  ORF3a protein, A23S</title>
	<circle cx="601.6" cy="2054.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03 USA: 190 samples</title>
	<line x1="1188.2" y1="1216.2" x2="1182.2" y2="1224.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-03 Canada: 26 samples</title>
	<line x1="1182.2" y1="1224.5" x2="1178.4" y2="1229.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-03 Mexico: 2 samples</title>
	<line x1="1178.4" y1="1229.7" x2="1177.2" y2="1231.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-03  C21575T  USA=3 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1095.3" cy="1344.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  C21707T  USA=2 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1078.0" cy="1367.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G21718T  USA=3 [1.6%]  surface glycoprotein, Q52H</title>
	<circle cx="1076.6" cy="1369.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  C21789T  USA=3 [1.6%]  surface glycoprotein, T76I</title>
	<circle cx="1067.3" cy="1382.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  TTTT21981T  Canada=6 [23.1%]  surface glycoprotein, F140L</title>
	<circle cx="1042.1" cy="1417.3" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G22021T  Canada=15 [57.7%]  surface glycoprotein, M153I</title>
	<circle cx="1036.9" cy="1424.5" r="4.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  A22320G  USA=4 [2.1%]  surface glycoprotein, D253G</title>
	<circle cx="997.7" cy="1478.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G23311T  USA=3 [1.6%]  surface glycoprotein, E583D</title>
	<circle cx="868.0" cy="1656.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  C23373T  USA=5 [2.6%]  surface glycoprotein, T604I</title>
	<circle cx="859.9" cy="1668.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  A23403G  USA=190 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="1673.5" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  A23403G  USA=190 [100.0%] Canada=26 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="1673.5" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  A23403G  USA=190 [100.0%] Canada=26 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="1673.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  C23625T  Canada=2 [7.7%]  surface glycoprotein, A688V</title>
	<circle cx="826.9" cy="1713.5" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  A23756G  USA=4 [2.1%]  surface glycoprotein, T732A</title>
	<circle cx="809.8" cy="1737.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G23900C  USA=5 [2.6%]  surface glycoprotein, E780Q</title>
	<circle cx="790.9" cy="1763.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  C24378T  USA=4 [2.1%]  surface glycoprotein, S939F</title>
	<circle cx="728.3" cy="1849.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G24620T  Canada=15 [57.7%]  surface glycoprotein, A1020S</title>
	<circle cx="696.7" cy="1892.8" r="4.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G24914T  USA=2 [1.1%]  surface glycoprotein, D1118Y</title>
	<circle cx="658.2" cy="1945.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  T25451C  USA=2 [1.1%]  ORF3a protein, I20T</title>
	<circle cx="587.9" cy="2042.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04 USA: 132 samples</title>
	<line x1="1188.0" y1="1216.0" x2="1182.2" y2="1223.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-04 Canada: 20 samples</title>
	<line x1="1182.2" y1="1223.6" x2="1178.6" y2="1228.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-04  C21575T  USA=6 [4.5%]  surface glycoprotein, L5F</title>
	<circle cx="1092.8" cy="1342.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  C21614T  USA=4 [3.0%]  surface glycoprotein, L18F</title>
	<circle cx="1087.5" cy="1349.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  G22021T  Canada=11 [55.0%]  surface glycoprotein, M153I</title>
	<circle cx="1033.0" cy="1421.6" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  A22320G  USA=2 [1.5%]  surface glycoprotein, D253G</title>
	<circle cx="992.9" cy="1474.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  T23042C  USA=6 [4.5%]  surface glycoprotein, S494P</title>
	<circle cx="896.1" cy="1603.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  A23403G  USA=132 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="1667.4" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  A23403G  USA=132 [100.0%] Canada=20 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="1667.4" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  C23604A  USA=2 [1.5%]  surface glycoprotein, P681H</title>
	<circle cx="820.8" cy="1703.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  G24620T  Canada=11 [55.0%]  surface glycoprotein, A1020S</title>
	<circle cx="684.6" cy="1883.9" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  C24771T  USA=2 [1.5%]  surface glycoprotein, A1070V</title>
	<circle cx="664.4" cy="1910.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05 USA: 158 samples</title>
	<line x1="1187.7" y1="1215.8" x2="1181.6" y2="1223.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-05 Canada: 20 samples</title>
	<line x1="1181.6" y1="1223.6" x2="1177.9" y2="1228.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-05  C21575T  USA=4 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1090.3" cy="1340.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  G21578T  USA=2 [1.3%]  surface glycoprotein, V6F</title>
	<circle cx="1089.9" cy="1340.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  C21621T  Canada=5 [25.0%]  surface glycoprotein, T20I</title>
	<circle cx="1084.0" cy="1348.5" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  C21846T  USA=2 [1.3%]  surface glycoprotein, T95I</title>
	<circle cx="1053.1" cy="1388.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  G22021T  Canada=6 [30.0%]  surface glycoprotein, M153I</title>
	<circle cx="1029.2" cy="1418.7" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  A22320G  USA=2 [1.3%]  surface glycoprotein, D253G</title>
	<circle cx="988.2" cy="1471.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  G22632A  Canada=5 [25.0%]  surface glycoprotein, R357K</title>
	<circle cx="945.4" cy="1525.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  ACC23076GGA  USA=2 [1.3%]  surface glycoprotein, Y505W</title>
	<circle cx="884.5" cy="1603.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  C23277T  USA=3 [1.9%]  surface glycoprotein, T572I</title>
	<circle cx="856.9" cy="1639.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  C23373T  USA=2 [1.3%]  surface glycoprotein, T604I</title>
	<circle cx="843.8" cy="1656.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  A23403G  USA=158 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="1661.2" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  A23403G  USA=158 [100.0%] Canada=20 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="1661.2" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  C23604A  USA=10 [6.3%]  surface glycoprotein, P681H</title>
	<circle cx="812.1" cy="1696.5" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  G24620T  Canada=6 [30.0%]  surface glycoprotein, A1020S</title>
	<circle cx="672.8" cy="1874.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  A25121T  USA=2 [1.3%]  surface glycoprotein, N1187Y</title>
	<circle cx="604.1" cy="1962.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  G25445T  USA=2 [1.3%]  ORF3a protein, G18V</title>
	<circle cx="559.7" cy="2019.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06 USA: 177 samples</title>
	<line x1="1187.4" y1="1215.5" x2="1181.0" y2="1223.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-06 Canada: 12 samples</title>
	<line x1="1181.0" y1="1223.4" x2="1177.9" y2="1227.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-06 Mexico: 9 samples</title>
	<line x1="1177.9" y1="1227.3" x2="1175.1" y2="1230.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-06  C21575T  USA=4 [2.3%]  surface glycoprotein, L5F</title>
	<circle cx="1087.9" cy="1338.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C21621T  Canada=3 [25.0%]  surface glycoprotein, T20I</title>
	<circle cx="1081.4" cy="1346.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G21718T  USA=2 [1.1%]  surface glycoprotein, Q52H</title>
	<circle cx="1067.8" cy="1363.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G21786T  USA=6 [3.4%]  surface glycoprotein, G75V</title>
	<circle cx="1058.3" cy="1375.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G22021T  Canada=2 [16.7%]  surface glycoprotein, M153I</title>
	<circle cx="1025.4" cy="1415.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G22021T  USA=2 [1.1%]  surface glycoprotein, M153I</title>
	<circle cx="1025.4" cy="1415.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  A22320G  USA=5 [2.8%]  surface glycoprotein, D253G</title>
	<circle cx="983.5" cy="1467.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C22482T  USA=2 [1.1%]  surface glycoprotein, T307I</title>
	<circle cx="960.7" cy="1495.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G22632A  Canada=3 [25.0%]  surface glycoprotein, R357K</title>
	<circle cx="939.7" cy="1521.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C23277T  USA=6 [3.4%]  surface glycoprotein, T572I</title>
	<circle cx="849.3" cy="1633.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C23373T  USA=3 [1.7%]  surface glycoprotein, T604I</title>
	<circle cx="835.9" cy="1649.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  A23403G  USA=176 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="1654.9" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  A23403G  USA=176 [99.4%] Canada=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="1654.9" r="4.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  A23403G  Mexico=8 [88.9%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="1654.9" r="3.6" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C23604A  USA=7 [4.0%]  surface glycoprotein, P681H</title>
	<circle cx="803.5" cy="1689.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C23709T  USA=2 [1.1%]  surface glycoprotein, T716I</title>
	<circle cx="788.8" cy="1707.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  A23756G  Mexico=4 [44.4%]  surface glycoprotein, T732A</title>
	<circle cx="782.2" cy="1716.0" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C23997T  USA=2 [1.1%]  surface glycoprotein, P812L</title>
	<circle cx="748.4" cy="1757.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G24620T  Canada=2 [16.7%]  surface glycoprotein, A1020S</title>
	<circle cx="661.1" cy="1865.5" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G24872T  USA=3 [1.7%]  surface glycoprotein, V1104L</title>
	<circle cx="625.8" cy="1909.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G25135T  USA=2 [1.1%]  surface glycoprotein, K1191N</title>
	<circle cx="588.9" cy="1954.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G25437T  USA=2 [1.1%]  ORF3a protein, L15F</title>
	<circle cx="546.6" cy="2006.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C25466A  USA=2 [1.1%]  ORF3a protein, P25H</title>
	<circle cx="542.5" cy="2011.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07 USA: 120 samples</title>
	<line x1="1187.1" y1="1215.3" x2="1181.1" y2="1222.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-07 Canada: 11 samples</title>
	<line x1="1181.1" y1="1222.5" x2="1178.0" y2="1226.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-07  C21575T  USA=3 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1085.5" cy="1336.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  G21724T  USA=16 [13.3%]  surface glycoprotein, L54F</title>
	<circle cx="1064.1" cy="1361.9" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  G21786T  USA=2 [1.7%]  surface glycoprotein, G75V</title>
	<circle cx="1055.3" cy="1372.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  C22082T  USA=2 [1.7%]  surface glycoprotein, P174S</title>
	<circle cx="1012.9" cy="1423.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  A22920T  USA=16 [13.3%]  surface glycoprotein, Y453F</title>
	<circle cx="892.9" cy="1566.0" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  C23373T  USA=2 [1.7%]  surface glycoprotein, T604I</title>
	<circle cx="828.1" cy="1643.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  A23403G  USA=120 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="823.8" cy="1648.4" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  A23403G  USA=120 [100.0%] Canada=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="823.8" cy="1648.4" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  A23586G  USA=2 [1.7%]  surface glycoprotein, Q675R</title>
	<circle cx="797.6" cy="1679.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  C23604A  USA=2 [1.7%]  surface glycoprotein, P681H</title>
	<circle cx="795.0" cy="1682.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  G25437T  USA=3 [2.5%]  ORF3a protein, L15F</title>
	<circle cx="532.6" cy="1995.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08 USA: 90 samples</title>
	<line x1="1186.9" y1="1215.1" x2="1181.1" y2="1221.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-08 Canada: 2 samples</title>
	<line x1="1181.1" y1="1221.7" x2="1179.7" y2="1223.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-08 Mexico: 2 samples</title>
	<line x1="1179.7" y1="1223.4" x2="1178.3" y2="1225.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-08 Costa Rica: 4 samples</title>
	<line x1="1178.3" y1="1225.0" x2="1176.2" y2="1227.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-08  G21718T  USA=2 [2.2%]  surface glycoprotein, Q52H</title>
	<circle cx="1062.2" cy="1358.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  A22320G  USA=2 [2.2%]  surface glycoprotein, D253G</title>
	<circle cx="974.3" cy="1459.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  A23403G  USA=90 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="1641.7" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  A23403G  USA=90 [100.0%] Costa Rica=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="1641.7" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  A23403G  USA=90 [100.0%] Costa Rica=4 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="1641.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  A23403G  USA=90 [100.0%] Costa Rica=4 [100.0%] Canada=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="1641.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  C23604A  USA=2 [2.2%]  surface glycoprotein, P681H</title>
	<circle cx="786.6" cy="1675.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  G24095T  USA=2 [2.2%]  surface glycoprotein, A845S</title>
	<circle cx="714.9" cy="1758.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  G24872T  USA=2 [2.2%]  surface glycoprotein, V1104L</title>
	<circle cx="601.4" cy="1888.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  C24912T  Costa Rica=2 [50.0%]  surface glycoprotein, T1117I</title>
	<circle cx="595.5" cy="1895.4" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09 USA: 67 samples</title>
	<line x1="1186.6" y1="1214.9" x2="1181.1" y2="1221.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-09 Canada: 4 samples</title>
	<line x1="1181.1" y1="1221.0" x2="1179.0" y2="1223.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-09 Mexico: 2 samples</title>
	<line x1="1179.0" y1="1223.3" x2="1177.6" y2="1224.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-09  C21575T  USA=2 [3.0%]  surface glycoprotein, L5F</title>
	<circle cx="1080.8" cy="1332.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  C21621T  Canada=2 [50.0%]  surface glycoprotein, T20I</title>
	<circle cx="1073.9" cy="1340.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  G22030T  USA=3 [4.5%]  surface glycoprotein, E156D</title>
	<circle cx="1013.0" cy="1407.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  A22320G  USA=7 [10.4%]  surface glycoprotein, D253G</title>
	<circle cx="969.8" cy="1455.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  G22632A  Canada=2 [50.0%]  surface glycoprotein, R357K</title>
	<circle cx="923.3" cy="1507.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  A23403G  USA=67 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="808.4" cy="1635.0" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  A23403G  USA=67 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="808.4" cy="1635.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  A23403G  USA=67 [100.0%] Canada=4 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="808.4" cy="1635.0" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  C23604A  USA=5 [7.5%]  surface glycoprotein, P681H</title>
	<circle cx="778.4" cy="1668.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  G24620T  USA=2 [3.0%]  surface glycoprotein, A1020S</title>
	<circle cx="627.0" cy="1836.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10 USA: 184 samples</title>
	<line x1="1186.4" y1="1214.6" x2="1179.4" y2="1222.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-10 Canada: 6 samples</title>
	<line x1="1179.4" y1="1222.1" x2="1176.8" y2="1224.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-10 Mexico: 2 samples</title>
	<line x1="1176.8" y1="1224.9" x2="1175.3" y2="1226.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-10 Costa Rica: 2 samples</title>
	<line x1="1175.3" y1="1226.4" x2="1173.9" y2="1228.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-10  T21570G  USA=3 [1.6%]  surface glycoprotein, V3G</title>
	<circle cx="1079.2" cy="1329.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  C21575T  USA=6 [3.3%]  surface glycoprotein, L5F</title>
	<circle cx="1078.5" cy="1330.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G21718T  USA=2 [1.1%]  surface glycoprotein, Q52H</title>
	<circle cx="1056.8" cy="1353.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G21746C  USA=4 [2.2%]  surface glycoprotein, V62L</title>
	<circle cx="1052.5" cy="1358.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G22021T  Canada=3 [50.0%]  surface glycoprotein, M153I</title>
	<circle cx="1010.7" cy="1403.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  A22320G  USA=6 [3.3%]  surface glycoprotein, D253G</title>
	<circle cx="965.3" cy="1451.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  C22482T  USA=2 [1.1%]  surface glycoprotein, T307I</title>
	<circle cx="940.7" cy="1478.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  A22920T  USA=2 [1.1%]  surface glycoprotein, Y453F</title>
	<circle cx="874.2" cy="1549.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  ACC23076GGA  USA=2 [1.1%]  surface glycoprotein, Y505W</title>
	<circle cx="850.5" cy="1574.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  C23373T  USA=3 [1.6%]  surface glycoprotein, T604I</title>
	<circle cx="805.4" cy="1623.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  A23403G  USA=184 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="800.8" cy="1628.1" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  A23403G  USA=184 [100.0%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="800.8" cy="1628.1" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  A23403G  USA=184 [100.0%] Canada=6 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="800.8" cy="1628.1" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  A23403G  USA=184 [100.0%] Canada=6 [100.0%] Costa Rica=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="800.8" cy="1628.1" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  C23604A  USA=19 [10.3%]  surface glycoprotein, P681H</title>
	<circle cx="770.3" cy="1660.8" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G24620T  Canada=3 [50.0%]  surface glycoprotein, A1020S</title>
	<circle cx="616.0" cy="1826.3" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G24620T  USA=2 [1.1%]  surface glycoprotein, A1020S</title>
	<circle cx="616.0" cy="1826.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G25088T  USA=2 [1.1%]  surface glycoprotein, V1176F</title>
	<circle cx="544.9" cy="1902.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G25445T  USA=2 [1.1%]  ORF3a protein, G18V</title>
	<circle cx="490.7" cy="1960.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11 USA: 215 samples</title>
	<line x1="1186.1" y1="1214.4" x2="1178.8" y2="1221.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-11 Canada: 13 samples</title>
	<line x1="1178.8" y1="1221.9" x2="1175.2" y2="1225.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-11 Mexico: 2 samples</title>
	<line x1="1175.2" y1="1225.7" x2="1173.7" y2="1227.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-11 Costa Rica: 2 samples</title>
	<line x1="1173.7" y1="1227.2" x2="1172.2" y2="1228.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-11  C21575T  USA=2 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1076.2" cy="1328.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G21785C  Canada=2 [15.4%]  surface glycoprotein, G75R</title>
	<circle cx="1043.7" cy="1361.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G21800T  Canada=4 [30.8%]  surface glycoprotein, D80Y</title>
	<circle cx="1041.4" cy="1364.2" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A22019G  USA=2 [0.9%]  surface glycoprotein, M153V</title>
	<circle cx="1007.5" cy="1399.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A22320G  USA=7 [3.3%]  surface glycoprotein, D253G</title>
	<circle cx="961.0" cy="1447.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C22550T  USA=2 [0.9%]  surface glycoprotein, P330S</title>
	<circle cx="925.4" cy="1484.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C23277T  USA=2 [0.9%]  surface glycoprotein, T572I</title>
	<circle cx="812.9" cy="1600.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C23373T  USA=4 [1.9%]  surface glycoprotein, T604I</title>
	<circle cx="798.1" cy="1616.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A23403G  USA=213 [99.1%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="1621.0" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A23403G  USA=213 [99.1%] Canada=13 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="1621.0" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A23403G  USA=213 [99.1%] Canada=13 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="1621.0" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A23403G  USA=213 [99.1%] Canada=13 [100.0%] Costa Rica=2 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="1621.0" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A23586G  USA=3 [1.4%]  surface glycoprotein, Q675R</title>
	<circle cx="765.1" cy="1650.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C23604A  USA=34 [15.8%]  surface glycoprotein, P681H</title>
	<circle cx="762.3" cy="1653.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A23756G  USA=4 [1.9%]  surface glycoprotein, T732A</title>
	<circle cx="738.8" cy="1677.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G24872T  USA=2 [0.9%]  surface glycoprotein, V1104L</title>
	<circle cx="566.1" cy="1856.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G24926T  USA=2 [0.9%]  surface glycoprotein, V1122L</title>
	<circle cx="557.8" cy="1865.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G25269T  Canada=2 [15.4%]  surface glycoprotein, C1236F</title>
	<circle cx="504.7" cy="1920.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G25437T  USA=2 [0.9%]  ORF3a protein, L15F</title>
	<circle cx="478.7" cy="1946.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C25469T  USA=2 [0.9%]  ORF3a protein, S26L</title>
	<circle cx="473.8" cy="1952.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12 USA: 134 samples</title>
	<line x1="1185.9" y1="1214.1" x2="1179.1" y2="1220.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-12  A21717T  USA=2 [1.5%]  surface glycoprotein, Q52L</title>
	<circle cx="1051.6" cy="1348.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G22289T  USA=4 [3.0%]  surface glycoprotein, A243S</title>
	<circle cx="961.6" cy="1438.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  A22320G  USA=3 [2.2%]  surface glycoprotein, D253G</title>
	<circle cx="956.7" cy="1443.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G23311T  USA=3 [2.2%]  surface glycoprotein, E583D</title>
	<circle cx="800.6" cy="1599.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  A23403G  USA=134 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="786.1" cy="1613.9" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  A23586G  USA=3 [2.2%]  surface glycoprotein, Q675R</title>
	<circle cx="757.3" cy="1642.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  C23604A  USA=16 [11.9%]  surface glycoprotein, P681H</title>
	<circle cx="754.5" cy="1645.5" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G24368C  USA=2 [1.5%]  surface glycoprotein, D936H</title>
	<circle cx="634.2" cy="1765.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G24872T  USA=2 [1.5%]  surface glycoprotein, V1104L</title>
	<circle cx="554.8" cy="1845.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G24992C  USA=2 [1.5%]  surface glycoprotein, E1144Q</title>
	<circle cx="535.9" cy="1864.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13 USA: 137 samples</title>
	<line x1="1185.6" y1="1213.9" x2="1178.7" y2="1220.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-13 Mexico: 6 samples</title>
	<line x1="1178.7" y1="1220.6" x2="1176.0" y2="1223.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-13  G21641A  USA=2 [1.5%]  surface glycoprotein, A27T</title>
	<circle cx="1061.3" cy="1334.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  G21718T  USA=3 [2.2%]  surface glycoprotein, Q52H</title>
	<circle cx="1048.9" cy="1345.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A22320G  USA=4 [2.9%]  surface glycoprotein, D253G</title>
	<circle cx="952.5" cy="1439.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  C22550T  USA=2 [1.5%]  surface glycoprotein, P330S</title>
	<circle cx="915.6" cy="1474.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  G22661T  USA=2 [1.5%]  surface glycoprotein, V367F</title>
	<circle cx="897.8" cy="1491.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A23403G  USA=137 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="1606.6" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A23403G  Mexico=5 [83.3%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="1606.6" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  C23604A  USA=9 [6.6%]  surface glycoprotein, P681H</title>
	<circle cx="746.8" cy="1637.7" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A23756G  USA=2 [1.5%]  surface glycoprotein, T732A</title>
	<circle cx="722.4" cy="1661.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A23756G  USA=2 [1.5%] Mexico=2 [33.3%]  surface glycoprotein, T732A</title>
	<circle cx="722.4" cy="1661.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  G24095T  USA=2 [1.5%]  surface glycoprotein, A845S</title>
	<circle cx="668.1" cy="1713.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  G24872T  USA=6 [4.4%]  surface glycoprotein, V1104L</title>
	<circle cx="543.6" cy="1833.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14 USA: 195 samples</title>
	<line x1="1185.4" y1="1213.6" x2="1177.8" y2="1220.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14 Mexico: 4 samples</title>
	<line x1="1177.8" y1="1220.7" x2="1175.5" y2="1222.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14  C21575T  USA=5 [2.6%]  surface glycoprotein, L5F</title>
	<circle cx="1069.7" cy="1321.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  C21707T  USA=3 [1.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1048.2" cy="1341.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G21718T  USA=2 [1.0%]  surface glycoprotein, Q52H</title>
	<circle cx="1046.4" cy="1343.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  A22320G  USA=4 [2.1%]  surface glycoprotein, D253G</title>
	<circle cx="948.3" cy="1434.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  C23373T  USA=2 [1.0%]  surface glycoprotein, T604I</title>
	<circle cx="776.8" cy="1594.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  A23403G  USA=194 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="1599.2" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  A23403G  USA=194 [99.5%] Mexico=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="1599.2" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G23522A  USA=2 [1.0%]  surface glycoprotein, E654K</title>
	<circle cx="752.6" cy="1617.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G23593C  USA=2 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="741.0" cy="1628.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  C23604A  USA=6 [3.1%]  surface glycoprotein, P681H</title>
	<circle cx="739.2" cy="1629.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G24236T  USA=4 [2.1%]  surface glycoprotein, A892S</title>
	<circle cx="636.3" cy="1725.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G24872T  USA=4 [2.1%]  surface glycoprotein, V1104L</title>
	<circle cx="532.7" cy="1822.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G25244T  USA=2 [1.0%]  surface glycoprotein, V1228L</title>
	<circle cx="472.1" cy="1878.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15 USA: 108 samples</title>
	<line x1="1185.1" y1="1213.4" x2="1178.3" y2="1219.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-15  C21707T  USA=3 [2.8%]  surface glycoprotein, H49Y</title>
	<circle cx="1045.7" cy="1338.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  G21718T  USA=2 [1.9%]  surface glycoprotein, Q52H</title>
	<circle cx="1043.9" cy="1340.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  C22550T  USA=3 [2.8%]  surface glycoprotein, P330S</title>
	<circle cx="906.2" cy="1464.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  A23403G  USA=108 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="765.0" cy="1591.6" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  C23604A  USA=4 [3.7%]  surface glycoprotein, P681H</title>
	<circle cx="731.8" cy="1621.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16 USA: 96 samples</title>
	<line x1="1184.9" y1="1213.1" x2="1178.2" y2="1219.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-16  C21575T  USA=3 [3.1%]  surface glycoprotein, L5F</title>
	<circle cx="1065.5" cy="1316.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  G21718T  USA=2 [2.1%]  surface glycoprotein, Q52H</title>
	<circle cx="1041.5" cy="1337.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  A23403G  USA=96 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="1584.0" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  A23570G  USA=2 [2.1%]  surface glycoprotein, I670V</title>
	<circle cx="730.2" cy="1608.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  C23604A  USA=13 [13.5%]  surface glycoprotein, P681H</title>
	<circle cx="724.5" cy="1613.4" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  C23604T  USA=2 [2.1%]  surface glycoprotein, P681L</title>
	<circle cx="724.5" cy="1613.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  A23949G  USA=2 [2.1%]  surface glycoprotein, D796G</title>
	<circle cx="666.5" cy="1663.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  G25049T  USA=2 [2.1%]  surface glycoprotein, D1163Y</title>
	<circle cx="481.6" cy="1824.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  G25455T  USA=2 [2.1%]  ORF3a protein, K21N</title>
	<circle cx="413.4" cy="1883.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  C25487T  USA=2 [2.1%]  ORF3a protein, T32I</title>
	<circle cx="408.0" cy="1888.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17 USA: 297 samples</title>
	<line x1="1184.7" y1="1212.9" x2="1176.1" y2="1220.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17 Costa Rica: 3 samples</title>
	<line x1="1176.1" y1="1220.0" x2="1174.1" y2="1221.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17  C21575T  USA=9 [3.0%]  surface glycoprotein, L5F</title>
	<circle cx="1063.5" cy="1314.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C21707T  USA=2 [0.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1041.0" cy="1333.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A22019G  USA=5 [1.7%]  surface glycoprotein, M153V</title>
	<circle cx="987.8" cy="1378.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G22205T  USA=2 [0.7%]  surface glycoprotein, D215Y</title>
	<circle cx="956.0" cy="1404.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G23236T  USA=2 [0.7%]  surface glycoprotein, K558N</title>
	<circle cx="780.1" cy="1552.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A23403G  USA=295 [99.3%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="1576.2" r="9.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A23403G  USA=295 [99.3%] Costa Rica=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="1576.2" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G23587T  USA=2 [0.7%]  surface glycoprotein, Q675H</title>
	<circle cx="720.2" cy="1602.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G23593T  USA=3 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="719.2" cy="1603.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C23604A  USA=11 [3.7%]  surface glycoprotein, P681H</title>
	<circle cx="717.3" cy="1605.0" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A23949G  USA=2 [0.7%]  surface glycoprotein, D796G</title>
	<circle cx="658.5" cy="1654.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C24378T  USA=2 [0.7%]  surface glycoprotein, S939F</title>
	<circle cx="585.3" cy="1715.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G24872T  USA=2 [0.7%]  surface glycoprotein, V1104L</title>
	<circle cx="501.0" cy="1786.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A25008G  USA=2 [0.7%]  surface glycoprotein, K1149R</title>
	<circle cx="477.8" cy="1806.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G25019T  USA=2 [0.7%]  surface glycoprotein, D1153Y</title>
	<circle cx="475.9" cy="1807.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A25121T  USA=2 [0.7%]  surface glycoprotein, N1187Y</title>
	<circle cx="458.5" cy="1822.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G25273T  USA=2 [0.7%]  surface glycoprotein, M1237I</title>
	<circle cx="432.6" cy="1843.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A25448G  USA=7 [2.4%]  ORF3a protein, E19G</title>
	<circle cx="402.7" cy="1869.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G25456T  USA=2 [0.7%]  ORF3a protein, D22Y</title>
	<circle cx="401.4" cy="1870.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  T25468C  USA=2 [0.7%]  ORF3a protein, S26P</title>
	<circle cx="399.3" cy="1871.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18 USA: 233 samples</title>
	<line x1="1184.5" y1="1212.6" x2="1176.2" y2="1219.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-18  A21547ACTCTA  USA=3 [1.3%]  orf1ab polyprotein, N7095T</title>
	<circle cx="1066.4" cy="1308.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  C21575T  USA=5 [2.1%]  surface glycoprotein, L5F</title>
	<circle cx="1061.5" cy="1312.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  C21648T  USA=2 [0.9%]  surface glycoprotein, T29I</title>
	<circle cx="1048.9" cy="1322.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G22205T  USA=5 [2.1%]  surface glycoprotein, D215Y</title>
	<circle cx="952.5" cy="1400.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  A23403G  USA=230 [98.7%]  surface glycoprotein, D614G</title>
	<circle cx="745.1" cy="1568.3" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G23593T  USA=2 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="712.3" cy="1595.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  C23604A  USA=14 [6.0%]  surface glycoprotein, P681H</title>
	<circle cx="710.3" cy="1596.5" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  C23997T  USA=2 [0.9%]  surface glycoprotein, P812L</title>
	<circle cx="642.3" cy="1651.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G24770T  USA=5 [2.1%]  surface glycoprotein, A1070S</title>
	<circle cx="508.5" cy="1759.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G24794T  USA=2 [0.9%]  surface glycoprotein, A1078S</title>
	<circle cx="504.4" cy="1763.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G25088T  USA=2 [0.9%]  surface glycoprotein, V1176F</title>
	<circle cx="453.5" cy="1804.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G25437T  USA=2 [0.9%]  ORF3a protein, L15F</title>
	<circle cx="393.1" cy="1853.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19 USA: 197 samples</title>
	<line x1="1184.2" y1="1212.3" x2="1176.1" y2="1218.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-19  C21575T  USA=6 [3.0%]  surface glycoprotein, L5F</title>
	<circle cx="1059.6" cy="1309.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C21614T  USA=2 [1.0%]  surface glycoprotein, L18F</title>
	<circle cx="1052.8" cy="1315.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  G21893A  USA=11 [5.6%]  surface glycoprotein, D111N</title>
	<circle cx="1003.8" cy="1353.3" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C22329T  USA=2 [1.0%]  surface glycoprotein, S256L</title>
	<circle cx="927.3" cy="1413.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  T23042C  USA=2 [1.0%]  surface glycoprotein, S494P</title>
	<circle cx="802.1" cy="1510.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C23127T  USA=2 [1.0%]  surface glycoprotein, A522V</title>
	<circle cx="787.2" cy="1522.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  A23403G  USA=195 [99.0%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="1560.3" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  G23587C  USA=2 [1.0%]  surface glycoprotein, Q675H</title>
	<circle cx="706.5" cy="1585.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C23604A  USA=5 [2.5%]  surface glycoprotein, P681H</title>
	<circle cx="703.5" cy="1587.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  G24770T  USA=2 [1.0%]  surface glycoprotein, A1070S</title>
	<circle cx="498.9" cy="1747.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  G25019T  USA=2 [1.0%]  surface glycoprotein, D1153Y</title>
	<circle cx="455.2" cy="1781.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  G25088T  USA=2 [1.0%]  surface glycoprotein, V1176F</title>
	<circle cx="443.1" cy="1791.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  A25448G  USA=3 [1.5%]  ORF3a protein, E19G</title>
	<circle cx="379.9" cy="1840.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20 USA: 156 samples</title>
	<line x1="1184.0" y1="1212.0" x2="1176.1" y2="1218.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-20 Canada: 2 samples</title>
	<line x1="1176.1" y1="1218.0" x2="1174.4" y2="1219.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-20 Mexico: 6 samples</title>
	<line x1="1174.4" y1="1219.3" x2="1171.4" y2="1221.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-20  C21575T  USA=4 [2.6%]  surface glycoprotein, L5F</title>
	<circle cx="1057.7" cy="1307.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  G22017T  USA=3 [1.9%]  surface glycoprotein, W152L</title>
	<circle cx="979.1" cy="1366.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  G22427A  USA=2 [1.3%]  surface glycoprotein, V289I</title>
	<circle cx="906.2" cy="1421.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  T23042C  USA=2 [1.3%]  surface glycoprotein, S494P</title>
	<circle cx="796.8" cy="1503.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  A23064C  USA=2 [1.3%]  surface glycoprotein, N501T</title>
	<circle cx="792.9" cy="1506.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  A23403G  USA=155 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="1552.2" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  A23403G  USA=155 [99.4%] Mexico=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="1552.2" r="3.1" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  A23403G  USA=155 [99.4%] Mexico=6 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="1552.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  C23604A  USA=6 [3.8%]  surface glycoprotein, P681H</title>
	<circle cx="696.8" cy="1579.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  A23756G  USA=4 [2.6%]  surface glycoprotein, T732A</title>
	<circle cx="669.8" cy="1599.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  G24933T  USA=2 [1.3%]  surface glycoprotein, G1124V</title>
	<circle cx="460.4" cy="1757.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  G25244T  USA=2 [1.3%]  surface glycoprotein, V1228L</title>
	<circle cx="405.1" cy="1799.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  C25487T  USA=3 [1.9%]  ORF3a protein, T32I</title>
	<circle cx="361.9" cy="1831.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21 USA: 141 samples</title>
	<line x1="1183.8" y1="1211.8" x2="1176.0" y2="1217.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-21 Canada: 8 samples</title>
	<line x1="1176.0" y1="1217.4" x2="1172.5" y2="1220.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-21 Mexico: 7 samples</title>
	<line x1="1172.5" y1="1220.0" x2="1169.2" y2="1222.4" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-21  C21575T  USA=3 [2.1%]  surface glycoprotein, L5F</title>
	<circle cx="1055.9" cy="1304.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C21621T  Canada=2 [25.0%]  surface glycoprotein, T20I</title>
	<circle cx="1047.6" cy="1310.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C21707T  USA=5 [3.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1032.1" cy="1322.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G22028C  USA=2 [1.4%]  surface glycoprotein, E156Q</title>
	<circle cx="974.2" cy="1364.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C22286T  USA=2 [1.4%]  surface glycoprotein, L242F</title>
	<circle cx="927.7" cy="1397.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C22295T  USA=3 [2.1%]  surface glycoprotein, H245Y</title>
	<circle cx="926.1" cy="1399.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G22632A  Canada=2 [25.0%]  surface glycoprotein, R357K</title>
	<circle cx="865.4" cy="1443.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  A23312G  USA=2 [1.4%]  surface glycoprotein, I584V</title>
	<circle cx="742.9" cy="1532.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  A23403G  USA=141 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="1544.0" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  A23403G  USA=141 [100.0%] Canada=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="1544.0" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  A23403G  USA=141 [100.0%] Canada=8 [100.0%] Mexico=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="1544.0" r="3.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C23604A  USA=3 [2.1%]  surface glycoprotein, P681H</title>
	<circle cx="690.3" cy="1570.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G23675T  Canada=2 [25.0%]  surface glycoprotein, V705F</title>
	<circle cx="677.5" cy="1579.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G24095T  USA=8 [5.7%]  surface glycoprotein, A845S</title>
	<circle cx="601.8" cy="1634.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G25062T  Mexico=2 [28.6%]  surface glycoprotein, G1167V</title>
	<circle cx="427.6" cy="1761.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22 USA: 121 samples</title>
	<line x1="1183.6" y1="1211.5" x2="1175.9" y2="1216.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-22 Mexico: 2 samples</title>
	<line x1="1175.9" y1="1216.9" x2="1174.2" y2="1218.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-22  C21575T  USA=5 [4.1%]  surface glycoprotein, L5F</title>
	<circle cx="1054.0" cy="1302.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  C21614T  USA=2 [1.7%]  surface glycoprotein, L18F</title>
	<circle cx="1046.9" cy="1307.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  A23403G  USA=120 [99.2%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="1535.7" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  A23403G  USA=120 [99.2%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="1535.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  C23604A  USA=3 [2.5%]  surface glycoprotein, P681H</title>
	<circle cx="683.9" cy="1561.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  A23756G  USA=2 [1.7%]  surface glycoprotein, T732A</title>
	<circle cx="656.1" cy="1580.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  C24138T  USA=2 [1.7%]  surface glycoprotein, T859I</title>
	<circle cx="586.5" cy="1629.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  A25121T  USA=42 [34.7%]  surface glycoprotein, N1187Y</title>
	<circle cx="407.1" cy="1755.2" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  G25244T  USA=2 [1.7%]  surface glycoprotein, V1228L</title>
	<circle cx="384.7" cy="1770.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  G25471C  USA=3 [2.5%]  ORF3a protein, D27H</title>
	<circle cx="343.3" cy="1799.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23 USA: 39 samples</title>
	<line x1="1183.4" y1="1211.2" x2="1177.4" y2="1215.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-23 Canada: 2 samples</title>
	<line x1="1177.4" y1="1215.2" x2="1175.7" y2="1216.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-23  C21575T  USA=2 [5.1%]  surface glycoprotein, L5F</title>
	<circle cx="1052.3" cy="1299.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  C21707T  USA=2 [5.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1027.9" cy="1316.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  A23403G  USA=38 [97.4%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="1527.3" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  A23403G  USA=38 [97.4%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="1527.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24 USA: 162 samples</title>
	<line x1="1183.2" y1="1210.9" x2="1174.9" y2="1216.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-24 Canada: 2 samples</title>
	<line x1="1174.9" y1="1216.3" x2="1173.1" y2="1217.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-24 Mexico: 6 samples</title>
	<line x1="1173.1" y1="1217.5" x2="1169.9" y2="1219.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-24  C21575T  USA=2 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1050.6" cy="1297.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G21893A  USA=3 [1.9%]  surface glycoprotein, D111N</title>
	<circle cx="991.2" cy="1335.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G21974T  USA=4 [2.5%]  surface glycoprotein, D138Y</title>
	<circle cx="976.0" cy="1345.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G22992T  USA=2 [1.2%]  surface glycoprotein, S477I</title>
	<circle cx="785.9" cy="1468.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  A23403G  USA=162 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="1518.8" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  A23403G  USA=162 [100.0%] Mexico=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="1518.8" r="3.1" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  A23403G  USA=162 [100.0%] Mexico=6 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="1518.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G23587C  USA=2 [1.2%]  surface glycoprotein, Q675H</title>
	<circle cx="674.8" cy="1541.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  C23604A  USA=2 [1.2%]  surface glycoprotein, P681H</title>
	<circle cx="671.6" cy="1543.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  A23756G  USA=2 [1.2%]  surface glycoprotein, T732A</title>
	<circle cx="643.2" cy="1561.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G23900C  USA=2 [1.2%]  surface glycoprotein, E780Q</title>
	<circle cx="616.3" cy="1579.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G24781T  USA=2 [1.2%]  surface glycoprotein, K1073N</title>
	<circle cx="451.7" cy="1685.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25 USA: 159 samples</title>
	<line x1="1183.0" y1="1210.6" x2="1174.6" y2="1215.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25 Canada: 3 samples</title>
	<line x1="1174.6" y1="1215.9" x2="1172.3" y2="1217.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25 Mexico: 11 samples</title>
	<line x1="1172.3" y1="1217.3" x2="1168.2" y2="1219.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25  C21575T  USA=4 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1048.9" cy="1294.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  C21707T  USA=4 [2.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1024.0" cy="1310.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  G22021A  USA=2 [1.3%]  surface glycoprotein, M153I</title>
	<circle cx="964.7" cy="1347.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  C22079A  USA=2 [1.3%]  surface glycoprotein, Q173K</title>
	<circle cx="953.7" cy="1353.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  G22992T  USA=3 [1.9%]  surface glycoprotein, S477I</title>
	<circle cx="781.3" cy="1461.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  A23403G  USA=159 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="1510.2" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  A23403G  USA=159 [100.0%] Mexico=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="1510.2" r="4.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  A23403G  USA=159 [100.0%] Mexico=11 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="1510.2" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  G23593T  USA=2 [1.3%]  surface glycoprotein, Q677H</title>
	<circle cx="667.8" cy="1532.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  C23604A  USA=5 [3.1%]  surface glycoprotein, P681H</title>
	<circle cx="665.7" cy="1533.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  G24770T  USA=2 [1.3%]  surface glycoprotein, A1070S</title>
	<circle cx="445.4" cy="1671.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  A25448G  USA=4 [2.5%]  ORF3a protein, E19G</title>
	<circle cx="317.4" cy="1751.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26 USA: 142 samples</title>
	<line x1="1182.9" y1="1210.3" x2="1174.5" y2="1215.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-26 Canada: 4 samples</title>
	<line x1="1174.5" y1="1215.3" x2="1171.8" y2="1216.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-26 Mexico: 2 samples</title>
	<line x1="1171.8" y1="1216.9" x2="1170.0" y2="1218.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-26  C21575T  USA=2 [1.4%]  surface glycoprotein, L5F</title>
	<circle cx="1047.3" cy="1291.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  G21724T  USA=2 [1.4%]  surface glycoprotein, L54F</title>
	<circle cx="1018.8" cy="1308.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A23403G  USA=141 [99.3%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="1501.5" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A23403G  USA=141 [99.3%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="1501.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A23403G  USA=141 [99.3%] Canada=4 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="1501.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  C23604A  USA=8 [5.6%]  surface glycoprotein, P681H</title>
	<circle cx="659.9" cy="1524.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  C24138T  USA=2 [1.4%]  surface glycoprotein, T859I</title>
	<circle cx="558.0" cy="1585.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A25121T  USA=16 [11.3%]  surface glycoprotein, N1187Y</title>
	<circle cx="370.3" cy="1698.5" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A25448G  USA=6 [4.2%]  ORF3a protein, E19G</title>
	<circle cx="307.9" cy="1736.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  G25471C  USA=3 [2.1%]  ORF3a protein, D27H</title>
	<circle cx="303.5" cy="1738.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27 USA: 137 samples</title>
	<line x1="1182.7" y1="1210.0" x2="1174.3" y2="1214.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-27 Canada: 3 samples</title>
	<line x1="1174.3" y1="1214.8" x2="1172.0" y2="1216.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-27  C21575T  USA=4 [2.9%]  surface glycoprotein, L5F</title>
	<circle cx="1045.7" cy="1289.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G21893A  USA=2 [1.5%]  surface glycoprotein, D111N</title>
	<circle cx="984.4" cy="1324.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G21974T  USA=5 [3.6%]  surface glycoprotein, D138Y</title>
	<circle cx="968.7" cy="1333.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G22103A  USA=2 [1.5%]  surface glycoprotein, G181R</title>
	<circle cx="943.9" cy="1347.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  C22227T  USA=2 [1.5%]  surface glycoprotein, A222V</title>
	<circle cx="919.9" cy="1361.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  A23403G  USA=137 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="1492.7" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  A23403G  USA=137 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="1492.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  C23604A  USA=8 [5.8%]  surface glycoprotein, P681H</title>
	<circle cx="654.3" cy="1515.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G24764T  USA=8 [5.8%]  surface glycoprotein, V1068F</title>
	<circle cx="430.6" cy="1644.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G24770T  USA=3 [2.2%]  surface glycoprotein, A1070S</title>
	<circle cx="429.4" cy="1644.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G25266T  USA=2 [1.5%]  surface glycoprotein, C1235F</title>
	<circle cx="333.8" cy="1700.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28 USA: 143 samples</title>
	<line x1="1182.5" y1="1209.7" x2="1174.0" y2="1214.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-28 Canada: 11 samples</title>
	<line x1="1174.0" y1="1214.4" x2="1169.8" y2="1216.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-28  C21575T  USA=7 [4.9%]  surface glycoprotein, L5F</title>
	<circle cx="1044.2" cy="1286.4" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  T21656C  USA=2 [1.4%]  surface glycoprotein, F32L</title>
	<circle cx="1028.4" cy="1295.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  T21771C  Canada=5 [45.5%]  surface glycoprotein, V70A</title>
	<circle cx="1006.0" cy="1307.5" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G22021A  USA=2 [1.4%]  surface glycoprotein, M153I</title>
	<circle cx="957.3" cy="1334.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G22103A  USA=2 [1.4%]  surface glycoprotein, G181R</title>
	<circle cx="941.3" cy="1343.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G22217A  USA=2 [1.4%]  surface glycoprotein, G219S</title>
	<circle cx="919.1" cy="1355.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G22232C  USA=3 [2.1%]  surface glycoprotein, E224Q</title>
	<circle cx="916.2" cy="1357.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  A23403G  USA=140 [97.9%]  surface glycoprotein, D614G</title>
	<circle cx="688.1" cy="1483.8" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  A23403G  USA=140 [97.9%] Canada=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="688.1" cy="1483.8" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  C23604A  USA=3 [2.1%]  surface glycoprotein, P681H</title>
	<circle cx="648.9" cy="1505.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  C23625T  USA=2 [1.4%]  surface glycoprotein, A688V</title>
	<circle cx="644.8" cy="1507.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  A23756G  USA=2 [1.4%]  surface glycoprotein, T732A</title>
	<circle cx="619.3" cy="1521.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G24770T  USA=2 [1.4%]  surface glycoprotein, A1070S</title>
	<circle cx="421.8" cy="1631.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29 USA: 78 samples</title>
	<line x1="1182.3" y1="1209.4" x2="1174.8" y2="1213.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-29 Canada: 3 samples</title>
	<line x1="1174.8" y1="1213.4" x2="1172.4" y2="1214.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-29  C21575T  USA=5 [6.4%]  surface glycoprotein, L5F</title>
	<circle cx="1042.7" cy="1283.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  G22103A  USA=2 [2.6%]  surface glycoprotein, G181R</title>
	<circle cx="938.9" cy="1338.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  G22232C  USA=3 [3.8%]  surface glycoprotein, E224Q</title>
	<circle cx="913.5" cy="1352.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  T22242C  USA=2 [2.6%]  surface glycoprotein, V227A</title>
	<circle cx="911.5" cy="1353.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  A23403G  USA=78 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="1474.8" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  A23403G  USA=78 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="1474.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  A23756G  USA=2 [2.6%]  surface glycoprotein, T732A</title>
	<circle cx="613.8" cy="1511.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  G25266T  USA=2 [2.6%]  surface glycoprotein, C1235F</title>
	<circle cx="316.9" cy="1669.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  C25487T  USA=3 [3.8%]  ORF3a protein, T32I</title>
	<circle cx="273.4" cy="1692.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30 USA: 43 samples</title>
	<line x1="1182.2" y1="1209.1" x2="1175.6" y2="1212.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-30 Canada: 10 samples</title>
	<line x1="1175.6" y1="1212.4" x2="1171.4" y2="1214.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-30  A23403G  USA=43 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="678.5" cy="1465.7" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  A23403G  USA=43 [100.0%] Canada=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="678.5" cy="1465.7" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  G23593T  USA=2 [4.7%]  surface glycoprotein, Q677H</title>
	<circle cx="640.8" cy="1484.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  G23900C  USA=3 [7.0%]  surface glycoprotein, E780Q</title>
	<circle cx="579.9" cy="1516.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  C25460T  USA=2 [4.7%]  ORF3a protein, A23V</title>
	<circle cx="270.3" cy="1673.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31 USA: 185 samples</title>
	<line x1="1182.0" y1="1208.8" x2="1172.8" y2="1213.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-31 Canada: 6 samples</title>
	<line x1="1172.8" y1="1213.2" x2="1169.4" y2="1214.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-31  C21575T  USA=5 [2.7%]  surface glycoprotein, L5F</title>
	<circle cx="1039.9" cy="1278.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C21707T  USA=2 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1013.4" cy="1291.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G23009T  USA=3 [1.6%]  surface glycoprotein, V483F</title>
	<circle cx="752.8" cy="1418.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  T23042C  USA=2 [1.1%]  surface glycoprotein, S494P</title>
	<circle cx="746.2" cy="1421.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C23277T  USA=2 [1.1%]  surface glycoprotein, T572I</title>
	<circle cx="699.2" cy="1444.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  A23403G  USA=184 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="1456.6" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  A23403G  USA=184 [99.5%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="1456.6" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C23525T  USA=2 [1.1%]  surface glycoprotein, H655Y</title>
	<circle cx="649.5" cy="1468.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C23604A  USA=4 [2.2%]  surface glycoprotein, P681H</title>
	<circle cx="633.7" cy="1476.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G24095T  USA=3 [1.6%]  surface glycoprotein, A845S</title>
	<circle cx="535.4" cy="1524.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G24926T  USA=2 [1.1%]  surface glycoprotein, V1122L</title>
	<circle cx="369.1" cy="1605.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G25088T  USA=2 [1.1%]  surface glycoprotein, V1176F</title>
	<circle cx="336.6" cy="1621.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  A25104G  USA=3 [1.6%]  surface glycoprotein, K1181R</title>
	<circle cx="333.4" cy="1622.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G25471T  USA=2 [1.1%]  ORF3a protein, D27Y</title>
	<circle cx="260.0" cy="1658.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C25480T  USA=3 [1.6%]  ORF3a protein, R30C</title>
	<circle cx="258.2" cy="1659.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C25487T  USA=2 [1.1%]  ORF3a protein, T32I</title>
	<circle cx="256.8" cy="1660.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01 USA: 184 samples</title>
	<line x1="1181.9" y1="1208.5" x2="1172.6" y2="1212.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-01 Canada: 14 samples</title>
	<line x1="1172.6" y1="1212.8" x2="1167.8" y2="1215.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-01  C21575T  USA=2 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1038.5" cy="1275.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C21614T  USA=5 [2.7%]  surface glycoprotein, L18F</title>
	<circle cx="1030.6" cy="1279.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C21621T  Canada=2 [14.3%]  surface glycoprotein, T20I</title>
	<circle cx="1029.2" cy="1279.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C21707T  USA=4 [2.2%]  surface glycoprotein, H49Y</title>
	<circle cx="1011.9" cy="1287.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G21724T  USA=3 [1.6%]  surface glycoprotein, L54F</title>
	<circle cx="1008.4" cy="1289.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G22021A  USA=2 [1.1%]  surface glycoprotein, M153I</title>
	<circle cx="948.5" cy="1317.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G22103A  USA=4 [2.2%]  surface glycoprotein, G181R</title>
	<circle cx="931.9" cy="1325.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G22203A  USA=2 [1.1%]  surface glycoprotein, R214H</title>
	<circle cx="911.8" cy="1334.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G22632A  Canada=2 [14.3%]  surface glycoprotein, R357K</title>
	<circle cx="825.2" cy="1374.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G22992T  USA=3 [1.6%]  surface glycoprotein, S477I</title>
	<circle cx="752.5" cy="1408.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  T23042C  USA=6 [3.3%]  surface glycoprotein, S494P</title>
	<circle cx="742.4" cy="1413.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G23311T  USA=2 [1.1%]  surface glycoprotein, E583D</title>
	<circle cx="688.1" cy="1438.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  A23403G  USA=184 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="1447.4" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  A23403G  USA=184 [100.0%] Canada=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="1447.4" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G23587C  USA=2 [1.1%]  surface glycoprotein, Q675H</title>
	<circle cx="632.4" cy="1464.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C23604A  USA=10 [5.4%]  surface glycoprotein, P681H</title>
	<circle cx="629.0" cy="1466.3" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C23625T  USA=4 [2.2%]  surface glycoprotein, A688V</title>
	<circle cx="624.7" cy="1468.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C24026T  USA=2 [1.1%]  surface glycoprotein, L822F</title>
	<circle cx="543.8" cy="1506.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C25046T  USA=2 [1.1%]  surface glycoprotein, P1162S</title>
	<circle cx="337.9" cy="1602.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G25340T  USA=5 [2.7%]  surface glycoprotein, D1260Y</title>
	<circle cx="278.6" cy="1629.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  A25448G  USA=8 [4.3%]  ORF3a protein, E19G</title>
	<circle cx="256.8" cy="1639.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G25483A  USA=2 [1.1%]  ORF3a protein, A31T</title>
	<circle cx="249.7" cy="1643.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  T25496C  USA=2 [1.1%]  ORF3a protein, I35T</title>
	<circle cx="247.1" cy="1644.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02 USA: 198 samples</title>
	<line x1="1181.7" y1="1208.1" x2="1172.3" y2="1212.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-02 Canada: 7 samples</title>
	<line x1="1172.3" y1="1212.3" x2="1168.6" y2="1214.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-02 Mexico: 2 samples</title>
	<line x1="1168.6" y1="1214.0" x2="1166.6" y2="1214.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-02  C21621T  Canada=2 [28.6%]  surface glycoprotein, T20I</title>
	<circle cx="1027.9" cy="1276.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C21707T  USA=6 [3.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1010.4" cy="1284.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G21724T  USA=4 [2.0%]  surface glycoprotein, L54F</title>
	<circle cx="1006.9" cy="1286.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G21786T  USA=2 [1.0%]  surface glycoprotein, G75V</title>
	<circle cx="994.3" cy="1291.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  A22095G  USA=4 [2.0%]  surface glycoprotein, D178G</title>
	<circle cx="931.4" cy="1319.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G22103A  USA=8 [4.0%]  surface glycoprotein, G181R</title>
	<circle cx="929.8" cy="1320.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C22227T  USA=2 [1.0%]  surface glycoprotein, A222V</title>
	<circle cx="904.6" cy="1331.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G22632A  Canada=2 [28.6%]  surface glycoprotein, R357K</title>
	<circle cx="822.2" cy="1368.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  A23125ATCC  USA=2 [1.0%]  surface glycoprotein, A522S</title>
	<circle cx="721.9" cy="1412.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G23126T  USA=2 [1.0%]  surface glycoprotein, A522S</title>
	<circle cx="721.7" cy="1413.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C23315T  USA=3 [1.5%]  surface glycoprotein, L585F</title>
	<circle cx="683.2" cy="1430.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C23373T  USA=2 [1.0%]  surface glycoprotein, T604I</title>
	<circle cx="671.4" cy="1435.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  A23403G  USA=198 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="665.3" cy="1438.1" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  A23403G  USA=198 [100.0%] Canada=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="665.3" cy="1438.1" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  A23403G  USA=198 [100.0%] Canada=7 [100.0%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="665.3" cy="1438.1" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G23593T  USA=2 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="626.6" cy="1455.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C23604A  USA=9 [4.5%]  surface glycoprotein, P681H</title>
	<circle cx="624.4" cy="1456.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G23868T  USA=2 [1.0%]  surface glycoprotein, G769V</title>
	<circle cx="570.7" cy="1480.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G23900C  USA=3 [1.5%]  surface glycoprotein, E780Q</title>
	<circle cx="564.2" cy="1483.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C23987T  USA=3 [1.5%]  surface glycoprotein, P809S</title>
	<circle cx="546.5" cy="1491.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G24770T  USA=3 [1.5%]  surface glycoprotein, A1070S</title>
	<circle cx="387.2" cy="1561.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C24863T  USA=2 [1.0%]  surface glycoprotein, H1101Y</title>
	<circle cx="368.2" cy="1570.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  T25233C  USA=2 [1.0%]  surface glycoprotein, L1224S</title>
	<circle cx="293.0" cy="1603.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G25266T  USA=2 [1.0%]  surface glycoprotein, C1235F</title>
	<circle cx="286.3" cy="1606.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G25340T  USA=2 [1.0%]  surface glycoprotein, D1260Y</title>
	<circle cx="271.2" cy="1613.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C25460T  USA=2 [1.0%]  ORF3a protein, A23V</title>
	<circle cx="246.8" cy="1624.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03 USA: 200 samples</title>
	<line x1="1181.6" y1="1207.8" x2="1172.0" y2="1211.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-03 Canada: 2 samples</title>
	<line x1="1172.0" y1="1211.9" x2="1170.1" y2="1212.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-03 Mexico: 3 samples</title>
	<line x1="1170.1" y1="1212.7" x2="1167.6" y2="1213.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-03  C21707T  USA=2 [1.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1008.9" cy="1281.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G21724T  USA=3 [1.5%]  surface glycoprotein, L54F</title>
	<circle cx="1005.4" cy="1282.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G21853T  USA=2 [1.0%]  surface glycoprotein, K97N</title>
	<circle cx="979.0" cy="1293.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G21974T  USA=5 [2.5%]  surface glycoprotein, D138Y</title>
	<circle cx="954.2" cy="1304.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G22021A  USA=2 [1.0%]  surface glycoprotein, M153I</title>
	<circle cx="944.6" cy="1308.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G22103A  USA=2 [1.0%]  surface glycoprotein, G181R</title>
	<circle cx="927.7" cy="1315.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  C22227T  USA=3 [1.5%]  surface glycoprotein, A222V</title>
	<circle cx="902.3" cy="1326.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  C22482T  USA=3 [1.5%]  surface glycoprotein, T307I</title>
	<circle cx="850.0" cy="1348.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G22484T  USA=3 [1.5%]  surface glycoprotein, V308L</title>
	<circle cx="849.6" cy="1348.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  C22713T  USA=2 [1.0%]  surface glycoprotein, P384L</title>
	<circle cx="802.7" cy="1368.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  C23315T  USA=2 [1.0%]  surface glycoprotein, L585F</title>
	<circle cx="679.3" cy="1421.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  A23403G  USA=199 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="1428.7" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  A23403G  USA=199 [99.5%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="1428.7" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  A23403G  USA=199 [99.5%] Mexico=3 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="1428.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  A23523T  USA=8 [4.0%]  surface glycoprotein, E654V</title>
	<circle cx="636.6" cy="1439.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G23593T  USA=2 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="622.3" cy="1445.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  C23604A  USA=8 [4.0%]  surface glycoprotein, P681H</title>
	<circle cx="620.0" cy="1446.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  C23664T  USA=8 [4.0%]  surface glycoprotein, A701V</title>
	<circle cx="607.7" cy="1451.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  A23756G  USA=5 [2.5%]  surface glycoprotein, T732A</title>
	<circle cx="588.9" cy="1459.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G23900C  USA=2 [1.0%]  surface glycoprotein, E780Q</title>
	<circle cx="559.3" cy="1471.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  C23996T  USA=2 [1.0%]  surface glycoprotein, P812S</title>
	<circle cx="539.7" cy="1480.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G24764A  USA=2 [1.0%]  surface glycoprotein, V1068I</title>
	<circle cx="382.2" cy="1547.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G24770T  USA=3 [1.5%]  surface glycoprotein, A1070S</title>
	<circle cx="381.0" cy="1547.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G24781T  USA=3 [1.5%]  surface glycoprotein, K1073N</title>
	<circle cx="378.7" cy="1548.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G25088T  USA=2 [1.0%]  surface glycoprotein, V1176F</title>
	<circle cx="315.8" cy="1575.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G25217T  USA=2 [1.0%]  surface glycoprotein, G1219C</title>
	<circle cx="289.3" cy="1586.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G25266T  USA=2 [1.0%]  surface glycoprotein, C1235F</title>
	<circle cx="279.3" cy="1590.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G25273T  USA=2 [1.0%]  surface glycoprotein, M1237I</title>
	<circle cx="277.9" cy="1591.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04 USA: 159 samples</title>
	<line x1="1181.5" y1="1207.5" x2="1172.3" y2="1211.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-04 Canada: 15 samples</title>
	<line x1="1172.3" y1="1211.2" x2="1167.2" y2="1213.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-04  C21575T  USA=2 [1.3%]  surface glycoprotein, L5F</title>
	<circle cx="1034.8" cy="1266.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  C21614T  USA=2 [1.3%]  surface glycoprotein, L18F</title>
	<circle cx="1026.7" cy="1270.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  C21621T  Canada=2 [13.3%]  surface glycoprotein, T20I</title>
	<circle cx="1025.3" cy="1270.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  C21639T  USA=4 [2.5%]  surface glycoprotein, P26L</title>
	<circle cx="1021.6" cy="1272.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  G21974C  USA=2 [1.3%]  surface glycoprotein, D138H</title>
	<circle cx="952.4" cy="1300.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  A22095G  USA=5 [3.1%]  surface glycoprotein, D178G</title>
	<circle cx="927.4" cy="1310.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  G22103A  USA=2 [1.3%]  surface glycoprotein, G181R</title>
	<circle cx="925.8" cy="1310.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  C22227T  USA=3 [1.9%]  surface glycoprotein, A222V</title>
	<circle cx="900.2" cy="1321.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  G22632A  Canada=2 [13.3%]  surface glycoprotein, R357K</title>
	<circle cx="816.5" cy="1354.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  C22802A  Canada=2 [13.3%]  surface glycoprotein, Q414K</title>
	<circle cx="781.4" cy="1369.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  G22992A  Canada=2 [13.3%]  surface glycoprotein, S477N</title>
	<circle cx="742.2" cy="1385.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  T23042C  USA=2 [1.3%]  surface glycoprotein, S494P</title>
	<circle cx="731.9" cy="1389.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  C23315T  USA=2 [1.3%]  surface glycoprotein, L585F</title>
	<circle cx="675.5" cy="1411.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  A23403G  USA=159 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="657.3" cy="1419.3" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  A23403G  USA=159 [100.0%] Canada=15 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="657.3" cy="1419.3" r="4.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  C23604A  USA=8 [5.0%]  surface glycoprotein, P681H</title>
	<circle cx="615.8" cy="1436.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  A23756G  USA=2 [1.3%]  surface glycoprotein, T732A</title>
	<circle cx="584.4" cy="1448.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  G25266T  USA=4 [2.5%]  surface glycoprotein, C1235F</title>
	<circle cx="272.6" cy="1574.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  A25448G  USA=2 [1.3%]  ORF3a protein, E19G</title>
	<circle cx="235.0" cy="1589.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05 USA: 63 samples</title>
	<line x1="1181.3" y1="1207.2" x2="1173.7" y2="1210.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-05 Canada: 4 samples</title>
	<line x1="1173.7" y1="1210.1" x2="1170.8" y2="1211.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-05 Costa Rica: 2 samples</title>
	<line x1="1170.8" y1="1211.2" x2="1168.8" y2="1212.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-05  C21575T  USA=2 [3.2%]  surface glycoprotein, L5F</title>
	<circle cx="1033.7" cy="1263.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  C21639T  USA=3 [4.8%]  surface glycoprotein, P26L</title>
	<circle cx="1020.4" cy="1269.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  C21707T  USA=2 [3.2%]  surface glycoprotein, H49Y</title>
	<circle cx="1006.2" cy="1274.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  G21770T  USA=2 [3.2%]  surface glycoprotein, V70F</title>
	<circle cx="993.1" cy="1279.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  A23403G  USA=63 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="653.6" cy="1409.8" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  A23403G  USA=63 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="653.6" cy="1409.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  A23403G  USA=63 [100.0%] Canada=4 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="653.6" cy="1409.8" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  G23900C  USA=2 [3.2%]  surface glycoprotein, E780Q</title>
	<circle cx="550.2" cy="1449.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  G25244T  USA=3 [4.8%]  surface glycoprotein, V1228L</title>
	<circle cx="270.8" cy="1556.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06 USA: 45 samples</title>
	<line x1="1181.2" y1="1206.8" x2="1174.2" y2="1209.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-06 Canada: 2 samples</title>
	<line x1="1174.2" y1="1209.4" x2="1172.2" y2="1210.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-06  C21707T  USA=4 [8.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1004.9" cy="1271.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  G23126T  USA=3 [6.7%]  surface glycoprotein, A522S</title>
	<circle cx="708.0" cy="1379.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  A23403G  USA=45 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="650.0" cy="1400.2" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  A23403G  USA=45 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="650.0" cy="1400.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  C23625T  USA=2 [4.4%]  surface glycoprotein, A688V</title>
	<circle cx="603.5" cy="1417.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  G23900C  USA=7 [15.6%]  surface glycoprotein, E780Q</title>
	<circle cx="546.0" cy="1438.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  G24883T  USA=3 [6.7%]  surface glycoprotein, R1107S</title>
	<circle cx="340.3" cy="1512.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  C25460T  USA=3 [6.7%]  ORF3a protein, A23V</title>
	<circle cx="219.5" cy="1556.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07 USA: 46 samples</title>
	<line x1="1181.1" y1="1206.5" x2="1174.0" y2="1209.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-07 Canada: 5 samples</title>
	<line x1="1174.0" y1="1209.0" x2="1170.7" y2="1210.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-07  G21893A  USA=3 [6.5%]  surface glycoprotein, D111N</title>
	<circle cx="964.6" cy="1281.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  A23403G  USA=46 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="646.6" cy="1390.6" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  A23403G  USA=46 [100.0%] Canada=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="646.6" cy="1390.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  C23604A  USA=2 [4.3%]  surface glycoprotein, P681H</title>
	<circle cx="604.3" cy="1405.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  G23900C  USA=3 [6.5%]  surface glycoprotein, E780Q</title>
	<circle cx="541.9" cy="1426.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  C25460T  USA=2 [4.3%]  ORF3a protein, A23V</title>
	<circle cx="213.4" cy="1539.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08 USA: 149 samples</title>
	<line x1="1181.0" y1="1206.2" x2="1171.7" y2="1209.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-08 Canada: 2 samples</title>
	<line x1="1171.7" y1="1209.2" x2="1169.6" y2="1209.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-08  C21575T  USA=4 [2.7%]  surface glycoprotein, L5F</title>
	<circle cx="1030.5" cy="1255.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  C21707T  USA=9 [6.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1002.6" cy="1264.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  G22205C  USA=2 [1.3%]  surface glycoprotein, D215H</title>
	<circle cx="897.1" cy="1298.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  C22224T  USA=2 [1.3%]  surface glycoprotein, S221L</title>
	<circle cx="893.1" cy="1299.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  A23403G  USA=149 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="643.3" cy="1380.9" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  A23403G  USA=149 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="643.3" cy="1380.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  G23593T  USA=4 [2.7%]  surface glycoprotein, Q677H</title>
	<circle cx="603.1" cy="1393.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  C23604A  USA=4 [2.7%]  surface glycoprotein, P681H</title>
	<circle cx="600.8" cy="1394.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  A23756G  USA=2 [1.3%]  surface glycoprotein, T732A</title>
	<circle cx="568.6" cy="1405.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  G23900C  USA=4 [2.7%]  surface glycoprotein, E780Q</title>
	<circle cx="538.1" cy="1415.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  G23948T  USA=3 [2.0%]  surface glycoprotein, D796Y</title>
	<circle cx="527.9" cy="1418.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  G25340T  USA=7 [4.7%]  surface glycoprotein, D1260Y</title>
	<circle cx="233.1" cy="1514.2" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  G25440T  USA=3 [2.0%]  ORF3a protein, K16N</title>
	<circle cx="211.9" cy="1521.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09 USA: 210 samples</title>
	<line x1="1180.9" y1="1205.8" x2="1170.9" y2="1208.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-09  C21575T  USA=2 [1.0%]  surface glycoprotein, L5F</title>
	<circle cx="1029.6" cy="1252.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C21597T  USA=4 [1.9%]  surface glycoprotein, S12F</title>
	<circle cx="1024.9" cy="1253.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C21707T  USA=7 [3.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1001.5" cy="1260.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G23120T  USA=2 [1.0%]  surface glycoprotein, A520S</title>
	<circle cx="700.5" cy="1352.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G23126T  USA=10 [4.8%]  surface glycoprotein, A522S</title>
	<circle cx="699.3" cy="1353.1" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  A23403G  USA=210 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="640.3" cy="1371.1" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G23522C  USA=2 [1.0%]  surface glycoprotein, E654Q</title>
	<circle cx="614.9" cy="1378.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G23593T  USA=2 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="599.8" cy="1383.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C23604A  USA=11 [5.2%]  surface glycoprotein, P681H</title>
	<circle cx="597.5" cy="1384.2" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C23625T  USA=2 [1.0%]  surface glycoprotein, A688V</title>
	<circle cx="593.0" cy="1385.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  A23756G  USA=3 [1.4%]  surface glycoprotein, T732A</title>
	<circle cx="565.1" cy="1394.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G23868T  USA=3 [1.4%]  surface glycoprotein, G769V</title>
	<circle cx="541.2" cy="1401.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G23900C  USA=38 [18.1%]  surface glycoprotein, E780Q</title>
	<circle cx="534.4" cy="1403.5" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C24378T  USA=2 [1.0%]  surface glycoprotein, S939F</title>
	<circle cx="432.6" cy="1434.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G24794T  USA=2 [1.0%]  surface glycoprotein, A1078S</title>
	<circle cx="344.0" cy="1461.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C25037T  USA=2 [1.0%]  surface glycoprotein, H1159Y</title>
	<circle cx="292.3" cy="1477.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G25183T  USA=3 [1.4%]  surface glycoprotein, E1207D</title>
	<circle cx="261.2" cy="1487.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G25340T  USA=3 [1.4%]  surface glycoprotein, D1260Y</title>
	<circle cx="227.7" cy="1497.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C25460T  USA=12 [5.7%]  ORF3a protein, A23V</title>
	<circle cx="202.2" cy="1505.1" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  C25487T  USA=3 [1.4%]  ORF3a protein, T32I</title>
	<circle cx="196.4" cy="1506.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10 USA: 172 samples</title>
	<line x1="1180.8" y1="1205.5" x2="1171.1" y2="1208.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-10  C21575T  USA=2 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1028.7" cy="1249.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  C21639T  USA=2 [1.2%]  surface glycoprotein, P26L</title>
	<circle cx="1015.0" cy="1253.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  C21707T  USA=2 [1.2%]  surface glycoprotein, H49Y</title>
	<circle cx="1000.5" cy="1257.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  G21893A  USA=3 [1.7%]  surface glycoprotein, D111N</title>
	<circle cx="960.6" cy="1268.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  G23126T  USA=4 [2.3%]  surface glycoprotein, A522S</title>
	<circle cx="696.7" cy="1344.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  A23403G  USA=172 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="637.4" cy="1361.3" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  C23604A  USA=6 [3.5%]  surface glycoprotein, P681H</title>
	<circle cx="594.3" cy="1373.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  G23900C  USA=22 [12.8%]  surface glycoprotein, E780Q</title>
	<circle cx="531.0" cy="1391.8" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  A24519G  USA=3 [1.7%]  surface glycoprotein, K986R</title>
	<circle cx="398.4" cy="1429.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  C25460T  USA=5 [2.9%]  ORF3a protein, A23V</title>
	<circle cx="197.0" cy="1487.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11 USA: 189 samples</title>
	<line x1="1180.7" y1="1205.2" x2="1170.8" y2="1207.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-11 Canada: 4 samples</title>
	<line x1="1170.8" y1="1207.8" x2="1167.7" y2="1208.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-11  C21575T  USA=5 [2.6%]  surface glycoprotein, L5F</title>
	<circle cx="1027.9" cy="1246.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  C21707T  USA=2 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="999.5" cy="1253.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  G21824C  USA=2 [1.1%]  surface glycoprotein, D88H</title>
	<circle cx="974.3" cy="1260.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  A23125ATCC  USA=2 [1.1%]  surface glycoprotein, A522S</title>
	<circle cx="694.4" cy="1335.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  G23126T  USA=18 [9.5%]  surface glycoprotein, A522S</title>
	<circle cx="694.2" cy="1335.5" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  A23403G  USA=189 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1351.5" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  A23403G  USA=189 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1351.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  G23593T  USA=5 [2.6%]  surface glycoprotein, Q677H</title>
	<circle cx="593.8" cy="1362.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  C23604A  USA=2 [1.1%]  surface glycoprotein, P681H</title>
	<circle cx="591.4" cy="1363.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  G23900C  USA=56 [29.6%]  surface glycoprotein, E780Q</title>
	<circle cx="527.7" cy="1380.1" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  C25460T  USA=34 [18.0%]  ORF3a protein, A23V</title>
	<circle cx="192.1" cy="1470.1" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12 USA: 48 samples</title>
	<line x1="1180.6" y1="1204.8" x2="1173.2" y2="1206.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-12 Canada: 2 samples</title>
	<line x1="1173.2" y1="1206.7" x2="1171.1" y2="1207.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-12  A23403G  USA=48 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1341.6" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  A23403G  USA=48 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1341.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  C23604A  USA=3 [6.2%]  surface glycoprotein, P681H</title>
	<circle cx="588.6" cy="1352.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  C23664T  USA=3 [6.2%]  surface glycoprotein, A701V</title>
	<circle cx="575.7" cy="1355.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  G23900C  USA=5 [10.4%]  surface glycoprotein, E780Q</title>
	<circle cx="524.7" cy="1368.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  C25460T  USA=3 [6.2%]  ORF3a protein, A23V</title>
	<circle cx="187.6" cy="1452.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13 USA: 23 samples</title>
	<line x1="1180.5" y1="1204.5" x2="1174.5" y2="1205.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-13  A23403G  USA=23 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1331.7" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  C23604A  USA=2 [8.7%]  surface glycoprotein, P681H</title>
	<circle cx="586.1" cy="1341.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  G23900C  USA=3 [13.0%]  surface glycoprotein, E780Q</title>
	<circle cx="521.8" cy="1356.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14 USA: 195 samples</title>
	<line x1="1180.4" y1="1204.2" x2="1170.3" y2="1206.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-14 Canada: 2 samples</title>
	<line x1="1170.3" y1="1206.3" x2="1168.2" y2="1206.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-14  C21575T  USA=4 [2.1%]  surface glycoprotein, L5F</title>
	<circle cx="1025.7" cy="1237.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  C21707T  USA=4 [2.1%]  surface glycoprotein, H49Y</title>
	<circle cx="997.0" cy="1243.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  G22289T  USA=21 [10.8%]  surface glycoprotein, A243S</title>
	<circle cx="870.2" cy="1270.1" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  G23126T  USA=5 [2.6%]  surface glycoprotein, A522S</title>
	<circle cx="687.8" cy="1308.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  A23403G  USA=195 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="627.5" cy="1321.7" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  A23403G  USA=195 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="627.5" cy="1321.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  C23604A  USA=3 [1.5%]  surface glycoprotein, P681H</title>
	<circle cx="583.7" cy="1331.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  G23678T  USA=2 [1.0%]  surface glycoprotein, A706S</title>
	<circle cx="567.6" cy="1334.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  A23756G  USA=2 [1.0%]  surface glycoprotein, T732A</title>
	<circle cx="550.6" cy="1338.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  G23900C  USA=17 [8.7%]  surface glycoprotein, E780Q</title>
	<circle cx="519.2" cy="1344.7" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  G24770T  USA=5 [2.6%]  surface glycoprotein, A1070S</title>
	<circle cx="329.7" cy="1385.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  C25460T  USA=6 [3.1%]  ORF3a protein, A23V</title>
	<circle cx="179.4" cy="1416.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15 USA: 159 samples</title>
	<line x1="1180.4" y1="1203.8" x2="1170.6" y2="1205.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-15 Canada: 2 samples</title>
	<line x1="1170.6" y1="1205.7" x2="1168.5" y2="1206.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-15  C21575T  USA=5 [3.1%]  surface glycoprotein, L5F</title>
	<circle cx="1025.1" cy="1234.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  G21893A  USA=3 [1.9%]  surface glycoprotein, D111N</title>
	<circle cx="955.6" cy="1247.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  A23403G  USA=159 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="625.5" cy="1311.7" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  A23403G  USA=159 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="625.5" cy="1311.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  G23593T  USA=2 [1.3%]  surface glycoprotein, Q677H</title>
	<circle cx="583.9" cy="1319.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  C23595T  USA=3 [1.9%]  surface glycoprotein, T678I</title>
	<circle cx="583.5" cy="1319.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  C23604A  USA=10 [6.3%]  surface glycoprotein, P681H</title>
	<circle cx="581.5" cy="1320.2" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  A23631G  USA=2 [1.3%]  surface glycoprotein, Q690R</title>
	<circle cx="575.6" cy="1321.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  A23756G  USA=2 [1.3%]  surface glycoprotein, T732A</title>
	<circle cx="548.3" cy="1326.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  G23900C  USA=7 [4.4%]  surface glycoprotein, E780Q</title>
	<circle cx="516.8" cy="1332.8" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  A24519G  USA=2 [1.3%]  surface glycoprotein, K986R</title>
	<circle cx="381.5" cy="1359.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  C25460T  USA=2 [1.3%]  ORF3a protein, A23V</title>
	<circle cx="175.7" cy="1399.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16 USA: 221 samples</title>
	<line x1="1180.3" y1="1203.5" x2="1169.9" y2="1205.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-16  C21575T  USA=6 [2.7%]  surface glycoprotein, L5F</title>
	<circle cx="1024.5" cy="1230.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  C21707T  USA=6 [2.7%]  surface glycoprotein, H49Y</title>
	<circle cx="995.6" cy="1236.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  G21893A  USA=6 [2.7%]  surface glycoprotein, D111N</title>
	<circle cx="954.8" cy="1243.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  C22329T  USA=2 [0.9%]  surface glycoprotein, S256L</title>
	<circle cx="859.2" cy="1260.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  G23126T  USA=3 [1.4%]  surface glycoprotein, A522S</title>
	<circle cx="684.3" cy="1290.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  G23282T  USA=2 [0.9%]  surface glycoprotein, D574Y</title>
	<circle cx="650.1" cy="1297.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  G23311T  USA=2 [0.9%]  surface glycoprotein, E583D</title>
	<circle cx="643.8" cy="1298.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  A23403G  USA=221 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="623.6" cy="1301.6" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  G23593T  USA=5 [2.3%]  surface glycoprotein, Q677H</title>
	<circle cx="581.9" cy="1309.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  A23756G  USA=4 [1.8%]  surface glycoprotein, T732A</title>
	<circle cx="546.2" cy="1315.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  G23900C  USA=23 [10.4%]  surface glycoprotein, E780Q</title>
	<circle cx="514.6" cy="1320.9" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  C24237T  USA=2 [0.9%]  surface glycoprotein, A892V</title>
	<circle cx="440.7" cy="1333.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  C25083T  USA=14 [6.3%]  surface glycoprotein, A1174V</title>
	<circle cx="255.1" cy="1366.6" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  G25340T  USA=5 [2.3%]  surface glycoprotein, D1260Y</title>
	<circle cx="198.7" cy="1376.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  C25460T  USA=6 [2.7%]  ORF3a protein, A23V</title>
	<circle cx="172.4" cy="1381.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  C25463T  USA=2 [0.9%]  ORF3a protein, T24I</title>
	<circle cx="171.8" cy="1381.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17 USA: 154 samples</title>
	<line x1="1180.2" y1="1203.1" x2="1170.5" y2="1204.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-17  C21575T  USA=5 [3.2%]  surface glycoprotein, L5F</title>
	<circle cx="1024.0" cy="1227.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  C22482T  USA=2 [1.3%]  surface glycoprotein, T307I</title>
	<circle cx="824.5" cy="1259.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  A23403G  USA=154 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="621.9" cy="1291.6" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  G23593T  USA=7 [4.5%]  surface glycoprotein, Q677H</title>
	<circle cx="580.1" cy="1298.2" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  C23604A  USA=4 [2.6%]  surface glycoprotein, P681H</title>
	<circle cx="577.7" cy="1298.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  G23900C  USA=9 [5.8%]  surface glycoprotein, E780Q</title>
	<circle cx="512.6" cy="1308.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  G24770T  USA=5 [3.2%]  surface glycoprotein, A1070S</title>
	<circle cx="321.2" cy="1339.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18 USA: 104 samples</title>
	<line x1="1180.2" y1="1202.8" x2="1171.2" y2="1204.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-18  C21575T  USA=2 [1.9%]  surface glycoprotein, L5F</title>
	<circle cx="1023.6" cy="1224.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G21761T  USA=2 [1.9%]  surface glycoprotein, A67S</title>
	<circle cx="982.5" cy="1230.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G21893A  USA=3 [2.9%]  surface glycoprotein, D111N</title>
	<circle cx="953.4" cy="1234.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G21974T  USA=2 [1.9%]  surface glycoprotein, D138Y</title>
	<circle cx="935.6" cy="1237.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  A23403G  USA=104 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="620.4" cy="1281.5" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G23593T  USA=2 [1.9%]  surface glycoprotein, Q677H</title>
	<circle cx="578.5" cy="1287.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  C23604A  USA=5 [4.8%]  surface glycoprotein, P681H</title>
	<circle cx="576.1" cy="1287.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G23876A  USA=2 [1.9%]  surface glycoprotein, V772I</title>
	<circle cx="516.1" cy="1296.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G23900C  USA=3 [2.9%]  surface glycoprotein, E780Q</title>
	<circle cx="510.8" cy="1296.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G24770T  USA=3 [2.9%]  surface glycoprotein, A1070S</title>
	<circle cx="318.9" cy="1323.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18  G25445T  USA=5 [4.8%]  ORF3a protein, G18V</title>
	<circle cx="170.0" cy="1344.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19 USA: 41 samples</title>
	<line x1="1180.1" y1="1202.4" x2="1172.9" y2="1203.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-19  C21707T  USA=2 [4.9%]  surface glycoprotein, H49Y</title>
	<circle cx="994.0" cy="1225.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19  A23403G  USA=41 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="619.1" cy="1271.3" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19  C23604A  USA=3 [7.3%]  surface glycoprotein, P681H</title>
	<circle cx="574.6" cy="1276.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19  C25046T  USA=2 [4.9%]  surface glycoprotein, P1162S</title>
	<circle cx="255.9" cy="1315.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-20 USA: 35 samples</title>
	<line x1="1180.1" y1="1202.1" x2="1173.1" y2="1202.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-20  C21707T  USA=2 [5.7%]  surface glycoprotein, H49Y</title>
	<circle cx="993.6" cy="1221.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-20  A23403G  USA=35 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="617.9" cy="1261.2" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-20  C25046T  USA=3 [8.6%]  surface glycoprotein, P1162S</title>
	<circle cx="254.0" cy="1299.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21 USA: 121 samples</title>
	<line x1="1180.1" y1="1201.7" x2="1170.7" y2="1202.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-21  C21575T  USA=4 [3.3%]  surface glycoprotein, L5F</title>
	<circle cx="1022.5" cy="1215.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  G21777A  USA=2 [1.7%]  surface glycoprotein, G72E</title>
	<circle cx="977.7" cy="1219.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  G21974T  USA=2 [1.7%]  surface glycoprotein, D138Y</title>
	<circle cx="934.0" cy="1223.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  C22689T  USA=5 [4.1%]  surface glycoprotein, T376I</title>
	<circle cx="775.3" cy="1237.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  A23403G  USA=121 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.9" cy="1251.0" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  G23593T  USA=7 [5.8%]  surface glycoprotein, Q677H</title>
	<circle cx="574.8" cy="1254.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  C23604A  USA=9 [7.4%]  surface glycoprotein, P681H</title>
	<circle cx="572.3" cy="1254.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  G24770T  USA=6 [5.0%]  surface glycoprotein, A1070S</title>
	<circle cx="313.6" cy="1277.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  G25088T  USA=2 [1.7%]  surface glycoprotein, V1176F</title>
	<circle cx="243.1" cy="1283.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  C25463T  USA=9 [7.4%]  ORF3a protein, T24I</title>
	<circle cx="159.9" cy="1291.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22 USA: 114 samples</title>
	<line x1="1180.0" y1="1201.4" x2="1170.8" y2="1202.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-22  C21575T  USA=6 [5.3%]  surface glycoprotein, L5F</title>
	<circle cx="1022.3" cy="1212.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  C21707T  USA=2 [1.8%]  surface glycoprotein, H49Y</title>
	<circle cx="992.9" cy="1214.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  A23403G  USA=114 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.1" cy="1240.8" r="8.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  C23481T  USA=2 [1.8%]  surface glycoprotein, S640F</title>
	<circle cx="598.8" cy="1242.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  C23604A  USA=6 [5.3%]  surface glycoprotein, P681H</title>
	<circle cx="571.5" cy="1244.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  A23756G  USA=3 [2.6%]  surface glycoprotein, T732A</title>
	<circle cx="537.7" cy="1246.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  G23900C  USA=2 [1.8%]  surface glycoprotein, E780Q</title>
	<circle cx="505.7" cy="1248.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  G24794A  USA=2 [1.8%]  surface glycoprotein, A1078T</title>
	<circle cx="307.1" cy="1262.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23 USA: 170 samples</title>
	<line x1="1180.0" y1="1201.0" x2="1170.0" y2="1201.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-23  C21575T  USA=2 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1022.1" cy="1209.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  C21707T  USA=2 [1.2%]  surface glycoprotein, H49Y</title>
	<circle cx="992.7" cy="1210.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  G21724T  USA=2 [1.2%]  surface glycoprotein, L54F</title>
	<circle cx="988.9" cy="1211.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  G21761T  USA=2 [1.2%]  surface glycoprotein, A67S</title>
	<circle cx="980.7" cy="1211.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  A22766G  USA=3 [1.8%]  surface glycoprotein, I402V</title>
	<circle cx="757.2" cy="1223.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  C23277T  USA=2 [1.2%]  surface glycoprotein, T572I</title>
	<circle cx="643.5" cy="1229.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  A23403G  USA=170 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.5" cy="1230.6" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  C23604A  USA=11 [6.5%]  surface glycoprotein, P681H</title>
	<circle cx="570.8" cy="1233.0" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  C23613T  USA=2 [1.2%]  surface glycoprotein, A684V</title>
	<circle cx="568.8" cy="1233.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  A23756G  USA=2 [1.2%]  surface glycoprotein, T732A</title>
	<circle cx="537.0" cy="1234.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  G23900C  USA=2 [1.2%]  surface glycoprotein, E780Q</title>
	<circle cx="505.0" cy="1236.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  G25340T  USA=2 [1.2%]  surface glycoprotein, D1260Y</title>
	<circle cx="184.7" cy="1253.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24 USA: 132 samples</title>
	<line x1="1180.0" y1="1200.7" x2="1170.5" y2="1201.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-24  C21575T  USA=2 [1.5%]  surface glycoprotein, L5F</title>
	<circle cx="1021.9" cy="1206.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  G21893A  USA=2 [1.5%]  surface glycoprotein, D111N</title>
	<circle cx="951.2" cy="1208.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  G21974T  USA=3 [2.3%]  surface glycoprotein, D138Y</title>
	<circle cx="933.1" cy="1209.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  G22706T  USA=2 [1.5%]  surface glycoprotein, V382L</title>
	<circle cx="770.2" cy="1215.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  A23403G  USA=132 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.1" cy="1220.4" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  G23593T  USA=5 [3.8%]  surface glycoprotein, Q677H</title>
	<circle cx="572.8" cy="1221.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  C23604A  USA=15 [11.4%]  surface glycoprotein, P681H</title>
	<circle cx="570.3" cy="1222.0" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  G23900C  USA=2 [1.5%]  surface glycoprotein, E780Q</title>
	<circle cx="504.4" cy="1224.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  G25340T  USA=2 [1.5%]  surface glycoprotein, D1260Y</title>
	<circle cx="183.9" cy="1235.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24  C25460T  USA=2 [1.5%]  ORF3a protein, A23V</title>
	<circle cx="157.2" cy="1236.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25 USA: 152 samples</title>
	<line x1="1180.0" y1="1200.3" x2="1170.2" y2="1200.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-25  C21575T  USA=3 [2.0%]  surface glycoprotein, L5F</title>
	<circle cx="1021.9" cy="1203.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  C21621T  USA=2 [1.3%]  surface glycoprotein, T20I</title>
	<circle cx="1011.6" cy="1203.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  G21761T  USA=3 [2.0%]  surface glycoprotein, A67S</title>
	<circle cx="980.4" cy="1203.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  G21893A  USA=2 [1.3%]  surface glycoprotein, D111N</title>
	<circle cx="951.0" cy="1204.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  C22502A  USA=2 [1.3%]  surface glycoprotein, Q314K</title>
	<circle cx="815.4" cy="1206.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  A23403G  USA=152 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="614.8" cy="1210.2" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  G23593T  USA=3 [2.0%]  surface glycoprotein, Q677H</title>
	<circle cx="572.5" cy="1211.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  C23604A  USA=7 [4.6%]  surface glycoprotein, P681H</title>
	<circle cx="570.0" cy="1211.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  A24014G  USA=7 [4.6%]  surface glycoprotein, I818V</title>
	<circle cx="478.7" cy="1212.6" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  C24921T  USA=3 [2.0%]  surface glycoprotein, T1120I</title>
	<circle cx="276.8" cy="1216.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  G25088T  USA=3 [2.0%]  surface glycoprotein, V1176F</title>
	<circle cx="239.6" cy="1216.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26 USA: 73 samples</title>
	<line x1="1180.0" y1="1200.0" x2="1171.6" y2="1200.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-26  G21893A  USA=2 [2.7%]  surface glycoprotein, D111N</title>
	<circle cx="951.0" cy="1200.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  A23125ATCC  USA=2 [2.7%]  surface glycoprotein, A522S</title>
	<circle cx="676.6" cy="1200.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  A23403G  USA=73 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="614.7" cy="1200.0" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  T23487G  USA=2 [2.7%]  surface glycoprotein, V642G</title>
	<circle cx="596.0" cy="1200.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  G23593T  USA=4 [5.5%]  surface glycoprotein, Q677H</title>
	<circle cx="572.4" cy="1200.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  G24124T  USA=7 [9.6%]  surface glycoprotein, K854N</title>
	<circle cx="454.1" cy="1200.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-27 USA: 45 samples</title>
	<line x1="1180.0" y1="1199.7" x2="1172.5" y2="1199.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-27  A23403G  USA=45 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="614.8" cy="1189.8" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-27  G23593T  USA=2 [4.4%]  surface glycoprotein, Q677H</title>
	<circle cx="572.5" cy="1189.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-27  C23604A  USA=2 [4.4%]  surface glycoprotein, P681H</title>
	<circle cx="570.0" cy="1189.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-27  C23604G  USA=2 [4.4%]  surface glycoprotein, P681R</title>
	<circle cx="570.0" cy="1189.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28 USA: 153 samples</title>
	<line x1="1180.0" y1="1199.3" x2="1170.2" y2="1199.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-28  G21600T  USA=2 [1.3%]  surface glycoprotein, S13I</title>
	<circle cx="1016.4" cy="1193.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  C21707T  USA=3 [2.0%]  surface glycoprotein, H49Y</title>
	<circle cx="992.6" cy="1192.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  G22018T  USA=2 [1.3%]  surface glycoprotein, W152C</title>
	<circle cx="923.3" cy="1190.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  C22079A  USA=4 [2.6%]  surface glycoprotein, Q173K</title>
	<circle cx="909.8" cy="1189.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  T22917G  USA=2 [1.3%]  surface glycoprotein, L452R</title>
	<circle cx="723.2" cy="1183.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  C23373T  USA=2 [1.3%]  surface glycoprotein, T604I</title>
	<circle cx="621.7" cy="1179.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  A23403G  USA=151 [98.7%]  surface glycoprotein, D614G</title>
	<circle cx="615.1" cy="1179.6" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  G23587C  USA=2 [1.3%]  surface glycoprotein, Q675H</title>
	<circle cx="574.1" cy="1178.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  C23604A  USA=9 [5.9%]  surface glycoprotein, P681H</title>
	<circle cx="570.3" cy="1178.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  G24095T  USA=2 [1.3%]  surface glycoprotein, A845S</title>
	<circle cx="461.0" cy="1174.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  G25088T  USA=3 [2.0%]  surface glycoprotein, V1176F</title>
	<circle cx="240.0" cy="1166.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29 USA: 119 samples</title>
	<line x1="1180.0" y1="1199.0" x2="1170.7" y2="1198.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-29  G23311T  USA=2 [1.7%]  surface glycoprotein, E583D</title>
	<circle cx="636.0" cy="1170.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29  A23403G  USA=119 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.5" cy="1169.4" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29  G23593T  USA=3 [2.5%]  surface glycoprotein, Q677H</title>
	<circle cx="573.2" cy="1167.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29  C23604A  USA=13 [10.9%]  surface glycoprotein, P681H</title>
	<circle cx="570.8" cy="1167.0" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29  A23756G  USA=2 [1.7%]  surface glycoprotein, T732A</title>
	<circle cx="537.0" cy="1165.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29  C25463T  USA=2 [1.7%]  ORF3a protein, T24I</title>
	<circle cx="157.3" cy="1145.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30 USA: 139 samples</title>
	<line x1="1180.0" y1="1198.6" x2="1170.4" y2="1197.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-30 Canada: 2 samples</title>
	<line x1="1170.4" y1="1197.9" x2="1168.3" y2="1197.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-30 Costa Rica: 4 samples</title>
	<line x1="1168.3" y1="1197.8" x2="1165.1" y2="1197.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-30  C21621T  USA=5 [3.6%]  surface glycoprotein, T20I</title>
	<circle cx="1012.0" cy="1186.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  G21761T  USA=2 [1.4%]  surface glycoprotein, A67S</title>
	<circle cx="980.9" cy="1184.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  G22205T  USA=3 [2.2%]  surface glycoprotein, D215Y</title>
	<circle cx="882.3" cy="1177.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  C22624A  USA=2 [1.4%]  surface glycoprotein, N354K</title>
	<circle cx="789.2" cy="1171.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  T22679C  USA=2 [1.4%]  surface glycoprotein, S373P</title>
	<circle cx="777.0" cy="1170.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  G22706T  USA=2 [1.4%]  surface glycoprotein, V382L</title>
	<circle cx="771.0" cy="1170.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  A22766G  USA=5 [3.6%]  surface glycoprotein, I402V</title>
	<circle cx="757.7" cy="1169.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  G22992A  USA=2 [1.4%]  surface glycoprotein, S477N</title>
	<circle cx="707.4" cy="1165.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  A23403G  USA=139 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.1" cy="1159.2" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  A23403G  USA=139 [100.0%] Costa Rica=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.1" cy="1159.2" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  A23403G  USA=139 [100.0%] Costa Rica=4 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.1" cy="1159.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  G23593T  USA=5 [3.6%]  surface glycoprotein, Q677H</title>
	<circle cx="573.9" cy="1156.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  C23604A  USA=5 [3.6%]  surface glycoprotein, P681H</title>
	<circle cx="571.5" cy="1156.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  A23756G  USA=3 [2.2%]  surface glycoprotein, T732A</title>
	<circle cx="537.7" cy="1153.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  A24170G  USA=2 [1.4%]  surface glycoprotein, I870V</title>
	<circle cx="445.7" cy="1147.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  C24912T  Costa Rica=3 [75.0%]  surface glycoprotein, T1117I</title>
	<circle cx="280.9" cy="1135.7" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  C25487T  USA=3 [2.2%]  ORF3a protein, T32I</title>
	<circle cx="153.1" cy="1126.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01 USA: 163 samples</title>
	<line x1="1180.1" y1="1198.3" x2="1170.1" y2="1197.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-01 Canada: 5 samples</title>
	<line x1="1170.1" y1="1197.4" x2="1166.7" y2="1197.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-01  C21575T  USA=3 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1022.5" cy="1184.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  C21621T  Canada=2 [40.0%]  surface glycoprotein, T20I</title>
	<circle cx="1012.3" cy="1183.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G21800T  Canada=2 [40.0%]  surface glycoprotein, D80Y</title>
	<circle cx="972.6" cy="1180.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G21893A  USA=3 [1.8%]  surface glycoprotein, D111N</title>
	<circle cx="951.9" cy="1178.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G21974C  USA=3 [1.8%]  surface glycoprotein, D138H</title>
	<circle cx="934.0" cy="1176.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G22487C  USA=3 [1.8%]  surface glycoprotein, E309Q</title>
	<circle cx="820.2" cy="1166.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G22632A  Canada=2 [40.0%]  surface glycoprotein, R357K</title>
	<circle cx="788.0" cy="1164.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  A22920T  USA=2 [1.2%]  surface glycoprotein, Y453F</title>
	<circle cx="724.1" cy="1158.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  A23403G  USA=163 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.9" cy="1149.0" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  A23403G  USA=163 [100.0%] Canada=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.9" cy="1149.0" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G23593T  USA=4 [2.5%]  surface glycoprotein, Q677H</title>
	<circle cx="574.8" cy="1145.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  C23604A  USA=6 [3.7%]  surface glycoprotein, P681H</title>
	<circle cx="572.3" cy="1145.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  A23756G  USA=5 [3.1%]  surface glycoprotein, T732A</title>
	<circle cx="538.6" cy="1142.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G23900C  USA=3 [1.8%]  surface glycoprotein, E780Q</title>
	<circle cx="506.7" cy="1139.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G24821T  USA=3 [1.8%]  surface glycoprotein, A1087S</title>
	<circle cx="302.3" cy="1121.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02 USA: 134 samples</title>
	<line x1="1180.1" y1="1197.9" x2="1170.6" y2="1196.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-02 Canada: 4 samples</title>
	<line x1="1170.6" y1="1196.9" x2="1167.4" y2="1196.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-02  C21575T  USA=3 [2.2%]  surface glycoprotein, L5F</title>
	<circle cx="1022.8" cy="1181.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  G21724T  Canada=2 [50.0%]  surface glycoprotein, L54F</title>
	<circle cx="989.8" cy="1177.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  A22101T  USA=2 [1.5%]  surface glycoprotein, E180V</title>
	<circle cx="906.3" cy="1169.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  T22220C  USA=2 [1.5%]  surface glycoprotein, F220L</title>
	<circle cx="879.9" cy="1166.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  A23403G  USA=134 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="617.9" cy="1138.8" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  A23403G  USA=134 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="617.9" cy="1138.8" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  C23604A  USA=7 [5.2%]  surface glycoprotein, P681H</title>
	<circle cx="573.4" cy="1134.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  C23673T  USA=2 [1.5%]  surface glycoprotein, S704L</title>
	<circle cx="558.1" cy="1132.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  C24378T  USA=2 [1.5%]  surface glycoprotein, S939F</title>
	<circle cx="401.9" cy="1116.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  G25052T  USA=6 [4.5%]  surface glycoprotein, V1164F</title>
	<circle cx="252.7" cy="1100.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03 USA: 63 samples</title>
	<line x1="1180.1" y1="1197.6" x2="1172.1" y2="1196.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-03 Canada: 3 samples</title>
	<line x1="1172.1" y1="1196.6" x2="1169.4" y2="1196.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-03  G21800T  Canada=2 [66.7%]  surface glycoprotein, D80Y</title>
	<circle cx="973.4" cy="1172.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  G21893A  USA=2 [3.2%]  surface glycoprotein, D111N</title>
	<circle cx="952.9" cy="1169.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  G21987A  USA=3 [4.8%]  surface glycoprotein, G142D</title>
	<circle cx="932.1" cy="1167.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  G22706T  USA=2 [3.2%]  surface glycoprotein, V382L</title>
	<circle cx="773.1" cy="1147.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  A23064C  USA=3 [4.8%]  surface glycoprotein, N501T</title>
	<circle cx="694.0" cy="1137.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  A23403G  USA=63 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="619.1" cy="1128.7" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  A23403G  USA=63 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="619.1" cy="1128.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  G23587C  USA=2 [3.2%]  surface glycoprotein, Q675H</title>
	<circle cx="578.4" cy="1123.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  C23604A  USA=8 [12.7%]  surface glycoprotein, P681H</title>
	<circle cx="574.6" cy="1123.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04 USA: 76 samples</title>
	<line x1="1180.2" y1="1197.2" x2="1171.8" y2="1196.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-04 Canada: 4 samples</title>
	<line x1="1171.8" y1="1196.0" x2="1168.7" y2="1195.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-04  C21846A  USA=2 [2.6%]  surface glycoprotein, T95N</title>
	<circle cx="963.8" cy="1166.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  G22604T  USA=2 [2.6%]  surface glycoprotein, A348S</title>
	<circle cx="796.6" cy="1143.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  G23236T  Canada=2 [50.0%]  surface glycoprotein, K558N</title>
	<circle cx="657.2" cy="1123.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  A23403G  USA=76 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="620.4" cy="1118.5" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  A23403G  USA=76 [100.0%] Canada=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="620.4" cy="1118.5" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  G23593T  USA=2 [2.6%]  surface glycoprotein, Q677H</title>
	<circle cx="578.5" cy="1112.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  C23604A  USA=2 [2.6%]  surface glycoprotein, P681H</title>
	<circle cx="576.1" cy="1112.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  G25471T  USA=2 [2.6%]  ORF3a protein, D27Y</title>
	<circle cx="164.3" cy="1054.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05 USA: 247 samples</title>
	<line x1="1180.2" y1="1196.9" x2="1169.6" y2="1195.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-05  C21575T  USA=9 [3.6%]  surface glycoprotein, L5F</title>
	<circle cx="1024.0" cy="1172.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G21777A  USA=3 [1.2%]  surface glycoprotein, G72E</title>
	<circle cx="979.6" cy="1165.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G21974T  USA=2 [0.8%]  surface glycoprotein, D138Y</title>
	<circle cx="936.2" cy="1158.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G22706T  USA=4 [1.6%]  surface glycoprotein, V382L</title>
	<circle cx="775.2" cy="1132.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  A23403G  USA=246 [99.6%]  surface glycoprotein, D614G</title>
	<circle cx="621.9" cy="1108.4" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G23564T  USA=3 [1.2%]  surface glycoprotein, A668S</title>
	<circle cx="586.5" cy="1102.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G23593T  USA=3 [1.2%]  surface glycoprotein, Q677H</title>
	<circle cx="580.1" cy="1101.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  C23604A  USA=20 [8.1%]  surface glycoprotein, P681H</title>
	<circle cx="577.7" cy="1101.4" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  C23673T  USA=4 [1.6%]  surface glycoprotein, S704L</title>
	<circle cx="562.5" cy="1099.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  A23756G  USA=3 [1.2%]  surface glycoprotein, T732A</title>
	<circle cx="544.3" cy="1096.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G23868T  USA=3 [1.2%]  surface glycoprotein, G769V</title>
	<circle cx="519.6" cy="1092.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G24781T  USA=2 [0.8%]  surface glycoprotein, K1073N</title>
	<circle cx="318.8" cy="1060.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G24794A  USA=2 [0.8%]  surface glycoprotein, A1078T</title>
	<circle cx="315.9" cy="1060.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G24926T  USA=6 [2.4%]  surface glycoprotein, V1122L</title>
	<circle cx="286.9" cy="1055.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G25052T  USA=4 [1.6%]  surface glycoprotein, V1164F</title>
	<circle cx="259.2" cy="1051.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G25429T  USA=2 [0.8%]  ORF3a protein, V13L</title>
	<circle cx="176.2" cy="1037.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G25455T  USA=2 [0.8%]  ORF3a protein, K21N</title>
	<circle cx="170.5" cy="1036.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05  G25477T  USA=4 [1.6%]  ORF3a protein, V29F</title>
	<circle cx="165.7" cy="1036.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06 USA: 199 samples</title>
	<line x1="1180.3" y1="1196.5" x2="1170.1" y2="1194.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-06  C21575T  USA=5 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1024.5" cy="1169.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G21724T  USA=2 [1.0%]  surface glycoprotein, L54F</title>
	<circle cx="991.9" cy="1163.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  C21789T  USA=2 [1.0%]  surface glycoprotein, T76I</title>
	<circle cx="977.6" cy="1160.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G21974T  USA=2 [1.0%]  surface glycoprotein, D138Y</title>
	<circle cx="937.0" cy="1153.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G22093T  USA=2 [1.0%]  surface glycoprotein, M177I</title>
	<circle cx="910.9" cy="1149.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G22289T  USA=20 [10.1%]  surface glycoprotein, A243S</title>
	<circle cx="867.9" cy="1141.4" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  C22502A  USA=2 [1.0%]  surface glycoprotein, Q314K</title>
	<circle cx="821.2" cy="1133.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  C22689T  USA=3 [1.5%]  surface glycoprotein, T376I</title>
	<circle cx="780.2" cy="1126.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G23120T  USA=3 [1.5%]  surface glycoprotein, A520S</title>
	<circle cx="685.7" cy="1109.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  C23277T  USA=2 [1.0%]  surface glycoprotein, T572I</title>
	<circle cx="651.2" cy="1103.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  A23403G  USA=199 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="623.6" cy="1098.4" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G23593T  USA=2 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="581.9" cy="1091.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G23593C  USA=2 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="581.9" cy="1091.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  C23604A  USA=9 [4.5%]  surface glycoprotein, P681H</title>
	<circle cx="579.5" cy="1090.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  A23756G  USA=2 [1.0%]  surface glycoprotein, T732A</title>
	<circle cx="546.2" cy="1084.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  A23756T  USA=2 [1.0%]  surface glycoprotein, T732S</title>
	<circle cx="546.2" cy="1084.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G23868T  USA=2 [1.0%]  surface glycoprotein, G769V</title>
	<circle cx="521.6" cy="1080.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G23900C  USA=2 [1.0%]  surface glycoprotein, E780Q</title>
	<circle cx="514.6" cy="1079.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G25088T  USA=2 [1.0%]  surface glycoprotein, V1176F</title>
	<circle cx="254.0" cy="1033.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G25135T  USA=2 [1.0%]  surface glycoprotein, K1191N</title>
	<circle cx="243.7" cy="1031.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07 USA: 189 samples</title>
	<line x1="1180.4" y1="1196.2" x2="1170.3" y2="1194.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-07  C21575T  USA=3 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1025.1" cy="1166.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  C21621T  USA=2 [1.1%]  surface glycoprotein, T20I</title>
	<circle cx="1015.0" cy="1164.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  C21638T  USA=2 [1.1%]  surface glycoprotein, P26S</title>
	<circle cx="1011.3" cy="1163.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  C21707T  USA=2 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="996.2" cy="1160.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  A22095G  USA=2 [1.1%]  surface glycoprotein, D178G</title>
	<circle cx="911.4" cy="1143.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  T22220C  USA=2 [1.1%]  surface glycoprotein, F220L</title>
	<circle cx="884.1" cy="1138.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  A23403G  USA=189 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="625.5" cy="1088.3" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  G23593T  USA=2 [1.1%]  surface glycoprotein, Q677H</title>
	<circle cx="583.9" cy="1080.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  G23593C  USA=3 [1.6%]  surface glycoprotein, Q677H</title>
	<circle cx="583.9" cy="1080.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  C23604A  USA=8 [4.2%]  surface glycoprotein, P681H</title>
	<circle cx="581.5" cy="1079.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  A23756T  USA=2 [1.1%]  surface glycoprotein, T732S</title>
	<circle cx="548.3" cy="1073.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  G23900C  USA=2 [1.1%]  surface glycoprotein, E780Q</title>
	<circle cx="516.8" cy="1067.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  G24770T  USA=2 [1.1%]  surface glycoprotein, A1070S</title>
	<circle cx="326.6" cy="1030.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  G25088T  USA=2 [1.1%]  surface glycoprotein, V1176F</title>
	<circle cx="257.1" cy="1016.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08 USA: 171 samples</title>
	<line x1="1180.4" y1="1195.8" x2="1170.6" y2="1193.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-08  C21575T  USA=3 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1025.7" cy="1163.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G21724T  USA=3 [1.8%]  surface glycoprotein, L54F</title>
	<circle cx="993.3" cy="1156.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G21830T  USA=2 [1.2%]  surface glycoprotein, V90F</title>
	<circle cx="970.2" cy="1151.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G21893A  USA=2 [1.2%]  surface glycoprotein, D111N</title>
	<circle cx="956.4" cy="1148.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  C22079A  USA=2 [1.2%]  surface glycoprotein, Q173K</title>
	<circle cx="915.9" cy="1139.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  C22088T  USA=2 [1.2%]  surface glycoprotein, L176F</title>
	<circle cx="914.0" cy="1139.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G22093T  USA=3 [1.8%]  surface glycoprotein, M177I</title>
	<circle cx="912.9" cy="1139.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  A22095G  USA=4 [2.3%]  surface glycoprotein, D178G</title>
	<circle cx="912.4" cy="1138.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G22706T  USA=5 [2.9%]  surface glycoprotein, V382L</title>
	<circle cx="779.3" cy="1110.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G23069T  USA=3 [1.8%]  surface glycoprotein, V503F</title>
	<circle cx="700.3" cy="1093.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G23120T  USA=3 [1.8%]  surface glycoprotein, A520S</title>
	<circle cx="689.1" cy="1091.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G23311T  USA=2 [1.2%]  surface glycoprotein, E583D</title>
	<circle cx="647.5" cy="1082.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  A23403G  USA=170 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="627.5" cy="1078.3" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G23593T  USA=5 [2.9%]  surface glycoprotein, Q677H</title>
	<circle cx="586.1" cy="1069.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  C23604A  USA=17 [9.9%]  surface glycoprotein, P681H</title>
	<circle cx="583.7" cy="1069.0" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  A23756G  USA=2 [1.2%]  surface glycoprotein, T732A</title>
	<circle cx="550.6" cy="1062.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  C25275T  USA=2 [1.2%]  surface glycoprotein, T1238I</title>
	<circle cx="219.7" cy="991.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09 USA: 168 samples</title>
	<line x1="1180.5" y1="1195.5" x2="1170.7" y2="1193.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-09  C21575T  USA=5 [3.0%]  surface glycoprotein, L5F</title>
	<circle cx="1026.4" cy="1159.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G21641T  USA=2 [1.2%]  surface glycoprotein, A27S</title>
	<circle cx="1012.1" cy="1156.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  C21897T  USA=2 [1.2%]  surface glycoprotein, S112L</title>
	<circle cx="956.5" cy="1143.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G21974T  USA=3 [1.8%]  surface glycoprotein, D138Y</title>
	<circle cx="939.8" cy="1139.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  C22079A  USA=2 [1.2%]  surface glycoprotein, Q173K</title>
	<circle cx="917.0" cy="1134.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  C22689T  USA=3 [1.8%]  surface glycoprotein, T376I</title>
	<circle cx="784.6" cy="1104.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  A23403G  USA=167 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1068.3" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  C23475T  USA=2 [1.2%]  surface glycoprotein, T638I</title>
	<circle cx="614.1" cy="1064.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G23593T  USA=6 [3.6%]  surface glycoprotein, Q677H</title>
	<circle cx="588.5" cy="1058.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  C23604A  USA=18 [10.7%]  surface glycoprotein, P681H</title>
	<circle cx="586.1" cy="1058.3" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  C23673T  USA=4 [2.4%]  surface glycoprotein, S704L</title>
	<circle cx="571.1" cy="1054.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G23868T  USA=2 [1.2%]  surface glycoprotein, G769V</title>
	<circle cx="528.8" cy="1045.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G24095T  USA=3 [1.8%]  surface glycoprotein, A845S</title>
	<circle cx="479.5" cy="1033.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  C24381T  USA=3 [1.8%]  surface glycoprotein, S940F</title>
	<circle cx="417.5" cy="1019.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G24680T  USA=2 [1.2%]  surface glycoprotein, V1040F</title>
	<circle cx="352.6" cy="1004.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G24781T  USA=3 [1.8%]  surface glycoprotein, K1073N</title>
	<circle cx="330.7" cy="999.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G24821T  USA=2 [1.2%]  surface glycoprotein, A1087S</title>
	<circle cx="322.0" cy="997.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10 USA: 70 samples</title>
	<line x1="1180.6" y1="1195.2" x2="1172.5" y2="1193.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-10 Canada: 2 samples</title>
	<line x1="1172.5" y1="1193.1" x2="1170.4" y2="1192.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-10  C21575T  USA=2 [2.9%]  surface glycoprotein, L5F</title>
	<circle cx="1027.1" cy="1156.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  G22240T  USA=4 [5.7%]  surface glycoprotein, L226F</title>
	<circle cx="883.4" cy="1121.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  A23403G  USA=70 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1058.4" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  A23403G  USA=70 [100.0%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1058.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  G23593T  USA=2 [2.9%]  surface glycoprotein, Q677H</title>
	<circle cx="591.0" cy="1048.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  C23604A  USA=4 [5.7%]  surface glycoprotein, P681H</title>
	<circle cx="588.6" cy="1047.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  G23900C  USA=3 [4.3%]  surface glycoprotein, E780Q</title>
	<circle cx="524.7" cy="1031.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  G24821T  USA=2 [2.9%]  surface glycoprotein, A1087S</title>
	<circle cx="325.7" cy="982.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11 USA: 81 samples</title>
	<line x1="1180.7" y1="1194.8" x2="1172.4" y2="1192.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-11  G21724T  USA=3 [3.7%]  surface glycoprotein, L54F</title>
	<circle cx="995.8" cy="1145.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  G22093T  USA=2 [2.5%]  surface glycoprotein, M177I</title>
	<circle cx="916.5" cy="1124.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  G23120T  USA=2 [2.5%]  surface glycoprotein, A520S</title>
	<circle cx="695.5" cy="1064.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  A23403G  USA=81 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1048.5" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  C23604A  USA=15 [18.5%]  surface glycoprotein, P681H</title>
	<circle cx="591.4" cy="1036.9" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12 USA: 230 samples</title>
	<line x1="1180.8" y1="1194.5" x2="1170.6" y2="1191.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-12  C21575T  USA=7 [3.0%]  surface glycoprotein, L5F</title>
	<circle cx="1028.7" cy="1150.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G21641T  USA=3 [1.3%]  surface glycoprotein, A27S</title>
	<circle cx="1014.6" cy="1146.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  C21707T  USA=2 [0.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1000.5" cy="1142.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G21777A  USA=2 [0.9%]  surface glycoprotein, G72E</title>
	<circle cx="985.5" cy="1138.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  C21855T  USA=2 [0.9%]  surface glycoprotein, S98F</title>
	<circle cx="968.8" cy="1133.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  C22079A  USA=7 [3.0%]  surface glycoprotein, Q173K</title>
	<circle cx="920.8" cy="1119.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  A22095G  USA=5 [2.2%]  surface glycoprotein, D178G</title>
	<circle cx="917.4" cy="1119.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G22661T  USA=2 [0.9%]  surface glycoprotein, V367F</title>
	<circle cx="796.2" cy="1084.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G22706T  USA=17 [7.4%]  surface glycoprotein, V382L</title>
	<circle cx="786.6" cy="1081.5" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G23120T  USA=2 [0.9%]  surface glycoprotein, A520S</title>
	<circle cx="698.0" cy="1056.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G23311T  USA=2 [0.9%]  surface glycoprotein, E583D</title>
	<circle cx="657.1" cy="1044.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  A23403G  USA=228 [99.1%]  surface glycoprotein, D614G</title>
	<circle cx="637.4" cy="1038.7" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  C23435T  USA=5 [2.2%]  surface glycoprotein, H625Y</title>
	<circle cx="630.5" cy="1036.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G23593T  USA=3 [1.3%]  surface glycoprotein, Q677H</title>
	<circle cx="596.7" cy="1027.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  C23604A  USA=9 [3.9%]  surface glycoprotein, P681H</title>
	<circle cx="594.3" cy="1026.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  A23756G  USA=4 [1.7%]  surface glycoprotein, T732A</title>
	<circle cx="561.8" cy="1017.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G23868T  USA=2 [0.9%]  surface glycoprotein, G769V</title>
	<circle cx="537.8" cy="1010.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G24368C  USA=2 [0.9%]  surface glycoprotein, D936H</title>
	<circle cx="430.8" cy="979.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G24680T  USA=2 [0.9%]  surface glycoprotein, V1040F</title>
	<circle cx="364.0" cy="960.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G24794A  USA=3 [1.3%]  surface glycoprotein, A1078T</title>
	<circle cx="339.6" cy="953.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G24816C  USA=3 [1.3%]  surface glycoprotein, G1085A</title>
	<circle cx="334.9" cy="951.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G25135T  USA=2 [0.9%]  surface glycoprotein, K1191N</title>
	<circle cx="266.6" cy="932.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13 USA: 171 samples</title>
	<line x1="1180.9" y1="1194.2" x2="1171.3" y2="1191.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-13  C21575T  USA=3 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1029.6" cy="1147.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  C21597T  USA=2 [1.2%]  surface glycoprotein, S12F</title>
	<circle cx="1024.9" cy="1146.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G21641T  USA=3 [1.8%]  surface glycoprotein, A27S</title>
	<circle cx="1015.6" cy="1143.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G21724T  USA=3 [1.8%]  surface glycoprotein, L54F</title>
	<circle cx="997.9" cy="1138.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G22021A  USA=2 [1.2%]  surface glycoprotein, M153I</title>
	<circle cx="934.6" cy="1118.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G22205T  USA=3 [1.8%]  surface glycoprotein, D215Y</title>
	<circle cx="895.4" cy="1106.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  C22998T  USA=2 [1.2%]  surface glycoprotein, P479L</title>
	<circle cx="726.5" cy="1055.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  C23271T  USA=2 [1.2%]  surface glycoprotein, A570V</title>
	<circle cx="668.4" cy="1037.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  A23403G  USA=171 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="640.3" cy="1028.9" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G23593T  USA=3 [1.8%]  surface glycoprotein, Q677H</title>
	<circle cx="599.8" cy="1016.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  A23598G  USA=3 [1.8%]  surface glycoprotein, N679S</title>
	<circle cx="598.7" cy="1016.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  C23604A  USA=8 [4.7%]  surface glycoprotein, P681H</title>
	<circle cx="597.5" cy="1015.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G24368T  USA=2 [1.2%]  surface glycoprotein, D936Y</title>
	<circle cx="434.7" cy="966.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G24680T  USA=2 [1.2%]  surface glycoprotein, V1040F</title>
	<circle cx="368.3" cy="945.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G24816C  USA=2 [1.2%]  surface glycoprotein, G1085A</title>
	<circle cx="339.3" cy="936.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G25049T  USA=2 [1.2%]  surface glycoprotein, D1163Y</title>
	<circle cx="289.7" cy="921.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G25273T  USA=2 [1.2%]  surface glycoprotein, M1237I</title>
	<circle cx="242.0" cy="907.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13  G25340A  USA=2 [1.2%]  surface glycoprotein, D1260N</title>
	<circle cx="227.7" cy="902.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14 USA: 180 samples</title>
	<line x1="1181.0" y1="1193.8" x2="1171.3" y2="1190.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-14  C21575T  USA=5 [2.8%]  surface glycoprotein, L5F</title>
	<circle cx="1030.5" cy="1144.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G21641T  USA=2 [1.1%]  surface glycoprotein, A27S</title>
	<circle cx="1016.6" cy="1140.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  C21707T  USA=3 [1.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1002.6" cy="1135.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G21724T  USA=3 [1.7%]  surface glycoprotein, L54F</title>
	<circle cx="999.0" cy="1134.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G21974T  USA=2 [1.1%]  surface glycoprotein, D138Y</title>
	<circle cx="946.0" cy="1117.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  C22227T  USA=2 [1.1%]  surface glycoprotein, A222V</title>
	<circle cx="892.4" cy="1100.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  A23403G  USA=178 [98.9%]  surface glycoprotein, D614G</title>
	<circle cx="643.3" cy="1019.1" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G23587C  USA=2 [1.1%]  surface glycoprotein, Q675H</title>
	<circle cx="604.4" cy="1006.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G23593T  USA=5 [2.8%]  surface glycoprotein, Q677H</title>
	<circle cx="603.1" cy="1006.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  C23604A  USA=6 [3.3%]  surface glycoprotein, P681H</title>
	<circle cx="600.8" cy="1005.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G23612A  USA=2 [1.1%]  surface glycoprotein, A684T</title>
	<circle cx="599.1" cy="1004.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  C24378T  USA=3 [1.7%]  surface glycoprotein, S939F</title>
	<circle cx="436.8" cy="952.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G24680T  USA=3 [1.7%]  surface glycoprotein, V1040F</title>
	<circle cx="372.9" cy="931.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G24794A  USA=4 [2.2%]  surface glycoprotein, A1078T</title>
	<circle cx="348.7" cy="923.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G24816C  USA=2 [1.1%]  surface glycoprotein, G1085A</title>
	<circle cx="344.0" cy="921.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  A25420C  USA=2 [1.1%]  ORF3a protein, I10L</title>
	<circle cx="216.1" cy="880.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15 USA: 216 samples</title>
	<line x1="1181.1" y1="1193.5" x2="1171.1" y2="1190.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-15  A21551T  USA=2 [0.9%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1036.6" cy="1143.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  C21575T  USA=10 [4.6%]  surface glycoprotein, L5F</title>
	<circle cx="1031.5" cy="1142.0" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G21641T  USA=9 [4.2%]  surface glycoprotein, A27S</title>
	<circle cx="1017.6" cy="1137.2" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G21668A  USA=4 [1.9%]  surface glycoprotein, V36I</title>
	<circle cx="1011.9" cy="1135.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G21974C  USA=2 [0.9%]  surface glycoprotein, D138H</title>
	<circle cx="947.5" cy="1113.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  C22079A  USA=3 [1.4%]  surface glycoprotein, Q173K</title>
	<circle cx="925.4" cy="1105.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G22706T  USA=4 [1.9%]  surface glycoprotein, V382L</title>
	<circle cx="793.4" cy="1060.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  A23403G  USA=214 [99.1%]  surface glycoprotein, D614G</title>
	<circle cx="646.6" cy="1009.4" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G23593T  USA=9 [4.2%]  surface glycoprotein, Q677H</title>
	<circle cx="606.6" cy="995.7" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  C23604A  USA=11 [5.1%]  surface glycoprotein, P681H</title>
	<circle cx="604.3" cy="994.9" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  C23673T  USA=3 [1.4%]  surface glycoprotein, S704L</title>
	<circle cx="589.7" cy="989.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  A23756G  USA=3 [1.4%]  surface glycoprotein, T732A</title>
	<circle cx="572.3" cy="983.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G24816C  USA=9 [4.2%]  surface glycoprotein, G1085A</title>
	<circle cx="349.0" cy="907.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G25062T  USA=2 [0.9%]  surface glycoprotein, G1167V</title>
	<circle cx="297.2" cy="889.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G25273T  USA=4 [1.9%]  surface glycoprotein, M1237I</title>
	<circle cx="252.8" cy="873.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16 USA: 178 samples</title>
	<line x1="1181.2" y1="1193.2" x2="1171.7" y2="1189.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-16  C21575T  USA=3 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1032.6" cy="1139.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  G21641T  USA=4 [2.2%]  surface glycoprotein, A27S</title>
	<circle cx="1018.8" cy="1134.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  G21941T  USA=3 [1.7%]  surface glycoprotein, V127F</title>
	<circle cx="956.0" cy="1111.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  A22080C  USA=3 [1.7%]  surface glycoprotein, Q173P</title>
	<circle cx="926.9" cy="1100.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  G22094A  USA=2 [1.1%]  surface glycoprotein, D178N</title>
	<circle cx="924.0" cy="1099.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  A22095G  USA=2 [1.1%]  surface glycoprotein, D178G</title>
	<circle cx="923.7" cy="1099.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  A23403G  USA=178 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="650.0" cy="999.8" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  G23593T  USA=2 [1.1%]  surface glycoprotein, Q677H</title>
	<circle cx="610.2" cy="985.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  C23625T  USA=2 [1.1%]  surface glycoprotein, A688V</title>
	<circle cx="603.5" cy="982.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  C23673T  USA=2 [1.1%]  surface glycoprotein, S704L</title>
	<circle cx="593.5" cy="979.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  A24383G  USA=2 [1.1%]  surface glycoprotein, T941A</title>
	<circle cx="444.9" cy="925.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  G24680T  USA=3 [1.7%]  surface glycoprotein, V1040F</title>
	<circle cx="382.7" cy="902.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  G24816C  USA=4 [2.2%]  surface glycoprotein, G1085A</title>
	<circle cx="354.3" cy="892.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  G25062T  USA=2 [1.1%]  surface glycoprotein, G1167V</title>
	<circle cx="302.8" cy="873.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  A25247C  USA=2 [1.1%]  surface glycoprotein, M1229L</title>
	<circle cx="264.1" cy="859.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17 USA: 84 samples</title>
	<line x1="1181.3" y1="1192.8" x2="1173.2" y2="1189.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-17  G21641T  USA=2 [2.4%]  surface glycoprotein, A27S</title>
	<circle cx="1019.9" cy="1130.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17  A23403G  USA=84 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="653.6" cy="990.2" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17  G24770T  USA=2 [2.4%]  surface glycoprotein, A1070S</title>
	<circle cx="369.3" cy="881.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17  G24816C  USA=2 [2.4%]  surface glycoprotein, G1085A</title>
	<circle cx="359.8" cy="877.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17  G25062T  USA=2 [2.4%]  surface glycoprotein, G1167V</title>
	<circle cx="308.6" cy="857.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17  G25088T  USA=3 [3.6%]  surface glycoprotein, V1176F</title>
	<circle cx="303.2" cy="855.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18 USA: 82 samples</title>
	<line x1="1181.5" y1="1192.5" x2="1173.4" y2="1189.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-18  C21575T  USA=11 [13.4%]  surface glycoprotein, L5F</title>
	<circle cx="1034.8" cy="1133.3" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  G21641T  USA=2 [2.4%]  surface glycoprotein, A27S</title>
	<circle cx="1021.2" cy="1127.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  C22079A  USA=2 [2.4%]  surface glycoprotein, Q173K</title>
	<circle cx="930.7" cy="1091.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  A23403G  USA=82 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="657.3" cy="980.7" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  G23593T  USA=3 [3.7%]  surface glycoprotein, Q677H</title>
	<circle cx="618.1" cy="964.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  G24816C  USA=2 [2.4%]  surface glycoprotein, G1085A</title>
	<circle cx="365.5" cy="862.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  G25135T  USA=4 [4.9%]  surface glycoprotein, K1191N</title>
	<circle cx="299.7" cy="836.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19 USA: 249 samples</title>
	<line x1="1181.6" y1="1192.2" x2="1171.7" y2="1188.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-19 Costa Rica: 2 samples</title>
	<line x1="1171.7" y1="1188.0" x2="1169.7" y2="1187.1" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-19  A21551T  USA=9 [3.6%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1040.9" cy="1132.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C21575T  USA=2 [0.8%]  surface glycoprotein, L5F</title>
	<circle cx="1036.0" cy="1130.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G21641T  USA=8 [3.2%]  surface glycoprotein, A27S</title>
	<circle cx="1022.5" cy="1124.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C21846T  USA=2 [0.8%]  surface glycoprotein, T95I</title>
	<circle cx="980.4" cy="1106.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G21941T  USA=7 [2.8%]  surface glycoprotein, V127F</title>
	<circle cx="961.0" cy="1098.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G21974T  USA=2 [0.8%]  surface glycoprotein, D138Y</title>
	<circle cx="954.2" cy="1095.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C22079A  USA=5 [2.0%]  surface glycoprotein, Q173K</title>
	<circle cx="932.7" cy="1086.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A22080C  USA=7 [2.8%]  surface glycoprotein, Q173P</title>
	<circle cx="932.5" cy="1086.4" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A22095G  USA=4 [1.6%]  surface glycoprotein, D178G</title>
	<circle cx="929.4" cy="1085.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G22706T  USA=6 [2.4%]  surface glycoprotein, V382L</title>
	<circle cx="804.1" cy="1032.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A23403G  USA=249 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="971.3" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A23403G  USA=249 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="971.3" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G23593T  USA=4 [1.6%]  surface glycoprotein, Q677H</title>
	<circle cx="622.3" cy="954.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C23604A  USA=10 [4.0%]  surface glycoprotein, P681H</title>
	<circle cx="620.0" cy="953.8" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A23756G  USA=14 [5.6%]  surface glycoprotein, T732A</title>
	<circle cx="588.9" cy="940.6" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G24095T  USA=3 [1.2%]  surface glycoprotein, A845S</title>
	<circle cx="519.4" cy="911.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C24138T  USA=2 [0.8%]  surface glycoprotein, T859I</title>
	<circle cx="510.5" cy="907.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C24588T  USA=2 [0.8%]  surface glycoprotein, T1009I</title>
	<circle cx="418.3" cy="868.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G24816C  USA=8 [3.2%]  surface glycoprotein, G1085A</title>
	<circle cx="371.5" cy="848.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C24912T  Costa Rica=2 [100.0%]  surface glycoprotein, T1117I</title>
	<circle cx="351.9" cy="840.0" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G25062T  USA=3 [1.2%]  surface glycoprotein, G1167V</title>
	<circle cx="321.1" cy="826.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G25440T  USA=2 [0.8%]  ORF3a protein, K16N</title>
	<circle cx="243.6" cy="794.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C25463T  USA=2 [0.8%]  ORF3a protein, T24I</title>
	<circle cx="238.9" cy="792.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20 USA: 227 samples</title>
	<line x1="1181.7" y1="1191.9" x2="1172.0" y2="1187.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-20  C21575T  USA=4 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1037.2" cy="1127.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C21597T  USA=2 [0.9%]  surface glycoprotein, S12F</title>
	<circle cx="1032.8" cy="1125.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C21614T  USA=2 [0.9%]  surface glycoprotein, L18F</title>
	<circle cx="1029.3" cy="1124.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C21618T  USA=3 [1.3%]  surface glycoprotein, T19I</title>
	<circle cx="1028.5" cy="1123.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G21641T  USA=9 [4.0%]  surface glycoprotein, A27S</title>
	<circle cx="1023.8" cy="1121.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C21707T  USA=3 [1.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1010.4" cy="1115.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G21974T  USA=2 [0.9%]  surface glycoprotein, D138Y</title>
	<circle cx="956.0" cy="1091.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  A22095G  USA=3 [1.3%]  surface glycoprotein, D178G</title>
	<circle cx="931.4" cy="1080.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  A22110G  USA=8 [3.5%]  surface glycoprotein, Q183R</title>
	<circle cx="928.4" cy="1079.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G22205T  USA=2 [0.9%]  surface glycoprotein, D215Y</title>
	<circle cx="909.0" cy="1070.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C22998T  USA=2 [0.9%]  surface glycoprotein, P479L</title>
	<circle cx="747.7" cy="998.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  A23403G  USA=226 [99.6%]  surface glycoprotein, D614G</title>
	<circle cx="665.3" cy="961.9" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G23593T  USA=2 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="626.6" cy="944.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  A23598G  USA=2 [0.9%]  surface glycoprotein, N679S</title>
	<circle cx="625.6" cy="944.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C23604A  USA=6 [2.6%]  surface glycoprotein, P681H</title>
	<circle cx="624.4" cy="943.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C23673T  USA=5 [2.2%]  surface glycoprotein, S704L</title>
	<circle cx="610.4" cy="937.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  A23756G  USA=3 [1.3%]  surface glycoprotein, T732A</title>
	<circle cx="593.5" cy="930.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G23900C  USA=2 [0.9%]  surface glycoprotein, E780Q</title>
	<circle cx="564.2" cy="916.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G24053T  USA=2 [0.9%]  surface glycoprotein, A831S</title>
	<circle cx="533.1" cy="903.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G24816C  USA=9 [4.0%]  surface glycoprotein, G1085A</title>
	<circle cx="377.8" cy="833.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G25062T  USA=2 [0.9%]  surface glycoprotein, G1167V</title>
	<circle cx="327.8" cy="811.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C25433T  USA=8 [3.5%]  ORF3a protein, T14I</title>
	<circle cx="252.3" cy="778.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G25440T  USA=13 [5.7%]  ORF3a protein, K16N</title>
	<circle cx="250.8" cy="777.4" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  G25445T  USA=2 [0.9%]  ORF3a protein, G18V</title>
	<circle cx="249.8" cy="777.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21 USA: 220 samples</title>
	<line x1="1181.9" y1="1191.5" x2="1172.3" y2="1187.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-21 Canada: 3 samples</title>
	<line x1="1172.3" y1="1187.1" x2="1169.9" y2="1185.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-21 Costa Rica: 2 samples</title>
	<line x1="1169.9" y1="1185.9" x2="1167.9" y2="1185.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-21  C21575T  USA=4 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1038.5" cy="1124.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G21641T  USA=13 [5.9%]  surface glycoprotein, A27S</title>
	<circle cx="1025.2" cy="1118.5" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G21724T  Canada=3 [100.0%]  surface glycoprotein, L54F</title>
	<circle cx="1008.4" cy="1110.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G21800T  Canada=3 [100.0%]  surface glycoprotein, D80Y</title>
	<circle cx="993.1" cy="1103.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G21956C  USA=28 [12.7%]  surface glycoprotein, E132Q</title>
	<circle cx="961.6" cy="1088.8" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  A22095G  USA=2 [0.9%]  surface glycoprotein, D178G</title>
	<circle cx="933.6" cy="1075.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  A23403G  USA=219 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="952.6" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  A23403G  USA=219 [99.5%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="952.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  A23403G  USA=219 [99.5%] Canada=3 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="952.6" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G23593T  USA=2 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="631.2" cy="934.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  C23604A  USA=7 [3.2%]  surface glycoprotein, P681H</title>
	<circle cx="629.0" cy="933.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  C23673T  USA=3 [1.4%]  surface glycoprotein, S704L</title>
	<circle cx="615.0" cy="927.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  C24138T  USA=3 [1.4%]  surface glycoprotein, T859I</title>
	<circle cx="521.2" cy="883.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G24680T  USA=2 [0.9%]  surface glycoprotein, V1040F</title>
	<circle cx="411.8" cy="832.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G24816C  USA=13 [5.9%]  surface glycoprotein, G1085A</title>
	<circle cx="384.3" cy="819.6" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  G25440T  USA=4 [1.8%]  ORF3a protein, K16N</title>
	<circle cx="258.4" cy="760.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  C25463T  USA=2 [0.9%]  ORF3a protein, T24I</title>
	<circle cx="253.7" cy="758.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22 USA: 205 samples</title>
	<line x1="1182.0" y1="1191.2" x2="1172.7" y2="1186.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-22  C21621T  USA=2 [1.0%]  surface glycoprotein, T20I</title>
	<circle cx="1030.7" cy="1117.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G21641T  USA=6 [2.9%]  surface glycoprotein, A27S</title>
	<circle cx="1026.6" cy="1115.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C21767T  USA=2 [1.0%]  surface glycoprotein, H69Y</title>
	<circle cx="1001.4" cy="1103.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G21956C  USA=2 [1.0%]  surface glycoprotein, E132Q</title>
	<circle cx="963.6" cy="1084.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G21974T  USA=3 [1.5%]  surface glycoprotein, D138Y</title>
	<circle cx="960.0" cy="1082.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G21974C  USA=16 [7.8%]  surface glycoprotein, D138H</title>
	<circle cx="960.0" cy="1082.9" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  A22095G  USA=3 [1.5%]  surface glycoprotein, D178G</title>
	<circle cx="935.8" cy="1071.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G22205T  USA=4 [2.0%]  surface glycoprotein, D215Y</title>
	<circle cx="913.7" cy="1060.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G22778C  USA=2 [1.0%]  surface glycoprotein, E406Q</title>
	<circle cx="799.0" cy="1004.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  A23403G  USA=205 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="943.4" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C23481T  USA=2 [1.0%]  surface glycoprotein, S640F</title>
	<circle cx="658.3" cy="935.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G23593T  USA=3 [1.5%]  surface glycoprotein, Q677H</title>
	<circle cx="635.9" cy="924.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C23604A  USA=13 [6.3%]  surface glycoprotein, P681H</title>
	<circle cx="633.7" cy="923.8" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C23673T  USA=4 [2.0%]  surface glycoprotein, S704L</title>
	<circle cx="619.9" cy="917.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G23868T  USA=2 [1.0%]  surface glycoprotein, G769V</title>
	<circle cx="580.9" cy="898.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G24095T  USA=2 [1.0%]  surface glycoprotein, A845S</title>
	<circle cx="535.4" cy="875.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G24816C  USA=6 [2.9%]  surface glycoprotein, G1085A</title>
	<circle cx="391.1" cy="805.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G25323T  USA=2 [1.0%]  surface glycoprotein, C1254F</title>
	<circle cx="289.6" cy="756.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23 USA: 188 samples</title>
	<line x1="1182.2" y1="1190.9" x2="1173.1" y2="1186.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-23  C21575T  USA=13 [6.9%]  surface glycoprotein, L5F</title>
	<circle cx="1041.2" cy="1119.1" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  C21638T  USA=2 [1.1%]  surface glycoprotein, P26S</title>
	<circle cx="1028.7" cy="1112.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G21641T  USA=11 [5.9%]  surface glycoprotein, A27S</title>
	<circle cx="1028.1" cy="1112.4" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  C21707T  USA=2 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1015.1" cy="1105.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G21956C  USA=2 [1.1%]  surface glycoprotein, E132Q</title>
	<circle cx="965.6" cy="1080.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G21974C  USA=14 [7.4%]  surface glycoprotein, D138H</title>
	<circle cx="962.1" cy="1078.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  C22313T  USA=4 [2.1%]  surface glycoprotein, P251S</title>
	<circle cx="894.8" cy="1044.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  A23403G  USA=188 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="678.5" cy="934.3" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G23593T  USA=3 [1.6%]  surface glycoprotein, Q677H</title>
	<circle cx="640.8" cy="915.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  C23604A  USA=8 [4.3%]  surface glycoprotein, P681H</title>
	<circle cx="638.6" cy="914.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G23900C  USA=5 [2.7%]  surface glycoprotein, E780Q</title>
	<circle cx="579.9" cy="884.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G24816C  USA=11 [5.9%]  surface glycoprotein, G1085A</title>
	<circle cx="398.1" cy="791.4" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  A25065G  USA=2 [1.1%]  surface glycoprotein, D1168G</title>
	<circle cx="348.7" cy="766.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G25429T  USA=2 [1.1%]  ORF3a protein, V13L</title>
	<circle cx="276.4" cy="729.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24 USA: 95 samples</title>
	<line x1="1182.3" y1="1190.6" x2="1174.5" y2="1186.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-24  C21575T  USA=10 [10.5%]  surface glycoprotein, L5F</title>
	<circle cx="1042.7" cy="1116.4" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24  G21776A  USA=2 [2.1%]  surface glycoprotein, G72R</title>
	<circle cx="1003.2" cy="1095.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24  C22313T  USA=2 [2.1%]  surface glycoprotein, P251S</title>
	<circle cx="897.6" cy="1039.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24  A23403G  USA=95 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="925.2" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24  G23593T  USA=3 [3.2%]  surface glycoprotein, Q677H</title>
	<circle cx="645.8" cy="905.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24  C23604A  USA=27 [28.4%]  surface glycoprotein, P681H</title>
	<circle cx="643.7" cy="904.2" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25 USA: 59 samples</title>
	<line x1="1182.5" y1="1190.3" x2="1175.5" y2="1186.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-25  C21575T  USA=9 [15.3%]  surface glycoprotein, L5F</title>
	<circle cx="1044.2" cy="1113.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  C21707T  USA=2 [3.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1018.5" cy="1099.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  G21974C  USA=5 [8.5%]  surface glycoprotein, D138H</title>
	<circle cx="966.4" cy="1070.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  G22021T  USA=2 [3.4%]  surface glycoprotein, M153I</title>
	<circle cx="957.3" cy="1065.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  A23403G  USA=59 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="688.1" cy="916.2" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  G23593T  USA=3 [5.1%]  surface glycoprotein, Q677H</title>
	<circle cx="651.1" cy="895.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  C23604A  USA=2 [3.4%]  surface glycoprotein, P681H</title>
	<circle cx="648.9" cy="894.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  C23987T  USA=2 [3.4%]  surface glycoprotein, P809S</title>
	<circle cx="574.3" cy="853.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  G24926T  USA=2 [3.4%]  surface glycoprotein, V1122L</title>
	<circle cx="391.4" cy="751.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  T25233C  USA=2 [3.4%]  surface glycoprotein, L1224S</title>
	<circle cx="331.6" cy="718.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26 USA: 248 samples</title>
	<line x1="1182.7" y1="1190.0" x2="1173.3" y2="1184.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-26  C21575T  USA=10 [4.0%]  surface glycoprotein, L5F</title>
	<circle cx="1045.7" cy="1110.9" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G21578T  USA=2 [0.8%]  surface glycoprotein, V6F</title>
	<circle cx="1045.1" cy="1110.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G21641T  USA=6 [2.4%]  surface glycoprotein, A27S</title>
	<circle cx="1033.0" cy="1103.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  C21707T  USA=6 [2.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1020.2" cy="1096.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G21724T  USA=2 [0.8%]  surface glycoprotein, L54F</title>
	<circle cx="1017.0" cy="1094.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G21974T  USA=3 [1.2%]  surface glycoprotein, D138Y</title>
	<circle cx="968.7" cy="1066.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G22017T  USA=2 [0.8%]  surface glycoprotein, W152L</title>
	<circle cx="960.4" cy="1061.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G22093C  USA=2 [0.8%]  surface glycoprotein, M177I</title>
	<circle cx="945.8" cy="1053.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A22095G  USA=3 [1.2%]  surface glycoprotein, D178G</title>
	<circle cx="945.4" cy="1053.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G22205T  USA=4 [1.6%]  surface glycoprotein, D215Y</title>
	<circle cx="924.2" cy="1040.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  C22482T  USA=4 [1.6%]  surface glycoprotein, T307I</title>
	<circle cx="870.8" cy="1009.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G22661C  USA=2 [0.8%]  surface glycoprotein, V367L</title>
	<circle cx="836.2" cy="990.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G22706T  USA=4 [1.6%]  surface glycoprotein, V382L</title>
	<circle cx="827.6" cy="985.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A23403G  USA=248 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="907.3" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G23593T  USA=4 [1.6%]  surface glycoprotein, Q677H</title>
	<circle cx="656.5" cy="886.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  C23604A  USA=3 [1.2%]  surface glycoprotein, P681H</title>
	<circle cx="654.3" cy="885.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A23756G  USA=3 [1.2%]  surface glycoprotein, T732A</title>
	<circle cx="625.0" cy="868.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G23868T  USA=2 [0.8%]  surface glycoprotein, G769V</title>
	<circle cx="603.4" cy="855.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  C24138T  USA=5 [2.0%]  surface glycoprotein, T859I</title>
	<circle cx="551.3" cy="825.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G24794A  USA=10 [4.0%]  surface glycoprotein, A1078T</title>
	<circle cx="424.8" cy="752.4" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G24816C  USA=6 [2.4%]  surface glycoprotein, G1085A</title>
	<circle cx="420.6" cy="750.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G24914T  USA=2 [0.8%]  surface glycoprotein, D1118Y</title>
	<circle cx="401.7" cy="739.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A25448G  USA=2 [0.8%]  ORF3a protein, E19G</title>
	<circle cx="298.7" cy="679.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27 USA: 218 samples</title>
	<line x1="1182.9" y1="1189.7" x2="1173.8" y2="1184.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-27 Costa Rica: 2 samples</title>
	<line x1="1173.8" y1="1184.3" x2="1172.0" y2="1183.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-27  C21575T  USA=2 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1047.3" cy="1108.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G21641T  USA=5 [2.3%]  surface glycoprotein, A27S</title>
	<circle cx="1034.7" cy="1100.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C21707T  USA=3 [1.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1022.1" cy="1093.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G21776A  USA=3 [1.4%]  surface glycoprotein, G72R</title>
	<circle cx="1008.9" cy="1085.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G21974C  USA=25 [11.5%]  surface glycoprotein, D138H</title>
	<circle cx="971.1" cy="1062.5" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  A22095G  USA=3 [1.4%]  surface glycoprotein, D178G</title>
	<circle cx="948.0" cy="1048.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  A23403G  USA=217 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="898.5" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  A23403G  USA=217 [99.5%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="898.5" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C23481T  USA=2 [0.9%]  surface glycoprotein, S640F</title>
	<circle cx="683.4" cy="889.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C23525T  USA=2 [0.9%]  surface glycoprotein, H655Y</title>
	<circle cx="675.0" cy="884.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  A23592C  USA=2 [0.9%]  surface glycoprotein, Q677P</title>
	<circle cx="662.2" cy="876.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G23593T  USA=5 [2.3%]  surface glycoprotein, Q677H</title>
	<circle cx="662.0" cy="876.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C23604A  USA=8 [3.7%]  surface glycoprotein, P681H</title>
	<circle cx="659.9" cy="875.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C23673T  USA=3 [1.4%]  surface glycoprotein, S704L</title>
	<circle cx="646.8" cy="867.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  A23756G  USA=3 [1.4%]  surface glycoprotein, T732A</title>
	<circle cx="630.9" cy="858.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G23868T  USA=2 [0.9%]  surface glycoprotein, G769V</title>
	<circle cx="609.5" cy="845.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G23900C  USA=4 [1.8%]  surface glycoprotein, E780Q</title>
	<circle cx="603.4" cy="841.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G24816C  USA=4 [1.8%]  surface glycoprotein, G1085A</title>
	<circle cx="428.5" cy="736.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C24912T  Costa Rica=2 [100.0%]  surface glycoprotein, T1117I</title>
	<circle cx="410.2" cy="725.5" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28 USA: 192 samples</title>
	<line x1="1183.0" y1="1189.4" x2="1174.3" y2="1184.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-28  C21575T  USA=10 [5.2%]  surface glycoprotein, L5F</title>
	<circle cx="1048.9" cy="1105.6" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G21641T  USA=3 [1.6%]  surface glycoprotein, A27S</title>
	<circle cx="1036.4" cy="1097.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C21707T  USA=7 [3.6%]  surface glycoprotein, H49Y</title>
	<circle cx="1024.0" cy="1090.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G21724T  USA=3 [1.6%]  surface glycoprotein, L54F</title>
	<circle cx="1020.8" cy="1088.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G21776A  USA=2 [1.0%]  surface glycoprotein, G72R</title>
	<circle cx="1010.9" cy="1081.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G21800T  USA=2 [1.0%]  surface glycoprotein, D80Y</title>
	<circle cx="1006.4" cy="1079.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G21974T  USA=2 [1.0%]  surface glycoprotein, D138Y</title>
	<circle cx="973.5" cy="1058.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G21974C  USA=6 [3.1%]  surface glycoprotein, D138H</title>
	<circle cx="973.5" cy="1058.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G22021T  USA=2 [1.0%]  surface glycoprotein, M153I</title>
	<circle cx="964.7" cy="1052.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  A22095G  USA=4 [2.1%]  surface glycoprotein, D178G</title>
	<circle cx="950.7" cy="1044.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G23224T  USA=8 [4.2%]  surface glycoprotein, E554D</title>
	<circle cx="737.4" cy="911.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C23277T  USA=2 [1.0%]  surface glycoprotein, T572I</title>
	<circle cx="727.4" cy="904.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  A23403G  USA=191 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="889.8" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C23423T  USA=2 [1.0%]  surface glycoprotein, P621S</title>
	<circle cx="699.9" cy="887.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C23481T  USA=2 [1.0%]  surface glycoprotein, S640F</title>
	<circle cx="688.9" cy="880.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C23604A  USA=11 [5.7%]  surface glycoprotein, P681H</title>
	<circle cx="665.7" cy="866.1" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C23673T  USA=2 [1.0%]  surface glycoprotein, S704L</title>
	<circle cx="652.6" cy="858.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  A23756G  USA=3 [1.6%]  surface glycoprotein, T732A</title>
	<circle cx="637.0" cy="848.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G23900C  USA=2 [1.0%]  surface glycoprotein, E780Q</title>
	<circle cx="609.8" cy="831.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G24638T  USA=5 [2.6%]  surface glycoprotein, A1026S</title>
	<circle cx="470.4" cy="744.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G24816C  USA=3 [1.6%]  surface glycoprotein, G1085A</title>
	<circle cx="436.8" cy="723.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  A25420C  USA=6 [3.1%]  ORF3a protein, I10L</title>
	<circle cx="322.7" cy="651.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G25440T  USA=2 [1.0%]  ORF3a protein, K16N</title>
	<circle cx="318.9" cy="649.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C25487T  USA=3 [1.6%]  ORF3a protein, T32I</title>
	<circle cx="310.0" cy="643.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29 USA: 173 samples</title>
	<line x1="1183.2" y1="1189.1" x2="1174.8" y2="1183.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-29 Bermuda: 2 samples</title>
	<line x1="1174.8" y1="1183.6" x2="1173.0" y2="1182.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-29  C21575T  USA=3 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1050.6" cy="1103.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G21641T  USA=3 [1.7%]  surface glycoprotein, A27S</title>
	<circle cx="1038.2" cy="1095.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  C21707T  USA=4 [2.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1025.9" cy="1086.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  C21846T  USA=4 [2.3%]  surface glycoprotein, T95I</title>
	<circle cx="1000.0" cy="1070.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G21974T  USA=2 [1.2%]  surface glycoprotein, D138Y</title>
	<circle cx="976.0" cy="1054.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G21974C  USA=5 [2.9%]  surface glycoprotein, D138H</title>
	<circle cx="976.0" cy="1054.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  A22095G  USA=5 [2.9%]  surface glycoprotein, D178G</title>
	<circle cx="953.4" cy="1039.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G22706T  USA=2 [1.2%]  surface glycoprotein, V382L</title>
	<circle cx="839.3" cy="965.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G22992A  Bermuda=2 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="785.9" cy="931.1" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  A23403G  USA=172 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="881.2" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  A23403G  USA=172 [99.4%] Bermuda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="881.2" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G23593T  USA=3 [1.7%]  surface glycoprotein, Q677H</title>
	<circle cx="673.6" cy="858.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  C23604A  USA=10 [5.8%]  surface glycoprotein, P681H</title>
	<circle cx="671.6" cy="856.8" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  C23673T  USA=3 [1.7%]  surface glycoprotein, S704L</title>
	<circle cx="658.7" cy="848.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G24368T  USA=4 [2.3%]  surface glycoprotein, D936Y</title>
	<circle cx="528.9" cy="764.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G24816C  USA=3 [1.7%]  surface glycoprotein, G1085A</title>
	<circle cx="445.2" cy="709.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G25019T  USA=3 [1.7%]  surface glycoprotein, D1153Y</title>
	<circle cx="407.3" cy="685.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  A25065G  USA=3 [1.7%]  surface glycoprotein, D1168G</title>
	<circle cx="398.7" cy="679.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  C25487T  USA=2 [1.2%]  ORF3a protein, T32I</title>
	<circle cx="319.9" cy="628.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30 USA: 194 samples</title>
	<line x1="1183.4" y1="1188.8" x2="1174.9" y2="1183.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-30  C21575T  USA=7 [3.6%]  surface glycoprotein, L5F</title>
	<circle cx="1052.3" cy="1100.4" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  C21597T  USA=2 [1.0%]  surface glycoprotein, S12F</title>
	<circle cx="1048.2" cy="1097.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  C21614T  USA=3 [1.5%]  surface glycoprotein, L18F</title>
	<circle cx="1045.1" cy="1095.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G21624T  USA=2 [1.0%]  surface glycoprotein, R21I</title>
	<circle cx="1043.2" cy="1094.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G21641T  USA=4 [2.1%]  surface glycoprotein, A27S</title>
	<circle cx="1040.1" cy="1092.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  C21707T  USA=6 [3.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1027.9" cy="1083.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G21724T  USA=3 [1.5%]  surface glycoprotein, L54F</title>
	<circle cx="1024.8" cy="1081.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G21974T  USA=2 [1.0%]  surface glycoprotein, D138Y</title>
	<circle cx="978.6" cy="1050.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  A22095G  USA=8 [4.1%]  surface glycoprotein, D178G</title>
	<circle cx="956.3" cy="1035.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  T22917G  USA=2 [1.0%]  surface glycoprotein, L452R</title>
	<circle cx="804.5" cy="933.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  T23042C  USA=7 [3.6%]  surface glycoprotein, S494P</title>
	<circle cx="781.4" cy="917.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  A23403G  USA=193 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="872.7" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G23587C  USA=2 [1.0%]  surface glycoprotein, Q675H</title>
	<circle cx="680.8" cy="849.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G23593T  USA=5 [2.6%]  surface glycoprotein, Q677H</title>
	<circle cx="679.7" cy="849.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  C23604A  USA=8 [4.1%]  surface glycoprotein, P681H</title>
	<circle cx="677.7" cy="847.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  A23756G  USA=5 [2.6%]  surface glycoprotein, T732A</title>
	<circle cx="649.6" cy="828.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G24368A  USA=2 [1.0%]  surface glycoprotein, D936N</title>
	<circle cx="536.6" cy="752.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G24816C  USA=4 [2.1%]  surface glycoprotein, G1085A</title>
	<circle cx="453.9" cy="696.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  A25065G  USA=3 [1.5%]  surface glycoprotein, D1168G</title>
	<circle cx="407.9" cy="665.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  G25440T  USA=2 [1.0%]  ORF3a protein, K16N</title>
	<circle cx="338.7" cy="619.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31 USA: 61 samples</title>
	<line x1="1183.6" y1="1188.5" x2="1177.0" y2="1183.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-31 Bermuda: 6 samples</title>
	<line x1="1177.0" y1="1183.9" x2="1173.9" y2="1181.7" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-31  C21575T  Bermuda=3 [50.0%]  surface glycoprotein, L5F</title>
	<circle cx="1054.0" cy="1097.8" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  C21575T  USA=2 [3.3%]  surface glycoprotein, L5F</title>
	<circle cx="1054.0" cy="1097.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  G21974C  USA=2 [3.3%]  surface glycoprotein, D138H</title>
	<circle cx="981.3" cy="1046.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  C22227T  Bermuda=4 [66.7%]  surface glycoprotein, A222V</title>
	<circle cx="935.1" cy="1014.5" r="2.4" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  C22329T  Bermuda=2 [33.3%]  surface glycoprotein, S256L</title>
	<circle cx="916.5" cy="1001.5" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  A23403G  USA=61 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="864.3" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  A23403G  USA=61 [100.0%] Bermuda=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="864.3" r="3.1" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  C23673T  USA=2 [3.3%]  surface glycoprotein, S704L</title>
	<circle cx="671.3" cy="829.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  G23900C  USA=2 [3.3%]  surface glycoprotein, E780Q</title>
	<circle cx="629.9" cy="800.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  G24368T  Bermuda=2 [33.3%]  surface glycoprotein, D936Y</title>
	<circle cx="544.5" cy="741.0" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  G25088T  Bermuda=2 [33.3%]  surface glycoprotein, V1176F</title>
	<circle cx="413.1" cy="649.0" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01 USA: 77 samples</title>
	<line x1="1183.8" y1="1188.2" x2="1176.9" y2="1183.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-01  C22088T  USA=2 [2.6%]  surface glycoprotein, L176F</title>
	<circle cx="963.4" cy="1028.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01  A23403G  USA=77 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="856.0" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01  G23593T  USA=2 [2.6%]  surface glycoprotein, Q677H</title>
	<circle cx="692.2" cy="831.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01  C23604A  USA=3 [3.9%]  surface glycoprotein, P681H</title>
	<circle cx="690.3" cy="829.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01  A23756G  USA=2 [2.6%]  surface glycoprotein, T732A</title>
	<circle cx="662.9" cy="809.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02 USA: 261 samples</title>
	<line x1="1184.0" y1="1188.0" x2="1175.3" y2="1181.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-02 Mexico: 9 samples</title>
	<line x1="1175.3" y1="1181.4" x2="1171.7" y2="1178.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-02  G21600T  USA=6 [2.3%]  surface glycoprotein, S13I</title>
	<circle cx="1053.3" cy="1089.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  C21638T  USA=6 [2.3%]  surface glycoprotein, P26S</title>
	<circle cx="1046.5" cy="1084.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G21641T  USA=2 [0.8%]  surface glycoprotein, A27S</title>
	<circle cx="1046.0" cy="1083.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  C21707T  USA=5 [1.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1034.2" cy="1075.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G21724T  USA=2 [0.8%]  surface glycoprotein, L54F</title>
	<circle cx="1031.2" cy="1072.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G21974T  USA=3 [1.1%]  surface glycoprotein, D138Y</title>
	<circle cx="986.7" cy="1039.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G21974C  USA=13 [5.0%]  surface glycoprotein, D138H</title>
	<circle cx="986.7" cy="1039.3" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G22018T  USA=6 [2.3%]  surface glycoprotein, W152C</title>
	<circle cx="978.9" cy="1033.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A22095G  USA=3 [1.1%]  surface glycoprotein, D178G</title>
	<circle cx="965.2" cy="1023.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G22706T  USA=4 [1.5%]  surface glycoprotein, V382L</title>
	<circle cx="856.5" cy="941.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  T22917G  USA=6 [2.3%]  surface glycoprotein, L452R</title>
	<circle cx="819.0" cy="912.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G22992A  Mexico=2 [22.2%]  surface glycoprotein, S477N</title>
	<circle cx="805.7" cy="902.8" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  T23255C  USA=2 [0.8%]  surface glycoprotein, F565L</title>
	<circle cx="758.9" cy="867.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23403G  USA=260 [99.6%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="847.8" r="9.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23403G  USA=260 [99.6%] Mexico=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="847.8" r="3.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  C23481T  USA=2 [0.8%]  surface glycoprotein, S640F</title>
	<circle cx="718.7" cy="837.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G23587C  USA=3 [1.1%]  surface glycoprotein, Q675H</title>
	<circle cx="699.8" cy="823.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G23593T  USA=8 [3.1%]  surface glycoprotein, Q677H</title>
	<circle cx="698.8" cy="822.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  C23604A  USA=9 [3.4%]  surface glycoprotein, P681H</title>
	<circle cx="696.8" cy="820.8" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  C23673T  USA=2 [0.8%]  surface glycoprotein, S704L</title>
	<circle cx="684.5" cy="811.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23756G  Mexico=3 [33.3%]  surface glycoprotein, T732A</title>
	<circle cx="669.8" cy="800.4" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23756G  USA=2 [0.8%]  surface glycoprotein, T732A</title>
	<circle cx="669.8" cy="800.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G23868T  USA=2 [0.8%]  surface glycoprotein, G769V</title>
	<circle cx="649.8" cy="785.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G23900C  USA=2 [0.8%]  surface glycoprotein, E780Q</title>
	<circle cx="644.2" cy="781.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G24816C  USA=2 [0.8%]  surface glycoprotein, G1085A</title>
	<circle cx="481.2" cy="658.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A25065G  USA=4 [1.5%]  surface glycoprotein, D1168G</title>
	<circle cx="436.9" cy="625.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G25244T  USA=4 [1.5%]  surface glycoprotein, V1228L</title>
	<circle cx="405.1" cy="601.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G25269C  USA=3 [1.1%]  surface glycoprotein, C1236S</title>
	<circle cx="400.7" cy="597.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G25273T  USA=2 [0.8%]  surface glycoprotein, M1237I</title>
	<circle cx="399.9" cy="597.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03 USA: 164 samples</title>
	<line x1="1184.2" y1="1187.7" x2="1176.4" y2="1181.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-03 Mexico: 3 samples</title>
	<line x1="1176.4" y1="1181.5" x2="1174.2" y2="1179.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-03  C21575T  USA=2 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1059.6" cy="1090.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G21641T  USA=4 [2.4%]  surface glycoprotein, A27S</title>
	<circle cx="1048.0" cy="1081.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  C21707T  USA=9 [5.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1036.4" cy="1072.2" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G21974T  USA=2 [1.2%]  surface glycoprotein, D138Y</title>
	<circle cx="989.6" cy="1035.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G21974C  USA=2 [1.2%]  surface glycoprotein, D138H</title>
	<circle cx="989.6" cy="1035.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G22017T  USA=2 [1.2%]  surface glycoprotein, W152L</title>
	<circle cx="982.0" cy="1029.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  C22079A  USA=3 [1.8%]  surface glycoprotein, Q173K</title>
	<circle cx="971.1" cy="1021.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  C22313T  USA=2 [1.2%]  surface glycoprotein, P251S</title>
	<circle cx="930.1" cy="989.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  A22320G  USA=2 [1.2%]  surface glycoprotein, D253G</title>
	<circle cx="928.8" cy="988.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  T23042C  USA=11 [6.7%]  surface glycoprotein, S494P</title>
	<circle cx="802.1" cy="889.2" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  A23403G  USA=163 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="839.7" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  A23403G  USA=163 [99.4%] Mexico=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="839.7" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G23593T  USA=9 [5.5%]  surface glycoprotein, Q677H</title>
	<circle cx="705.4" cy="813.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G23593C  USA=2 [1.2%]  surface glycoprotein, Q677H</title>
	<circle cx="705.4" cy="813.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  C23604A  USA=3 [1.8%]  surface glycoprotein, P681H</title>
	<circle cx="703.5" cy="812.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  A23756T  USA=2 [1.2%]  surface glycoprotein, T732S</title>
	<circle cx="676.8" cy="791.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G24368T  USA=2 [1.2%]  surface glycoprotein, D936Y</title>
	<circle cx="569.4" cy="707.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G24816C  USA=4 [2.4%]  surface glycoprotein, G1085A</title>
	<circle cx="490.8" cy="645.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G25019T  USA=2 [1.2%]  surface glycoprotein, D1153Y</title>
	<circle cx="455.2" cy="618.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04 USA: 200 samples</title>
	<line x1="1184.5" y1="1187.4" x2="1176.4" y2="1180.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-04 Bermuda: 2 samples</title>
	<line x1="1176.4" y1="1180.9" x2="1174.7" y2="1179.5" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-04  A21551T  USA=2 [1.0%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1065.7" cy="1091.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C21575T  USA=6 [3.0%]  surface glycoprotein, L5F</title>
	<circle cx="1061.5" cy="1087.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C21707T  USA=6 [3.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1038.7" cy="1069.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G21724T  USA=3 [1.5%]  surface glycoprotein, L54F</title>
	<circle cx="1035.7" cy="1067.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G21776A  USA=3 [1.5%]  surface glycoprotein, G72R</title>
	<circle cx="1026.7" cy="1059.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A21868T  USA=2 [1.0%]  surface glycoprotein, R102S</title>
	<circle cx="1010.8" cy="1046.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G21974T  USA=2 [1.0%]  surface glycoprotein, D138Y</title>
	<circle cx="992.5" cy="1031.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G22017T  USA=2 [1.0%]  surface glycoprotein, W152L</title>
	<circle cx="985.0" cy="1025.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C22079A  USA=4 [2.0%]  surface glycoprotein, Q173K</title>
	<circle cx="974.3" cy="1017.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A22095G  USA=4 [2.0%]  surface glycoprotein, D178G</title>
	<circle cx="971.5" cy="1015.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C22227T  USA=4 [2.0%]  surface glycoprotein, A222V</title>
	<circle cx="948.7" cy="996.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C22313T  USA=2 [1.0%]  surface glycoprotein, P251S</title>
	<circle cx="933.8" cy="984.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G22992A  Bermuda=2 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="816.3" cy="889.3" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G23120T  USA=2 [1.0%]  surface glycoprotein, A520S</title>
	<circle cx="794.1" cy="871.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A23403G  USA=200 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="745.1" cy="831.7" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A23403G  USA=200 [100.0%] Bermuda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="745.1" cy="831.7" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G23593T  USA=5 [2.5%]  surface glycoprotein, Q677H</title>
	<circle cx="712.3" cy="805.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G23593C  USA=2 [1.0%]  surface glycoprotein, Q677H</title>
	<circle cx="712.3" cy="805.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C23604A  USA=6 [3.0%]  surface glycoprotein, P681H</title>
	<circle cx="710.3" cy="803.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A23756G  USA=8 [4.0%]  surface glycoprotein, T732A</title>
	<circle cx="684.0" cy="782.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G25088T  USA=2 [1.0%]  surface glycoprotein, V1176F</title>
	<circle cx="453.5" cy="595.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G25217T  USA=2 [1.0%]  surface glycoprotein, G1219C</title>
	<circle cx="431.2" cy="577.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G25244T  USA=3 [1.5%]  surface glycoprotein, V1228L</title>
	<circle cx="426.5" cy="573.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G25269T  USA=2 [1.0%]  surface glycoprotein, C1236F</title>
	<circle cx="422.2" cy="570.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  T25458A  USA=8 [4.0%]  ORF3a protein, D22E</title>
	<circle cx="389.4" cy="543.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C25463T  USA=3 [1.5%]  ORF3a protein, T24I</title>
	<circle cx="388.6" cy="542.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G25471T  USA=2 [1.0%]  ORF3a protein, D27Y</title>
	<circle cx="387.2" cy="541.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05 USA: 175 samples</title>
	<line x1="1184.7" y1="1187.1" x2="1176.9" y2="1180.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-05  C21575T  USA=6 [3.4%]  surface glycoprotein, L5F</title>
	<circle cx="1063.5" cy="1085.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  C21627T  USA=5 [2.9%]  surface glycoprotein, T22I</title>
	<circle cx="1054.6" cy="1078.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  C21707T  USA=5 [2.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1041.0" cy="1066.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G21724T  USA=2 [1.1%]  surface glycoprotein, L54F</title>
	<circle cx="1038.1" cy="1064.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G21974C  USA=5 [2.9%]  surface glycoprotein, D138H</title>
	<circle cx="995.4" cy="1028.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G21985T  USA=5 [2.9%]  surface glycoprotein, L141F</title>
	<circle cx="993.6" cy="1026.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  A22095G  USA=2 [1.1%]  surface glycoprotein, D178G</title>
	<circle cx="974.8" cy="1011.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G22319A  USA=5 [2.9%]  surface glycoprotein, D253N</title>
	<circle cx="936.6" cy="979.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  A23064C  USA=2 [1.1%]  surface glycoprotein, N501T</title>
	<circle cx="809.5" cy="872.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  A23403G  USA=175 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="823.8" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G23593T  USA=5 [2.9%]  surface glycoprotein, Q677H</title>
	<circle cx="719.2" cy="796.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  C23604A  USA=30 [17.1%]  surface glycoprotein, P681H</title>
	<circle cx="717.3" cy="795.0" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G24368T  USA=5 [2.9%]  surface glycoprotein, D936Y</title>
	<circle cx="587.0" cy="685.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G25313A  USA=6 [3.4%]  surface glycoprotein, G1251R</title>
	<circle cx="425.8" cy="550.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06 USA: 137 samples</title>
	<line x1="1184.9" y1="1186.9" x2="1177.6" y2="1180.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-06 Costa Rica: 2 samples</title>
	<line x1="1177.6" y1="1180.6" x2="1176.0" y2="1179.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-06 Bermuda: 2 samples</title>
	<line x1="1176.0" y1="1179.2" x2="1174.4" y2="1177.7" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-06  G21600T  USA=2 [1.5%]  surface glycoprotein, S13I</title>
	<circle cx="1061.3" cy="1079.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C21621T  USA=2 [1.5%]  surface glycoprotein, T20I</title>
	<circle cx="1057.8" cy="1076.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G21641T  USA=2 [1.5%]  surface glycoprotein, A27S</title>
	<circle cx="1054.4" cy="1073.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C21707T  USA=4 [2.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1043.3" cy="1063.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G21776A  USA=2 [1.5%]  surface glycoprotein, G72R</title>
	<circle cx="1031.7" cy="1053.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G22018T  USA=2 [1.5%]  surface glycoprotein, W152C</title>
	<circle cx="991.1" cy="1018.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C22088T  USA=3 [2.2%]  surface glycoprotein, L176F</title>
	<circle cx="979.3" cy="1008.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A22095G  USA=2 [1.5%]  surface glycoprotein, D178G</title>
	<circle cx="978.1" cy="1007.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C22313T  USA=3 [2.2%]  surface glycoprotein, P251S</title>
	<circle cx="941.5" cy="975.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  T22917G  USA=2 [1.5%]  surface glycoprotein, L452R</title>
	<circle cx="840.0" cy="887.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  T23042C  USA=2 [1.5%]  surface glycoprotein, S494P</title>
	<circle cx="818.9" cy="868.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23403G  USA=137 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="816.0" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23403G  USA=137 [100.0%] Bermuda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="816.0" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23403G  USA=137 [100.0%] Bermuda=2 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="816.0" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C23439T  USA=2 [1.5%]  surface glycoprotein, A626V</title>
	<circle cx="752.2" cy="810.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C23481T  USA=2 [1.5%]  surface glycoprotein, S640F</title>
	<circle cx="745.2" cy="804.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23586G  USA=2 [1.5%]  surface glycoprotein, Q675R</title>
	<circle cx="727.5" cy="789.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G23593T  USA=3 [2.2%]  surface glycoprotein, Q677H</title>
	<circle cx="726.3" cy="788.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C23604A  USA=2 [1.5%]  surface glycoprotein, P681H</title>
	<circle cx="724.5" cy="786.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23756G  USA=4 [2.9%]  surface glycoprotein, T732A</title>
	<circle cx="698.9" cy="764.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G24197T  USA=3 [2.2%]  surface glycoprotein, A879S</title>
	<circle cx="624.8" cy="700.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G24816C  USA=2 [1.5%]  surface glycoprotein, G1085A</title>
	<circle cx="520.8" cy="609.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A25065G  USA=2 [1.5%]  surface glycoprotein, D1168G</title>
	<circle cx="478.9" cy="573.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G25244T  USA=2 [1.5%]  surface glycoprotein, V1228L</title>
	<circle cx="448.8" cy="547.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07 USA: 77 samples</title>
	<line x1="1185.1" y1="1186.6" x2="1178.8" y2="1180.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-07  G21974C  USA=2 [2.6%]  surface glycoprotein, D138H</title>
	<circle cx="1001.6" cy="1021.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07  C22088T  USA=3 [3.9%]  surface glycoprotein, L176F</title>
	<circle cx="982.7" cy="1004.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07  C22313T  USA=5 [6.5%]  surface glycoprotein, P251S</title>
	<circle cx="945.4" cy="970.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07  A23403G  USA=77 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="765.0" cy="808.4" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07  G23593T  USA=3 [3.9%]  surface glycoprotein, Q677H</title>
	<circle cx="733.6" cy="780.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08 USA: 33 samples</title>
	<line x1="1185.4" y1="1186.4" x2="1180.3" y2="1181.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-08 Bermuda: 2 samples</title>
	<line x1="1180.3" y1="1181.7" x2="1178.8" y2="1180.2" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-08  G23236T  USA=2 [6.1%]  surface glycoprotein, K558N</title>
	<circle cx="799.1" cy="826.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  A23403G  USA=33 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="800.8" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  A23403G  USA=33 [100.0%] Bermuda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="800.8" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  G23593T  USA=4 [12.1%]  surface glycoprotein, Q677H</title>
	<circle cx="741.0" cy="772.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09 USA: 216 samples</title>
	<line x1="1185.6" y1="1186.1" x2="1178.1" y2="1178.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-09  C21575T  USA=5 [2.3%]  surface glycoprotein, L5F</title>
	<circle cx="1071.8" cy="1076.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G21600T  USA=14 [6.5%]  surface glycoprotein, S13I</title>
	<circle cx="1067.8" cy="1072.4" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G21624T  USA=2 [0.9%]  surface glycoprotein, R21I</title>
	<circle cx="1064.0" cy="1068.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  C21627T  USA=2 [0.9%]  surface glycoprotein, T22I</title>
	<circle cx="1063.5" cy="1068.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  C21638T  USA=11 [5.1%]  surface glycoprotein, P26S</title>
	<circle cx="1061.7" cy="1066.5" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G21800T  USA=2 [0.9%]  surface glycoprotein, D80Y</title>
	<circle cx="1035.8" cy="1041.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G21974T  USA=2 [0.9%]  surface glycoprotein, D138Y</title>
	<circle cx="1007.9" cy="1014.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G22018T  USA=14 [6.5%]  surface glycoprotein, W152C</title>
	<circle cx="1000.9" cy="1007.7" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  C22088T  USA=6 [2.8%]  surface glycoprotein, L176F</title>
	<circle cx="989.6" cy="996.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G22332A  USA=2 [0.9%]  surface glycoprotein, G257D</title>
	<circle cx="950.6" cy="959.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G22332T  USA=2 [0.9%]  surface glycoprotein, G257V</title>
	<circle cx="950.6" cy="959.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G22484T  USA=2 [0.9%]  surface glycoprotein, V308L</title>
	<circle cx="926.2" cy="935.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  T22917G  USA=13 [6.0%]  surface glycoprotein, L452R</title>
	<circle cx="856.8" cy="868.6" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  A23403G  USA=214 [99.1%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="793.4" r="9.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G23593T  USA=11 [5.1%]  surface glycoprotein, Q677H</title>
	<circle cx="748.5" cy="764.0" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G23593C  USA=2 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="748.5" cy="764.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  C23604A  USA=7 [3.2%]  surface glycoprotein, P681H</title>
	<circle cx="746.8" cy="762.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  A23756T  USA=2 [0.9%]  surface glycoprotein, T732S</title>
	<circle cx="722.4" cy="738.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G24095T  USA=2 [0.9%]  surface glycoprotein, A845S</title>
	<circle cx="668.1" cy="686.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  A25065G  USA=2 [0.9%]  surface glycoprotein, D1168G</title>
	<circle cx="512.7" cy="536.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  G25273T  USA=4 [1.9%]  surface glycoprotein, M1237I</title>
	<circle cx="479.4" cy="504.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  C25350T  USA=8 [3.7%]  surface glycoprotein, P1263L</title>
	<circle cx="467.0" cy="492.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  T25365C  USA=2 [0.9%]  surface glycoprotein, V1268A</title>
	<circle cx="464.6" cy="489.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09  T25458A  USA=2 [0.9%]  ORF3a protein, D22E</title>
	<circle cx="449.7" cy="475.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10 USA: 201 samples</title>
	<line x1="1185.9" y1="1185.9" x2="1178.5" y2="1178.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-10 Bermuda: 3 samples</title>
	<line x1="1178.5" y1="1178.5" x2="1176.6" y2="1176.6" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-10  C21575T  USA=9 [4.5%]  surface glycoprotein, L5F</title>
	<circle cx="1074.0" cy="1074.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G21600T  USA=5 [2.5%]  surface glycoprotein, S13I</title>
	<circle cx="1070.1" cy="1070.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A21651G  USA=2 [1.0%]  surface glycoprotein, N30S</title>
	<circle cx="1062.0" cy="1062.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  C21707T  USA=4 [2.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1053.2" cy="1053.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G21974T  USA=2 [1.0%]  surface glycoprotein, D138Y</title>
	<circle cx="1011.2" cy="1011.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G22018T  USA=5 [2.5%]  surface glycoprotein, W152C</title>
	<circle cx="1004.2" cy="1004.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  C22088T  USA=2 [1.0%]  surface glycoprotein, L176F</title>
	<circle cx="993.2" cy="993.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A22095G  USA=2 [1.0%]  surface glycoprotein, D178G</title>
	<circle cx="992.1" cy="992.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  C22313T  USA=3 [1.5%]  surface glycoprotein, P251S</title>
	<circle cx="957.8" cy="957.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G22332A  USA=3 [1.5%]  surface glycoprotein, G257D</title>
	<circle cx="954.8" cy="954.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G22332T  USA=2 [1.0%]  surface glycoprotein, G257V</title>
	<circle cx="954.8" cy="954.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G22638A  USA=3 [1.5%]  surface glycoprotein, S359N</title>
	<circle cx="906.6" cy="906.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  T22917G  USA=5 [2.5%]  surface glycoprotein, L452R</title>
	<circle cx="862.7" cy="862.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A23064C  USA=2 [1.0%]  surface glycoprotein, N501T</title>
	<circle cx="839.5" cy="839.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A23312G  USA=3 [1.5%]  surface glycoprotein, I584V</title>
	<circle cx="800.5" cy="800.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A23403G  USA=198 [98.5%]  surface glycoprotein, D614G</title>
	<circle cx="786.1" cy="786.1" r="9.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A23403G  USA=198 [98.5%] Bermuda=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="786.1" cy="786.1" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A23586G  USA=2 [1.0%]  surface glycoprotein, Q675R</title>
	<circle cx="757.3" cy="757.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G23593T  USA=5 [2.5%]  surface glycoprotein, Q677H</title>
	<circle cx="756.2" cy="756.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  C23604A  USA=15 [7.5%]  surface glycoprotein, P681H</title>
	<circle cx="754.5" cy="754.5" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  C23604G  USA=8 [4.0%]  surface glycoprotein, P681R</title>
	<circle cx="754.5" cy="754.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G23900C  USA=2 [1.0%]  surface glycoprotein, E780Q</title>
	<circle cx="707.9" cy="707.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G24197T  USA=2 [1.0%]  surface glycoprotein, A879S</title>
	<circle cx="661.1" cy="661.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G24794T  USA=2 [1.0%]  surface glycoprotein, A1078S</title>
	<circle cx="567.1" cy="567.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  A25065G  USA=2 [1.0%]  surface glycoprotein, D1168G</title>
	<circle cx="524.4" cy="524.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  G25135T  USA=2 [1.0%]  surface glycoprotein, K1191N</title>
	<circle cx="513.4" cy="513.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-10  C25433T  USA=3 [1.5%]  ORF3a protein, T14I</title>
	<circle cx="466.4" cy="466.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11 USA: 130 samples</title>
	<line x1="1186.1" y1="1185.6" x2="1179.5" y2="1178.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-11  C21575T  USA=3 [2.3%]  surface glycoprotein, L5F</title>
	<circle cx="1076.2" cy="1071.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  C21614T  USA=3 [2.3%]  surface glycoprotein, L18F</title>
	<circle cx="1070.2" cy="1065.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  T21656C  USA=2 [1.5%]  surface glycoprotein, F32L</title>
	<circle cx="1063.7" cy="1058.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  C21707T  USA=3 [2.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1055.8" cy="1050.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  G21974T  USA=2 [1.5%]  surface glycoprotein, D138Y</title>
	<circle cx="1014.5" cy="1007.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  G22992A  USA=2 [1.5%]  surface glycoprotein, S477N</title>
	<circle cx="857.0" cy="844.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  T23042C  USA=3 [2.3%]  surface glycoprotein, S494P</title>
	<circle cx="849.3" cy="836.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  A23403G  USA=127 [97.7%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="779.0" r="8.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  G23593T  USA=2 [1.5%]  surface glycoprotein, Q677H</title>
	<circle cx="764.0" cy="748.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  C23604A  USA=2 [1.5%]  surface glycoprotein, P681H</title>
	<circle cx="762.3" cy="746.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  A23756G  USA=2 [1.5%]  surface glycoprotein, T732A</title>
	<circle cx="738.8" cy="722.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  G23900C  USA=2 [1.5%]  surface glycoprotein, E780Q</title>
	<circle cx="716.5" cy="699.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12 USA: 142 samples</title>
	<line x1="1186.4" y1="1185.4" x2="1179.7" y2="1178.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-12  G21538T  USA=3 [2.1%]  orf1ab polyprotein, V7092F</title>
	<circle cx="1084.1" cy="1075.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C21575T  USA=7 [4.9%]  surface glycoprotein, L5F</title>
	<circle cx="1078.5" cy="1069.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C21707T  USA=2 [1.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1058.4" cy="1048.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G21724T  USA=3 [2.1%]  surface glycoprotein, L54F</title>
	<circle cx="1055.9" cy="1045.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C21855T  USA=3 [2.1%]  surface glycoprotein, S98F</title>
	<circle cx="1036.0" cy="1024.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G21974T  USA=3 [2.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1017.9" cy="1004.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G21985T  USA=3 [2.1%]  surface glycoprotein, L141F</title>
	<circle cx="1016.2" cy="1002.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G22017T  USA=2 [1.4%]  surface glycoprotein, W152L</title>
	<circle cx="1011.3" cy="997.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C22088T  USA=2 [1.4%]  surface glycoprotein, L176F</title>
	<circle cx="1000.6" cy="986.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G22487C  USA=2 [1.4%]  surface glycoprotein, E309Q</title>
	<circle cx="940.0" cy="921.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G23012A  USA=3 [2.1%]  surface glycoprotein, E484K</title>
	<circle cx="860.2" cy="835.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  A23064C  USA=3 [2.1%]  surface glycoprotein, N501T</title>
	<circle cx="852.3" cy="827.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G23285T  USA=2 [1.4%]  surface glycoprotein, A575S</title>
	<circle cx="818.7" cy="791.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  A23403G  USA=140 [98.6%]  surface glycoprotein, D614G</title>
	<circle cx="800.8" cy="771.9" r="8.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C23481T  USA=2 [1.4%]  surface glycoprotein, S640F</title>
	<circle cx="789.0" cy="759.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G23587C  USA=2 [1.4%]  surface glycoprotein, Q675H</title>
	<circle cx="772.9" cy="742.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G23593T  USA=2 [1.4%]  surface glycoprotein, Q677H</title>
	<circle cx="772.0" cy="741.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G23593C  USA=2 [1.4%]  surface glycoprotein, Q677H</title>
	<circle cx="772.0" cy="741.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C23604A  USA=6 [4.2%]  surface glycoprotein, P681H</title>
	<circle cx="770.3" cy="739.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C23673T  USA=2 [1.4%]  surface glycoprotein, S704L</title>
	<circle cx="759.8" cy="728.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G25088T  USA=3 [2.1%]  surface glycoprotein, V1176F</title>
	<circle cx="544.9" cy="497.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G25186T  USA=2 [1.4%]  surface glycoprotein, Q1208H</title>
	<circle cx="530.0" cy="481.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  A25259G  USA=2 [1.4%]  surface glycoprotein, M1233V</title>
	<circle cx="518.9" cy="469.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13 USA: 153 samples</title>
	<line x1="1186.6" y1="1185.1" x2="1180.0" y2="1177.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-13 Bermuda: 2 samples</title>
	<line x1="1180.0" y1="1177.8" x2="1178.6" y2="1176.2" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-13  C21575T  USA=5 [3.3%]  surface glycoprotein, L5F</title>
	<circle cx="1080.8" cy="1067.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G21600T  USA=2 [1.3%]  surface glycoprotein, S13I</title>
	<circle cx="1077.1" cy="1063.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G21724T  USA=3 [2.0%]  surface glycoprotein, L54F</title>
	<circle cx="1058.6" cy="1042.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G21893A  USA=2 [1.3%]  surface glycoprotein, D111N</title>
	<circle cx="1033.4" cy="1015.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G22018T  USA=2 [1.3%]  surface glycoprotein, W152C</title>
	<circle cx="1014.8" cy="994.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  T22917G  USA=2 [1.3%]  surface glycoprotein, L452R</title>
	<circle cx="880.8" cy="845.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G22992A  USA=2 [1.3%]  surface glycoprotein, S477N</title>
	<circle cx="869.6" cy="833.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  C23127T  USA=2 [1.3%]  surface glycoprotein, A522V</title>
	<circle cx="849.5" cy="810.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A23403G  USA=153 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="808.4" cy="765.0" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A23403G  USA=153 [100.0%] Bermuda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="808.4" cy="765.0" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G23593T  USA=6 [3.9%]  surface glycoprotein, Q677H</title>
	<circle cx="780.0" cy="733.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G23593C  USA=4 [2.6%]  surface glycoprotein, Q677H</title>
	<circle cx="780.0" cy="733.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  C23604A  USA=4 [2.6%]  surface glycoprotein, P681H</title>
	<circle cx="778.4" cy="731.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A23756G  USA=2 [1.3%]  surface glycoprotein, T732A</title>
	<circle cx="755.8" cy="706.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G24095T  USA=3 [2.0%]  surface glycoprotein, A845S</title>
	<circle cx="705.2" cy="650.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G24933T  USA=5 [3.3%]  surface glycoprotein, G1124V</title>
	<circle cx="580.3" cy="511.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A25065G  USA=2 [1.3%]  surface glycoprotein, D1168G</title>
	<circle cx="560.7" cy="490.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G25088T  USA=2 [1.3%]  surface glycoprotein, V1176F</title>
	<circle cx="557.2" cy="486.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  C25487T  USA=2 [1.3%]  ORF3a protein, T32I</title>
	<circle cx="497.8" cy="420.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14 USA: 104 samples</title>
	<line x1="1186.9" y1="1184.9" x2="1180.9" y2="1178.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-14  C21614T  USA=2 [1.9%]  surface glycoprotein, L18F</title>
	<circle cx="1077.4" cy="1059.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  G21985T  USA=7 [6.7%]  surface glycoprotein, L141F</title>
	<circle cx="1023.2" cy="996.6" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  C22088T  USA=2 [1.9%]  surface glycoprotein, L176F</title>
	<circle cx="1008.2" cy="979.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  A23403G  USA=103 [99.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="758.3" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  G23593T  USA=9 [8.7%]  surface glycoprotein, Q677H</title>
	<circle cx="788.2" cy="726.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  G23628T  USA=2 [1.9%]  surface glycoprotein, S689I</title>
	<circle cx="783.1" cy="720.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  G23900C  USA=2 [1.9%]  surface glycoprotein, E780Q</title>
	<circle cx="743.4" cy="674.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  C24588T  USA=2 [1.9%]  surface glycoprotein, T1009I</title>
	<circle cx="642.9" cy="559.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  G24794T  USA=3 [2.9%]  surface glycoprotein, A1078S</title>
	<circle cx="612.8" cy="524.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  A25256T  USA=3 [2.9%]  surface glycoprotein, I1232F</title>
	<circle cx="545.3" cy="446.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14  A25259G  USA=4 [3.8%]  surface glycoprotein, M1233V</title>
	<circle cx="544.8" cy="446.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15 USA: 101 samples</title>
	<line x1="1187.1" y1="1184.7" x2="1181.3" y2="1177.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-15 Canada: 6 samples</title>
	<line x1="1181.3" y1="1177.8" x2="1178.9" y2="1174.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-15  C21575T  USA=2 [2.0%]  surface glycoprotein, L5F</title>
	<circle cx="1085.5" cy="1063.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G21724T  USA=2 [2.0%]  surface glycoprotein, L54F</title>
	<circle cx="1064.1" cy="1038.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G21785C  Canada=2 [33.3%]  surface glycoprotein, G75R</title>
	<circle cx="1055.4" cy="1027.7" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G21800T  Canada=2 [33.3%]  surface glycoprotein, D80Y</title>
	<circle cx="1053.3" cy="1025.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G21974T  USA=5 [5.0%]  surface glycoprotein, D138Y</title>
	<circle cx="1028.4" cy="995.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G21985T  USA=32 [31.7%]  surface glycoprotein, L141F</title>
	<circle cx="1026.8" cy="993.6" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  C22079A  USA=2 [2.0%]  surface glycoprotein, Q173K</title>
	<circle cx="1013.3" cy="977.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  C22227T  USA=2 [2.0%]  surface glycoprotein, A222V</title>
	<circle cx="992.1" cy="952.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G22992A  USA=4 [4.0%]  surface glycoprotein, S477N</title>
	<circle cx="882.6" cy="821.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  A23403G  USA=100 [99.0%]  surface glycoprotein, D614G</title>
	<circle cx="823.8" cy="751.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  A23403G  USA=100 [99.0%] Canada=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="823.8" cy="751.6" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  C23525T  USA=2 [2.0%]  surface glycoprotein, H655Y</title>
	<circle cx="806.3" cy="730.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  C23604A  USA=2 [2.0%]  surface glycoprotein, P681H</title>
	<circle cx="795.0" cy="717.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  C23664T  USA=3 [3.0%]  surface glycoprotein, A701V</title>
	<circle cx="786.4" cy="707.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  A25259G  USA=11 [10.9%]  surface glycoprotein, M1233V</title>
	<circle cx="558.1" cy="435.0" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16 USA: 357 samples</title>
	<line x1="1187.4" y1="1184.5" x2="1180.2" y2="1175.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-16 Canada: 3 samples</title>
	<line x1="1180.2" y1="1175.5" x2="1178.5" y2="1173.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-16 Costa Rica: 2 samples</title>
	<line x1="1178.5" y1="1173.4" x2="1177.1" y2="1171.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-16  G21538T  USA=3 [0.8%]  orf1ab polyprotein, V7092F</title>
	<circle cx="1093.1" cy="1067.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21575T  USA=5 [1.4%]  surface glycoprotein, L5F</title>
	<circle cx="1087.9" cy="1061.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G21600T  USA=13 [3.6%]  surface glycoprotein, S13I</title>
	<circle cx="1084.4" cy="1057.2" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21614T  USA=4 [1.1%]  surface glycoprotein, L18F</title>
	<circle cx="1082.4" cy="1054.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21618T  USA=2 [0.6%]  surface glycoprotein, T19I</title>
	<circle cx="1081.8" cy="1054.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21627T  USA=2 [0.6%]  surface glycoprotein, T22I</title>
	<circle cx="1080.6" cy="1052.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21638T  USA=9 [2.5%]  surface glycoprotein, P26S</title>
	<circle cx="1079.0" cy="1050.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21642T  USA=7 [2.0%]  surface glycoprotein, A27V</title>
	<circle cx="1078.5" cy="1049.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21707T  USA=3 [0.8%]  surface glycoprotein, H49Y</title>
	<circle cx="1069.4" cy="1038.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C21855T  USA=4 [1.1%]  surface glycoprotein, S98F</title>
	<circle cx="1048.6" cy="1013.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G21974C  USA=3 [0.8%]  surface glycoprotein, D138H</title>
	<circle cx="1031.9" cy="992.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G22018T  USA=12 [3.4%]  surface glycoprotein, W152C</title>
	<circle cx="1025.8" cy="984.9" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C22079A  USA=2 [0.6%]  surface glycoprotein, Q173K</title>
	<circle cx="1017.2" cy="974.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G22093C  USA=2 [0.6%]  surface glycoprotein, M177I</title>
	<circle cx="1015.3" cy="971.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C22314A  USA=4 [1.1%]  surface glycoprotein, P251H</title>
	<circle cx="984.3" cy="933.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G22319A  USA=2 [0.6%]  surface glycoprotein, D253N</title>
	<circle cx="983.6" cy="932.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C22323T  USA=3 [0.8%]  surface glycoprotein, S254F</title>
	<circle cx="983.0" cy="932.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G22349T  USA=7 [2.0%]  surface glycoprotein, A263S</title>
	<circle cx="979.4" cy="927.6" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C22458T  USA=3 [0.8%]  surface glycoprotein, T299I</title>
	<circle cx="964.1" cy="908.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A22629G  USA=2 [0.6%]  surface glycoprotein, K356R</title>
	<circle cx="940.1" cy="879.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  T22917G  USA=13 [3.6%]  surface glycoprotein, L452R</title>
	<circle cx="899.8" cy="829.3" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G22992A  USA=4 [1.1%]  surface glycoprotein, S477N</title>
	<circle cx="889.3" cy="816.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  T23042C  USA=3 [0.8%]  surface glycoprotein, S494P</title>
	<circle cx="882.3" cy="807.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A23064C  USA=3 [0.8%]  surface glycoprotein, N501T</title>
	<circle cx="879.2" cy="803.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A23403G  USA=357 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="745.1" r="10.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A23403G  USA=357 [100.0%] Canada=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="745.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A23403G  USA=357 [100.0%] Canada=3 [100.0%] Costa Rica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="745.1" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C23415T  USA=3 [0.8%]  surface glycoprotein, T618I</title>
	<circle cx="830.0" cy="743.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G23501T  USA=2 [0.6%]  surface glycoprotein, A647S</title>
	<circle cx="817.9" cy="728.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C23525T  USA=2 [0.6%]  surface glycoprotein, H655Y</title>
	<circle cx="814.6" cy="724.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A23592G  USA=3 [0.8%]  surface glycoprotein, Q677R</title>
	<circle cx="805.2" cy="712.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G23593T  USA=8 [2.2%]  surface glycoprotein, Q677H</title>
	<circle cx="805.0" cy="712.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G23593C  USA=3 [0.8%]  surface glycoprotein, Q677H</title>
	<circle cx="805.0" cy="712.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C23604T  USA=2 [0.6%]  surface glycoprotein, P681L</title>
	<circle cx="803.5" cy="710.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C23604A  USA=9 [2.5%]  surface glycoprotein, P681H</title>
	<circle cx="803.5" cy="710.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C23673T  USA=3 [0.8%]  surface glycoprotein, S704L</title>
	<circle cx="793.8" cy="698.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G23868T  USA=3 [0.8%]  surface glycoprotein, G769V</title>
	<circle cx="766.5" cy="664.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C23987T  USA=4 [1.1%]  surface glycoprotein, P809S</title>
	<circle cx="749.8" cy="644.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G24603A  USA=10 [2.8%]  surface glycoprotein, R1014K</title>
	<circle cx="663.5" cy="537.4" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C24771T  USA=2 [0.6%]  surface glycoprotein, A1070V</title>
	<circle cx="639.9" cy="508.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G24794A  USA=3 [0.8%]  surface glycoprotein, A1078T</title>
	<circle cx="636.7" cy="504.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C24912T  Costa Rica=2 [100.0%]  surface glycoprotein, T1117I</title>
	<circle cx="620.2" cy="484.0" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G24914T  USA=2 [0.6%]  surface glycoprotein, D1118Y</title>
	<circle cx="619.9" cy="483.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A25065G  USA=3 [0.8%]  surface glycoprotein, D1168G</title>
	<circle cx="598.7" cy="457.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G25186T  USA=2 [0.6%]  surface glycoprotein, Q1208H</title>
	<circle cx="581.8" cy="436.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G25244T  USA=3 [0.8%]  surface glycoprotein, V1228L</title>
	<circle cx="573.6" cy="426.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G25429T  USA=2 [0.6%]  ORF3a protein, V13L</title>
	<circle cx="547.7" cy="394.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G25437T  USA=2 [0.6%]  ORF3a protein, L15F</title>
	<circle cx="546.6" cy="393.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  G25444T  USA=2 [0.6%]  ORF3a protein, G18C</title>
	<circle cx="545.6" cy="391.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17 USA: 283 samples</title>
	<line x1="1187.7" y1="1184.2" x2="1180.9" y2="1175.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-17 Bermuda: 3 samples</title>
	<line x1="1180.9" y1="1175.5" x2="1179.2" y2="1173.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-17  A21551T  USA=2 [0.7%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1093.6" cy="1063.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C21575T  USA=6 [2.1%]  surface glycoprotein, L5F</title>
	<circle cx="1090.3" cy="1059.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G21600T  USA=3 [1.1%]  surface glycoprotein, S13I</title>
	<circle cx="1086.9" cy="1055.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C21614T  USA=4 [1.4%]  surface glycoprotein, L18F</title>
	<circle cx="1085.0" cy="1052.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G21974T  USA=2 [0.7%]  surface glycoprotein, D138Y</title>
	<circle cx="1035.6" cy="989.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G22018T  USA=3 [1.1%]  surface glycoprotein, W152C</title>
	<circle cx="1029.6" cy="981.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G22093C  USA=2 [0.7%]  surface glycoprotein, M177I</title>
	<circle cx="1019.3" cy="968.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G22199T  USA=2 [0.7%]  surface glycoprotein, V213L</title>
	<circle cx="1004.7" cy="950.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C22224T  USA=3 [1.1%]  surface glycoprotein, S221L</title>
	<circle cx="1001.3" cy="945.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C22313T  USA=2 [0.7%]  surface glycoprotein, P251S</title>
	<circle cx="989.1" cy="930.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C22323T  USA=2 [0.7%]  surface glycoprotein, S254F</title>
	<circle cx="987.7" cy="928.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  T22917G  USA=4 [1.4%]  surface glycoprotein, L452R</title>
	<circle cx="906.3" cy="824.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G22992A  USA=4 [1.4%]  surface glycoprotein, S477N</title>
	<circle cx="896.0" cy="810.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A23064C  USA=5 [1.8%]  surface glycoprotein, N501T</title>
	<circle cx="886.1" cy="798.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G23120T  USA=3 [1.1%]  surface glycoprotein, A520S</title>
	<circle cx="878.5" cy="788.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G23311T  USA=2 [0.7%]  surface glycoprotein, E583D</title>
	<circle cx="852.3" cy="754.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A23403G  USA=281 [99.3%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="738.8" r="9.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A23403G  USA=281 [99.3%] Bermuda=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="738.8" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C23415T  USA=2 [0.7%]  surface glycoprotein, T618I</title>
	<circle cx="838.0" cy="736.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G23587C  USA=2 [0.7%]  surface glycoprotein, Q675H</title>
	<circle cx="814.4" cy="706.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C23589T  USA=2 [0.7%]  surface glycoprotein, T676I</title>
	<circle cx="814.1" cy="706.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A23592C  USA=2 [0.7%]  surface glycoprotein, Q677P</title>
	<circle cx="813.7" cy="705.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G23593T  USA=2 [0.7%]  surface glycoprotein, Q677H</title>
	<circle cx="813.6" cy="705.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G23593C  USA=2 [0.7%]  surface glycoprotein, Q677H</title>
	<circle cx="813.6" cy="705.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C23604A  USA=6 [2.1%]  surface glycoprotein, P681H</title>
	<circle cx="812.1" cy="703.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C23604A  USA=6 [2.1%] Bermuda=3 [100.0%]  surface glycoprotein, P681H</title>
	<circle cx="812.1" cy="703.5" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A23756G  USA=3 [1.1%]  surface glycoprotein, T732A</title>
	<circle cx="791.3" cy="676.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G23900C  USA=3 [1.1%]  surface glycoprotein, E780Q</title>
	<circle cx="771.5" cy="651.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G24095T  USA=2 [0.7%]  surface glycoprotein, A845S</title>
	<circle cx="744.8" cy="617.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C24588T  USA=2 [0.7%]  surface glycoprotein, T1009I</title>
	<circle cx="677.2" cy="530.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G24794A  USA=2 [0.7%]  surface glycoprotein, A1078T</title>
	<circle cx="648.9" cy="494.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G24794T  USA=4 [1.4%]  surface glycoprotein, A1078S</title>
	<circle cx="648.9" cy="494.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  C24797T  USA=6 [2.1%]  surface glycoprotein, P1079S</title>
	<circle cx="648.5" cy="494.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G25062T  USA=2 [0.7%]  surface glycoprotein, G1167V</title>
	<circle cx="612.2" cy="447.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A25065G  USA=2 [0.7%]  surface glycoprotein, D1168G</title>
	<circle cx="611.8" cy="447.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G25088T  USA=2 [0.7%]  surface glycoprotein, V1176F</title>
	<circle cx="608.6" cy="443.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G25244T  USA=3 [1.1%]  surface glycoprotein, V1228L</title>
	<circle cx="587.2" cy="415.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G25244A  USA=2 [0.7%]  surface glycoprotein, V1228I</title>
	<circle cx="587.2" cy="415.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A25256T  USA=2 [0.7%]  surface glycoprotein, I1232F</title>
	<circle cx="585.6" cy="413.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  G25273T  USA=2 [0.7%]  surface glycoprotein, M1237I</title>
	<circle cx="583.2" cy="410.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18 USA: 319 samples</title>
	<line x1="1188.0" y1="1184.0" x2="1181.2" y2="1175.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-18 Bermuda: 2 samples</title>
	<line x1="1181.2" y1="1175.0" x2="1179.9" y2="1173.3" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-18  A21551T  USA=5 [1.6%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1096.0" cy="1062.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C21575T  USA=5 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1092.8" cy="1057.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G21600T  USA=7 [2.2%]  surface glycoprotein, S13I</title>
	<circle cx="1089.4" cy="1053.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  T21698G  USA=2 [0.6%]  surface glycoprotein, S46A</title>
	<circle cx="1076.3" cy="1035.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G21724T  USA=2 [0.6%]  surface glycoprotein, L54F</title>
	<circle cx="1072.8" cy="1031.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C21846T  USA=10 [3.1%]  surface glycoprotein, T95I</title>
	<circle cx="1056.4" cy="1009.5" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G21974T  USA=3 [0.9%]  surface glycoprotein, D138Y</title>
	<circle cx="1039.3" cy="986.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G21974C  USA=2 [0.6%]  surface glycoprotein, D138H</title>
	<circle cx="1039.3" cy="986.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22018T  USA=7 [2.2%]  surface glycoprotein, W152C</title>
	<circle cx="1033.4" cy="978.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22021T  USA=5 [1.6%]  surface glycoprotein, M153I</title>
	<circle cx="1033.0" cy="978.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22093C  USA=3 [0.9%]  surface glycoprotein, M177I</title>
	<circle cx="1023.3" cy="965.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A22101T  USA=2 [0.6%]  surface glycoprotein, E180V</title>
	<circle cx="1022.3" cy="964.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C22323T  USA=2 [0.6%]  surface glycoprotein, S254F</title>
	<circle cx="992.5" cy="924.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22487C  USA=3 [0.9%]  surface glycoprotein, E309Q</title>
	<circle cx="970.5" cy="895.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C22713T  USA=3 [0.9%]  surface glycoprotein, P384L</title>
	<circle cx="940.2" cy="855.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  T22917G  USA=7 [2.2%]  surface glycoprotein, L452R</title>
	<circle cx="912.9" cy="819.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22992A  USA=5 [1.6%]  surface glycoprotein, S477N</title>
	<circle cx="902.8" cy="805.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22992A  USA=5 [1.6%] Bermuda=2 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="902.8" cy="805.7" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A23403G  USA=317 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="732.6" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A23403G  USA=317 [99.4%] Bermuda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="732.6" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A23583T  USA=2 [0.6%]  surface glycoprotein, Y674F</title>
	<circle cx="823.6" cy="700.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G23587C  USA=2 [0.6%]  surface glycoprotein, Q675H</title>
	<circle cx="823.1" cy="699.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A23592C  USA=3 [0.9%]  surface glycoprotein, Q677P</title>
	<circle cx="822.4" cy="698.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G23593T  USA=3 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="822.3" cy="698.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C23595T  USA=2 [0.6%]  surface glycoprotein, T678I</title>
	<circle cx="822.0" cy="698.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C23604A  USA=5 [1.6%]  surface glycoprotein, P681H</title>
	<circle cx="820.8" cy="696.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G23621T  USA=5 [1.6%]  surface glycoprotein, V687L</title>
	<circle cx="818.5" cy="693.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C23625T  USA=3 [0.9%]  surface glycoprotein, A688V</title>
	<circle cx="818.0" cy="693.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A23756G  USA=16 [5.0%]  surface glycoprotein, T732A</title>
	<circle cx="800.4" cy="669.8" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G23868T  USA=2 [0.6%]  surface glycoprotein, G769V</title>
	<circle cx="785.4" cy="649.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G23873T  USA=2 [0.6%]  surface glycoprotein, A771S</title>
	<circle cx="784.8" cy="649.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G24095T  USA=4 [1.3%]  surface glycoprotein, A845S</title>
	<circle cx="755.0" cy="609.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G24197T  USA=3 [0.9%]  surface glycoprotein, A879S</title>
	<circle cx="741.3" cy="591.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G24842A  USA=3 [0.9%]  surface glycoprotein, V1094I</title>
	<circle cx="654.9" cy="476.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C24863T  USA=2 [0.6%]  surface glycoprotein, H1101Y</title>
	<circle cx="652.1" cy="472.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C24897T  USA=3 [0.9%]  surface glycoprotein, P1112L</title>
	<circle cx="647.5" cy="466.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G25052A  USA=8 [2.5%]  surface glycoprotein, V1164I</title>
	<circle cx="626.7" cy="439.3" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G25062T  USA=2 [0.6%]  surface glycoprotein, G1167V</title>
	<circle cx="625.4" cy="437.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A25065G  USA=2 [0.6%]  surface glycoprotein, D1168G</title>
	<circle cx="625.0" cy="436.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G25088T  USA=8 [2.5%]  surface glycoprotein, V1176F</title>
	<circle cx="621.9" cy="432.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G25244A  USA=3 [0.9%]  surface glycoprotein, V1228I</title>
	<circle cx="601.0" cy="405.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G25444T  USA=2 [0.6%]  ORF3a protein, G18C</title>
	<circle cx="574.2" cy="369.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G25455T  USA=2 [0.6%]  ORF3a protein, K21N</title>
	<circle cx="572.7" cy="367.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19 USA: 250 samples</title>
	<line x1="1188.2" y1="1183.8" x2="1181.9" y2="1175.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-19 Mexico: 2 samples</title>
	<line x1="1181.9" y1="1175.1" x2="1180.6" y2="1173.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-19  G21538T  USA=2 [0.8%]  orf1ab polyprotein, V7092F</title>
	<circle cx="1100.1" cy="1062.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A21551T  USA=2 [0.8%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1098.4" cy="1060.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C21575T  USA=3 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1095.3" cy="1055.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G21600T  USA=3 [1.2%]  surface glycoprotein, S13I</title>
	<circle cx="1092.0" cy="1051.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C21614T  USA=4 [1.6%]  surface glycoprotein, L18F</title>
	<circle cx="1090.2" cy="1048.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C21621T  USA=3 [1.2%]  surface glycoprotein, T20I</title>
	<circle cx="1089.3" cy="1047.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C21855T  USA=2 [0.8%]  surface glycoprotein, S98F</title>
	<circle cx="1058.6" cy="1005.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G22018T  USA=3 [1.2%]  surface glycoprotein, W152C</title>
	<circle cx="1037.3" cy="976.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G22093C  USA=2 [0.8%]  surface glycoprotein, M177I</title>
	<circle cx="1027.5" cy="962.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C22227T  USA=2 [0.8%]  surface glycoprotein, A222V</title>
	<circle cx="1009.9" cy="938.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  T22917G  USA=3 [1.2%]  surface glycoprotein, L452R</title>
	<circle cx="919.6" cy="814.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G22992A  USA=3 [1.2%]  surface glycoprotein, S477N</title>
	<circle cx="909.8" cy="800.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G23236T  USA=2 [0.8%]  surface glycoprotein, K558N</title>
	<circle cx="877.8" cy="756.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G23311T  USA=16 [6.4%]  surface glycoprotein, E583D</title>
	<circle cx="868.0" cy="743.1" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A23403G  USA=249 [99.6%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="726.5" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A23403G  USA=249 [99.6%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="726.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C23415T  USA=4 [1.6%]  surface glycoprotein, T618I</title>
	<circle cx="854.4" cy="724.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G23593T  USA=5 [2.0%]  surface glycoprotein, Q677H</title>
	<circle cx="831.1" cy="692.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C23604A  USA=9 [3.6%]  surface glycoprotein, P681H</title>
	<circle cx="829.7" cy="690.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A23756G  USA=6 [2.4%]  surface glycoprotein, T732A</title>
	<circle cx="809.8" cy="662.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G23900C  USA=3 [1.2%]  surface glycoprotein, E780Q</title>
	<circle cx="790.9" cy="636.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G24680T  USA=2 [0.8%]  surface glycoprotein, V1040F</title>
	<circle cx="688.8" cy="496.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G25244T  USA=3 [1.2%]  surface glycoprotein, V1228L</title>
	<circle cx="615.0" cy="394.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G25459T  USA=2 [0.8%]  ORF3a protein, A23S</title>
	<circle cx="586.8" cy="356.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20 USA: 275 samples</title>
	<line x1="1188.5" y1="1183.6" x2="1182.2" y2="1174.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-20  A21551T  USA=2 [0.7%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1100.9" cy="1058.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C21575T  USA=2 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1097.8" cy="1054.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C21614T  USA=2 [0.7%]  surface glycoprotein, L18F</title>
	<circle cx="1092.8" cy="1046.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C21621T  USA=4 [1.5%]  surface glycoprotein, T20I</title>
	<circle cx="1091.9" cy="1045.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C21707T  USA=2 [0.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1080.9" cy="1030.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G21724T  USA=2 [0.7%]  surface glycoprotein, L54F</title>
	<circle cx="1078.8" cy="1026.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G21974T  USA=3 [1.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1046.8" cy="981.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G21986A  USA=3 [1.1%]  surface glycoprotein, G142S</title>
	<circle cx="1045.3" cy="979.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G22018T  USA=3 [1.1%]  surface glycoprotein, W152C</title>
	<circle cx="1041.2" cy="973.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C22079A  USA=3 [1.1%]  surface glycoprotein, Q173K</title>
	<circle cx="1033.4" cy="962.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G22093C  USA=3 [1.1%]  surface glycoprotein, M177I</title>
	<circle cx="1031.6" cy="959.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A22101T  USA=5 [1.8%]  surface glycoprotein, E180V</title>
	<circle cx="1030.6" cy="958.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G22349T  USA=3 [1.1%]  surface glycoprotein, A263S</title>
	<circle cx="998.9" cy="912.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G22985T  USA=15 [5.5%]  surface glycoprotein, A475S</title>
	<circle cx="917.7" cy="796.8" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G22992A  USA=4 [1.5%]  surface glycoprotein, S477N</title>
	<circle cx="916.8" cy="795.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A23403G  USA=271 [98.5%]  surface glycoprotein, D614G</title>
	<circle cx="864.3" cy="720.5" r="9.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G23587C  USA=3 [1.1%]  surface glycoprotein, Q675H</title>
	<circle cx="840.8" cy="687.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A23592C  USA=3 [1.1%]  surface glycoprotein, Q677P</title>
	<circle cx="840.1" cy="686.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G23593T  USA=4 [1.5%]  surface glycoprotein, Q677H</title>
	<circle cx="840.0" cy="685.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C23604A  USA=3 [1.1%]  surface glycoprotein, P681H</title>
	<circle cx="838.6" cy="683.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C23673T  USA=2 [0.7%]  surface glycoprotein, S704L</title>
	<circle cx="829.8" cy="671.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A23756G  USA=8 [2.9%]  surface glycoprotein, T732A</title>
	<circle cx="819.2" cy="656.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G23900C  USA=3 [1.1%]  surface glycoprotein, E780Q</title>
	<circle cx="800.8" cy="629.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G24095T  USA=2 [0.7%]  surface glycoprotein, A845S</title>
	<circle cx="775.9" cy="594.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G24368T  USA=2 [0.7%]  surface glycoprotein, D936Y</title>
	<circle cx="741.0" cy="544.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A24383G  USA=2 [0.7%]  surface glycoprotein, T941A</title>
	<circle cx="739.1" cy="541.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G24680T  USA=3 [1.1%]  surface glycoprotein, V1040F</title>
	<circle cx="701.2" cy="487.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G24794A  USA=6 [2.2%]  surface glycoprotein, A1078T</title>
	<circle cx="686.6" cy="466.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A25065G  USA=2 [0.7%]  surface glycoprotein, D1168G</title>
	<circle cx="652.0" cy="417.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G25186T  USA=2 [0.7%]  surface glycoprotein, Q1208H</title>
	<circle cx="636.5" cy="395.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A25247C  USA=2 [0.7%]  surface glycoprotein, M1229L</title>
	<circle cx="628.7" cy="384.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G25437T  USA=2 [0.7%]  ORF3a protein, L15F</title>
	<circle cx="604.5" cy="349.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21 USA: 95 samples</title>
	<line x1="1188.8" y1="1183.4" x2="1183.8" y2="1176.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-21  A21551T  USA=3 [3.2%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1103.4" cy="1056.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  C21614T  USA=2 [2.1%]  surface glycoprotein, L18F</title>
	<circle cx="1095.5" cy="1045.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  C21642T  USA=3 [3.2%]  surface glycoprotein, A27V</title>
	<circle cx="1092.0" cy="1039.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  A22101T  USA=2 [2.1%]  surface glycoprotein, E180V</title>
	<circle cx="1034.9" cy="955.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  G23311T  USA=2 [2.1%]  surface glycoprotein, E583D</title>
	<circle cx="884.2" cy="731.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  A23403G  USA=93 [97.9%]  surface glycoprotein, D614G</title>
	<circle cx="872.7" cy="714.8" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  G23426T  USA=3 [3.2%]  surface glycoprotein, V622F</title>
	<circle cx="869.8" cy="710.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  C23604A  USA=8 [8.4%]  surface glycoprotein, P681H</title>
	<circle cx="847.7" cy="677.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  C23673T  USA=3 [3.2%]  surface glycoprotein, S704L</title>
	<circle cx="839.1" cy="664.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  A23756G  USA=4 [4.2%]  surface glycoprotein, T732A</title>
	<circle cx="828.7" cy="649.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  G23900C  USA=2 [2.1%]  surface glycoprotein, E780Q</title>
	<circle cx="810.8" cy="623.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  G24794A  USA=2 [2.1%]  surface glycoprotein, A1078T</title>
	<circle cx="699.5" cy="457.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  G25305T  USA=2 [2.1%]  surface glycoprotein, C1248F</title>
	<circle cx="635.8" cy="363.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  G25445T  USA=2 [2.1%]  ORF3a protein, G18V</title>
	<circle cx="618.4" cy="337.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22 USA: 110 samples</title>
	<line x1="1189.1" y1="1183.2" x2="1184.1" y2="1175.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-22  C21575T  USA=28 [25.5%]  surface glycoprotein, L5F</title>
	<circle cx="1103.0" cy="1050.6" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  G21600T  USA=5 [4.5%]  surface glycoprotein, S13I</title>
	<circle cx="1099.9" cy="1045.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  C21614T  USA=2 [1.8%]  surface glycoprotein, L18F</title>
	<circle cx="1098.2" cy="1043.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  C21638T  USA=3 [2.7%]  surface glycoprotein, P26S</title>
	<circle cx="1095.3" cy="1038.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  C21846T  USA=2 [1.8%]  surface glycoprotein, T95I</title>
	<circle cx="1070.1" cy="1000.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  G21974C  USA=2 [1.8%]  surface glycoprotein, D138H</title>
	<circle cx="1054.6" cy="976.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  G22018T  USA=5 [4.5%]  surface glycoprotein, W152C</title>
	<circle cx="1049.2" cy="967.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  T22917G  USA=5 [4.5%]  surface glycoprotein, L452R</title>
	<circle cx="940.2" cy="799.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  A23403G  USA=108 [98.2%]  surface glycoprotein, D614G</title>
	<circle cx="881.2" cy="709.1" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  C23604A  USA=32 [29.1%]  surface glycoprotein, P681H</title>
	<circle cx="856.8" cy="671.6" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  C23673T  USA=2 [1.8%]  surface glycoprotein, S704L</title>
	<circle cx="848.5" cy="658.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  C24138T  USA=27 [24.5%]  surface glycoprotein, T859I</title>
	<circle cx="792.1" cy="571.8" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  G24680T  USA=2 [1.8%]  surface glycoprotein, V1040F</title>
	<circle cx="726.3" cy="470.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-22  G24794T  USA=2 [1.8%]  surface glycoprotein, A1078S</title>
	<circle cx="712.5" cy="449.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23 USA: 322 samples</title>
	<line x1="1189.4" y1="1183.0" x2="1183.4" y2="1173.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-23  C21575T  USA=9 [2.8%]  surface glycoprotein, L5F</title>
	<circle cx="1105.6" cy="1048.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G21600T  USA=4 [1.2%]  surface glycoprotein, S13I</title>
	<circle cx="1102.6" cy="1044.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C21614T  USA=3 [0.9%]  surface glycoprotein, L18F</title>
	<circle cx="1101.0" cy="1041.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G21624C  USA=2 [0.6%]  surface glycoprotein, R21T</title>
	<circle cx="1099.8" cy="1039.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  A21651G  USA=3 [0.9%]  surface glycoprotein, N30S</title>
	<circle cx="1096.6" cy="1034.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C21707T  USA=3 [0.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1090.0" cy="1024.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G21776A  USA=3 [0.9%]  surface glycoprotein, G72R</title>
	<circle cx="1081.9" cy="1010.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C21846T  USA=4 [1.2%]  surface glycoprotein, T95I</title>
	<circle cx="1073.6" cy="997.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G22018T  USA=4 [1.2%]  surface glycoprotein, W152C</title>
	<circle cx="1053.3" cy="965.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C22079A  USA=5 [1.6%]  surface glycoprotein, Q173K</title>
	<circle cx="1046.1" cy="953.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C22088T  USA=2 [0.6%]  surface glycoprotein, L176F</title>
	<circle cx="1045.0" cy="952.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C22281T  USA=2 [0.6%]  surface glycoprotein, T240I</title>
	<circle cx="1022.3" cy="915.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G22349T  USA=12 [3.7%]  surface glycoprotein, A263S</title>
	<circle cx="1014.2" cy="902.7" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C22482T  USA=4 [1.2%]  surface glycoprotein, T307I</title>
	<circle cx="998.5" cy="877.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G22778C  USA=2 [0.6%]  surface glycoprotein, E406Q</title>
	<circle cx="963.6" cy="821.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  T22917G  USA=4 [1.2%]  surface glycoprotein, L452R</title>
	<circle cx="947.2" cy="795.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  A23403G  USA=320 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="889.8" cy="703.6" r="10.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G23522C  USA=2 [0.6%]  surface glycoprotein, E654Q</title>
	<circle cx="875.8" cy="681.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G23593C  USA=3 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="867.4" cy="667.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C23601T  USA=2 [0.6%]  surface glycoprotein, S680F</title>
	<circle cx="866.5" cy="666.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C23604A  USA=44 [13.7%]  surface glycoprotein, P681H</title>
	<circle cx="866.1" cy="665.7" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C23673T  USA=2 [0.6%]  surface glycoprotein, S704L</title>
	<circle cx="858.0" cy="652.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  A23756G  USA=5 [1.6%]  surface glycoprotein, T732A</title>
	<circle cx="848.2" cy="637.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  A23756T  USA=2 [0.6%]  surface glycoprotein, T732S</title>
	<circle cx="848.2" cy="637.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G23900C  USA=4 [1.2%]  surface glycoprotein, E780Q</title>
	<circle cx="831.2" cy="609.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  C23987T  USA=2 [0.6%]  surface glycoprotein, P809S</title>
	<circle cx="820.9" cy="593.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G24087T  USA=2 [0.6%]  surface glycoprotein, G842V</title>
	<circle cx="809.1" cy="574.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G24794A  USA=2 [0.6%]  surface glycoprotein, A1078T</title>
	<circle cx="725.7" cy="440.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G24842A  USA=3 [0.9%]  surface glycoprotein, V1094I</title>
	<circle cx="720.0" cy="431.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G24872T  USA=5 [1.6%]  surface glycoprotein, V1104L</title>
	<circle cx="716.5" cy="426.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G25019T  USA=2 [0.6%]  surface glycoprotein, D1153Y</title>
	<circle cx="699.1" cy="398.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G25135T  USA=5 [1.6%]  surface glycoprotein, K1191N</title>
	<circle cx="685.4" cy="376.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G25244A  USA=2 [0.6%]  surface glycoprotein, V1228I</title>
	<circle cx="672.6" cy="355.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23  G25440T  USA=2 [0.6%]  ORF3a protein, K16N</title>
	<circle cx="649.4" cy="318.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24 USA: 248 samples</title>
	<line x1="1189.7" y1="1182.9" x2="1184.1" y2="1173.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-24 Canada: 181 samples</title>
	<line x1="1184.1" y1="1173.6" x2="1178.9" y2="1164.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-24  C21575T  USA=3 [1.2%]  surface glycoprotein, L5F</title>
	<circle cx="1108.2" cy="1047.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G21600T  USA=12 [4.8%]  surface glycoprotein, S13I</title>
	<circle cx="1105.4" cy="1042.5" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C21614T  USA=4 [1.6%]  surface glycoprotein, L18F</title>
	<circle cx="1103.8" cy="1039.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C21638T  USA=6 [2.4%]  surface glycoprotein, P26S</title>
	<circle cx="1101.0" cy="1035.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C21639T  Canada=4 [2.2%]  surface glycoprotein, P26L</title>
	<circle cx="1100.9" cy="1035.1" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  T21656C  USA=4 [1.6%]  surface glycoprotein, F32L</title>
	<circle cx="1098.9" cy="1031.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C21707T  USA=6 [2.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1093.1" cy="1022.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G21724T  Canada=12 [6.6%]  surface glycoprotein, L54F</title>
	<circle cx="1091.1" cy="1018.8" r="4.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G21785C  Canada=49 [27.1%]  surface glycoprotein, G75R</title>
	<circle cx="1084.1" cy="1007.2" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C21789T  Canada=2 [1.1%]  surface glycoprotein, T76I</title>
	<circle cx="1083.7" cy="1006.4" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G21800T  Canada=20 [11.0%]  surface glycoprotein, D80Y</title>
	<circle cx="1082.4" cy="1004.3" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A21868T  Canada=2 [1.1%]  surface glycoprotein, R102S</title>
	<circle cx="1074.6" cy="991.3" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G21941T  USA=2 [0.8%]  surface glycoprotein, V127F</title>
	<circle cx="1066.3" cy="977.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G21974T  USA=3 [1.2%]  surface glycoprotein, D138Y</title>
	<circle cx="1062.5" cy="971.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G21986A  USA=2 [0.8%]  surface glycoprotein, G142S</title>
	<circle cx="1061.1" cy="968.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G22018T  USA=11 [4.4%]  surface glycoprotein, W152C</title>
	<circle cx="1057.4" cy="962.7" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C22033A  Canada=2 [1.1%]  surface glycoprotein, F157L</title>
	<circle cx="1055.7" cy="959.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C22079A  USA=3 [1.2%]  surface glycoprotein, Q173K</title>
	<circle cx="1050.4" cy="951.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A22101T  USA=3 [1.2%]  surface glycoprotein, E180V</title>
	<circle cx="1047.9" cy="946.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C22227T  Canada=2 [1.1%]  surface glycoprotein, A222V</title>
	<circle cx="1033.4" cy="922.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C22313T  USA=2 [0.8%]  surface glycoprotein, P251S</title>
	<circle cx="1023.6" cy="906.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G22349T  USA=7 [2.8%]  surface glycoprotein, A263S</title>
	<circle cx="1019.4" cy="899.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C22502A  Canada=4 [2.2%]  surface glycoprotein, Q314K</title>
	<circle cx="1001.9" cy="870.3" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  T22917G  USA=11 [4.4%]  surface glycoprotein, L452R</title>
	<circle cx="954.3" cy="791.1" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G22992A  Canada=2 [1.1%]  surface glycoprotein, S477N</title>
	<circle cx="945.7" cy="776.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G23012A  Canada=4 [2.2%]  surface glycoprotein, E484K</title>
	<circle cx="943.4" cy="772.9" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23064C  USA=2 [0.8%]  surface glycoprotein, N501T</title>
	<circle cx="937.4" cy="763.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23403G  USA=247 [99.6%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="698.3" r="9.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23403G  USA=247 [99.6%] Canada=180 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="698.3" r="9.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23592C  USA=2 [0.8%]  surface glycoprotein, Q677P</title>
	<circle cx="876.9" cy="662.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G23593T  USA=5 [2.0%]  surface glycoprotein, Q677H</title>
	<circle cx="876.8" cy="662.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G23593T  USA=5 [2.0%] Canada=3 [1.7%]  surface glycoprotein, Q677H</title>
	<circle cx="876.8" cy="662.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G23593C  Canada=5 [2.8%]  surface glycoprotein, Q677H</title>
	<circle cx="876.8" cy="662.0" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C23604A  USA=6 [2.4%]  surface glycoprotein, P681H</title>
	<circle cx="875.5" cy="659.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C23613T  Canada=2 [1.1%]  surface glycoprotein, A684V</title>
	<circle cx="874.5" cy="658.2" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C23718T  USA=2 [0.8%]  surface glycoprotein, T719I</title>
	<circle cx="862.4" cy="638.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23756G  USA=2 [0.8%]  surface glycoprotein, T732A</title>
	<circle cx="858.1" cy="630.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C23987T  USA=2 [0.8%]  surface glycoprotein, P809S</title>
	<circle cx="831.6" cy="586.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C23997T  USA=2 [0.8%]  surface glycoprotein, P812L</title>
	<circle cx="830.4" cy="584.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G24781T  USA=2 [0.8%]  surface glycoprotein, K1073N</title>
	<circle cx="740.5" cy="435.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C25046T  Canada=2 [1.1%]  surface glycoprotein, P1162S</title>
	<circle cx="710.1" cy="384.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G25088T  Canada=5 [2.8%]  surface glycoprotein, V1176F</title>
	<circle cx="705.3" cy="376.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G25088T  Canada=5 [2.8%] USA=2 [0.8%]  surface glycoprotein, V1176F</title>
	<circle cx="705.3" cy="376.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G25135T  Canada=5 [2.8%]  surface glycoprotein, K1191N</title>
	<circle cx="699.9" cy="367.7" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G25266T  USA=2 [0.8%]  surface glycoprotein, C1235F</title>
	<circle cx="684.8" cy="342.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  T25268A  USA=2 [0.8%]  surface glycoprotein, C1236S</title>
	<circle cx="684.6" cy="342.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G25340T  Canada=6 [3.3%]  surface glycoprotein, D1260Y</title>
	<circle cx="676.4" cy="328.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G25429T  Canada=5 [2.8%]  ORF3a protein, V13L</title>
	<circle cx="666.1" cy="311.5" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G25459T  USA=2 [0.8%]  ORF3a protein, A23S</title>
	<circle cx="662.7" cy="305.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C25463T  Canada=2 [1.1%]  ORF3a protein, T24I</title>
	<circle cx="662.2" cy="305.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C25487T  Canada=10 [5.5%]  ORF3a protein, T32I</title>
	<circle cx="659.5" cy="300.5" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25 USA: 230 samples</title>
	<line x1="1190.0" y1="1182.7" x2="1184.7" y2="1173.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-25  G21538T  USA=2 [0.9%]  orf1ab polyprotein, V7092F</title>
	<circle cx="1115.0" cy="1052.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C21575T  USA=5 [2.2%]  surface glycoprotein, L5F</title>
	<circle cx="1110.9" cy="1045.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G21600T  USA=4 [1.7%]  surface glycoprotein, S13I</title>
	<circle cx="1108.1" cy="1040.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C21614T  USA=7 [3.0%]  surface glycoprotein, L18F</title>
	<circle cx="1106.6" cy="1038.2" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C21638T  USA=2 [0.9%]  surface glycoprotein, P26S</title>
	<circle cx="1103.9" cy="1033.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G21724T  USA=2 [0.9%]  surface glycoprotein, L54F</title>
	<circle cx="1094.3" cy="1017.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G21776A  USA=3 [1.3%]  surface glycoprotein, G72R</title>
	<circle cx="1088.5" cy="1006.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C21846T  USA=2 [0.9%]  surface glycoprotein, T95I</title>
	<circle cx="1080.7" cy="993.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G21974T  USA=5 [2.2%]  surface glycoprotein, D138Y</title>
	<circle cx="1066.5" cy="968.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G22018T  USA=4 [1.7%]  surface glycoprotein, W152C</title>
	<circle cx="1061.6" cy="960.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C22079A  USA=2 [0.9%]  surface glycoprotein, Q173K</title>
	<circle cx="1054.8" cy="948.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A22101T  USA=3 [1.3%]  surface glycoprotein, E180V</title>
	<circle cx="1052.3" cy="944.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G22785T  USA=6 [2.6%]  surface glycoprotein, R408I</title>
	<circle cx="976.2" cy="812.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  T22917G  USA=4 [1.7%]  surface glycoprotein, L452R</title>
	<circle cx="961.5" cy="786.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G22985T  USA=17 [7.4%]  surface glycoprotein, A475S</title>
	<circle cx="953.9" cy="773.7" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G22992A  USA=4 [1.7%]  surface glycoprotein, S477N</title>
	<circle cx="953.1" cy="772.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23064C  USA=3 [1.3%]  surface glycoprotein, N501T</title>
	<circle cx="945.1" cy="758.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G23236T  USA=2 [0.9%]  surface glycoprotein, K558N</title>
	<circle cx="925.9" cy="725.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C23277T  USA=2 [0.9%]  surface glycoprotein, T572I</title>
	<circle cx="921.4" cy="717.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23403G  USA=229 [99.6%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="693.1" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23583T  USA=4 [1.7%]  surface glycoprotein, Y674F</title>
	<circle cx="887.3" cy="658.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G23593T  USA=3 [1.3%]  surface glycoprotein, Q677H</title>
	<circle cx="886.2" cy="656.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G23593C  USA=2 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="886.2" cy="656.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C23604A  USA=12 [5.2%]  surface glycoprotein, P681H</title>
	<circle cx="885.0" cy="654.3" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23756G  USA=7 [3.0%]  surface glycoprotein, T732A</title>
	<circle cx="868.0" cy="625.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23756T  USA=2 [0.9%]  surface glycoprotein, T732S</title>
	<circle cx="868.0" cy="625.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G24095T  USA=3 [1.3%]  surface glycoprotein, A845S</title>
	<circle cx="830.3" cy="559.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G24368T  USA=3 [1.3%]  surface glycoprotein, D936Y</title>
	<circle cx="799.9" cy="507.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C24378T  USA=2 [0.9%]  surface glycoprotein, S939F</title>
	<circle cx="798.8" cy="505.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G24680T  USA=2 [0.9%]  surface glycoprotein, V1040F</title>
	<circle cx="765.1" cy="446.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G24794A  USA=3 [1.3%]  surface glycoprotein, A1078T</title>
	<circle cx="752.4" cy="424.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A25065G  USA=2 [0.9%]  surface glycoprotein, D1168G</title>
	<circle cx="722.3" cy="372.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  T25268A  USA=2 [0.9%]  surface glycoprotein, C1236S</title>
	<circle cx="699.7" cy="333.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26 USA: 62 samples</title>
	<line x1="1190.3" y1="1182.5" x2="1186.4" y2="1175.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-26  C21575T  USA=2 [3.2%]  surface glycoprotein, L5F</title>
	<circle cx="1113.6" cy="1044.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  C21614T  USA=3 [4.8%]  surface glycoprotein, L18F</title>
	<circle cx="1109.4" cy="1036.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  G21724T  USA=2 [3.2%]  surface glycoprotein, L54F</title>
	<circle cx="1097.5" cy="1015.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  C22079A  USA=2 [3.2%]  surface glycoprotein, Q173K</title>
	<circle cx="1059.2" cy="946.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  A22101T  USA=2 [3.2%]  surface glycoprotein, E180V</title>
	<circle cx="1056.8" cy="941.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  C22458T  USA=2 [3.2%]  surface glycoprotein, T299I</title>
	<circle cx="1018.3" cy="872.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  G23120T  USA=2 [3.2%]  surface glycoprotein, A520S</title>
	<circle cx="946.8" cy="743.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  A23403G  USA=62 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="688.1" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  A23592C  USA=2 [3.2%]  surface glycoprotein, Q677P</title>
	<circle cx="895.8" cy="651.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  C23604A  USA=5 [8.1%]  surface glycoprotein, P681H</title>
	<circle cx="894.5" cy="648.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  C23673T  USA=2 [3.2%]  surface glycoprotein, S704L</title>
	<circle cx="887.1" cy="635.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26  G23900C  USA=3 [4.8%]  surface glycoprotein, E780Q</title>
	<circle cx="862.6" cy="591.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27 USA: 162 samples</title>
	<line x1="1190.6" y1="1182.3" x2="1185.9" y2="1173.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-27  C21575T  USA=4 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1116.4" cy="1042.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  C21614T  USA=4 [2.5%]  surface glycoprotein, L18F</title>
	<circle cx="1112.3" cy="1035.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  C21621T  USA=2 [1.2%]  surface glycoprotein, T20I</title>
	<circle cx="1111.5" cy="1033.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  C21648T  USA=2 [1.2%]  surface glycoprotein, T29I</title>
	<circle cx="1108.7" cy="1028.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G21985T  USA=3 [1.9%]  surface glycoprotein, L141F</title>
	<circle cx="1073.5" cy="962.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  C22313T  USA=4 [2.5%]  surface glycoprotein, P251S</title>
	<circle cx="1039.2" cy="897.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G22785T  USA=3 [1.9%]  surface glycoprotein, R408I</title>
	<circle cx="989.8" cy="804.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  C23277T  USA=2 [1.2%]  surface glycoprotein, T572I</title>
	<circle cx="938.4" cy="708.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  A23403G  USA=162 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="925.2" cy="683.2" r="8.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G23593T  USA=6 [3.7%]  surface glycoprotein, Q677H</title>
	<circle cx="905.4" cy="645.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  C23604A  USA=7 [4.3%]  surface glycoprotein, P681H</title>
	<circle cx="904.2" cy="643.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G23900C  USA=3 [1.9%]  surface glycoprotein, E780Q</title>
	<circle cx="873.3" cy="585.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G24368A  USA=2 [1.2%]  surface glycoprotein, D936N</title>
	<circle cx="824.3" cy="493.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G24926T  USA=2 [1.2%]  surface glycoprotein, V1122L</title>
	<circle cx="766.0" cy="383.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G25062T  USA=2 [1.2%]  surface glycoprotein, G1167V</title>
	<circle cx="751.8" cy="357.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  A25065G  USA=2 [1.2%]  surface glycoprotein, D1168G</title>
	<circle cx="751.4" cy="356.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G25266T  USA=2 [1.2%]  surface glycoprotein, C1235F</title>
	<circle cx="730.4" cy="316.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  A25420C  USA=3 [1.9%]  ORF3a protein, I10L</title>
	<circle cx="714.3" cy="286.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  C25433T  USA=2 [1.2%]  ORF3a protein, T14I</title>
	<circle cx="713.0" cy="284.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27  G25459T  USA=2 [1.2%]  ORF3a protein, A23S</title>
	<circle cx="710.2" cy="278.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28 USA: 103 samples</title>
	<line x1="1190.9" y1="1182.2" x2="1186.8" y2="1174.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-28  G21600T  USA=6 [5.8%]  surface glycoprotein, S13I</title>
	<circle cx="1116.6" cy="1036.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G21624A  USA=2 [1.9%]  surface glycoprotein, R21K</title>
	<circle cx="1114.2" cy="1031.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G21724T  USA=2 [1.9%]  surface glycoprotein, L54F</title>
	<circle cx="1104.0" cy="1011.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G21985T  USA=2 [1.9%]  surface glycoprotein, L141F</title>
	<circle cx="1077.7" cy="959.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G22018T  USA=6 [5.8%]  surface glycoprotein, W152C</title>
	<circle cx="1074.3" cy="953.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  C22326T  USA=2 [1.9%]  surface glycoprotein, S255F</title>
	<circle cx="1043.2" cy="892.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  T22917G  USA=6 [5.8%]  surface glycoprotein, L452R</title>
	<circle cx="983.4" cy="774.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G23236T  USA=2 [1.9%]  surface glycoprotein, K558N</title>
	<circle cx="951.2" cy="711.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  A23403G  USA=99 [96.1%]  surface glycoprotein, D614G</title>
	<circle cx="934.3" cy="678.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G23593T  USA=3 [2.9%]  surface glycoprotein, Q677H</title>
	<circle cx="915.1" cy="640.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  C23604A  USA=4 [3.9%]  surface glycoprotein, P681H</title>
	<circle cx="914.0" cy="638.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29 USA: 121 samples</title>
	<line x1="1191.2" y1="1182.0" x2="1187.1" y2="1173.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-29  C21575T  USA=6 [5.0%]  surface glycoprotein, L5F</title>
	<circle cx="1121.9" cy="1039.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G21600T  USA=9 [7.4%]  surface glycoprotein, S13I</title>
	<circle cx="1119.5" cy="1034.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  C21638T  USA=2 [1.7%]  surface glycoprotein, P26S</title>
	<circle cx="1115.7" cy="1027.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  C21767T  USA=5 [4.1%]  surface glycoprotein, H69Y</title>
	<circle cx="1103.1" cy="1001.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  C21789T  USA=2 [1.7%]  surface glycoprotein, T76I</title>
	<circle cx="1101.0" cy="997.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  C21846T  USA=4 [3.3%]  surface glycoprotein, T95I</title>
	<circle cx="1095.4" cy="985.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G21974T  USA=5 [4.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1082.9" cy="960.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G22018T  USA=9 [7.4%]  surface glycoprotein, W152C</title>
	<circle cx="1078.6" cy="951.2" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G22661A  USA=4 [3.3%]  surface glycoprotein, V367I</title>
	<circle cx="1015.9" cy="822.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  T22917G  USA=10 [8.3%]  surface glycoprotein, L452R</title>
	<circle cx="990.9" cy="771.2" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  A23403G  USA=117 [96.7%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="673.9" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G23593T  USA=5 [4.1%]  surface glycoprotein, Q677H</title>
	<circle cx="924.9" cy="635.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  C23604A  USA=2 [1.7%]  surface glycoprotein, P681H</title>
	<circle cx="923.8" cy="633.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  C23664T  USA=2 [1.7%]  surface glycoprotein, A701V</title>
	<circle cx="917.9" cy="621.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G24197T  USA=2 [1.7%]  surface glycoprotein, A879S</title>
	<circle cx="865.9" cy="515.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  C24378T  USA=3 [2.5%]  surface glycoprotein, S939F</title>
	<circle cx="848.2" cy="478.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G24770T  USA=3 [2.5%]  surface glycoprotein, A1070S</title>
	<circle cx="810.0" cy="400.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29  G25135C  USA=2 [1.7%]  surface glycoprotein, K1191N</title>
	<circle cx="774.3" cy="327.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30 USA: 455 samples</title>
	<line x1="1191.5" y1="1181.9" x2="1186.5" y2="1171.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-30  C21575T  USA=9 [2.0%]  surface glycoprotein, L5F</title>
	<circle cx="1124.7" cy="1038.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G21600T  USA=43 [9.5%]  surface glycoprotein, S13I</title>
	<circle cx="1122.3" cy="1033.5" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C21614T  USA=6 [1.3%]  surface glycoprotein, L18F</title>
	<circle cx="1121.0" cy="1030.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G21624C  USA=2 [0.4%]  surface glycoprotein, R21T</title>
	<circle cx="1120.1" cy="1028.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C21638T  USA=6 [1.3%]  surface glycoprotein, P26S</title>
	<circle cx="1118.8" cy="1025.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C21707T  USA=5 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1112.3" cy="1011.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G21761T  USA=2 [0.4%]  surface glycoprotein, A67S</title>
	<circle cx="1107.2" cy="1001.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G21974T  USA=8 [1.8%]  surface glycoprotein, D138Y</title>
	<circle cx="1087.1" cy="958.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G22018T  USA=45 [9.9%]  surface glycoprotein, W152C</title>
	<circle cx="1083.0" cy="949.1" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C22079A  USA=2 [0.4%]  surface glycoprotein, Q173K</title>
	<circle cx="1077.3" cy="936.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C22227T  USA=8 [1.8%]  surface glycoprotein, A222V</title>
	<circle cx="1063.3" cy="906.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C22295T  USA=2 [0.4%]  surface glycoprotein, H245Y</title>
	<circle cx="1056.9" cy="893.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C22323T  USA=2 [0.4%]  surface glycoprotein, S254F</title>
	<circle cx="1054.3" cy="887.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C22326T  USA=3 [0.7%]  surface glycoprotein, S255F</title>
	<circle cx="1054.0" cy="886.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G22335T  USA=8 [1.8%]  surface glycoprotein, W258L</title>
	<circle cx="1053.2" cy="885.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  T22917G  USA=44 [9.7%]  surface glycoprotein, L452R</title>
	<circle cx="998.4" cy="767.6" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G22985T  USA=12 [2.6%]  surface glycoprotein, A475S</title>
	<circle cx="992.0" cy="753.9" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G22992A  USA=3 [0.7%]  surface glycoprotein, S477N</title>
	<circle cx="991.3" cy="752.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23012C  USA=3 [0.7%]  surface glycoprotein, E484Q</title>
	<circle cx="989.4" cy="748.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  A23064C  USA=5 [1.1%]  surface glycoprotein, N501T</title>
	<circle cx="984.5" cy="738.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23120T  USA=3 [0.7%]  surface glycoprotein, A520S</title>
	<circle cx="979.3" cy="726.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C23277T  USA=3 [0.7%]  surface glycoprotein, T572I</title>
	<circle cx="964.5" cy="695.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  A23403G  USA=449 [98.7%]  surface glycoprotein, D614G</title>
	<circle cx="952.6" cy="669.5" r="10.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23429T  USA=2 [0.4%]  surface glycoprotein, A623S</title>
	<circle cx="950.2" cy="664.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C23453T  USA=4 [0.9%]  surface glycoprotein, P631S</title>
	<circle cx="947.9" cy="659.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C23481T  USA=4 [0.9%]  surface glycoprotein, S640F</title>
	<circle cx="945.3" cy="653.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  T23487G  USA=2 [0.4%]  surface glycoprotein, V642G</title>
	<circle cx="944.7" cy="652.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  A23586G  USA=2 [0.4%]  surface glycoprotein, Q675R</title>
	<circle cx="935.4" cy="632.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23587C  USA=8 [1.8%]  surface glycoprotein, Q675H</title>
	<circle cx="935.3" cy="632.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  A23592C  USA=5 [1.1%]  surface glycoprotein, Q677P</title>
	<circle cx="934.9" cy="631.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23593T  USA=10 [2.2%]  surface glycoprotein, Q677H</title>
	<circle cx="934.8" cy="631.2" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23593C  USA=4 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="934.8" cy="631.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C23604A  USA=23 [5.1%]  surface glycoprotein, P681H</title>
	<circle cx="933.7" cy="629.0" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C23604G  USA=3 [0.7%]  surface glycoprotein, P681R</title>
	<circle cx="933.7" cy="629.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23628T  USA=3 [0.7%]  surface glycoprotein, S689I</title>
	<circle cx="931.5" cy="624.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23755T  USA=2 [0.4%]  surface glycoprotein, M731I</title>
	<circle cx="919.5" cy="598.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  A23756G  USA=4 [0.9%]  surface glycoprotein, T732A</title>
	<circle cx="919.4" cy="598.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23868T  USA=5 [1.1%]  surface glycoprotein, G769V</title>
	<circle cx="908.9" cy="575.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G23900C  USA=2 [0.4%]  surface glycoprotein, E780Q</title>
	<circle cx="905.9" cy="569.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C23987T  USA=3 [0.7%]  surface glycoprotein, P809S</title>
	<circle cx="897.7" cy="551.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C24138T  USA=2 [0.4%]  surface glycoprotein, T859I</title>
	<circle cx="883.5" cy="521.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C24174T  USA=2 [0.4%]  surface glycoprotein, A871V</title>
	<circle cx="880.1" cy="513.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G24197T  USA=2 [0.4%]  surface glycoprotein, A879S</title>
	<circle cx="877.9" cy="509.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G24236T  USA=2 [0.4%]  surface glycoprotein, A892S</title>
	<circle cx="874.2" cy="501.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C24374T  USA=2 [0.4%]  surface glycoprotein, L938F</title>
	<circle cx="861.2" cy="473.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G24680T  USA=2 [0.4%]  surface glycoprotein, V1040F</title>
	<circle cx="832.4" cy="411.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G24697T  USA=2 [0.4%]  surface glycoprotein, K1045N</title>
	<circle cx="830.8" cy="408.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C24863T  USA=3 [0.7%]  surface glycoprotein, H1101Y</title>
	<circle cx="815.2" cy="374.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  A25065G  USA=3 [0.7%]  surface glycoprotein, D1168G</title>
	<circle cx="796.2" cy="334.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G25166C  USA=3 [0.7%]  surface glycoprotein, E1202Q</title>
	<circle cx="786.7" cy="313.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  T25233C  USA=2 [0.4%]  surface glycoprotein, L1224S</title>
	<circle cx="780.4" cy="300.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G25244T  USA=2 [0.4%]  surface glycoprotein, V1228L</title>
	<circle cx="779.4" cy="297.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G25311T  USA=5 [1.1%]  surface glycoprotein, C1250F</title>
	<circle cx="773.1" cy="284.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G25429T  USA=3 [0.7%]  ORF3a protein, V13L</title>
	<circle cx="761.9" cy="260.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  C25433T  USA=4 [0.9%]  ORF3a protein, T14I</title>
	<circle cx="761.6" cy="259.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30  G25456T  USA=2 [0.4%]  ORF3a protein, D22Y</title>
	<circle cx="759.4" cy="255.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01 USA: 183 samples</title>
	<line x1="1191.9" y1="1181.7" x2="1187.7" y2="1172.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-01  C21575T  USA=3 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1127.5" cy="1037.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G21600T  USA=10 [5.5%]  surface glycoprotein, S13I</title>
	<circle cx="1125.3" cy="1032.1" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C21638T  USA=2 [1.1%]  surface glycoprotein, P26S</title>
	<circle cx="1121.8" cy="1024.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C21648T  USA=2 [1.1%]  surface glycoprotein, T29I</title>
	<circle cx="1120.9" cy="1022.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G21830T  USA=2 [1.1%]  surface glycoprotein, V90F</title>
	<circle cx="1104.4" cy="985.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G21974T  USA=4 [2.2%]  surface glycoprotein, D138Y</title>
	<circle cx="1091.4" cy="956.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G22018T  USA=10 [5.5%]  surface glycoprotein, W152C</title>
	<circle cx="1087.4" cy="947.1" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G22340T  USA=6 [3.3%]  surface glycoprotein, A260S</title>
	<circle cx="1058.2" cy="881.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C22713T  USA=8 [4.4%]  surface glycoprotein, P384L</title>
	<circle cx="1024.4" cy="805.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  T22917G  USA=9 [4.9%]  surface glycoprotein, L452R</title>
	<circle cx="1006.0" cy="764.2" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G22985T  USA=5 [2.7%]  surface glycoprotein, A475S</title>
	<circle cx="999.8" cy="750.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C23277T  USA=2 [1.1%]  surface glycoprotein, T572I</title>
	<circle cx="973.4" cy="690.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  A23403G  USA=183 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="961.9" cy="665.3" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C23577T  USA=2 [1.1%]  surface glycoprotein, A672V</title>
	<circle cx="946.2" cy="629.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  A23592C  USA=3 [1.6%]  surface glycoprotein, Q677P</title>
	<circle cx="944.8" cy="626.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G23593T  USA=5 [2.7%]  surface glycoprotein, Q677H</title>
	<circle cx="944.7" cy="626.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G23593C  USA=3 [1.6%]  surface glycoprotein, Q677H</title>
	<circle cx="944.7" cy="626.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C23604A  USA=41 [22.4%]  surface glycoprotein, P681H</title>
	<circle cx="943.7" cy="624.4" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G23868T  USA=2 [1.1%]  surface glycoprotein, G769V</title>
	<circle cx="919.8" cy="570.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C23996T  USA=2 [1.1%]  surface glycoprotein, P812S</title>
	<circle cx="908.2" cy="544.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G24368A  USA=2 [1.1%]  surface glycoprotein, D936N</title>
	<circle cx="874.5" cy="469.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C24771T  USA=2 [1.1%]  surface glycoprotein, A1070V</title>
	<circle cx="838.0" cy="387.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  C25002T  USA=6 [3.3%]  surface glycoprotein, S1147L</title>
	<circle cx="817.1" cy="340.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01  G25088T  USA=6 [3.3%]  surface glycoprotein, V1176F</title>
	<circle cx="809.3" cy="322.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02 USA: 189 samples</title>
	<line x1="1192.2" y1="1181.6" x2="1188.2" y2="1172.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-02  A21551T  USA=3 [1.6%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1132.5" cy="1040.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C21575T  USA=5 [2.6%]  surface glycoprotein, L5F</title>
	<circle cx="1130.4" cy="1036.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G21600T  USA=17 [9.0%]  surface glycoprotein, S13I</title>
	<circle cx="1128.2" cy="1030.9" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C21638T  USA=7 [3.7%]  surface glycoprotein, P26S</title>
	<circle cx="1124.9" cy="1023.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C21648T  USA=2 [1.1%]  surface glycoprotein, T29I</title>
	<circle cx="1124.0" cy="1021.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G21724T  USA=4 [2.1%]  surface glycoprotein, L54F</title>
	<circle cx="1117.4" cy="1005.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C21846T  USA=4 [2.1%]  surface glycoprotein, T95I</title>
	<circle cx="1106.8" cy="980.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G21974T  USA=2 [1.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1095.7" cy="954.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G21986A  USA=2 [1.1%]  surface glycoprotein, G142S</title>
	<circle cx="1094.6" cy="951.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G22018T  USA=17 [9.0%]  surface glycoprotein, W152C</title>
	<circle cx="1091.8" cy="945.2" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C22079A  USA=3 [1.6%]  surface glycoprotein, Q173K</title>
	<circle cx="1086.5" cy="932.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G22205T  USA=2 [1.1%]  surface glycoprotein, D215Y</title>
	<circle cx="1075.6" cy="906.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G22226T  USA=2 [1.1%]  surface glycoprotein, A222S</title>
	<circle cx="1073.7" cy="902.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C22227T  USA=2 [1.1%]  surface glycoprotein, A222V</title>
	<circle cx="1073.6" cy="902.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G22484T  USA=3 [1.6%]  surface glycoprotein, V308L</title>
	<circle cx="1051.3" cy="849.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G22706T  USA=2 [1.1%]  surface glycoprotein, V382L</title>
	<circle cx="1032.0" cy="804.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  T22917G  USA=17 [9.0%]  surface glycoprotein, L452R</title>
	<circle cx="1013.6" cy="760.9" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G22985T  USA=5 [2.6%]  surface glycoprotein, A475S</title>
	<circle cx="1007.7" cy="746.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G22992A  USA=2 [1.1%]  surface glycoprotein, S477N</title>
	<circle cx="1007.1" cy="745.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  T23042C  USA=4 [2.1%]  surface glycoprotein, S494P</title>
	<circle cx="1002.7" cy="735.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  A23064C  USA=3 [1.6%]  surface glycoprotein, N501T</title>
	<circle cx="1000.8" cy="730.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G23236T  USA=2 [1.1%]  surface glycoprotein, K558N</title>
	<circle cx="985.8" cy="695.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C23277T  USA=2 [1.1%]  surface glycoprotein, T572I</title>
	<circle cx="982.3" cy="687.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  A23403G  USA=189 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="661.2" r="9.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G23522A  USA=4 [2.1%]  surface glycoprotein, E654K</title>
	<circle cx="960.9" cy="636.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G23593T  USA=6 [3.2%]  surface glycoprotein, Q677H</title>
	<circle cx="954.8" cy="622.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C23604A  USA=21 [11.1%]  surface glycoprotein, P681H</title>
	<circle cx="953.8" cy="620.0" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  A23756G  USA=7 [3.7%]  surface glycoprotein, T732A</title>
	<circle cx="940.6" cy="588.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G23868T  USA=3 [1.6%]  surface glycoprotein, G769V</title>
	<circle cx="930.8" cy="565.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G23900C  USA=6 [3.2%]  surface glycoprotein, E780Q</title>
	<circle cx="928.1" cy="559.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C23996T  USA=2 [1.1%]  surface glycoprotein, P812S</title>
	<circle cx="919.7" cy="539.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G24095T  USA=3 [1.6%]  surface glycoprotein, A845S</title>
	<circle cx="911.1" cy="519.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  C24138T  USA=5 [2.6%]  surface glycoprotein, T859I</title>
	<circle cx="907.3" cy="510.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G24368A  USA=2 [1.1%]  surface glycoprotein, D936N</title>
	<circle cx="887.3" cy="463.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G25049T  USA=2 [1.1%]  surface glycoprotein, D1163Y</title>
	<circle cx="828.1" cy="323.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  A25065G  USA=2 [1.1%]  surface glycoprotein, D1168G</title>
	<circle cx="826.7" cy="320.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G25244T  USA=4 [2.1%]  surface glycoprotein, V1228L</title>
	<circle cx="811.1" cy="283.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02  G25444T  USA=2 [1.1%]  ORF3a protein, G18C</title>
	<circle cx="793.7" cy="242.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03 USA: 149 samples</title>
	<line x1="1192.5" y1="1181.5" x2="1188.8" y2="1172.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-03  A21551T  USA=2 [1.3%]  orf1ab polyprotein, N7096I</title>
	<circle cx="1135.3" cy="1039.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C21575T  USA=6 [4.0%]  surface glycoprotein, L5F</title>
	<circle cx="1133.3" cy="1034.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G21600T  USA=15 [10.1%]  surface glycoprotein, S13I</title>
	<circle cx="1131.2" cy="1029.6" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C21614T  USA=3 [2.0%]  surface glycoprotein, L18F</title>
	<circle cx="1130.0" cy="1026.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C21627T  USA=2 [1.3%]  surface glycoprotein, T22I</title>
	<circle cx="1128.9" cy="1024.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C21638T  USA=2 [1.3%]  surface glycoprotein, P26S</title>
	<circle cx="1128.0" cy="1021.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G22018T  USA=15 [10.1%]  surface glycoprotein, W152C</title>
	<circle cx="1096.3" cy="943.3" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C22227T  USA=2 [1.3%]  surface glycoprotein, A222V</title>
	<circle cx="1078.9" cy="900.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C22323T  USA=3 [2.0%]  surface glycoprotein, S254F</title>
	<circle cx="1070.8" cy="880.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G22335T  USA=2 [1.3%]  surface glycoprotein, W258L</title>
	<circle cx="1069.8" cy="877.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  T22917G  USA=15 [10.1%]  surface glycoprotein, L452R</title>
	<circle cx="1021.3" cy="757.7" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  A23064C  USA=4 [2.7%]  surface glycoprotein, N501T</title>
	<circle cx="1009.0" cy="727.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  A23403G  USA=149 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="657.3" r="8.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C23577T  USA=2 [1.3%]  surface glycoprotein, A672V</title>
	<circle cx="966.2" cy="621.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G23587C  USA=2 [1.3%]  surface glycoprotein, Q675H</title>
	<circle cx="965.4" cy="619.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G23593T  USA=7 [4.7%]  surface glycoprotein, Q677H</title>
	<circle cx="964.9" cy="618.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C23604A  USA=10 [6.7%]  surface glycoprotein, P681H</title>
	<circle cx="964.0" cy="615.8" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C23604G  USA=3 [2.0%]  surface glycoprotein, P681R</title>
	<circle cx="964.0" cy="615.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  C23709T  USA=2 [1.3%]  surface glycoprotein, T716I</title>
	<circle cx="955.2" cy="594.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  A23756G  USA=3 [2.0%]  surface glycoprotein, T732A</title>
	<circle cx="951.3" cy="584.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G23868T  USA=4 [2.7%]  surface glycoprotein, G769V</title>
	<circle cx="941.9" cy="561.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G24095T  USA=2 [1.3%]  surface glycoprotein, A845S</title>
	<circle cx="923.0" cy="514.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  A25065G  USA=3 [2.0%]  surface glycoprotein, D1168G</title>
	<circle cx="842.1" cy="314.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G25217T  USA=2 [1.3%]  surface glycoprotein, G1219C</title>
	<circle cx="829.4" cy="282.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G25244A  USA=2 [1.3%]  surface glycoprotein, V1228I</title>
	<circle cx="827.1" cy="277.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G25352T  USA=2 [1.3%]  surface glycoprotein, V1264L</title>
	<circle cx="818.1" cy="254.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03  G25445T  USA=2 [1.3%]  ORF3a protein, G18V</title>
	<circle cx="810.4" cy="235.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04 USA: 184 samples</title>
	<line x1="1192.8" y1="1181.3" x2="1189.2" y2="1171.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-04  C21575T  USA=2 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1136.1" cy="1033.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G21600T  USA=11 [6.0%]  surface glycoprotein, S13I</title>
	<circle cx="1134.2" cy="1028.5" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  C21614T  USA=2 [1.1%]  surface glycoprotein, L18F</title>
	<circle cx="1133.0" cy="1025.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  C21621T  USA=2 [1.1%]  surface glycoprotein, T20I</title>
	<circle cx="1132.5" cy="1024.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  C21638T  USA=4 [2.2%]  surface glycoprotein, P26S</title>
	<circle cx="1131.1" cy="1020.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  C21707T  USA=2 [1.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1125.6" cy="1006.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G21985T  USA=4 [2.2%]  surface glycoprotein, L141F</title>
	<circle cx="1103.4" cy="948.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  ATTA21993A  USA=2 [1.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1102.8" cy="946.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G22018T  USA=11 [6.0%]  surface glycoprotein, W152C</title>
	<circle cx="1100.8" cy="941.6" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  C22079A  USA=5 [2.7%]  surface glycoprotein, Q173K</title>
	<circle cx="1095.9" cy="928.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G22205T  USA=3 [1.6%]  surface glycoprotein, D215Y</title>
	<circle cx="1085.9" cy="902.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  T22917G  USA=11 [6.0%]  surface glycoprotein, L452R</title>
	<circle cx="1029.0" cy="754.6" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G22992A  USA=2 [1.1%]  surface glycoprotein, S477N</title>
	<circle cx="1023.1" cy="739.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  A23403G  USA=183 [99.5%]  surface glycoprotein, D614G</title>
	<circle cx="990.2" cy="653.6" r="9.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G23522A  USA=3 [1.6%]  surface glycoprotein, E654K</title>
	<circle cx="980.7" cy="628.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  A23586G  USA=2 [1.1%]  surface glycoprotein, Q675R</title>
	<circle cx="975.6" cy="615.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G23587T  USA=2 [1.1%]  surface glycoprotein, Q675H</title>
	<circle cx="975.6" cy="615.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  A23592C  USA=4 [2.2%]  surface glycoprotein, Q677P</title>
	<circle cx="975.2" cy="614.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G23593T  USA=21 [11.4%]  surface glycoprotein, Q677H</title>
	<circle cx="975.1" cy="614.1" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  T23599G  USA=2 [1.1%]  surface glycoprotein, N679K</title>
	<circle cx="974.6" cy="612.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  C23604A  USA=10 [5.4%]  surface glycoprotein, P681H</title>
	<circle cx="974.2" cy="611.8" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  A23756G  USA=4 [2.2%]  surface glycoprotein, T732A</title>
	<circle cx="962.1" cy="580.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  A25065G  USA=2 [1.1%]  surface glycoprotein, D1168G</title>
	<circle cx="857.6" cy="308.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04  G25266T  USA=2 [1.1%]  surface glycoprotein, C1235F</title>
	<circle cx="841.6" cy="266.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-05 USA: 45 samples</title>
	<line x1="1193.2" y1="1181.2" x2="1190.6" y2="1174.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-05 Mexico: 2 samples</title>
	<line x1="1190.6" y1="1174.2" x2="1189.9" y2="1172.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-05  G21600T  USA=3 [6.7%]  surface glycoprotein, S13I</title>
	<circle cx="1137.2" cy="1027.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-05  G22018T  USA=3 [6.7%]  surface glycoprotein, W152C</title>
	<circle cx="1105.3" cy="939.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-05  G22205T  USA=3 [6.7%]  surface glycoprotein, D215Y</title>
	<circle cx="1091.1" cy="900.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-05  T22917G  USA=3 [6.7%]  surface glycoprotein, L452R</title>
	<circle cx="1036.8" cy="751.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-05  A23403G  USA=43 [95.6%]  surface glycoprotein, D614G</title>
	<circle cx="999.8" cy="650.0" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-05  A23403G  USA=43 [95.6%] Mexico=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="999.8" cy="650.0" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-05  C23604A  USA=15 [33.3%]  surface glycoprotein, P681H</title>
	<circle cx="984.5" cy="607.9" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-06 USA: 21 samples</title>
	<line x1="1193.5" y1="1181.1" x2="1191.5" y2="1175.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-06  A23403G  USA=21 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="646.6" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-06  G25489T  USA=4 [19.0%]  ORF3a protein, A33S</title>
	<circle cx="858.2" cy="207.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07 USA: 121 samples</title>
	<line x1="1193.8" y1="1181.0" x2="1190.9" y2="1172.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-07  C21575T  USA=3 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1144.9" cy="1030.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G21600T  USA=5 [4.1%]  surface glycoprotein, S13I</title>
	<circle cx="1143.2" cy="1025.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C21614T  USA=2 [1.7%]  surface glycoprotein, L18F</title>
	<circle cx="1142.3" cy="1022.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C21621T  USA=3 [2.5%]  surface glycoprotein, T20I</title>
	<circle cx="1141.8" cy="1020.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C21648T  USA=2 [1.7%]  surface glycoprotein, T29I</title>
	<circle cx="1139.9" cy="1015.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C21707T  USA=2 [1.7%]  surface glycoprotein, H49Y</title>
	<circle cx="1135.9" cy="1002.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G22018T  USA=5 [4.1%]  surface glycoprotein, W152C</title>
	<circle cx="1114.5" cy="936.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  T22020C  USA=2 [1.7%]  surface glycoprotein, M153T</title>
	<circle cx="1114.3" cy="936.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C22313T  USA=2 [1.7%]  surface glycoprotein, P251S</title>
	<circle cx="1094.1" cy="874.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  T22917G  USA=5 [4.1%]  surface glycoprotein, L452R</title>
	<circle cx="1052.6" cy="746.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G22992A  USA=3 [2.5%]  surface glycoprotein, S477N</title>
	<circle cx="1047.4" cy="730.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  T23031C  USA=2 [1.7%]  surface glycoprotein, F490S</title>
	<circle cx="1044.7" cy="722.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C23277T  USA=2 [1.7%]  surface glycoprotein, T572I</title>
	<circle cx="1027.8" cy="670.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  A23403G  USA=119 [98.3%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="643.3" r="8.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G23593T  USA=6 [5.0%]  surface glycoprotein, Q677H</title>
	<circle cx="1006.1" cy="603.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C23604A  USA=6 [5.0%]  surface glycoprotein, P681H</title>
	<circle cx="1005.3" cy="600.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G23868T  USA=2 [1.7%]  surface glycoprotein, G769V</title>
	<circle cx="987.1" cy="544.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G23900C  USA=2 [1.7%]  surface glycoprotein, E780Q</title>
	<circle cx="984.9" cy="538.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C23997T  USA=5 [4.1%]  surface glycoprotein, P812L</title>
	<circle cx="978.3" cy="517.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G24368A  USA=2 [1.7%]  surface glycoprotein, D936N</title>
	<circle cx="952.7" cy="438.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C24771T  USA=2 [1.7%]  surface glycoprotein, A1070V</title>
	<circle cx="925.0" cy="353.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  A25065G  USA=4 [3.3%]  surface glycoprotein, D1168G</title>
	<circle cx="904.7" cy="291.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G25440T  USA=2 [1.7%]  ORF3a protein, K16N</title>
	<circle cx="878.9" cy="211.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08 USA: 111 samples</title>
	<line x1="1194.2" y1="1180.9" x2="1191.5" y2="1172.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-08  C21575T  USA=5 [4.5%]  surface glycoprotein, L5F</title>
	<circle cx="1147.9" cy="1029.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G21600T  USA=11 [9.9%]  surface glycoprotein, S13I</title>
	<circle cx="1146.3" cy="1024.3" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  C21707T  USA=2 [1.8%]  surface glycoprotein, H49Y</title>
	<circle cx="1139.3" cy="1001.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  C21846T  USA=4 [3.6%]  surface glycoprotein, T95I</title>
	<circle cx="1130.3" cy="971.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G22018T  USA=11 [9.9%]  surface glycoprotein, W152C</title>
	<circle cx="1119.1" cy="935.3" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G22241T  USA=2 [1.8%]  surface glycoprotein, V227L</title>
	<circle cx="1104.5" cy="887.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  C22329T  USA=7 [6.3%]  surface glycoprotein, S256L</title>
	<circle cx="1098.8" cy="869.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  T22917G  USA=11 [9.9%]  surface glycoprotein, L452R</title>
	<circle cx="1060.5" cy="743.8" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G22973C  USA=4 [3.6%]  surface glycoprotein, E471Q</title>
	<circle cx="1056.9" cy="731.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  A23064C  USA=2 [1.8%]  surface glycoprotein, N501T</title>
	<circle cx="1050.9" cy="712.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  A23403G  USA=110 [99.1%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="640.3" r="8.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G23593T  USA=2 [1.8%]  surface glycoprotein, Q677H</title>
	<circle cx="1016.5" cy="599.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  C23997T  USA=3 [2.7%]  surface glycoprotein, P812L</title>
	<circle cx="990.2" cy="513.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  A24780C  USA=6 [5.4%]  surface glycoprotein, K1073T</title>
	<circle cx="939.2" cy="347.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  A25065G  USA=3 [2.7%]  surface glycoprotein, D1168G</title>
	<circle cx="920.7" cy="286.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G25440T  USA=6 [5.4%]  ORF3a protein, K16N</title>
	<circle cx="896.2" cy="206.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G25444T  USA=3 [2.7%]  ORF3a protein, G18C</title>
	<circle cx="896.0" cy="205.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09 USA: 108 samples</title>
	<line x1="1194.5" y1="1180.8" x2="1192.0" y2="1172.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-09  G21600T  USA=5 [4.6%]  surface glycoprotein, S13I</title>
	<circle cx="1149.4" cy="1023.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  G22018T  USA=5 [4.6%]  surface glycoprotein, W152C</title>
	<circle cx="1123.7" cy="933.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  T22917G  USA=5 [4.6%]  surface glycoprotein, L452R</title>
	<circle cx="1068.5" cy="741.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  A23403G  USA=108 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="637.4" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  G23593T  USA=2 [1.9%]  surface glycoprotein, Q677H</title>
	<circle cx="1027.0" cy="596.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  C23604A  USA=36 [33.3%]  surface glycoprotein, P681H</title>
	<circle cx="1026.3" cy="594.3" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  A25065G  USA=6 [5.6%]  surface glycoprotein, D1168G</title>
	<circle cx="936.6" cy="281.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  G25302T  USA=2 [1.9%]  surface glycoprotein, C1247F</title>
	<circle cx="922.1" cy="230.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10 USA: 109 samples</title>
	<line x1="1194.8" y1="1180.7" x2="1192.4" y2="1171.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-10  G21600T  USA=2 [1.8%]  surface glycoprotein, S13I</title>
	<circle cx="1152.4" cy="1022.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  C21621T  USA=2 [1.8%]  surface glycoprotein, T20I</title>
	<circle cx="1151.2" cy="1018.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  A21651G  USA=2 [1.8%]  surface glycoprotein, N30S</title>
	<circle cx="1149.5" cy="1011.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  G21974T  USA=2 [1.8%]  surface glycoprotein, D138Y</title>
	<circle cx="1130.9" cy="942.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  G22018T  USA=2 [1.8%]  surface glycoprotein, W152C</title>
	<circle cx="1128.3" cy="932.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  A22101T  USA=2 [1.8%]  surface glycoprotein, E180V</title>
	<circle cx="1123.6" cy="914.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  G22317T  USA=2 [1.8%]  surface glycoprotein, G252V</title>
	<circle cx="1111.1" cy="868.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  C22326T  USA=2 [1.8%]  surface glycoprotein, S255F</title>
	<circle cx="1110.6" cy="866.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  T22917G  USA=2 [1.8%]  surface glycoprotein, L452R</title>
	<circle cx="1076.5" cy="739.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  A23403G  USA=109 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1048.5" cy="634.6" r="8.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  A23592C  USA=2 [1.8%]  surface glycoprotein, Q677P</title>
	<circle cx="1037.6" cy="594.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  C23604A  USA=9 [8.3%]  surface glycoprotein, P681H</title>
	<circle cx="1036.9" cy="591.4" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  C24378T  USA=2 [1.8%]  surface glycoprotein, S939F</title>
	<circle cx="992.3" cy="424.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10  G25135T  USA=2 [1.8%]  surface glycoprotein, K1191N</title>
	<circle cx="948.7" cy="262.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11 USA: 219 samples</title>
	<line x1="1195.2" y1="1180.6" x2="1192.6" y2="1170.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-11  G21600T  USA=5 [2.3%]  surface glycoprotein, S13I</title>
	<circle cx="1155.5" cy="1021.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  G21974T  USA=4 [1.8%]  surface glycoprotein, D138Y</title>
	<circle cx="1135.4" cy="940.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  G22018T  USA=5 [2.3%]  surface glycoprotein, W152C</title>
	<circle cx="1133.0" cy="931.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  T22917G  USA=5 [2.3%]  surface glycoprotein, L452R</title>
	<circle cx="1084.6" cy="737.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  A23064C  USA=2 [0.9%]  surface glycoprotein, N501T</title>
	<circle cx="1076.7" cy="705.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  A23403G  USA=219 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1058.4" cy="632.1" r="9.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  A23592C  USA=129 [58.9%]  surface glycoprotein, Q677P</title>
	<circle cx="1048.2" cy="591.2" r="8.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  G23593T  USA=8 [3.7%]  surface glycoprotein, Q677H</title>
	<circle cx="1048.2" cy="591.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  C23604A  USA=3 [1.4%]  surface glycoprotein, P681H</title>
	<circle cx="1047.6" cy="588.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  G24680T  USA=2 [0.9%]  surface glycoprotein, V1040F</title>
	<circle cx="989.6" cy="356.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12 USA: 70 samples</title>
	<line x1="1195.5" y1="1180.5" x2="1193.6" y2="1172.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-12  G21600T  USA=4 [5.7%]  surface glycoprotein, S13I</title>
	<circle cx="1158.7" cy="1021.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  C21614T  USA=3 [4.3%]  surface glycoprotein, L18F</title>
	<circle cx="1158.0" cy="1017.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  G21974T  USA=5 [7.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1139.9" cy="939.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  G22018T  USA=4 [5.7%]  surface glycoprotein, W152C</title>
	<circle cx="1137.7" cy="930.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  T22020C  USA=2 [2.9%]  surface glycoprotein, M153T</title>
	<circle cx="1137.6" cy="929.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  C22314A  USA=3 [4.3%]  surface glycoprotein, P251H</title>
	<circle cx="1122.9" cy="866.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  T22917G  USA=4 [5.7%]  surface glycoprotein, L452R</title>
	<circle cx="1092.7" cy="735.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  A23403G  USA=70 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1068.3" cy="629.7" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  A23592C  USA=4 [5.7%]  surface glycoprotein, Q677P</title>
	<circle cx="1058.9" cy="588.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  C23604A  USA=3 [4.3%]  surface glycoprotein, P681H</title>
	<circle cx="1058.3" cy="586.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  C23643T  USA=2 [2.9%]  surface glycoprotein, A694V</title>
	<circle cx="1056.3" cy="577.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  A23756G  USA=2 [2.9%]  surface glycoprotein, T732A</title>
	<circle cx="1050.7" cy="553.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  C24642T  USA=3 [4.3%]  surface glycoprotein, T1027I</title>
	<circle cx="1006.3" cy="360.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12  G25489T  USA=7 [10.0%]  ORF3a protein, A33S</title>
	<circle cx="963.8" cy="177.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-13 USA: 11 samples</title>
	<line x1="1195.8" y1="1180.4" x2="1194.8" y2="1175.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-13  G21600T  USA=3 [27.3%]  surface glycoprotein, S13I</title>
	<circle cx="1161.8" cy="1020.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-13  G22018T  USA=3 [27.3%]  surface glycoprotein, W152C</title>
	<circle cx="1142.4" cy="929.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-13  G22335T  USA=2 [18.2%]  surface glycoprotein, W258L</title>
	<circle cx="1127.8" cy="860.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-13  T22917G  USA=3 [27.3%]  surface glycoprotein, L452R</title>
	<circle cx="1100.8" cy="733.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-13  A23403G  USA=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="627.5" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-13  G23593T  USA=3 [27.3%]  surface glycoprotein, Q677H</title>
	<circle cx="1069.5" cy="586.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14 USA: 134 samples</title>
	<line x1="1196.2" y1="1180.4" x2="1194.4" y2="1171.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-14  C21575T  USA=3 [2.2%]  surface glycoprotein, L5F</title>
	<circle cx="1166.0" cy="1025.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G21600T  USA=2 [1.5%]  surface glycoprotein, S13I</title>
	<circle cx="1164.9" cy="1019.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C21627T  USA=2 [1.5%]  surface glycoprotein, T22I</title>
	<circle cx="1163.8" cy="1013.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C21648T  USA=2 [1.5%]  surface glycoprotein, T29I</title>
	<circle cx="1162.9" cy="1009.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  ATTA21993A  USA=2 [1.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1148.2" cy="933.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G22018T  USA=2 [1.5%]  surface glycoprotein, W152C</title>
	<circle cx="1147.2" cy="928.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C22329T  USA=2 [1.5%]  surface glycoprotein, S256L</title>
	<circle cx="1134.0" cy="860.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  T22917G  USA=2 [1.5%]  surface glycoprotein, L452R</title>
	<circle cx="1109.0" cy="731.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  A23064C  USA=2 [1.5%]  surface glycoprotein, N501T</title>
	<circle cx="1102.7" cy="699.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C23277T  USA=3 [2.2%]  surface glycoprotein, T572I</title>
	<circle cx="1093.7" cy="653.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  A23403G  USA=134 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="625.5" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  A23592C  USA=2 [1.5%]  surface glycoprotein, Q677P</title>
	<circle cx="1080.3" cy="584.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G23593T  USA=3 [2.2%]  surface glycoprotein, Q677H</title>
	<circle cx="1080.2" cy="583.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G23593C  USA=2 [1.5%]  surface glycoprotein, Q677H</title>
	<circle cx="1080.2" cy="583.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C23604A  USA=4 [3.0%]  surface glycoprotein, P681H</title>
	<circle cx="1079.8" cy="581.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G24368A  USA=2 [1.5%]  surface glycoprotein, D936N</title>
	<circle cx="1047.3" cy="414.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C24579T  USA=2 [1.5%]  surface glycoprotein, T1006I</title>
	<circle cx="1038.3" cy="368.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G25352T  USA=6 [4.5%]  surface glycoprotein, V1264L</title>
	<circle cx="1005.5" cy="199.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G25444T  USA=3 [2.2%]  ORF3a protein, G18C</title>
	<circle cx="1001.6" cy="179.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G25456T  USA=2 [1.5%]  ORF3a protein, D22Y</title>
	<circle cx="1001.1" cy="176.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15 USA: 129 samples</title>
	<line x1="1196.5" y1="1180.3" x2="1194.9" y2="1170.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-15  G21600T  USA=9 [7.0%]  surface glycoprotein, S13I</title>
	<circle cx="1168.1" cy="1019.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  C21618T  USA=2 [1.6%]  surface glycoprotein, T19I</title>
	<circle cx="1167.4" cy="1015.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  C21621T  USA=3 [2.3%]  surface glycoprotein, T20I</title>
	<circle cx="1167.3" cy="1014.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  C21648T  USA=2 [1.6%]  surface glycoprotein, T29I</title>
	<circle cx="1166.2" cy="1008.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G21761T  USA=5 [3.9%]  surface glycoprotein, A67S</title>
	<circle cx="1161.9" cy="983.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G21974T  USA=2 [1.6%]  surface glycoprotein, D138Y</title>
	<circle cx="1153.6" cy="937.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G22018T  USA=9 [7.0%]  surface glycoprotein, W152C</title>
	<circle cx="1151.9" cy="927.4" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  T22917G  USA=9 [7.0%]  surface glycoprotein, L452R</title>
	<circle cx="1117.2" cy="730.2" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  A23064C  USA=2 [1.6%]  surface glycoprotein, N501T</title>
	<circle cx="1111.5" cy="697.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G23120T  USA=2 [1.6%]  surface glycoprotein, A520S</title>
	<circle cx="1109.3" cy="685.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  C23277T  USA=2 [1.6%]  surface glycoprotein, T572I</title>
	<circle cx="1103.2" cy="651.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  A23403G  USA=129 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="623.6" r="8.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G23429T  USA=4 [3.1%]  surface glycoprotein, A623S</title>
	<circle cx="1097.4" cy="617.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  C23481T  USA=2 [1.6%]  surface glycoprotein, S640F</title>
	<circle cx="1095.3" cy="606.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  A23592C  USA=13 [10.1%]  surface glycoprotein, Q677P</title>
	<circle cx="1091.1" cy="582.1" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G23593T  USA=4 [3.1%]  surface glycoprotein, Q677H</title>
	<circle cx="1091.0" cy="581.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G23593C  USA=2 [1.6%]  surface glycoprotein, Q677H</title>
	<circle cx="1091.0" cy="581.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  C23604A  USA=13 [10.1%]  surface glycoprotein, P681H</title>
	<circle cx="1090.6" cy="579.5" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G24368A  USA=2 [1.6%]  surface glycoprotein, D936N</title>
	<circle cx="1061.0" cy="411.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  C25002T  USA=2 [1.6%]  surface glycoprotein, S1147L</title>
	<circle cx="1036.5" cy="272.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G25088T  USA=2 [1.6%]  surface glycoprotein, V1176F</title>
	<circle cx="1033.2" cy="254.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  G25244T  USA=4 [3.1%]  surface glycoprotein, V1228L</title>
	<circle cx="1027.2" cy="219.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  T25268A  USA=2 [1.6%]  surface glycoprotein, C1236S</title>
	<circle cx="1026.2" cy="214.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16 USA: 94 samples</title>
	<line x1="1196.9" y1="1180.2" x2="1195.5" y2="1171.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-16  G21538T  USA=2 [2.1%]  orf1ab polyprotein, V7092F</title>
	<circle cx="1173.4" cy="1032.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  G21600T  USA=2 [2.1%]  surface glycoprotein, S13I</title>
	<circle cx="1171.3" cy="1018.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  G21624T  USA=2 [2.1%]  surface glycoprotein, R21I</title>
	<circle cx="1170.4" cy="1013.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  C21707T  USA=2 [2.1%]  surface glycoprotein, H49Y</title>
	<circle cx="1167.5" cy="995.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  G22018T  USA=3 [3.2%]  surface glycoprotein, W152C</title>
	<circle cx="1156.7" cy="926.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  T22917G  USA=3 [3.2%]  surface glycoprotein, L452R</title>
	<circle cx="1125.4" cy="728.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  A23403G  USA=94 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1108.4" cy="621.9" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  G23593T  USA=3 [3.2%]  surface glycoprotein, Q677H</title>
	<circle cx="1101.8" cy="580.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  C23604A  USA=2 [2.1%]  surface glycoprotein, P681H</title>
	<circle cx="1101.4" cy="577.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  A23756G  USA=3 [3.2%]  surface glycoprotein, T732A</title>
	<circle cx="1096.1" cy="544.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  G24794T  USA=3 [3.2%]  surface glycoprotein, A1078S</title>
	<circle cx="1060.0" cy="315.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  A25065G  USA=2 [2.1%]  surface glycoprotein, D1168G</title>
	<circle cx="1050.5" cy="256.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  G25323T  USA=2 [2.1%]  surface glycoprotein, C1254F</title>
	<circle cx="1041.5" cy="199.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17 USA: 126 samples</title>
	<line x1="1197.2" y1="1180.2" x2="1195.9" y2="1170.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-17  C21575T  USA=2 [1.6%]  surface glycoprotein, L5F</title>
	<circle cx="1175.2" cy="1023.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  G21600T  USA=9 [7.1%]  surface glycoprotein, S13I</title>
	<circle cx="1174.4" cy="1018.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  ATTA21993A  USA=3 [2.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1162.2" cy="931.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  G22018T  USA=8 [6.3%]  surface glycoprotein, W152C</title>
	<circle cx="1161.5" cy="925.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  T22917G  USA=8 [6.3%]  surface glycoprotein, L452R</title>
	<circle cx="1133.6" cy="727.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  A23403G  USA=125 [99.2%]  surface glycoprotein, D614G</title>
	<circle cx="1118.5" cy="620.4" r="8.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  A23592C  USA=19 [15.1%]  surface glycoprotein, Q677P</title>
	<circle cx="1112.7" cy="578.7" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  G23593T  USA=5 [4.0%]  surface glycoprotein, Q677H</title>
	<circle cx="1112.7" cy="578.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  C23604A  USA=3 [2.4%]  surface glycoprotein, P681H</title>
	<circle cx="1112.3" cy="576.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  A23756G  USA=2 [1.6%]  surface glycoprotein, T732A</title>
	<circle cx="1107.6" cy="542.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  A24070C  USA=2 [1.6%]  surface glycoprotein, Q836H</title>
	<circle cx="1097.9" cy="473.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  A25065G  USA=3 [2.4%]  surface glycoprotein, D1168G</title>
	<circle cx="1067.0" cy="253.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  G25217T  USA=2 [1.6%]  surface glycoprotein, G1219C</title>
	<circle cx="1062.3" cy="220.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  C25427T  USA=3 [2.4%]  ORF3a protein, T12I</title>
	<circle cx="1055.8" cy="174.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18 USA: 130 samples</title>
	<line x1="1197.6" y1="1180.1" x2="1196.4" y2="1170.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-18  C21575T  USA=2 [1.5%]  surface glycoprotein, L5F</title>
	<circle cx="1178.3" cy="1023.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G21600T  USA=9 [6.9%]  surface glycoprotein, S13I</title>
	<circle cx="1177.6" cy="1017.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C21614T  USA=5 [3.8%]  surface glycoprotein, L18F</title>
	<circle cx="1177.2" cy="1014.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C21621T  USA=2 [1.5%]  surface glycoprotein, T20I</title>
	<circle cx="1177.0" cy="1013.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C21707T  USA=3 [2.3%]  surface glycoprotein, H49Y</title>
	<circle cx="1174.7" cy="994.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G21776A  USA=2 [1.5%]  surface glycoprotein, G72R</title>
	<circle cx="1172.8" cy="978.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G22018T  USA=9 [6.9%]  surface glycoprotein, W152C</title>
	<circle cx="1166.3" cy="925.2" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C22227T  USA=4 [3.1%]  surface glycoprotein, A222V</title>
	<circle cx="1160.6" cy="879.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  T22917G  USA=9 [6.9%]  surface glycoprotein, L452R</title>
	<circle cx="1141.9" cy="726.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G22992A  USA=5 [3.8%]  surface glycoprotein, S477N</title>
	<circle cx="1139.8" cy="709.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G23012A  USA=2 [1.5%]  surface glycoprotein, E484K</title>
	<circle cx="1139.3" cy="705.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  A23063T  USA=2 [1.5%]  surface glycoprotein, N501Y</title>
	<circle cx="1137.9" cy="694.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  A23064C  USA=2 [1.5%]  surface glycoprotein, N501T</title>
	<circle cx="1137.9" cy="694.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G23120T  USA=3 [2.3%]  surface glycoprotein, A520S</title>
	<circle cx="1136.4" cy="681.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  A23403G  USA=130 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="619.1" r="8.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G23587C  USA=2 [1.5%]  surface glycoprotein, Q675H</title>
	<circle cx="1123.7" cy="578.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  A23592G  USA=2 [1.5%]  surface glycoprotein, Q677R</title>
	<circle cx="1123.5" cy="577.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G23593T  USA=2 [1.5%]  surface glycoprotein, Q677H</title>
	<circle cx="1123.5" cy="577.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  G23593C  USA=2 [1.5%]  surface glycoprotein, Q677H</title>
	<circle cx="1123.5" cy="577.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C23604A  USA=6 [4.6%]  surface glycoprotein, P681H</title>
	<circle cx="1123.2" cy="574.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C24378T  USA=2 [1.5%]  surface glycoprotein, S939F</title>
	<circle cx="1102.2" cy="403.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  A25065G  USA=4 [3.1%]  surface glycoprotein, D1168G</title>
	<circle cx="1083.6" cy="251.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  T25268A  USA=4 [3.1%]  surface glycoprotein, C1236S</title>
	<circle cx="1078.0" cy="206.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C25350T  USA=2 [1.5%]  surface glycoprotein, P1263L</title>
	<circle cx="1075.8" cy="188.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  C25433T  USA=2 [1.5%]  ORF3a protein, T14I</title>
	<circle cx="1073.6" cy="170.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19 USA: 77 samples</title>
	<line x1="1197.9" y1="1180.1" x2="1197.0" y2="1171.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-19  G21600T  USA=9 [11.7%]  surface glycoprotein, S13I</title>
	<circle cx="1180.8" cy="1017.3" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  C21621T  USA=2 [2.6%]  surface glycoprotein, T20I</title>
	<circle cx="1180.3" cy="1012.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  G21974T  USA=2 [2.6%]  surface glycoprotein, D138Y</title>
	<circle cx="1172.1" cy="934.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  G22018T  USA=9 [11.7%]  surface glycoprotein, W152C</title>
	<circle cx="1171.1" cy="924.7" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  G22241T  USA=2 [2.6%]  surface glycoprotein, V227L</title>
	<circle cx="1165.9" cy="875.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  T22917G  USA=10 [13.0%]  surface glycoprotein, L452R</title>
	<circle cx="1150.1" cy="725.6" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  A23403G  USA=76 [98.7%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="617.9" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  C23481T  USA=2 [2.6%]  surface glycoprotein, S640F</title>
	<circle cx="1137.0" cy="600.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  A23592C  USA=2 [2.6%]  surface glycoprotein, Q677P</title>
	<circle cx="1134.4" cy="576.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  C23604A  USA=4 [5.2%]  surface glycoprotein, P681H</title>
	<circle cx="1134.1" cy="573.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  A23712G  USA=2 [2.6%]  surface glycoprotein, N717S</title>
	<circle cx="1131.6" cy="549.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  C24378T  USA=2 [2.6%]  surface glycoprotein, S939F</title>
	<circle cx="1116.1" cy="401.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  G25135T  USA=2 [2.6%]  surface glycoprotein, K1191N</title>
	<circle cx="1098.5" cy="234.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  C25463T  USA=2 [2.6%]  ORF3a protein, T24I</title>
	<circle cx="1090.9" cy="161.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20 USA: 170 samples</title>
	<line x1="1198.3" y1="1180.1" x2="1197.4" y2="1170.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-20  C21575T  USA=4 [2.4%]  surface glycoprotein, L5F</title>
	<circle cx="1184.5" cy="1022.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G21600T  USA=25 [14.7%]  surface glycoprotein, S13I</title>
	<circle cx="1184.0" cy="1017.0" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  C21638T  USA=9 [5.3%]  surface glycoprotein, P26S</title>
	<circle cx="1183.2" cy="1008.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G21974C  USA=3 [1.8%]  surface glycoprotein, D138H</title>
	<circle cx="1176.7" cy="934.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G22018T  USA=25 [14.7%]  surface glycoprotein, W152C</title>
	<circle cx="1175.9" cy="924.2" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G22289T  USA=2 [1.2%]  surface glycoprotein, A243S</title>
	<circle cx="1170.6" cy="864.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G22335T  USA=3 [1.8%]  surface glycoprotein, W258L</title>
	<circle cx="1169.7" cy="853.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G22403C  USA=2 [1.2%]  surface glycoprotein, E281Q</title>
	<circle cx="1168.4" cy="838.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G22599A  USA=6 [3.5%]  surface glycoprotein, R346K</title>
	<circle cx="1164.6" cy="795.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  T22917G  USA=26 [15.3%]  surface glycoprotein, L452R</title>
	<circle cx="1158.4" cy="724.8" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  T23042C  USA=3 [1.8%]  surface glycoprotein, S494P</title>
	<circle cx="1156.0" cy="697.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G23311T  USA=3 [1.8%]  surface glycoprotein, E583D</title>
	<circle cx="1150.8" cy="637.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  A23403G  USA=170 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="616.9" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  C23481T  USA=2 [1.2%]  surface glycoprotein, S640F</title>
	<circle cx="1147.5" cy="599.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  A23592C  USA=2 [1.2%]  surface glycoprotein, Q677P</title>
	<circle cx="1145.3" cy="575.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  T23599A  USA=3 [1.8%]  surface glycoprotein, N679K</title>
	<circle cx="1145.2" cy="573.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  C23604A  USA=16 [9.4%]  surface glycoprotein, P681H</title>
	<circle cx="1145.1" cy="572.3" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  C23709T  USA=2 [1.2%]  surface glycoprotein, T716I</title>
	<circle cx="1143.0" cy="549.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  A23756G  USA=6 [3.5%]  surface glycoprotein, T732A</title>
	<circle cx="1142.1" cy="538.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G23868T  USA=3 [1.8%]  surface glycoprotein, G769V</title>
	<circle cx="1140.0" cy="513.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G24992C  USA=4 [2.4%]  surface glycoprotein, E1144Q</title>
	<circle cx="1118.1" cy="264.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  A25065G  USA=2 [1.2%]  surface glycoprotein, D1168G</title>
	<circle cx="1116.7" cy="248.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G25135T  USA=3 [1.8%]  surface glycoprotein, K1191N</title>
	<circle cx="1115.4" cy="232.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  G25437T  USA=2 [1.2%]  ORF3a protein, L15F</title>
	<circle cx="1109.5" cy="165.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21 USA: 171 samples</title>
	<line x1="1198.6" y1="1180.0" x2="1197.9" y2="1170.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-21 Canada: 2 samples</title>
	<line x1="1197.9" y1="1170.0" x2="1197.8" y2="1167.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-21  C21575T  USA=3 [1.8%]  surface glycoprotein, L5F</title>
	<circle cx="1187.6" cy="1022.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G21600T  USA=27 [15.8%]  surface glycoprotein, S13I</title>
	<circle cx="1187.2" cy="1016.7" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  C21638T  USA=5 [2.9%]  surface glycoprotein, P26S</title>
	<circle cx="1186.6" cy="1008.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  C21642T  USA=2 [1.2%]  surface glycoprotein, A27V</title>
	<circle cx="1186.5" cy="1007.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  C21648T  USA=2 [1.2%]  surface glycoprotein, T29I</title>
	<circle cx="1186.4" cy="1006.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G21785C  Canada=2 [100.0%]  surface glycoprotein, G75R</title>
	<circle cx="1184.3" cy="975.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G21974T  USA=2 [1.2%]  surface glycoprotein, D138Y</title>
	<circle cx="1181.4" cy="933.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G22018T  USA=28 [16.4%]  surface glycoprotein, W152C</title>
	<circle cx="1180.7" cy="923.8" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  T22917G  USA=27 [15.8%]  surface glycoprotein, L452R</title>
	<circle cx="1166.7" cy="724.1" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  A23064C  USA=2 [1.2%]  surface glycoprotein, N501T</title>
	<circle cx="1164.4" cy="691.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G23120T  USA=2 [1.2%]  surface glycoprotein, A520S</title>
	<circle cx="1163.6" cy="679.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  A23403G  USA=168 [98.2%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="616.1" r="8.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  A23403G  USA=168 [98.2%] Canada=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="616.1" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G23545T  USA=2 [1.2%]  surface glycoprotein, E661D</title>
	<circle cx="1157.0" cy="584.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G23593T  USA=3 [1.8%]  surface glycoprotein, Q677H</title>
	<circle cx="1156.2" cy="573.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G23593C  USA=3 [1.8%]  surface glycoprotein, Q677H</title>
	<circle cx="1156.2" cy="573.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  C23595T  USA=2 [1.2%]  surface glycoprotein, T678I</title>
	<circle cx="1156.2" cy="573.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  C23604A  USA=24 [14.0%]  surface glycoprotein, P681H</title>
	<circle cx="1156.0" cy="571.5" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  A23756G  USA=3 [1.8%]  surface glycoprotein, T732A</title>
	<circle cx="1153.7" cy="537.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  A23756T  USA=3 [1.8%]  surface glycoprotein, T732S</title>
	<circle cx="1153.7" cy="537.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G24095T  USA=3 [1.8%]  surface glycoprotein, A845S</title>
	<circle cx="1148.4" cy="462.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G24680T  USA=5 [2.9%]  surface glycoprotein, V1040F</title>
	<circle cx="1139.3" cy="332.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  C25002T  USA=5 [2.9%]  surface glycoprotein, S1147L</title>
	<circle cx="1134.3" cy="260.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G25088T  USA=2 [1.2%]  surface glycoprotein, V1176F</title>
	<circle cx="1133.0" cy="241.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G25135T  USA=2 [1.2%]  surface glycoprotein, K1191N</title>
	<circle cx="1132.3" cy="231.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  G25266T  USA=3 [1.8%]  surface glycoprotein, C1235F</title>
	<circle cx="1130.2" cy="202.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22 USA: 59 samples</title>
	<line x1="1199.0" y1="1180.0" x2="1198.5" y2="1172.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-22  G21600T  USA=10 [16.9%]  surface glycoprotein, S13I</title>
	<circle cx="1190.4" cy="1016.5" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  C21638T  USA=3 [5.1%]  surface glycoprotein, P26S</title>
	<circle cx="1189.9" cy="1008.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  G22018T  USA=11 [18.6%]  surface glycoprotein, W152C</title>
	<circle cx="1185.5" cy="923.5" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  C22227T  USA=2 [3.4%]  surface glycoprotein, A222V</title>
	<circle cx="1183.1" cy="877.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  G22335T  USA=2 [3.4%]  surface glycoprotein, W258L</title>
	<circle cx="1181.8" cy="853.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  T22917G  USA=11 [18.6%]  surface glycoprotein, L452R</title>
	<circle cx="1175.0" cy="723.6" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  A23403G  USA=59 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="615.5" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  G23593T  USA=2 [3.4%]  surface glycoprotein, Q677H</title>
	<circle cx="1167.2" cy="573.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  C23604A  USA=6 [10.2%]  surface glycoprotein, P681H</title>
	<circle cx="1167.0" cy="570.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  G23900C  USA=2 [3.4%]  surface glycoprotein, E780Q</title>
	<circle cx="1163.6" cy="505.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  G24095T  USA=2 [3.4%]  surface glycoprotein, A845S</title>
	<circle cx="1161.3" cy="461.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  C24138T  USA=4 [6.8%]  surface glycoprotein, T859I</title>
	<circle cx="1160.8" cy="452.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  G25019T  USA=3 [5.1%]  surface glycoprotein, D1153Y</title>
	<circle cx="1150.5" cy="256.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22  A25065G  USA=3 [5.1%]  surface glycoprotein, D1168G</title>
	<circle cx="1150.0" cy="245.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23 USA: 48 samples</title>
	<line x1="1199.3" y1="1180.0" x2="1199.0" y2="1172.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-23  G21600T  USA=6 [12.5%]  surface glycoprotein, S13I</title>
	<circle cx="1193.6" cy="1016.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  G22018T  USA=6 [12.5%]  surface glycoprotein, W152C</title>
	<circle cx="1190.3" cy="923.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  T22917G  USA=6 [12.5%]  surface glycoprotein, L452R</title>
	<circle cx="1183.4" cy="723.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  A23064C  USA=3 [6.2%]  surface glycoprotein, N501T</title>
	<circle cx="1182.2" cy="690.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  A23403G  USA=45 [93.8%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="615.1" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  C23481T  USA=2 [4.2%]  surface glycoprotein, S640F</title>
	<circle cx="1179.0" cy="597.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  C23604A  USA=3 [6.2%]  surface glycoprotein, P681H</title>
	<circle cx="1178.0" cy="570.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  G24680T  USA=3 [6.2%]  surface glycoprotein, V1040F</title>
	<circle cx="1169.6" cy="330.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24 USA: 61 samples</title>
	<line x1="1199.7" y1="1180.0" x2="1199.5" y2="1171.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-24 Canada: 8 samples</title>
	<line x1="1199.5" y1="1171.9" x2="1199.4" y2="1167.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-24  C21575T  USA=2 [3.3%]  surface glycoprotein, L5F</title>
	<circle cx="1196.9" cy="1021.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  G21600T  USA=3 [4.9%]  surface glycoprotein, S13I</title>
	<circle cx="1196.8" cy="1016.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  C21614T  USA=2 [3.3%]  surface glycoprotein, L18F</title>
	<circle cx="1196.7" cy="1013.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  C21621T  USA=3 [4.9%]  surface glycoprotein, T20I</title>
	<circle cx="1196.7" cy="1011.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  C21846T  USA=2 [3.3%]  surface glycoprotein, T95I</title>
	<circle cx="1195.8" cy="961.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  G22018T  USA=3 [4.9%]  surface glycoprotein, W152C</title>
	<circle cx="1195.2" cy="923.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  A22155G  Canada=3 [37.5%]  surface glycoprotein, D198G</title>
	<circle cx="1194.6" cy="892.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  T22917G  USA=3 [4.9%]  surface glycoprotein, L452R</title>
	<circle cx="1191.7" cy="723.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  G23012A  Canada=2 [25.0%]  surface glycoprotein, E484K</title>
	<circle cx="1191.3" cy="701.9" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  A23403G  USA=61 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="614.8" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  A23403G  USA=61 [100.0%] Canada=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="614.8" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  T23599G  Canada=3 [37.5%]  surface glycoprotein, N679K</title>
	<circle cx="1189.0" cy="571.1" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  C23604A  USA=15 [24.6%]  surface glycoprotein, P681H</title>
	<circle cx="1189.0" cy="570.0" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  C23604A  USA=15 [24.6%] Canada=2 [25.0%]  surface glycoprotein, P681H</title>
	<circle cx="1189.0" cy="570.0" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  A23756G  USA=2 [3.3%]  surface glycoprotein, T732A</title>
	<circle cx="1188.4" cy="536.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  C23987T  USA=2 [3.3%]  surface glycoprotein, P809S</title>
	<circle cx="1187.5" cy="484.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  C25002T  USA=7 [11.5%]  surface glycoprotein, S1147L</title>
	<circle cx="1183.6" cy="258.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  G25088T  Canada=2 [25.0%]  surface glycoprotein, V1176F</title>
	<circle cx="1183.2" cy="239.6" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  G25244T  USA=2 [3.3%]  surface glycoprotein, V1228L</title>
	<circle cx="1182.6" cy="204.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-25 USA: 24 samples</title>
	<line x1="1200.0" y1="1180.0" x2="1200.0" y2="1173.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-25  C21648T  USA=2 [8.3%]  surface glycoprotein, T29I</title>
	<circle cx="1200.0" cy="1005.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-25  A23403G  USA=24 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1200.0" cy="614.7" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-25  G23593T  USA=2 [8.3%]  surface glycoprotein, Q677H</title>
	<circle cx="1200.0" cy="572.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-25  C23604A  USA=7 [29.2%]  surface glycoprotein, P681H</title>
	<circle cx="1200.0" cy="569.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-25  G24680T  USA=2 [8.3%]  surface glycoprotein, V1040F</title>
	<circle cx="1200.0" cy="330.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<rect x="1865" y="140" width="500" height="135" rx="15" style="fill:gainsboro;stroke-width:0;fill-opacity:0.15;" />
<text font-size="1.8em" x="1880" y="170" fill="white">Data from 15 countries in North America</text>
<text font-size="1.8em" x="1880" y="200" fill="white">Genomes/year≥10  Genomes/day≥2</text>
<text font-size="1.8em" x="1880" y="230" fill="white">461 distinct missense variants mapped</text>
<text font-size="1.8em" x="1880" y="260" fill="white">Updated 2021-01-21</text>
</svg>
